<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><title>KeiserLab Journal Blitz</title><link>keiserlab.org</link><description>Read your journals, peeps.</description><language>en-us</language><channel><item><author><name>Thuy G. Le, Abhijit Kundu, Atanu Ghoshal, Nghi H. Nguyen, Sarah Preston, Yaqing Jiao, Banfeng Ruan, Lian Xue, Fei Huang, Jennifer Keiser, Andreas Hofmann, Bill C. H. Chang, Jose Garcia-Bustos, Timothy N. C. Wells, Michael J. Palmer, Abdul Jabbar, Robin B. Gasser, Jonathan B. Baell</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_1682a2b21a3:16ebe65:56b782f7</id><published>1546837200000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01789/20190107/images/medium/jm-2018-01789s_0012.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01789&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=tH78J0_hyPk:s9Ta4X_PTwU:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/tH78J0_hyPk&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>58ee085f</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01789</link><crawled>1546895696291</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01789</href></item></canonical><engagement>0</engagement><title>[ASAP] Structure–Activity Relationship Studies of Tolfenpyrad Reveal Subnanomolar Inhibitors of Haemonchus contortus Development</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01789/20190107/images/medium/jm-2018-01789s_0012.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01789&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=tH78J0_hyPk:s9Ta4X_PTwU:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/tH78J0_hyPk&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01789</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/tH78J0_hyPk/acs.jmedchem.8b01789</href></item></alternate><visual><url>none</url></visual></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1684d5bee2a:2df15c9:3a104d3b</id><published>1547424000000</published><unread>True</unread><summary><direction>ltr</direction><content>[n]Cycloparaphenylenes, or “carbon nanohoops,” are unique conjugated macrocycles with radially oriented p-systems similar to those in carbon nanotubes. The centrosymmetric nature and conformational rigidity of these molecules lead to unusual size-dependent photophysical characteristics. To investigate these effects further and expand the family of possible structures, a new class of related carbon nanohoops with broken symmetry is disclosed. In these structures, referred to as meta[n]cycloparaphenylenes, a single carbon-carbon bond is shifted by one position in order to break the centrosymmetric nature of the parent [n]cycloparaphenylenes. Advantageously, the symmetry breaking leads to bright emission in the smaller nanohoops, which are typically non-fluorescent due to optical selection rules. Moreover, this simple structural manipulation retains one of the most unique features of the nanohoop structures-size dependent emissive properties with relatively large extinction coefficents and quantum yields. Inspired by earlier theoretical work by Tretiak and co-workers, this joint synthetic, photophysical, and theoretical study provides further design principles to manipulate the optical properties of this growing class of molecules with radially oriented p-systems.</content></summary><fingerprint>63975c52</fingerprint><link>https://chemrxiv.org/articles/Symmetry_Breaking_and_the_Turn-On_Fluorescence_of_Small_Highly_Strained_Carbon_Nanohoops/7580027</link><engagement>2</engagement><crawled>1547486096938</crawled><title>Symmetry Breaking and the Turn-On Fluorescence of Small, Highly Strained Carbon Nanohoops</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>[n]Cycloparaphenylenes, or “carbon nanohoops,” are unique conjugated macrocycles with radially oriented p-systems similar to those in carbon nanotubes. The centrosymmetric nature and conformational rigidity of these molecules lead to unusual size-dependent photophysical characteristics. To investigate these effects further and expand the family of possible structures, a new class of related carbon nanohoops with broken symmetry is disclosed. In these structures, referred to as meta[n]cycloparaphenylenes, a single carbon-carbon bond is shifted by one position in order to break the centrosymmetric nature of the parent [n]cycloparaphenylenes. Advantageously, the symmetry breaking leads to bright emission in the smaller nanohoops, which are typically non-fluorescent due to optical selection rules. Moreover, this simple structural manipulation retains one of the most unique features of the nanohoop structures-size dependent emissive properties with relatively large extinction coefficents and quantum yields. Inspired by earlier theoretical work by Tretiak and co-workers, this joint synthetic, photophysical, and theoretical study provides further design principles to manipulate the optical properties of this growing class of molecules with radially oriented p-systems.</description><originId>https://chemrxiv.org/articles/Symmetry_Breaking_and_the_Turn-On_Fluorescence_of_Small_Highly_Strained_Carbon_Nanohoops/7580027</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Symmetry_Breaking_and_the_Turn-On_Fluorescence_of_Small_Highly_Strained_Carbon_Nanohoops/7580027</href></item></alternate><visual><height>354</height><processor>feedly-nikon-v3.1</processor><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14078036/thumb.png</url><contentType>image/png</contentType><width>250</width></visual></item><item><author><name>Gabriel Popkin</name></author><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>VOCs</text></item></mentions><label>Volatile organic compound</label><id>nlp/f/entity/en/w/Volatile organic compound</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Nadine Unger</text></item><item><text>Unger</text></item></mentions><label>Nadine Unger</label><id>nlp/f/entity/en/-/nadine unger</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Ellis</text></item><item><text>Peter Ellis</text></item></mentions><label>Peter Ellis</label><id>nlp/f/entity/en/-/peter ellis</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Pangala</text></item></mentions><label>Pangala</label><id>nlp/f/entity/en/w/Pangala</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Vincent Gauci</text></item><item><text>Gauci</text></item></mentions><label>Vincent Gauci</label><id>nlp/f/entity/en/-/vincent gauci</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1685137db94:33635bb:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;How much can forests fight climate change?&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How much can forests fight climate change?, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00122-z&quot;&gt;doi:10.1038/d41586-019-00122-z&lt;/a&gt;&lt;/p&gt;Trees are supposed to slow global warming, but growing evidence suggests they might not always be climate saviours.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00122-z</href></item></alternate><published>1547539200000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00122-z/d41586-019-00122-z_16352474.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>b96f337e</fingerprint><commonTopics><item><probability>0.998</probability><label>climate</label><id>nlp/f/topic/482</id></item><item><probability>0.99</probability><label>environment</label><id>nlp/f/topic/780</id></item><item><probability>0.986</probability><label>conservation</label><id>nlp/f/topic/532</id></item><item><probability>0.943</probability><label>sustainable development</label><id>nlp/f/topic/2215</id></item><item><probability>0.86</probability><label>ted</label><id>nlp/f/topic/2261</id></item><item><probability>0.763</probability><label>wildlife</label><id>nlp/f/topic/2486</id></item><item><probability>0.763</probability><label>energy</label><id>nlp/f/topic/772</id></item><item><probability>0.753</probability><label>landscape</label><id>nlp/f/topic/1289</id></item><item><probability>0.73</probability><label>waste</label><id>nlp/f/topic/2453</id></item><item><probability>0.722</probability><label>science</label><id>nlp/f/topic/2017</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00122-z</link><engagement>21</engagement><title>How much can forests fight climate change?</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;How much can forests fight climate change?&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How much can forests fight climate change?, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00122-z&quot;&gt;doi:10.1038/d41586-019-00122-z&lt;/a&gt;&lt;/p&gt;Trees are supposed to slow global warming, but growing evidence suggests they might not always be climate saviours.</description><originId>https://www.nature.com/articles/d41586-019-00122-z</originId><crawled>1547550841748</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_16895772d2d:50494aa:ad2b6584</id><published>1548633600000</published><unread>True</unread><summary><direction>ltr</direction><content>Metal-organic framework
(MOF) glasses are a newly discovered family of melt-quenched glasses.
However, so far it is not known whether these glasses exhibit photonic
functionalities. Here, we show the discovery of the luminescent behavior of a
MOF glass, i.e., the cobalt doped zeolitic imidazolate frameworks-62 (ZIF-62)
glass (Zn1-x Cox (Im)1.9 (bIm)0.1,
x = 0, 0.1 and 0.5), which was obtained by melt-quenching its
corresponding ZIF-62 crystal. The synthesized crystal was precipitated in the
form of spherical nano/micro-crystalline structure, which collapses structurally to form laminated
glass with ultrahigh glass forming ability and the same short
range molecular structure of the parent crystalline MOF. We observed the super-broadband mid-infrared (Mid-IR) luminescence (in the
wavelength range of 1.5 µm – 4.8 µm) both in the crystalline and amorphous
phases. The observed Mid-IR emission originates from d-d transition of Co2+
ions that is protected by the strong Co-N coordination. The discovery of the luminescent glasses may
pave the way towards new photonic applications of bulk MOF glasses,
such as Mid-IR lasers.</content></summary><fingerprint>d218e80b</fingerprint><link>https://chemrxiv.org/articles/Discovery_of_Superbroad_Mid-Infrared_Luminescent_Metal-Organic_Framework_Glass/7635746</link><engagement>0</engagement><crawled>1548695842093</crawled><title>Discovery of Superbroad Mid-Infrared Luminescent Metal-Organic Framework Glass</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>Metal-organic framework
(MOF) glasses are a newly discovered family of melt-quenched glasses.
However, so far it is not known whether these glasses exhibit photonic
functionalities. Here, we show the discovery of the luminescent behavior of a
MOF glass, i.e., the cobalt doped zeolitic imidazolate frameworks-62 (ZIF-62)
glass (Zn1-x Cox (Im)1.9 (bIm)0.1,
x = 0, 0.1 and 0.5), which was obtained by melt-quenching its
corresponding ZIF-62 crystal. The synthesized crystal was precipitated in the
form of spherical nano/micro-crystalline structure, which collapses structurally to form laminated
glass with ultrahigh glass forming ability and the same short
range molecular structure of the parent crystalline MOF. We observed the super-broadband mid-infrared (Mid-IR) luminescence (in the
wavelength range of 1.5 µm – 4.8 µm) both in the crystalline and amorphous
phases. The observed Mid-IR emission originates from d-d transition of Co2+
ions that is protected by the strong Co-N coordination. The discovery of the luminescent glasses may
pave the way towards new photonic applications of bulk MOF glasses,
such as Mid-IR lasers.</description><originId>https://chemrxiv.org/articles/Discovery_of_Superbroad_Mid-Infrared_Luminescent_Metal-Organic_Framework_Glass/7635746</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Discovery_of_Superbroad_Mid-Infrared_Luminescent_Metal-Organic_Framework_Glass/7635746</href></item></alternate><visual><height>354</height><processor>feedly-nikon-v3.1</processor><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14184533/thumb.png</url><contentType>image/png</contentType><width>250</width></visual></item><item><author><name>Yingchun Cai, Hongbin Yang, Weihua Li, Guixia Liu, Philip W. Lee, Yun Tang</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>bE0mPve90xtDW7Mgx9+xm/gIKXt54qktoOvefuUy0ZI=_16839c7c8a5:1768e7:875042c9</id><published>1547096400000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00851/20190110/images/medium/ci-2018-00851d_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00851&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=WxlD9qFtk8Y:0-KUJqv4MlE:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/WxlD9qFtk8Y&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>1d6b264f</fingerprint><link>http://dx.doi.org/10.1021/acs.jcim.8b00851</link><crawled>1547157620901</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jcim.8b00851</href></item></canonical><engagement>0</engagement><title>[ASAP] Computational Prediction of Site of Metabolism for UGT-Catalyzed Reactions</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jcisd8</streamId><title>Journal of Chemical Information and Modeling: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00851/20190110/images/medium/ci-2018-00851d_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00851&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=WxlD9qFtk8Y:0-KUJqv4MlE:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/WxlD9qFtk8Y&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jcim.8b00851</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jcisd8/~3/WxlD9qFtk8Y/acs.jcim.8b00851</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Samantha R.  Edwards</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Intron</text></item><item><text>Introns</text></item></mentions><label>Intron</label><id>nlp/f/entity/en/w/Intron</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Morgan</text></item><item><text>Morgan et al</text></item></mentions><label>Morgan et al</label><id>nlp/f/entity/en/-/morgan et al</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Parenteau</text></item><item><text>Parenteau et al</text></item></mentions><label>Parenteau et al</label><id>nlp/f/entity/en/-/parenteau et al</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>messenger RNA</text></item><item><text>mRNA</text></item></mentions><label>Messenger RNA</label><id>nlp/f/entity/en/w/Messenger RNA</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>baker</text></item></mentions><label>baker</label><id>nlp/f/entity/en/-/baker</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16857ddbaa0:3dd05e3:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Intron RNA sequences help yeast cells to survive starvation&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Intron RNA sequences help yeast cells to survive starvation, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00088-y&quot;&gt;doi:10.1038/d41586-019-00088-y&lt;/a&gt;&lt;/p&gt;Intron sequences are removed from newly synthesized RNA and usually rapidly degraded. However, it now seems that introns have a surprising role — helping yeast cells survive when nutrients are scarce.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00088-y</href></item></alternate><published>1547625600000</published><unread>True</unread><visual><height>450</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00088-y/d41586-019-00088-y_16395222.jpg</url><contentType>image/jpeg</contentType><width>800</width></visual><fingerprint>12d60d4f</fingerprint><commonTopics><item><probability>1.0</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>0.973</probability><label>stem cells</label><id>nlp/f/topic/2185</id></item><item><probability>0.912</probability><label>biochemistry</label><id>nlp/f/topic/257</id></item><item><probability>0.874</probability><label>genetics</label><id>nlp/f/topic/955</id></item><item><probability>0.862</probability><label>biology</label><id>nlp/f/topic/263</id></item><item><probability>0.86</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.835</probability><label>synthetic biology</label><id>nlp/f/topic/2228</id></item><item><probability>0.83</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.796</probability><label>bioinformatics</label><id>nlp/f/topic/262</id></item><item><probability>0.713</probability><label>rationality</label><id>nlp/f/topic/1895</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00088-y</link><engagement>12</engagement><title>Intron RNA sequences help yeast cells to survive starvation</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Intron RNA sequences help yeast cells to survive starvation&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Intron RNA sequences help yeast cells to survive starvation, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00088-y&quot;&gt;doi:10.1038/d41586-019-00088-y&lt;/a&gt;&lt;/p&gt;Intron sequences are removed from newly synthesized RNA and usually rapidly degraded. However, it now seems that introns have a surprising role — helping yeast cells survive when nutrients are scarce.</description><originId>https://www.nature.com/articles/d41586-019-00088-y</originId><crawled>1547662375584</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Xia Sheng</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1687f678758:3406952:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling&lt;/b&gt;&lt;/p&gt;&lt;p&gt;IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08152-3&quot;&gt;doi:10.1038/s41467-018-08152-3&lt;/a&gt;&lt;/p&gt;ER stress and UPR are implicated in various cancers. Here, the authors show that one of the canonical UPR pathways, IRE1α-XBP1 regulates c-MYC signaling to promote prostate tumorigenesis, and pharmacological inhibition of IRE1α with MKC8866 inhibits prostate cancer growth and synergizes with clinically used prostate cancer drugs.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/1GLdyjRkMlM&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/1GLdyjRkMlM/s41467-018-08152-3</href></item></alternate><published>1548316800000</published><unread>True</unread><fingerprint>4412b0dd</fingerprint><link>https://www.nature.com/articles/s41467-018-08152-3</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08152-3</href></item></canonical><title>IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling&lt;/b&gt;&lt;/p&gt;&lt;p&gt;IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08152-3&quot;&gt;doi:10.1038/s41467-018-08152-3&lt;/a&gt;&lt;/p&gt;ER stress and UPR are implicated in various cancers. Here, the authors show that one of the canonical UPR pathways, IRE1α-XBP1 regulates c-MYC signaling to promote prostate tumorigenesis, and pharmacological inhibition of IRE1α with MKC8866 inhibits prostate cancer growth and synergizes with clinically used prostate cancer drugs.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/1GLdyjRkMlM&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-08152-3</originId><crawled>1548325717848</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Thomas Wohlfahrt</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Nat</text></item></mentions><label>Nat</label><id>nlp/f/entity/en/-/nat</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Driskell</text></item></mentions><label>Driskell</label><id>nlp/f/entity/en/-/driskell</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Br</text></item></mentions><label>Br</label><id>nlp/f/entity/en/-/br</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>H.</text></item></mentions><label>H.</label><id>nlp/f/entity/en/-/h.</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>A.</text></item></mentions><label>A.</label><id>nlp/f/entity/en/-/a.</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ff99aeb:c7ac4a:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;PU.1 controls fibroblast polarization and tissue fibrosis&lt;/b&gt;&lt;/p&gt;&lt;p&gt;PU.1 controls fibroblast polarization and tissue fibrosis, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0896-x&quot;&gt;doi:10.1038/s41586-019-0896-x&lt;/a&gt;&lt;/p&gt;The transcription factor PU.1 is an essential regulator of the pro-fibrotic gene expression program in fibroblasts; PU.1 expression is upregulated in various fibrotic diseases, whereas inactivation of PU.1 induces regression of fibrosis in a number of organs.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0896-x</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-019-0896-x/MediaObjects/41586_2019_896_Fig1_HTML.png</url><contentType>image/png</contentType><width>514</width></visual><fingerprint>96a71c8b</fingerprint><commonTopics><item><probability>1.0</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>1.0</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>0.998</probability><label>stem cells</label><id>nlp/f/topic/2185</id></item><item><probability>0.994</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.907</probability><label>neurology</label><id>nlp/f/topic/1563</id></item><item><probability>0.881</probability><label>bioinformatics</label><id>nlp/f/topic/262</id></item><item><probability>0.877</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item><item><probability>0.839</probability><label>genetics</label><id>nlp/f/topic/955</id></item><item><probability>0.73</probability><label>emergency medicine</label><id>nlp/f/topic/764</id></item></commonTopics><link>https://www.nature.com/articles/s41586-019-0896-x</link><engagement>0</engagement><title>PU.1 controls fibroblast polarization and tissue fibrosis</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;PU.1 controls fibroblast polarization and tissue fibrosis&lt;/b&gt;&lt;/p&gt;&lt;p&gt;PU.1 controls fibroblast polarization and tissue fibrosis, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0896-x&quot;&gt;doi:10.1038/s41586-019-0896-x&lt;/a&gt;&lt;/p&gt;The transcription factor PU.1 is an essential regulator of the pro-fibrotic gene expression program in fibroblasts; PU.1 expression is upregulated in various fibrotic diseases, whereas inactivation of PU.1 induces regression of fibrosis in a number of organs.</description><originId>https://www.nature.com/articles/s41586-019-0896-x</originId><crawled>1548872162027</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Jordan J. Clark</name></author><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_168a01c7caf:45eeb:875042c9</id><content><direction>ltr</direction><content>&lt;p&gt;by Jordan J. Clark, Mark L. Benson, Richard D. Smith, Heather A. Carlson&lt;/p&gt;
Understanding how ligand binding influences protein flexibility is important, especially in rational drug design. Protein flexibility upon ligand binding is analyzed herein using 305 proteins with 2369 crystal structures with ligands (holo) and 1679 without (apo). Each protein has at least two apo and two holo structures for analysis. The inherent variation in structures with and without ligands is first established as a baseline. This baseline is then compared to the change in conformation in going from the apo to holo states to probe induced flexibility. The inherent backbone flexibility across the apo structures is roughly the same as the variation across holo structures. The induced backbone flexibility across apo-holo pairs is larger than that of the apo or holo states, but the increase in RMSD is less than 0.5Å. Analysis of χ&lt;sub&gt;1&lt;/sub&gt; angles revealed a distinctly different pattern with significant influences seen for ligand binding on side-chain conformations in the binding site. Within the apo and holo states themselves, the variation of the χ&lt;sub&gt;1&lt;/sub&gt; angles is the same. However, the data combining both apo and holo states show significant displacements. Upon ligand binding, χ&lt;sub&gt;1&lt;/sub&gt; angles are frequently pushed to new orientations outside the range seen in the apo states. Influences on binding site variation could not be easily attributed to features such as ligand size or x-ray structure resolution. By combining these findings, we find that most binding site flexibility is compatible with the common practice in flexible docking, where backbones are kept rigid and side chains are allowed some degree of flexibility.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/gUvhEfpxopQ&quot; height=&quot;1&quot;&gt;</content></content><updateCount>1</updateCount><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/gUvhEfpxopQ/article</href></item></alternate><published>1548885600000</published><unread>True</unread><fingerprint>daa3c8fb</fingerprint><link>10.1371/journal.pcbi.1006705</link><recrawled>1548883625992</recrawled><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006705</href></item></canonical><updated>1548885600000</updated><engagement>0</engagement><title>Inherent versus induced protein flexibility: Comparisons within and between apo and holo structures</title><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><description>&lt;p&gt;by Jordan J. Clark, Mark L. Benson, Richard D. Smith, Heather A. Carlson&lt;/p&gt;
Understanding how ligand binding influences protein flexibility is important, especially in rational drug design. Protein flexibility upon ligand binding is analyzed herein using 305 proteins with 2369 crystal structures with ligands (holo) and 1679 without (apo). Each protein has at least two apo and two holo structures for analysis. The inherent variation in structures with and without ligands is first established as a baseline. This baseline is then compared to the change in conformation in going from the apo to holo states to probe induced flexibility. The inherent backbone flexibility across the apo structures is roughly the same as the variation across holo structures. The induced backbone flexibility across apo-holo pairs is larger than that of the apo or holo states, but the increase in RMSD is less than 0.5Å. Analysis of χ&lt;sub&gt;1&lt;/sub&gt; angles revealed a distinctly different pattern with significant influences seen for ligand binding on side-chain conformations in the binding site. Within the apo and holo states themselves, the variation of the χ&lt;sub&gt;1&lt;/sub&gt; angles is the same. However, the data combining both apo and holo states show significant displacements. Upon ligand binding, χ&lt;sub&gt;1&lt;/sub&gt; angles are frequently pushed to new orientations outside the range seen in the apo states. Influences on binding site variation could not be easily attributed to features such as ligand size or x-ray structure resolution. By combining these findings, we find that most binding site flexibility is compatible with the common practice in flexible docking, where backbones are kept rigid and side chains are allowed some degree of flexibility.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/gUvhEfpxopQ&quot; height=&quot;1&quot;&gt;</description><originId>10.1371/journal.pcbi.1006705</originId><crawled>1548874448047</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Stefano Sainas, Agnese C. Pippione, Elisa Lupino, Marta Giorgis, Paola Circosta, Valentina Gaidano, Parveen Goyal, Davide Bonanni, Barbara Rolando, Alessandro Cignetti, Alex Ducime, Mikael Andersson, Michael Järvå, Rosmarie Friemann, Marco Piccinini, Cristina Ramondetti, Barbara Buccinnà, Salam Al-Karadaghi, Donatella Boschi, Giuseppe Saglio, Marco L. Lolli</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_1689b7bb332:2c61639:56b782f7</id><published>1548738000000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.9b00057&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=KPru3ePij3w:h2DIbi63hfs:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/KPru3ePij3w&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>f5b2fe2f</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.9b00057</link><crawled>1548796801842</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.9b00057</href></item></canonical><engagement>0</engagement><title>[ASAP] Correction to Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.9b00057&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=KPru3ePij3w:h2DIbi63hfs:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/KPru3ePij3w&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.9b00057</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/KPru3ePij3w/acs.jmedchem.9b00057</href></item></alternate><visual><url>none</url></visual></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_168385a4668:136b961:c2ce2e2e</id><published>1547078400000</published><unread>True</unread><summary><direction>ltr</direction><content>L-Proline
is an important amino acid for the pathogenic protists belonging to Trypanosoma
and Leishmania genera. In Trypanosoma cruzi, the etiological
agent of Chagas disease, this amino acid is involved in fundamental biological
processes such as ATP production, differentiation of the insect and
intracellular stages, the host cell infection and the resistance to a variety
of stresses, including nutritional and osmotic as well as oxidative imbalance.
In this study, we explore the L-Proline uptake as a chemotherapeutic target for
T. cruzi. For this, we propose a novel rational to design inhibitors
containing this amino acid as a recognizable motif. This rational consists of
conjugating the amino acid (proline in this case) to a linker and a variable
region able to block the transporter. We obtained a series of sixteen 1,2,3-triazolyl-proline
derivatives through alkylation and copper(I)-catalyzed azide-alkyne cycloaddition
(click chemistry) for in vitro screening against T. cruzi epimastigotes,
trypanocidal activity and proline uptake. We successfully obtained inhibitors
that are able to interfere with the amino acid uptake, which validated the
first example of a rationally designed chemotherapeutic agent targeting a
metabolite&apos;s transport. Additionally, we designed and prepared fluorescent
analogues of the inhibitors that were successfully taken up by T. cruzi, allowing following up their intracellular
fate. In conclusion, we successfully designed and produced a series of
metabolite uptake inhibitors. This is one of few examples of rationally designed
amino acid transporter inhibitor, being the first case where the strategy is
applied on the development of chemotherapy against Chagas disease. This
unprecedented development is remarkable having in mind that only a small
percent of the metabolite transporters has been studied at the structural
and/or molecular level.</content></summary><fingerprint>75c2f983</fingerprint><link>https://chemrxiv.org/articles/Rationally_Design_of_a_Proline_Transporter_Inhibitor_with_Anti-Trypanosoma_Cruzi_Activity/7564991</link><engagement>0</engagement><crawled>1547133666920</crawled><title>Rationally Design of a Proline Transporter Inhibitor with Anti-Trypanosoma Cruzi Activity</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>L-Proline
is an important amino acid for the pathogenic protists belonging to Trypanosoma
and Leishmania genera. In Trypanosoma cruzi, the etiological
agent of Chagas disease, this amino acid is involved in fundamental biological
processes such as ATP production, differentiation of the insect and
intracellular stages, the host cell infection and the resistance to a variety
of stresses, including nutritional and osmotic as well as oxidative imbalance.
In this study, we explore the L-Proline uptake as a chemotherapeutic target for
T. cruzi. For this, we propose a novel rational to design inhibitors
containing this amino acid as a recognizable motif. This rational consists of
conjugating the amino acid (proline in this case) to a linker and a variable
region able to block the transporter. We obtained a series of sixteen 1,2,3-triazolyl-proline
derivatives through alkylation and copper(I)-catalyzed azide-alkyne cycloaddition
(click chemistry) for in vitro screening against T. cruzi epimastigotes,
trypanocidal activity and proline uptake. We successfully obtained inhibitors
that are able to interfere with the amino acid uptake, which validated the
first example of a rationally designed chemotherapeutic agent targeting a
metabolite&apos;s transport. Additionally, we designed and prepared fluorescent
analogues of the inhibitors that were successfully taken up by T. cruzi, allowing following up their intracellular
fate. In conclusion, we successfully designed and produced a series of
metabolite uptake inhibitors. This is one of few examples of rationally designed
amino acid transporter inhibitor, being the first case where the strategy is
applied on the development of chemotherapy against Chagas disease. This
unprecedented development is remarkable having in mind that only a small
percent of the metabolite transporters has been studied at the structural
and/or molecular level.</description><originId>https://chemrxiv.org/articles/Rationally_Design_of_a_Proline_Transporter_Inhibitor_with_Anti-Trypanosoma_Cruzi_Activity/7564991</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Rationally_Design_of_a_Proline_Transporter_Inhibitor_with_Anti-Trypanosoma_Cruzi_Activity/7564991</href></item></alternate></item><item><author><name>Lavine, M. S.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a6a:c2ce2e2e</id><published>1548355045000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>a1d0d20b</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6425/361-a?rss=1</link><engagement>0</engagement><crawled>1548357093757</crawled><title>Guided growth for spinal injury repair</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6425/361-a?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/361-a?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6425/361.1.full</canonicalUrl></item><item><author><name>Baptiste Rode</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_16893f8a5a8:4dee28d:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;TRPC5 ion channel permeation promotes weight gain in hypercholesterolaemic mice&lt;/b&gt;&lt;/p&gt;&lt;p&gt;TRPC5 ion channel permeation promotes weight gain in hypercholesterolaemic mice, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37299-8&quot;&gt;doi:10.1038/s41598-018-37299-8&lt;/a&gt;&lt;/p&gt;TRPC5 ion channel permeation promotes weight gain in hypercholesterolaemic mice&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Y_j3hq6nnZ8&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/Y_j3hq6nnZ8/s41598-018-37299-8</href></item></alternate><published>1548662400000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37299-8/MediaObjects/41598_2018_37299_Fig1_HTML.png</url><contentType>image/png</contentType><width>623</width></visual><fingerprint>a794a9a6</fingerprint><link>https://www.nature.com/articles/s41598-018-37299-8</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37299-8</href></item></canonical><title>TRPC5 ion channel permeation promotes weight gain in hypercholesterolaemic mice</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;TRPC5 ion channel permeation promotes weight gain in hypercholesterolaemic mice&lt;/b&gt;&lt;/p&gt;&lt;p&gt;TRPC5 ion channel permeation promotes weight gain in hypercholesterolaemic mice, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37299-8&quot;&gt;doi:10.1038/s41598-018-37299-8&lt;/a&gt;&lt;/p&gt;TRPC5 ion channel permeation promotes weight gain in hypercholesterolaemic mice&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Y_j3hq6nnZ8&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-37299-8</originId><crawled>1548670772648</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Flora Graham</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>min</text></item></mentions><label>min</label><id>nlp/f/entity/en/-/min</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Hello Nature</text></item></mentions><label>Hello Nature</label><id>nlp/f/entity/en/-/hello nature</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Getty</text></item></mentions><label>Getty Images</label><id>nlp/f/entity/en/w/Getty Images</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Alex Edelman</text></item></mentions><label>Alex Edelman</label><id>nlp/f/entity/en/-/alex edelman</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>UNESCO</text></item></mentions><label>UNESCO</label><id>nlp/f/entity/en/w/UNESCO</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689548d15d:4ffa2c3:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Daily briefing: How to run a 500-year experiment&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Daily briefing: How to run a 500-year experiment, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00328-1&quot;&gt;doi:10.1038/d41586-019-00328-1&lt;/a&gt;&lt;/p&gt;First, assume that science still exists. Plus: the unsung women behind the periodic table and scientists respond to the end of the US shutdown.</content></content><engagementRate>0.11</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00328-1</href></item></alternate><published>1548662400000</published><unread>True</unread><visual><height>393</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00328-1/d41586-019-00328-1_16112928.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>fa89c613</fingerprint><commonTopics><item><probability>0.986</probability><label>wildlife</label><id>nlp/f/topic/2486</id></item><item><probability>0.966</probability><label>conservation</label><id>nlp/f/topic/532</id></item><item><probability>0.805</probability><label>current affairs</label><id>nlp/f/topic/600</id></item><item><probability>0.77</probability><label>food</label><id>nlp/f/topic/890</id></item><item><probability>0.767</probability><label>science policy</label><id>nlp/f/topic/2019</id></item><item><probability>0.751</probability><label>anarchism</label><id>nlp/f/topic/91</id></item><item><probability>0.711</probability><label>singularity</label><id>nlp/f/topic/2074</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00328-1</link><engagement>1</engagement><title>Daily briefing: How to run a 500-year experiment</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Daily briefing: How to run a 500-year experiment&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Daily briefing: How to run a 500-year experiment, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00328-1&quot;&gt;doi:10.1038/d41586-019-00328-1&lt;/a&gt;&lt;/p&gt;First, assume that science still exists. Plus: the unsung women behind the periodic table and scientists respond to the end of the US shutdown.</description><originId>https://www.nature.com/articles/d41586-019-00328-1</originId><crawled>1548692803933</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Niek van Hilten, Florent Chevillard, Peter Kolb</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>bE0mPve90xtDW7Mgx9+xm/gIKXt54qktoOvefuUy0ZI=_16880d96ad6:94796:875042c9</id><published>1548306000000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00737/20190124/images/medium/ci-2018-00737a_0003.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00737&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=B_2DwJ9RIjc:cy9JoqEGaxY:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/B_2DwJ9RIjc&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>ca464c37</fingerprint><link>http://dx.doi.org/10.1021/acs.jcim.8b00737</link><crawled>1548349958870</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jcim.8b00737</href></item></canonical><engagement>0</engagement><title>[ASAP] Virtual Compound Libraries in Computer-Assisted Drug Discovery</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jcisd8</streamId><title>Journal of Chemical Information and Modeling: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00737/20190124/images/medium/ci-2018-00737a_0003.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00737&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=B_2DwJ9RIjc:cy9JoqEGaxY:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/B_2DwJ9RIjc&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jcim.8b00737</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jcisd8/~3/B_2DwJ9RIjc/acs.jcim.8b00737</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Kelly A. Bachovchin, Amrita Sharma, Seema Bag, Dana M. Klug, Katherine M. Schneider, Baljinder Singh, Hitesh B. Jalani, Melissa J. Buskes, Naimee Mehta, Scott Tanghe, Jeremiah D. Momper, Richard J. Sciotti, Ana Rodriguez, Kojo Mensa-Wilmot, Michael P. Pollastri, Lori Ferrins</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_16838d9f7a3:1402b0c:b77f238b</id><published>1547096400000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01365/20190110/images/medium/jm-2018-01365z_0017.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01365&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=tyX6Acjzcac:JZuqcqfJQns:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/tyX6Acjzcac&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>31b52c4</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01365</link><crawled>1547142035363</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01365</href></item></canonical><engagement>0</engagement><title>[ASAP] Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug Development</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01365/20190110/images/medium/jm-2018-01365z_0017.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01365&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=tyX6Acjzcac:JZuqcqfJQns:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/tyX6Acjzcac&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01365</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/tyX6Acjzcac/acs.jmedchem.8b01365</href></item></alternate><visual><url>none</url></visual></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1687650ea7b:2671250:3a104d3b</id><published>1548115200000</published><unread>True</unread><summary><direction>ltr</direction><content>A conjugated β-triketone, tris(2-naphthoyl)methane (tnmH), has been synthesized and successfully utilized as an antenna moiety for sensitization of the trivalent lanthanoids Eu3+,Sm3+,Yb3+and Nd3+, in an isomorphous series of mononuclear complexes formulated as [Ln(tnm)3(DMSO)2] (Ln3+ = Nd3+, Sm3+, Eu3+, Gd3+and Yb3+). The photophysical properties of the materials were characterized as comprehensively as possible, with overall quantum yields, intrinsic quantum yields based on calculated radiative decays, and sensitization efficiencies reported. This investigation improves understanding of the sensitization processes occurring in the near-infrared (NIR) region systems in particular, where quantitative data is currently scarce. In fact, the [Yb(tnm)3(DMSO)2] and its deuterated analogue, [Yb(tnm)3(d6-DMSO)2], present high values of overall quantum yield of 4% and 6%, respectively, which makes them useful and readily accessible references for future investigation of NIR-emitting systems.</content></summary><fingerprint>dd76edce</fingerprint><link>https://chemrxiv.org/articles/Photophysical_Investigation_of_near_Infrared_Emitting_Lanthanoid_Complexes_Incorporating_Tris_2-Naphthoyl_methane_as_a_New_Antenna_Ligand/7611188</link><engagement>0</engagement><crawled>1548173240955</crawled><title>Photophysical Investigation of near Infrared Emitting Lanthanoid Complexes Incorporating Tris(2-Naphthoyl)methane as a New Antenna Ligand</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>A conjugated β-triketone, tris(2-naphthoyl)methane (tnmH), has been synthesized and successfully utilized as an antenna moiety for sensitization of the trivalent lanthanoids Eu3+,Sm3+,Yb3+and Nd3+, in an isomorphous series of mononuclear complexes formulated as [Ln(tnm)3(DMSO)2] (Ln3+ = Nd3+, Sm3+, Eu3+, Gd3+and Yb3+). The photophysical properties of the materials were characterized as comprehensively as possible, with overall quantum yields, intrinsic quantum yields based on calculated radiative decays, and sensitization efficiencies reported. This investigation improves understanding of the sensitization processes occurring in the near-infrared (NIR) region systems in particular, where quantitative data is currently scarce. In fact, the [Yb(tnm)3(DMSO)2] and its deuterated analogue, [Yb(tnm)3(d6-DMSO)2], present high values of overall quantum yield of 4% and 6%, respectively, which makes them useful and readily accessible references for future investigation of NIR-emitting systems.</description><originId>https://chemrxiv.org/articles/Photophysical_Investigation_of_near_Infrared_Emitting_Lanthanoid_Complexes_Incorporating_Tris_2-Naphthoyl_methane_as_a_New_Antenna_Ligand/7611188</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Photophysical_Investigation_of_near_Infrared_Emitting_Lanthanoid_Complexes_Incorporating_Tris_2-Naphthoyl_methane_as_a_New_Antenna_Ligand/7611188</href></item></alternate></item><item><author><name>Jeff Tollefson</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Madagascar</text></item></mentions><label>Madagascar</label><id>nlp/f/entity/en/w/Madagascar</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Rajoelina</text></item><item><text>Andry Rajoelina</text></item></mentions><label>Andry Rajoelina</label><id>nlp/f/entity/en/w/Andry Rajoelina</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Panos</text></item></mentions><label>Panos</label><id>nlp/f/entity/en/-/panos</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Jonah Ratsimbazafy</text></item><item><text>Ratsimbazafy</text></item></mentions><label>Jonah Ratsimbazafy</label><id>nlp/f/entity/en/-/jonah ratsimbazafy</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Pascal Maitre</text></item></mentions><label>Pascal Maitre</label><id>nlp/f/entity/en/-/pascal maitre</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16861b1404e:c83dc3:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Fate of Madagascar&apos;s forests in the hands of incoming president&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Fate of Madagascar&apos;s forests in the hands of incoming president, Published online: 18 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00189-8&quot;&gt;doi:10.1038/d41586-019-00189-8&lt;/a&gt;&lt;/p&gt;Andry Rajoelina has a spotty record on environmental regulation and conservation.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00189-8</href></item></alternate><published>1547798400000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00189-8/d41586-019-00189-8_16400484.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>b851c4d5</fingerprint><commonTopics><item><probability>1.0</probability><label>conservation</label><id>nlp/f/topic/532</id></item><item><probability>0.985</probability><label>wildlife</label><id>nlp/f/topic/2486</id></item><item><probability>0.866</probability><label>waste</label><id>nlp/f/topic/2453</id></item><item><probability>0.864</probability><label>ted</label><id>nlp/f/topic/2261</id></item><item><probability>0.852</probability><label>south africa</label><id>nlp/f/topic/2136</id></item><item><probability>0.844</probability><label>africa</label><id>nlp/f/topic/47</id></item><item><probability>0.777</probability><label>corruption</label><id>nlp/f/topic/551</id></item><item><probability>0.711</probability><label>culture</label><id>nlp/f/topic/597</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00189-8</link><engagement>9</engagement><title>Fate of Madagascar&apos;s forests in the hands of incoming president</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Fate of Madagascar&apos;s forests in the hands of incoming president&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Fate of Madagascar&apos;s forests in the hands of incoming president, Published online: 18 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00189-8&quot;&gt;doi:10.1038/d41586-019-00189-8&lt;/a&gt;&lt;/p&gt;Andry Rajoelina has a spotty record on environmental regulation and conservation.</description><originId>https://www.nature.com/articles/d41586-019-00189-8</originId><crawled>1547827232846</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Schneditz, G., Elias, J. E., Pagano, E., Zaeem Cader, M., Saveljeva, S., Long, K., Mukhopadhyay, S., Arasteh, M., Lawley, T. D., Dougan, G., Bassett, A., Karlsen, T. H., Kaser, A., Kaneider, N. C.</name></author><id>RuJRIXzN26JgDGk9YhlIBfh4YrPi0r+1c4exm9G1IBw=_1680ada2f60:5c7ce35:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;The sodium potassium pump (Na/K-ATPase) ensures the electrochemical gradient of a cell through an energy-dependent process that consumes about one-third of regenerated ATP. We report that the G protein–coupled receptor GPR35 interacted with the α chain of Na/K-ATPase and promotes its ion transport and Src signaling activity in a ligand-independent manner. Deletion of Gpr35 increased baseline Ca&lt;sup&gt;2+&lt;/sup&gt; to maximal levels and reduced Src activation and overall metabolic activity in macrophages and intestinal epithelial cells (IECs). In contrast, a common T108M polymorphism in GPR35 was hypermorphic and had the opposite effects to Gpr35 deletion on Src activation and metabolic activity. The T108M polymorphism is associated with ulcerative colitis and primary sclerosing cholangitis, inflammatory diseases with a high cancer risk. GPR35 promoted homeostatic IEC turnover, whereas Gpr35 deletion or inhibition by a selective pepducin prevented inflammation-associated and spontaneous intestinal tumorigenesis in mice. Thus, GPR35 acts as a central signaling and metabolic pacesetter, which reveals an unexpected role of Na/K-ATPase in macrophage and IEC biology.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stke.sciencemag.org/cgi/content/short/12/562/eaau9048?rss=1</href></item></alternate><published>1546368670000</published><unread>True</unread><fingerprint>f6733896</fingerprint><link>http://stke.sciencemag.org/cgi/content/short/12/562/eaau9048?rss=1</link><engagement>0</engagement><title>GPR35 promotes glycolysis, proliferation, and oncogenic signaling by engaging with the sodium potassium pump</title><origin><htmlUrl>http://stke.sciencemag.org</htmlUrl><streamId>feed/http://stke.sciencemag.org/rss/current.xml</streamId><title>Science Signaling current issue</title></origin><description>&lt;p&gt;The sodium potassium pump (Na/K-ATPase) ensures the electrochemical gradient of a cell through an energy-dependent process that consumes about one-third of regenerated ATP. We report that the G protein–coupled receptor GPR35 interacted with the α chain of Na/K-ATPase and promotes its ion transport and Src signaling activity in a ligand-independent manner. Deletion of Gpr35 increased baseline Ca&lt;sup&gt;2+&lt;/sup&gt; to maximal levels and reduced Src activation and overall metabolic activity in macrophages and intestinal epithelial cells (IECs). In contrast, a common T108M polymorphism in GPR35 was hypermorphic and had the opposite effects to Gpr35 deletion on Src activation and metabolic activity. The T108M polymorphism is associated with ulcerative colitis and primary sclerosing cholangitis, inflammatory diseases with a high cancer risk. GPR35 promoted homeostatic IEC turnover, whereas Gpr35 deletion or inhibition by a selective pepducin prevented inflammation-associated and spontaneous intestinal tumorigenesis in mice. Thus, GPR35 acts as a central signaling and metabolic pacesetter, which reveals an unexpected role of Na/K-ATPase in macrophage and IEC biology.&lt;/p&gt;</description><originId>http://stke.sciencemag.org/cgi/content/short/12/562/eaau9048?rss=1</originId><crawled>1546370297696</crawled><canonicalUrl>http://stke.sciencemag.org/content/12/562/eaau9048.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Grocholski, B.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168a5541f68:1508099:3a104d3b</id><published>1548959829000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>f5600f89</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6426/495-g?rss=1</link><engagement>0</engagement><crawled>1548961980264</crawled><title>Surface-driven phase coexistence</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6426/495-g?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6426/495-g?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6426/495.7.full</canonicalUrl></item><item><author><name>Simon Wang</name></author><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>Getty</text></item></mentions><label>Getty Images</label><id>nlp/f/entity/en/w/Getty Images</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Google</text></item></mentions><label>Google</label><id>nlp/f/entity/en/w/Google</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>English</text></item></mentions><label>English language</label><id>nlp/f/entity/en/w/English language</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Zotero</text></item></mentions><label>Zotero</label><id>nlp/f/entity/en/w/Zotero</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>source : Nature</text></item></mentions><label>source : Nature</label><id>nlp/f/entity/en/-/source : nature</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168a04983a3:cb0469:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;How to write effectively for international journals&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How to write effectively for international journals, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00359-8&quot;&gt;doi:10.1038/d41586-019-00359-8&lt;/a&gt;&lt;/p&gt;Use modern tools to manage research literature, analyse published articles and find language teachers to improve manuscripts for publication.</content></content><engagementRate>1.5</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00359-8</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00359-8/d41586-019-00359-8_16430148.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>b3ae1985</fingerprint><commonTopics><item><probability>0.993</probability><label>research</label><id>nlp/f/topic/1931</id></item><item><probability>0.935</probability><label>phd</label><id>nlp/f/topic/1737</id></item><item><probability>0.897</probability><label>academic</label><id>nlp/f/topic/17</id></item><item><probability>0.891</probability><label>cybercrime</label><id>nlp/f/topic/603</id></item><item><probability>0.843</probability><label>political science</label><id>nlp/f/topic/1789</id></item><item><probability>0.817</probability><label>sociology</label><id>nlp/f/topic/2122</id></item><item><probability>0.809</probability><label>writing</label><id>nlp/f/topic/2514</id></item><item><probability>0.792</probability><label>wildlife</label><id>nlp/f/topic/2486</id></item><item><probability>0.749</probability><label>elt</label><id>nlp/f/topic/756</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00359-8</link><engagement>12</engagement><title>How to write effectively for international journals</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;How to write effectively for international journals&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How to write effectively for international journals, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00359-8&quot;&gt;doi:10.1038/d41586-019-00359-8&lt;/a&gt;&lt;/p&gt;Use modern tools to manage research literature, analyse published articles and find language teachers to improve manuscripts for publication.</description><originId>https://www.nature.com/articles/d41586-019-00359-8</originId><crawled>1548877398947</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Rachel M. Vaden, Katrin P. Guillen, Justin M. Salvant, Celine B. Santiago, Joseph B. Gibbons, Satya S. Pathi, Sasi Arunachalam, Matthew S. Sigman, Ryan E. Looper, Bryan E. Welm</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>ofNPcmQ46PpGzt1nO49W9STAvkUsM7jssLxNXMp09ME=_1682f5fbe1d:67b6cb:b77f238b</id><published>1546923600000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b00977/20190108/images/medium/cb-2018-009772_0009.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b00977&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=wqSQWI7z3Ns:u_rTy4Q7_JA:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/wqSQWI7z3Ns&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>ad41f2ce</fingerprint><link>http://dx.doi.org/10.1021/acschembio.8b00977</link><crawled>1546983030301</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acschembio.8b00977</href></item></canonical><engagement>0</engagement><title>[ASAP] A Cancer-Selective Zinc Ionophore Inspired by the Natural Product Naamidine A</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acbcct</streamId><title>ACS Chemical Biology: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b00977/20190108/images/medium/cb-2018-009772_0009.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b00977&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=wqSQWI7z3Ns:u_rTy4Q7_JA:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/wqSQWI7z3Ns&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acschembio.8b00977</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/acbcct/~3/wqSQWI7z3Ns/acschembio.8b00977</href></item></alternate><visual><url>none</url></visual></item><item><author><name>M. Teresa Villanueva</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Springer Nature Limited</text></item></mentions><label>Springer Nature Limited</label><id>nlp/f/entity/en/-/springer nature limited</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>ADAR1</text></item><item><text>Adar1</text></item></mentions><label>ADAR</label><id>nlp/f/entity/en/w/ADAR</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>ISG</text></item></mentions><label>ISG</label><id>nlp/f/entity/en/-/isg</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>dsRNA</text></item></mentions><label>RNA</label><id>nlp/f/entity/en/w/RNA</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Haining</text></item><item><text>Nicholas Haining</text></item></mentions><label>Nicholas Haining</label><id>nlp/f/entity/en/-/nicholas haining</id></item></entities><id>YLwIhSxZAzQIEnJq1FGGcXUQMCbQUlr9cyNMExMVeyY=_16837c7ea2c:12d0a2d:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Unmasking cancer cell character&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Unmasking cancer cell character, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41573-019-00005-y&quot;&gt;doi:10.1038/d41573-019-00005-y&lt;/a&gt;&lt;/p&gt;Unmasking cancer cell character&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/aATjR3By4gc&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nrd/rss/current/~3/aATjR3By4gc/d41573-019-00005-y</href></item></alternate><published>1547107200000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>413d3b85</fingerprint><commonTopics><item><probability>0.986</probability><label>cancer</label><id>nlp/f/topic/377</id></item><item><probability>0.922</probability><label>biology</label><id>nlp/f/topic/263</id></item><item><probability>0.908</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.848</probability><label>biochemistry</label><id>nlp/f/topic/257</id></item><item><probability>0.805</probability><label>hematology</label><id>nlp/f/topic/1058</id></item><item><probability>0.75</probability><label>cell</label><id>nlp/f/topic/403</id></item></commonTopics><link>https://www.nature.com/articles/d41573-019-00005-y</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/d41573-019-00005-y</href></item></canonical><title>Unmasking cancer cell character</title><origin><htmlUrl>http://feeds.nature.com/nrd/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nrd/rss/current</streamId><title>Nature Reviews Drug Discovery - Issue - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Unmasking cancer cell character&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Unmasking cancer cell character, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41573-019-00005-y&quot;&gt;doi:10.1038/d41573-019-00005-y&lt;/a&gt;&lt;/p&gt;Unmasking cancer cell character&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/aATjR3By4gc&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/d41573-019-00005-y</originId><crawled>1547124075052</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><engagement>0</engagement><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_1685e8483fd:112c06:1451c985</id><author><name>NA</name></author><published>1547701200000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01733/20190117/images/medium/jm-2018-01733s_0011.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01733&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=uSA0vj915Ps:bnswbHeqfWk:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/uSA0vj915Ps&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>43bd0c58</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01733</link><crawled>1547773969405</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01733</href></item></canonical><title>[ASAP] Discovery of (R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4-b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3H)-one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological Malignancies</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01733/20190117/images/medium/jm-2018-01733s_0011.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01733&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=uSA0vj915Ps:bnswbHeqfWk:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/uSA0vj915Ps&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01733</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/uSA0vj915Ps/acs.jmedchem.8b01733</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Yifang Ma</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Linda Buck</text></item></mentions><label>Linda B. Buck</label><id>nlp/f/entity/en/w/Linda B. Buck</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>SI</text></item></mentions><label>SI</label><id>nlp/f/entity/en/-/si</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Richard Axel</text></item></mentions><label>Richard Axel</label><id>nlp/f/entity/en/w/Richard Axel</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Nobel</text></item><item><text>Nobel Prize in Medicine or Physiology</text></item></mentions><label>Nobel Prize in Medicine or Physiology</label><id>nlp/f/entity/en/-/nobel prize in medicine or physiology</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Science</text></item></mentions><label>Science</label><id>nlp/f/entity/en/w/Science</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168576e9aeb:3ddde37:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Women who win prizes get less money and prestige&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Women who win prizes get less money and prestige, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00091-3&quot;&gt;doi:10.1038/d41586-019-00091-3&lt;/a&gt;&lt;/p&gt;A new analysis of biomedical awards over five decades shows men receive more cash and more respect for their research than women do, report Brian Uzzi and colleagues.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00091-3</href></item></alternate><published>1547625600000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00091-3/d41586-019-00091-3_16387246.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>44553d7</fingerprint><commonTopics><item><probability>0.932</probability><label>women</label><id>nlp/f/topic/2498</id></item><item><probability>0.81</probability><label>feminism</label><id>nlp/f/topic/850</id></item><item><probability>0.77</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00091-3</link><engagement>6</engagement><title>Women who win prizes get less money and prestige</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Women who win prizes get less money and prestige&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Women who win prizes get less money and prestige, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00091-3&quot;&gt;doi:10.1038/d41586-019-00091-3&lt;/a&gt;&lt;/p&gt;A new analysis of biomedical awards over five decades shows men receive more cash and more respect for their research than women do, report Brian Uzzi and colleagues.</description><originId>https://www.nature.com/articles/d41586-019-00091-3</originId><crawled>1547655092971</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Johansen, N.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1687e6d7cf8:32a6ddc:3a104d3b</id><content><direction>ltr</direction><content>scRNA-seq dataset integration occurs in different contexts, such as the identification of cell type-specific differences in gene expression across conditions or species, or batch effect correction. We present scAlign, an unsupervised deep learning method for data integration that can incorporate partial, overlapping or a complete set of cell labels, and estimate per-cell differences in gene expression across datasets. scAlign performance is state-of-the-art and robust to cross-dataset variation in cell type-specific expression and cell type composition. We demonstrate that scAlign identifies a rare cell population likely to drive malaria transmission. Our framework is widely applicable to integration challenges in other domains.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/504944v2?rss=1</href></item></alternate><published>1548230400000</published><unread>True</unread><fingerprint>a620167f</fingerprint><link>http://biorxiv.org/cgi/content/short/504944v2?rss=1</link><engagement>0</engagement><title>scAlign: a tool for alignment, integration and rare cell identification from scRNA-seq data [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>scRNA-seq dataset integration occurs in different contexts, such as the identification of cell type-specific differences in gene expression across conditions or species, or batch effect correction. We present scAlign, an unsupervised deep learning method for data integration that can incorporate partial, overlapping or a complete set of cell labels, and estimate per-cell differences in gene expression across datasets. scAlign performance is state-of-the-art and robust to cross-dataset variation in cell type-specific expression and cell type composition. We demonstrate that scAlign identifies a rare cell population likely to drive malaria transmission. Our framework is widely applicable to integration challenges in other domains.</description><originId>http://biorxiv.org/cgi/content/short/504944v2?rss=1</originId><crawled>1548309331192</crawled><canonicalUrl>https://www.biorxiv.org/content/10.1101/504944v2</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Niccolò Tempini</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Nature 563</text></item></mentions><label>Nature 563</label><id>nlp/f/entity/en/-/nature 563</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Soc</text></item></mentions><label>Soc</label><id>nlp/f/entity/en/-/soc</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>N.T</text></item></mentions><label>N.T</label><id>nlp/f/entity/en/-/n.t</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>PatientsLikeMe</text></item></mentions><label>PatientsLikeMe</label><id>nlp/f/entity/en/w/PatientsLikeMe</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>N. Tempini</text></item></mentions><label>N. Tempini</label><id>nlp/f/entity/en/-/n. tempini</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1687ad367a0:2d3ea75:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Patients’ online interventions can scupper clinical trials&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Patients’ online interventions can scupper clinical trials, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00229-3&quot;&gt;doi:10.1038/d41586-019-00229-3&lt;/a&gt;&lt;/p&gt;Patients’ online interventions can scupper clinical trials</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00229-3</href></item></alternate><published>1548230400000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>b240134</fingerprint><commonTopics><item><probability>0.798</probability><label>culture</label><id>nlp/f/topic/597</id></item><item><probability>0.738</probability><label>ethics</label><id>nlp/f/topic/803</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00229-3</link><engagement>1</engagement><title>Patients’ online interventions can scupper clinical trials</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Patients’ online interventions can scupper clinical trials&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Patients’ online interventions can scupper clinical trials, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00229-3&quot;&gt;doi:10.1038/d41586-019-00229-3&lt;/a&gt;&lt;/p&gt;Patients’ online interventions can scupper clinical trials</description><originId>https://www.nature.com/articles/d41586-019-00229-3</originId><crawled>1548248901536</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Derek Lowe</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>2k24/TFePIh3MUUJr/vqRk++EkKG/RZ2TtOvsKiJXX4=_1689f364026:b316ff:3a104d3b</id><unread>True</unread><fingerprint>83d8f2fb</fingerprint><origin><htmlUrl>https://blogs.sciencemag.org/pipeline</htmlUrl><streamId>feed/http://blogs.sciencemag.org/pipeline/feed</streamId><title>Sciencemag</title></origin><originId>http://blogs.sciencemag.org/pipeline/?p=14137</originId><alternate><item><type>text/html</type><href>https://blogs.sciencemag.org/pipeline/archives/2019/01/30/another-alzheimers-antibody-fails-there-will-be-more</href></item></alternate><engagement>5</engagement><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Alzheimer</text></item></mentions><label>Alzheimer&apos;s disease</label><id>nlp/f/entity/en/w/Alzheimer&apos;s disease</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Roche</text></item></mentions><label>Hoffmann-La Roche</label><id>nlp/f/entity/en/w/Hoffmann-La Roche</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>AC</text></item></mentions><label>AC</label><id>nlp/f/entity/en/-/ac</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Phase III work</text></item></mentions><label>Phase III work</label><id>nlp/f/entity/en/-/phase iii work</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Eisai</text></item></mentions><label>Eisai</label><id>nlp/f/entity/en/w/Eisai (company)</id></item></entities><updateCount>3</updateCount><published>1548858937000</published><engagementRate>0.31</engagementRate><link>http://blogs.sciencemag.org/pipeline/?p=14137</link><commonTopics><item><probability>0.85</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item><item><probability>0.759</probability><label>medical devices</label><id>nlp/f/topic/1430</id></item><item><probability>0.726</probability><label>drug discovery</label><id>nlp/f/topic/697</id></item></commonTopics><recrawled>1548961812937</recrawled><content><direction>ltr</direction><content>&lt;p&gt;To what should be absolutely no human being’s surprise, another amyloid-antibody trial has failed. Roche &lt;a href=&quot;https://www.reuters.com/article/us-roche-hldg-alzheimers-ac-immune/roche-drops-alzheimer-drug-trials-after-setback-idUSKCN1PO0GT&quot;&gt;announced today&lt;/a&gt; that the Phase III work (two 750-patient trials) on crenezumab after an interim analysis showed a strong chance of futility. They’re still going on with a study in familial early-onset disease in Colombia, and they have yet another amyloid antibody (gantenerumab) in the pipeline, but crenezumab itself for Alzheimer’s in the general population appears to have failed.&lt;/p&gt;
&lt;p&gt;You may be wondering about your own memory by this point – it’s hard to keep track, but crenezumab had already failed a few years ago. But Roche &lt;a href=&quot;https://www.fiercebiotech.com/biotech/roche-halts-phase-3-anti-abeta-alzheimer-s-trials-for-futility&quot;&gt;kept the faith&lt;/a&gt; after subgroup analysis, and went on what is now the traditional route for Alzheimer’s antibodies: move into earlier-stage patients at even higher doses. In fact, that’s exactly the same place that gantenerumab is in, because it too failed an earlier trial only to have development continue. You can imagine what its chances for success are at this point. Not to worry, though – the company’s chairman gave an interview &lt;a href=&quot;https://www.bloomberg.com/news/articles/2019-01-27/swiss-drugs-boss-optimistic-on-finding-an-alzheimer-s-treatment&quot;&gt;just last weekend&lt;/a&gt; saying that he expected breakthroughs in Alzheimer’s treatment in the next few years. To be fair, I don’t think he said that he expected them from his company.&lt;/p&gt;
&lt;p&gt;This is even harder on Roche’s partner, AC Immune, who are also working on an amyloid-targeting vaccine. They have programs targeting tau protein as well (such as RG-6100, an antibody that’s also a Roche partnership). Working on tau has the advantage of not having to climb over the huge pile of failures that amyloid-targeting therapies have left, but it might just be the devil that we don’t know so well yet. It’ll be quite interesting to see how the current crop of tau-targeting ideas works out, that’s for sure.&lt;/p&gt;
&lt;p&gt;But there are still amyloid diehards out there, and Biogen has found itself leading that list, whether they envisioned themselves in that position or not. As those watching the field know, they have an amyloid antibody &lt;a href=&quot;https://blogs.sciencemag.org/pipeline/archives/2018/02/15/more-rough-alzheimers-news&quot;&gt;late in trials&lt;/a&gt; (aducanumab), and another one partnered with Eisai (&lt;a href=&quot;https://blogs.sciencemag.org/pipeline/archives/2018/10/25/more-on-ban2401-unfortunately&quot;&gt;BAN-2401&lt;/a&gt;). The company had its earnings call just the other day, and spent a good part of it &lt;a href=&quot;https://www.fiercepharma.com/pharma/alzheimer-s-pipeline-concerns-steal-spotlight-from-biogen-s-strong-q4-results&quot;&gt;fending off questions&lt;/a&gt; about these programs, especially since analysts were expecting the Roche analysis to come out very shortly. Biogen, naturally enough, didn’t want to speculate in front of everyone, but I’ll be glad to do so here.&lt;/p&gt;
&lt;p&gt;I don’t think that aducanumab is going to work. And I don’t think that BAN-2401 is going to work, either. (Those two links in the last paragraph will take you to longer reasons why I believe that). I would be very happy to be wrong about those predictions, but you’d have to be out of your mind to be optimistic given how anti-amyloid antibodies (and anti-amyloid therapies in general) have gone. I know, I know – earlier patients. Higher doses. Targeting the &lt;em&gt;real&lt;/em&gt; form of disease-forming amyloid, the perfect little oligomers/soluble thingies/whatevers that actually like give you Alzheimer’s, instead of what all those crude fist-ax antibodies were doing that came before. I’ve heard all of that. I just don’t believe it. We as an industry have slammed into the amyloid hypothesis &lt;a href=&quot;https://blogs.sciencemag.org/pipeline/archives/2018/06/12/an-alzheimers-statement&quot;&gt;over and over&lt;/a&gt;, and the results might be trying to tell us something.&lt;/p&gt;
&lt;p&gt;Now, I could be wrong about these last anti-amyloid therapies. There is an outside chance that one of them may come through. But “Hey, you never know!” is not a business plan.&lt;/p&gt;
&lt;p&gt;&lt;em&gt;As a side point, this field illustrates in fact what I was &lt;a href=&quot;https://blogs.sciencemag.org/pipeline/archives/2019/01/29/defending-drug-synthesis&quot;&gt;talking about yesterday&lt;/a&gt; on the role of chemistry in drug discovery. In my recent post on a possible infectious disease mechanism for Alzheimer’s, I mentioned Lilly’s gamma-secretase inhibitor in passing as having “done nothing”. A longtime friend in the industry (who knew that program well) wrote to take me to task about that, pointing out that the compound was in fact an excellent gamma-secretase inhibitor and was the best shot at the target ever taken. He’s right, and I’m adding a note to that earlier post. Lilly’s med-chem team and preclinical development group did a great job by getting a compound that good in an area that difficult. But in the end, it was to no avail, because gamma-secretase inhibition does not seem to do anything for Alzheimer’s no matter how good your compound is and no matter how talented and hard-working your medicinal chemists are. So when I say “did nothing”, I mean “for the patients in the trial”, which (sadly) is indeed the bottom line.&lt;/em&gt;&lt;/p&gt;</content></content><title>Another Alzheimer’s Antibody Fails. There Will Be More.</title><summary><direction>ltr</direction><content>To what should be absolutely no human being’s surprise, another amyloid-antibody trial has failed. Roche announced today that the Phase III work (two 750-patient trials) on crenezumab after an interim analysis showed a strong chance of futility. They’re still going on with a study in familial early-onset disease in Colombia, and they have yet another</content></summary><description>To what should be absolutely no human being’s surprise, another amyloid-antibody trial has failed. Roche announced today that the Phase III work (two 750-patient trials) on crenezumab after an interim analysis showed a strong chance of futility. They’re still going on with a study in familial early-onset disease in Colombia, and they have yet another</description><crawled>1548859359270</crawled><keywords><item>Alzheimer&apos;s Disease</item><item>Clinical Trials</item></keywords></item><item><author><name>Wenhong Yang, 
Zhifeng Ma, 
Jun Yi, 
Sadia Ahmed, 
Wen‐Hua Sun</name></author><id>6wY2EtDmLbeMr9WopopAzS1SKiHs2ogsOuunEriW7zs=_1689dd99162:8fcf15:3a104d3b</id><content><direction>ltr</direction><content>&lt;img alt=&quot;Journal of Computational Chemistry Catalytic performance of bis(imino)pyridine Fe/Co complexes toward ethylene polymerization by 2D‐/3D‐QSPR modeling&quot; src=&quot;https://onlinelibrary.wiley.com/cms/attachment/3b2486e4-5f9a-4908-acfa-5a2903b8470d/jcc25792-toc-0001-m.png&quot;&gt;
&lt;p&gt;The two‐dimensional and three‐dimensional quantitative structure–property relationship (2D‐ and 3D‐QSPR) approaches are applied to investigate the catalytic performance for 55 bis(imino)pryridine iron and cobalt complexes, including the catalytic activity, molecular weight, and melting temperature of the product. The obtained models for the catalytic performance of interest exhibit quite good results by both 2D‐ and 3D‐QSPR modeling. Accordingly, new designed complexes are predicted with good catalytic performance which is validated by recent experimental report.
&lt;/p&gt;
&lt;br&gt;
&lt;p&gt;The two‐dimensional and three‐dimensional quantitative structure–property relationship (2D‐ and 3D‐QSPR) approaches are applied to investigate the catalytic performance for a total data set of 55 bis(imino)pryridine iron and cobalt complexes, including the catalytic activity, molecular weight, and melting temperature of the product. The obtained models for the catalytic performance of interest exhibit good results by both 2D‐ and 3D‐QSPR modeling, meanwhile higher predictive and validation powers observed in the 3D type. The modeling results indicate that the bulky substituents on &lt;i&gt;ortho&lt;/i&gt;‐position of the singular side phenyl ring and positive charge on &lt;i&gt;para&lt;/i&gt;‐position of the phenyl ring within the ligand are favorable to catalytic activity, while unfavorable to the molecular weight of product. Based on the obtained QSPR models, four new complexes are designed and predicted with good catalytic activity and very high molecular weight, which are in good agreement with our recent experimental report. © 2019 Wiley Periodicals, Inc.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25792?af=R</href></item></alternate><unread>True</unread><origin><htmlUrl>https://onlinelibrary.wiley.com/journal/1096987x?af=R</htmlUrl><streamId>feed/https://onlinelibrary.wiley.com/action/showFeed?jc=1096987x&amp;type=etoc&amp;feed=rss</streamId><title>Wiley: Journal of Computational Chemistry: Table of Contents</title></origin><fingerprint>7e0ecef4</fingerprint><link>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25792?af=R</link><summary><direction>ltr</direction><content>The two‐dimensional and three‐dimensional quantitative structure–property relationship (2D‐ and 3D‐QSPR) approaches are applied to investigate the catalytic performance for 55 bis(imino)pryridine iron and cobalt complexes, including the catalytic activity, molecular weight, and melting temperature of the product. The obtained models for the catalytic performance of interest exhibit quite good results by both 2D‐ and 3D‐QSPR modeling. Accordingly, new designed complexes are predicted with good catalytic performance which is validated by recent experimental report.
The two‐dimensional and three‐dimensional quantitative structure–property relationship (2D‐ and 3D‐QSPR) approaches are applied to investigate the catalytic performance for a total data set of 55 bis(imino)pryridine iron and cobalt complexes, including the catalytic activity, molecular weight, and melting temperature of the product. The obtained models for the catalytic performance of interest exhibit good results by both 2D‐ and 3D‐QSPR modeling, meanwhile higher predictive and validation powers observed in the 3D type. The modeling results indicate that the bulky substituents on ortho‐position of the singular side phenyl ring and positive charge on para‐position of the phenyl ring within the ligand are favorable to catalytic activity, while unfavorable to the molecular weight of product. Based on the obtained QSPR models, four new complexes are designed and predicted with good catalytic activity and very high molecular weight, which are in good agreement with our recent experimental report. © 2019 Wiley Periodicals, Inc.</content></summary><title>Catalytic performance of bis(imino)pyridine Fe/Co complexes toward ethylene polymerization by 2D‐/3D‐QSPR modeling</title><published>1548777768000</published><description>The two‐dimensional and three‐dimensional quantitative structure–property relationship (2D‐ and 3D‐QSPR) approaches are applied to investigate the catalytic performance for 55 bis(imino)pryridine iron and cobalt complexes, including the catalytic activity, molecular weight, and melting temperature of the product. The obtained models for the catalytic performance of interest exhibit quite good results by both 2D‐ and 3D‐QSPR modeling. Accordingly, new designed complexes are predicted with good catalytic performance which is validated by recent experimental report.
The two‐dimensional and three‐dimensional quantitative structure–property relationship (2D‐ and 3D‐QSPR) approaches are applied to investigate the catalytic performance for a total data set of 55 bis(imino)pryridine iron and cobalt complexes, including the catalytic activity, molecular weight, and melting temperature of the product. The obtained models for the catalytic performance of interest exhibit good results by both 2D‐ and 3D‐QSPR modeling, meanwhile higher predictive and validation powers observed in the 3D type. The modeling results indicate that the bulky substituents on ortho‐position of the singular side phenyl ring and positive charge on para‐position of the phenyl ring within the ligand are favorable to catalytic activity, while unfavorable to the molecular weight of product. Based on the obtained QSPR models, four new complexes are designed and predicted with good catalytic activity and very high molecular weight, which are in good agreement with our recent experimental report. © 2019 Wiley Periodicals, Inc.</description><originId>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25792?af=R</originId><crawled>1548836508002</crawled><visual><height>394</height><processor>feedly-nikon-v3.1</processor><url>https://onlinelibrary.wiley.com/cms/attachment/3b2486e4-5f9a-4908-acfa-5a2903b8470d/jcc25792-toc-0001-m.png</url><contentType>image/png; charset=UTF-8</contentType><width>394</width></visual><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Suderman, M.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16805441370:56b1f36:3a104d3b</id><content><direction>ltr</direction><content>A differentially methylated region (DMR) is a genomic region in which DNA methylation is consistently positively or negatively associated with a phenotype or exposure. We demonstrate that existing algorithms for identifying DMRs either fail to consistently control false positive rates (comb-p and DMRcate), suffer from low power (bumphunter) or lack modeling flexibility (seqlm). We introduce a new method, dmrff, that overcomes these shortcomings and can additionally be used to meta-analyze multiple datasets. When applied to investigate associations of age in multiple datasets, dmrff identifies novel DMRs near genes previously linked to age. An R implementation is available on Github (http://github.com/perishky/dmrff).</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/508556v1?rss=1</href></item></alternate><published>1546243200000</published><unread>False</unread><fingerprint>6b84dc43</fingerprint><link>http://biorxiv.org/cgi/content/short/508556v1?rss=1</link><engagement>0</engagement><title>dmrff: identifying differentially methylated regions efficiently with power and control [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>A differentially methylated region (DMR) is a genomic region in which DNA methylation is consistently positively or negatively associated with a phenotype or exposure. We demonstrate that existing algorithms for identifying DMRs either fail to consistently control false positive rates (comb-p and DMRcate), suffer from low power (bumphunter) or lack modeling flexibility (seqlm). We introduce a new method, dmrff, that overcomes these shortcomings and can additionally be used to meta-analyze multiple datasets. When applied to investigate associations of age in multiple datasets, dmrff identifies novel DMRs near genes previously linked to age. An R implementation is available on Github (http://github.com/perishky/dmrff).</description><originId>http://biorxiv.org/cgi/content/short/508556v1?rss=1</originId><crawled>1546276574064</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2018/12/31/508556</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Dietmar  Müller</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Earth</text></item></mentions><label>Earth</label><id>nlp/f/entity/en/w/Earth</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Nazca</text></item></mentions><label>Nazca</label><id>nlp/f/entity/en/w/Nazca</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Chen et al</text></item><item><text>Chen</text></item></mentions><label>Chen et al</label><id>nlp/f/entity/en/-/chen et al</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Farallon and Nazca</text></item></mentions><label>Farallon and Nazca</label><id>nlp/f/entity/en/-/farallon and nazca</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Cenozoic</text></item></mentions><label>Cenozoic</label><id>nlp/f/entity/en/w/Cenozoic</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1687be0093d:2e2c1b8:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Lost tectonic history recovered from Earth’s deep mantle&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Lost tectonic history recovered from Earth’s deep mantle, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00160-7&quot;&gt;doi:10.1038/d41586-019-00160-7&lt;/a&gt;&lt;/p&gt;Tectonic plates lost to the deep mantle carry a record of ancient surface tectonic processes. A method for retrieving such records has been developed that could clarify the links between tectonics and mountain building.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00160-7</href></item></alternate><published>1548230400000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00160-7/d41586-019-00160-7_16408276.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>59d45328</fingerprint><commonTopics><item><probability>0.988</probability><label>geology</label><id>nlp/f/topic/959</id></item><item><probability>0.924</probability><label>paleontology</label><id>nlp/f/topic/1683</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00160-7</link><engagement>5</engagement><title>Lost tectonic history recovered from Earth’s deep mantle</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Lost tectonic history recovered from Earth’s deep mantle&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Lost tectonic history recovered from Earth’s deep mantle, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00160-7&quot;&gt;doi:10.1038/d41586-019-00160-7&lt;/a&gt;&lt;/p&gt;Tectonic plates lost to the deep mantle carry a record of ancient surface tectonic processes. A method for retrieving such records has been developed that could clarify the links between tectonics and mountain building.</description><originId>https://www.nature.com/articles/d41586-019-00160-7</originId><crawled>1548266506557</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Derek Lowe</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>GABA</text></item></mentions><label>GABA</label><id>nlp/f/entity/en/-/gaba</id></item></entities><id>2k24/TFePIh3MUUJr/vqRk++EkKG/RZ2TtOvsKiJXX4=_1685c4a7841:420123:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;Microbiome, microbiome – you haven’t been able to turn around in this business the last few years without hitting some sort of story about the microbiome. It’s easy to roll your eyes and decide that it’s all hype, but that’s the thing: it really is important. It can’t be dismissed just because we don’t understand what’s going on (and just because there are people lined up trying to sell you things based on the &lt;a href=&quot;https://blogs.sciencemag.org/pipeline/archives/2017/03/06/the-microbiome-and-human-obesity-wait-a-minute&quot;&gt;tiny scraps&lt;/a&gt; of knowledge we &lt;a href=&quot;https://blogs.sciencemag.org/pipeline/archives/2017/09/13/wednesday&quot;&gt;do have&lt;/a&gt;). Things are starting to be worked out, and there will be more.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;https://www.nature.com/articles/s41564-018-0307-3&quot;&gt;Here’s one&lt;/a&gt;. For some years, there have been reports of microbiome effects on depression and mood in humans. Some of that has been junk, but some of it hasn’t, and it’s pointed to &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127831/&quot;&gt;some real effect&lt;/a&gt; that hasn’t quite been worked out, quite possibly through production of neurotransmitter molecules. Now perhaps it has – this paper reports that the human gut hosts a large number of bacterial species that produce GABA (gamma-amino butyric acid, famous as a neurotransmitter) and another large population of bacteria that actually use it – or outright require it – as a growth factor. There are a lot of thus-far-unculturable bacteria in the gut (and everywhere else, honestly), and one of the most obvious reasons for this is the lack of some key nutrient or growth factor in the culture medium. In this case, the strain KLE1738 was finally cultured in the presence of other gut bacteria (and could not be grown without them), and it turns out that it requires GABA that the others can provide. (Co-culture of KLE1738 with bacteria engineered to produce even more GABA confirmed the effect). This strain is missing a key enzyme in a carbohydrate-handling pathway that makes it require GABA, and that uptake (the bacteria have rigged up their own enhanced transport system) was confirmed by radiolabel studies. Those also suggested a metabolic path for GABA as a nutrient, through 4-hydroxybutyrate and then crotonyl-CoA.&lt;/p&gt;
&lt;p&gt;And what’s more, when the team studied 23 individuals with major depressive disorder, their gut microbiota (as monitored by 16S sequencing of fecal samples) showed a negative correlation with the GABA-producing strains. This is not a large study, but it’s very suggestive of further lines of research. Is that (as it would appear at first glance) really the causative order of things? If so, what starts off the imbalance in the GABA-using gut ecosystem? Is there some way to monitor that or prevent it? How long ago did that imbalance occur in patients who eventually are diagnosed with depression (for example, does it affect brain development)? And at what point could one intervene in the microbiota to have a therapeutic effect?&lt;/p&gt;
&lt;p&gt;We’re going to have to study more people and more of their bacteria to answer those questions, but there is at least a clear line of inquiry to pursue. That means a lot in a field like this, and there are a lot of field like this: big piles of data, with greater or lesser correlations running through them like bumps or folds in a bedsheet. Does the sheet look like that because there’s something under there? Or was it laid down that way via some other cause? Or it is just an accident or an illusion? Is it that there’s nothing under there at all and no particular reason for it to look that way in the first place? But in this case, we have a place to start looking and a plan for how to look at it. I look forward to seeing how this story plays out!&lt;/p&gt;</content></content><updateCount>5</updateCount><alternate><item><type>text/html</type><href>https://blogs.sciencemag.org/pipeline/archives/2019/01/17/bacteria-and-depression-something-to-test</href></item></alternate><published>1547736335000</published><unread>True</unread><origin><htmlUrl>https://blogs.sciencemag.org/pipeline</htmlUrl><streamId>feed/http://blogs.sciencemag.org/pipeline/feed</streamId><title>Sciencemag</title></origin><fingerprint>f1ab39a9</fingerprint><commonTopics><item><probability>0.881</probability><label>psychiatry</label><id>nlp/f/topic/1844</id></item><item><probability>0.779</probability><label>microbiology</label><id>nlp/f/topic/1455</id></item></commonTopics><link>http://blogs.sciencemag.org/pipeline/?p=14114</link><recrawled>1548961812937</recrawled><engagement>45</engagement><title>Bacteria and Depression: Something to Test</title><summary><direction>ltr</direction><content>Microbiome, microbiome – you haven’t been able to turn around in this business the last few years without hitting some sort of story about the microbiome. It’s easy to roll your eyes and decide that it’s all hype, but that’s the thing: it really is important. It can’t be dismissed just because we don’t understand</content></summary><description>Microbiome, microbiome – you haven’t been able to turn around in this business the last few years without hitting some sort of story about the microbiome. It’s easy to roll your eyes and decide that it’s all hype, but that’s the thing: it really is important. It can’t be dismissed just because we don’t understand</description><originId>http://blogs.sciencemag.org/pipeline/?p=14114</originId><crawled>1547736610881</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><keywords><item>Biological News</item><item>Chemical Biology</item><item>Natural Products</item><item>The Central Nervous System</item></keywords></item><item><author><name>Xiaowei Han</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Ustilago maydis</text></item><item><text>Smut fungus Ustilago maydis</text></item><item><text>Ustilago Maydis</text></item></mentions><label>Smut fungus Ustilago maydis</label><id>nlp/f/entity/en/-/smut fungus ustilago maydis</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>J. Mol</text></item><item><text>Mol</text></item></mentions><label>J. Mol</label><id>nlp/f/entity/en/-/j. mol</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Nat</text></item></mentions><label>Nat</label><id>nlp/f/entity/en/-/nat</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Lanver</text></item></mentions><label>Lanver</label><id>nlp/f/entity/en/-/lanver</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Microbiol</text></item></mentions><label>Microbiol</label><id>nlp/f/entity/en/-/microbiol</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16857ddbaa0:3dd05ea:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;A kiwellin disarms the metabolic activity of a secreted fungal virulence factor&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A kiwellin disarms the metabolic activity of a secreted fungal virulence factor, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0857-9&quot;&gt;doi:10.1038/s41586-018-0857-9&lt;/a&gt;&lt;/p&gt;A kiwellin protein in maize is found to inhibit the activity of the secreted enzyme chorismate mutase from a maize-infecting pathogenic fungus, suggesting a role for kiwellins in plant immunity.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0857-9</href></item></alternate><published>1547625600000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0857-9/MediaObjects/41586_2018_857_Fig1_HTML.png</url><contentType>image/png</contentType><width>447</width></visual><fingerprint>86bfc79e</fingerprint><commonTopics><item><probability>0.98</probability><label>classics</label><id>nlp/f/topic/477</id></item><item><probability>0.977</probability><label>bioinformatics</label><id>nlp/f/topic/262</id></item><item><probability>0.884</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.873</probability><label>mp3</label><id>nlp/f/topic/1508</id></item><item><probability>0.868</probability><label>emergency medicine</label><id>nlp/f/topic/764</id></item><item><probability>0.808</probability><label>rationality</label><id>nlp/f/topic/1895</id></item><item><probability>0.766</probability><label>genetics</label><id>nlp/f/topic/955</id></item><item><probability>0.751</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.741</probability><label>coupons</label><id>nlp/f/topic/560</id></item><item><probability>0.74</probability><label>ecology</label><id>nlp/f/topic/725</id></item></commonTopics><link>https://www.nature.com/articles/s41586-018-0857-9</link><engagement>1</engagement><title>A kiwellin disarms the metabolic activity of a secreted fungal virulence factor</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;A kiwellin disarms the metabolic activity of a secreted fungal virulence factor&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A kiwellin disarms the metabolic activity of a secreted fungal virulence factor, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0857-9&quot;&gt;doi:10.1038/s41586-018-0857-9&lt;/a&gt;&lt;/p&gt;A kiwellin protein in maize is found to inhibit the activity of the secreted enzyme chorismate mutase from a maize-infecting pathogenic fungus, suggesting a role for kiwellins in plant immunity.</description><originId>https://www.nature.com/articles/s41586-018-0857-9</originId><crawled>1547662375584</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Barbara Kiser</name></author><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>Universe</text></item></mentions><label>Universe</label><id>nlp/f/entity/en/w/Universe</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Richard Wrangham Profile</text></item></mentions><label>Richard Wrangham Profile</label><id>nlp/f/entity/en/-/richard wrangham profile</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Zeus</text></item></mentions><label>Zeus</label><id>nlp/f/entity/en/w/Zeus</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Richard Wrangham</text></item></mentions><label>Richard Wrangham</label><id>nlp/f/entity/en/w/Richard Wrangham</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Royal Society</text></item></mentions><label>Royal Society</label><id>nlp/f/entity/en/w/Royal Society</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16855ec2d2b:3a564b0:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;The paradox of human nature, our obsession with the skies, and the realities of transplant surgery: Books in brief&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The paradox of human nature, our obsession with the skies, and the realities of transplant surgery: Books in brief, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00126-9&quot;&gt;doi:10.1038/d41586-019-00126-9&lt;/a&gt;&lt;/p&gt;Barbara Kiser reviews five of the week’s best science picks.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00126-9</href></item></alternate><published>1547625600000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00126-9/d41586-019-00126-9_16386788.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>f83fb6f2</fingerprint><commonTopics><item><probability>0.973</probability><label>conservation</label><id>nlp/f/topic/532</id></item><item><probability>0.719</probability><label>hbd</label><id>nlp/f/topic/1042</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00126-9</link><engagement>2</engagement><title>The paradox of human nature, our obsession with the skies, and the realities of transplant surgery: Books in brief</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;The paradox of human nature, our obsession with the skies, and the realities of transplant surgery: Books in brief&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The paradox of human nature, our obsession with the skies, and the realities of transplant surgery: Books in brief, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00126-9&quot;&gt;doi:10.1038/d41586-019-00126-9&lt;/a&gt;&lt;/p&gt;Barbara Kiser reviews five of the week’s best science picks.</description><originId>https://www.nature.com/articles/d41586-019-00126-9</originId><crawled>1547629767979</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Legrand, J.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1689c781b9e:733687:3a104d3b</id><content><direction>ltr</direction><content>Pharmacogenomics (PGx) studies how individual gene variations impact drug response phenotypes, which makes knowledge related to PGx a key component towards precision medicine. A significant part of the state-of-the-art knowledge in PGx is accumulated in scientific publications, where it is hardly usable to humans or software. Natural language processing techniques have been developed and are indeed employed for guiding experts curating this amount of knowledge. But, existing works are limited by the absence of high quality annotated corpora focusing on the domain. This absence restricts in particular the use of PGxCorpus, a manually annotated corpus, designed for the automatic extraction of PGx relationships from text. It comprises 945 sentences from 911 PubMed abstracts, annotated with PGx entities of interest (mainly genes variations, gene, drugs and phenotypes), and relationships between those. We present in this article the method used to annotate consistently texts, and a baseline experiment that illustrates how this resource may be leveraged to synthesize and summarize PGx knowledge.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/534388v1?rss=1</href></item></alternate><published>1548748800000</published><unread>True</unread><fingerprint>3a555f89</fingerprint><link>http://biorxiv.org/cgi/content/short/534388v1?rss=1</link><engagement>0</engagement><title>PGxCorpus: a Manually Annotated Corpus for Pharmacogenomics [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Pharmacogenomics (PGx) studies how individual gene variations impact drug response phenotypes, which makes knowledge related to PGx a key component towards precision medicine. A significant part of the state-of-the-art knowledge in PGx is accumulated in scientific publications, where it is hardly usable to humans or software. Natural language processing techniques have been developed and are indeed employed for guiding experts curating this amount of knowledge. But, existing works are limited by the absence of high quality annotated corpora focusing on the domain. This absence restricts in particular the use of PGxCorpus, a manually annotated corpus, designed for the automatic extraction of PGx relationships from text. It comprises 945 sentences from 911 PubMed abstracts, annotated with PGx entities of interest (mainly genes variations, gene, drugs and phenotypes), and relationships between those. We present in this article the method used to annotate consistently texts, and a baseline experiment that illustrates how this resource may be leveraged to synthesize and summarize PGx knowledge.</description><originId>http://biorxiv.org/cgi/content/short/534388v1?rss=1</originId><crawled>1548813343646</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Johnson, J. A.</name></author><content><direction>ltr</direction><content>&lt;p&gt;Elements heavier than helium are produced in the lives and deaths of stars. This Review discusses when and how the process of nucleosynthesis made elements. High-mass stars fuse elements much faster, fuse heavier nuclei, and die more catastrophically than low-mass stars. The explosions of high-mass stars as supernovae release elements into their surroundings. Supernovae can leave behind neutron stars, which may later merge to produce additional heavy elements. Dying low-mass stars throw off their enriched outer layers, leaving behind white dwarfs. These white dwarfs may also later merge and synthesize elements as well. Because these processes occur on different time scales and produce a different pattern of elements, the composition of the Universe changes over time as stars populate the periodic table.&lt;/p&gt;</content></content><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168a5541f68:15080b4:3a104d3b</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6426/474?rss=1</href></item></alternate><published>1548959829000</published><unread>True</unread><fingerprint>4b27bd0c</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6426/474?rss=1</link><engagement>0</engagement><title>Populating the periodic table: Nucleosynthesis of the elements</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><description>&lt;p&gt;Elements heavier than helium are produced in the lives and deaths of stars. This Review discusses when and how the process of nucleosynthesis made elements. High-mass stars fuse elements much faster, fuse heavier nuclei, and die more catastrophically than low-mass stars. The explosions of high-mass stars as supernovae release elements into their surroundings. Supernovae can leave behind neutron stars, which may later merge to produce additional heavy elements. Dying low-mass stars throw off their enriched outer layers, leaving behind white dwarfs. These white dwarfs may also later merge and synthesize elements as well. Because these processes occur on different time scales and produce a different pattern of elements, the composition of the Universe changes over time as stars populate the periodic table.&lt;/p&gt;</description><originId>http://science.sciencemag.org/cgi/content/short/363/6426/474?rss=1</originId><crawled>1548961980264</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6426/474.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><keywords><item>Astronomy, Chemistry, Geochemistry, Geophysics</item></keywords></item><item><author><name>Wayne Adams</name></author><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_16876e5d729:325dae3:b77f238b</id><content><direction>ltr</direction><content>&lt;p&gt;by Wayne Adams, James N. Graham, Xuchen Han, Hermann Riecke&lt;/p&gt;
Much of the computational power of the mammalian brain arises from its extensive top-down projections. To enable neuron-specific information processing these projections have to be precisely targeted. How such a specific connectivity emerges and what functions it supports is still poorly understood. We addressed these questions in silico in the context of the profound structural plasticity of the olfactory system. At the core of this plasticity are the granule cells of the olfactory bulb, which integrate bottom-up sensory inputs and top-down inputs delivered by vast top-down projections from cortical and other brain areas. We developed a biophysically supported computational model for the rewiring of the top-down projections and the intra-bulbar network via adult neurogenesis. The model captures various previous physiological and behavioral observations and makes specific predictions for the cortico-bulbar network connectivity that is learned by odor exposure and environmental contexts. Specifically, it predicts that—after learning—the granule-cell receptive fields with respect to sensory and with respect to cortical inputs are highly correlated. This enables cortical cells that respond to a learned odor to enact disynaptic inhibitory control specifically of bulbar principal cells that respond to that odor. For this the reciprocal nature of the granule cell synapses with the principal cells is essential. Functionally, the model predicts context-enhanced stimulus discrimination in cluttered environments (‘olfactory cocktail parties’) and the ability of the system to adapt to its tasks by rapidly switching between different odor-processing modes. These predictions are experimentally testable. At the same time they provide guidance for future experiments aimed at unraveling the cortico-bulbar connectivity.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/Zr8mG2szw1g&quot; height=&quot;1&quot;&gt;</content></content><updateCount>1</updateCount><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/Zr8mG2szw1g/article</href></item></alternate><published>1548194400000</published><unread>True</unread><fingerprint>25d97171</fingerprint><link>10.1371/journal.pcbi.1006611</link><recrawled>1548192423393</recrawled><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006611</href></item></canonical><updated>1548194400000</updated><engagement>0</engagement><title>Top-down inputs drive neuronal network rewiring and context-enhanced sensory processing in olfaction</title><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><description>&lt;p&gt;by Wayne Adams, James N. Graham, Xuchen Han, Hermann Riecke&lt;/p&gt;
Much of the computational power of the mammalian brain arises from its extensive top-down projections. To enable neuron-specific information processing these projections have to be precisely targeted. How such a specific connectivity emerges and what functions it supports is still poorly understood. We addressed these questions in silico in the context of the profound structural plasticity of the olfactory system. At the core of this plasticity are the granule cells of the olfactory bulb, which integrate bottom-up sensory inputs and top-down inputs delivered by vast top-down projections from cortical and other brain areas. We developed a biophysically supported computational model for the rewiring of the top-down projections and the intra-bulbar network via adult neurogenesis. The model captures various previous physiological and behavioral observations and makes specific predictions for the cortico-bulbar network connectivity that is learned by odor exposure and environmental contexts. Specifically, it predicts that—after learning—the granule-cell receptive fields with respect to sensory and with respect to cortical inputs are highly correlated. This enables cortical cells that respond to a learned odor to enact disynaptic inhibitory control specifically of bulbar principal cells that respond to that odor. For this the reciprocal nature of the granule cell synapses with the principal cells is essential. Functionally, the model predicts context-enhanced stimulus discrimination in cluttered environments (‘olfactory cocktail parties’) and the ability of the system to adapt to its tasks by rapidly switching between different odor-processing modes. These predictions are experimentally testable. At the same time they provide guidance for future experiments aimed at unraveling the cortico-bulbar connectivity.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/Zr8mG2szw1g&quot; height=&quot;1&quot;&gt;</description><originId>10.1371/journal.pcbi.1006611</originId><crawled>1548183000873</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Jiang, T.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1688c256fe4:456abc8:ad2b6584</id><content><direction>ltr</direction><content>Motivation: Same-species contamination detection is an important quality control step in genetic data analysis. Compared with widely discussed cross-species contamination, same-species contamination is more challenging to detect, and there is a scarcity of methods to detect and correct for this quality control issue. Same-species contamination may be due to contamination by lab technicians or samples from other contributors. Here, we introduce a novel machine learning algorithm to detect same species contamination in next generation sequence data using support vector machines. Our approach uniquely detects such contamination using variant calling information stored in the variant call format (VCF) files (either DNA or RNA), and importantly can differentiate between same species contamination and mixtures of tumor and normal cells. Methods: In the first stage of our approach, a change-point detection method is used to identify copy number variations or copy number aberrations (CNVs or CNAs) for filtering prior to testing for contamination. Next, single nucleotide polymorphism (SNP) data is used to test for same species contamination using a support vector machine model. Based on the assumption that alternative allele frequencies in next generation sequencing follow the beta-binomial distribution, the deviation parameter {rho} is estimated by maximum likelihood method. All features of a radial basis function (RBF) kernel support vector machine (SVM) are generated using either publicly available or private training data. Lastly, the generated SVM is applied in the test data to detect contamination. If training data is not available, a default RBF kernel SVM model is used. Results: We demonstrate the potential of our approach using simulation experiments, creating datasets with varying levels of contamination. The datasets combine, in silico, exome sequencing data of DNA from two lymphoblastoid cell lines (NA12878 and NA10855). We generated VCF files using variants identified in these data, and then evaluated the power and false positive rate of our approach to detect same species contamination. Our simulation experiments show that our method can detect levels of contamination as low as 5% with reasonable false positive rates. Results in real data have sensitivity above 99.99% and specificity at 90.24%, even in the presence of DNA degradation that has similar features to contaminated samples. Additionally, the approach can identify the difference between mixture of tumor-normal cells and contamination. We provide an R software implementation of our approach using the defcon()function in the vanquish: Variant Quality Investigation Helper R package on CRAN.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/531558v1?rss=1</href></item></alternate><published>1548489600000</published><unread>True</unread><fingerprint>a3a0c86</fingerprint><link>http://biorxiv.org/cgi/content/short/531558v1?rss=1</link><engagement>0</engagement><title>Same-Species Contamination Detection with Variant Calling Information from Next Generation Sequencing [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Motivation: Same-species contamination detection is an important quality control step in genetic data analysis. Compared with widely discussed cross-species contamination, same-species contamination is more challenging to detect, and there is a scarcity of methods to detect and correct for this quality control issue. Same-species contamination may be due to contamination by lab technicians or samples from other contributors. Here, we introduce a novel machine learning algorithm to detect same species contamination in next generation sequence data using support vector machines. Our approach uniquely detects such contamination using variant calling information stored in the variant call format (VCF) files (either DNA or RNA), and importantly can differentiate between same species contamination and mixtures of tumor and normal cells. Methods: In the first stage of our approach, a change-point detection method is used to identify copy number variations or copy number aberrations (CNVs or CNAs) for filtering prior to testing for contamination. Next, single nucleotide polymorphism (SNP) data is used to test for same species contamination using a support vector machine model. Based on the assumption that alternative allele frequencies in next generation sequencing follow the beta-binomial distribution, the deviation parameter {rho} is estimated by maximum likelihood method. All features of a radial basis function (RBF) kernel support vector machine (SVM) are generated using either publicly available or private training data. Lastly, the generated SVM is applied in the test data to detect contamination. If training data is not available, a default RBF kernel SVM model is used. Results: We demonstrate the potential of our approach using simulation experiments, creating datasets with varying levels of contamination. The datasets combine, in silico, exome sequencing data of DNA from two lymphoblastoid cell lines (NA12878 and NA10855). We generated VCF files using variants identified in these data, and then evaluated the power and false positive rate of our approach to detect same species contamination. Our simulation experiments show that our method can detect levels of contamination as low as 5% with reasonable false positive rates. Results in real data have sensitivity above 99.99% and specificity at 90.24%, even in the presence of DNA degradation that has similar features to contaminated samples. Additionally, the approach can identify the difference between mixture of tumor-normal cells and contamination. We provide an R software implementation of our approach using the defcon()function in the vanquish: Variant Quality Investigation Helper R package on CRAN.</description><originId>http://biorxiv.org/cgi/content/short/531558v1?rss=1</originId><crawled>1548539490276</crawled><canonicalUrl>https://www.biorxiv.org/content/10.1101/531558v1</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Bai, Y.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168360fd545:1067701:3a104d3b</id><content><direction>ltr</direction><content>The paired repeated measures (PRM) design has been commonly used in comparison studies to demonstrate that two measures agree sufficiently up to a pre-specified threshold. Due to the nature of dependence in repeated measures, existing methods for analyzing these comparison studies are often ad hoc and less than satisfactory. We propose a new test together with sample size and power calculation for PRM designs, which exhibit very good finite sample performance. We demonstrate favorable performance of the proposed methods through numerical studies. We provide very efficient R programs for our methods in a publicly available R package. Our proposed methods and developed R package provide practical tools which bridge an existing gap in the field.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/516658v2?rss=1</href></item></alternate><published>1547020800000</published><unread>True</unread><fingerprint>899501f0</fingerprint><link>http://biorxiv.org/cgi/content/short/516658v2?rss=1</link><engagement>0</engagement><title>Statistical test with sample size and power calculation for paired repeated measures designs of method comparison studies [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>The paired repeated measures (PRM) design has been commonly used in comparison studies to demonstrate that two measures agree sufficiently up to a pre-specified threshold. Due to the nature of dependence in repeated measures, existing methods for analyzing these comparison studies are often ad hoc and less than satisfactory. We propose a new test together with sample size and power calculation for PRM designs, which exhibit very good finite sample performance. We demonstrate favorable performance of the proposed methods through numerical studies. We provide very efficient R programs for our methods in a publicly available R package. Our proposed methods and developed R package provide practical tools which bridge an existing gap in the field.</description><originId>http://biorxiv.org/cgi/content/short/516658v2?rss=1</originId><crawled>1547095233861</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/09/516658.1</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Brendan D. Manning</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Ranek</text></item><item><text>Ranek et al</text></item></mentions><label>Ranek et al</label><id>nlp/f/entity/en/-/ranek et al</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Sildenafil</text></item><item><text>sildenafil</text></item><item><text>Viagra</text></item></mentions><label>Sildenafil</label><id>nlp/f/entity/en/w/Sildenafil</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>TSC2</text></item></mentions><label>TSC2</label><id>nlp/f/entity/en/w/TSC2</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>mTOR</text></item></mentions><label>MTOR</label><id>nlp/f/entity/en/w/MTOR</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>endothelin - 1</text></item><item><text>Endothelin - 1</text></item></mentions><label>Endothelin 1</label><id>nlp/f/entity/en/w/Endothelin 1</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ff99aeb:c7ac51:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Signalling protein protects the heart muscle from pressure-related stress&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Signalling protein protects the heart muscle from pressure-related stress, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00245-3&quot;&gt;doi:10.1038/d41586-019-00245-3&lt;/a&gt;&lt;/p&gt;If blood flow from the heart is impeded, the pressure created causes tissue dysfunction. It emerges that different signals converge on the TSC2 and mTOR proteins to fine-tune the response of heart cells to stress.</content></content><engagementRate>1.0</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00245-3</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><height>450</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00245-3/d41586-019-00245-3_16423378.jpg</url><contentType>image/jpeg</contentType><width>800</width></visual><fingerprint>741da976</fingerprint><commonTopics><item><probability>0.979</probability><label>cardiology</label><id>nlp/f/topic/387</id></item><item><probability>0.927</probability><label>biochemistry</label><id>nlp/f/topic/257</id></item><item><probability>0.925</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>0.835</probability><label>biology</label><id>nlp/f/topic/263</id></item><item><probability>0.834</probability><label>fitness</label><id>nlp/f/topic/874</id></item><item><probability>0.744</probability><label>pharmacology</label><id>nlp/f/topic/1735</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00245-3</link><engagement>8</engagement><title>Signalling protein protects the heart muscle from pressure-related stress</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Signalling protein protects the heart muscle from pressure-related stress&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Signalling protein protects the heart muscle from pressure-related stress, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00245-3&quot;&gt;doi:10.1038/d41586-019-00245-3&lt;/a&gt;&lt;/p&gt;If blood flow from the heart is impeded, the pressure created causes tissue dysfunction. It emerges that different signals converge on the TSC2 and mTOR proteins to fine-tune the response of heart cells to stress.</description><originId>https://www.nature.com/articles/d41586-019-00245-3</originId><crawled>1548872162027</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Kaeberlein, M., Galvan, V.</name></author><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1687c1a95dc:2f6433e:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;The drug rapamycin has beneficial effects in a number of animal models of neurodegeneration and aging including mouse models of Alzheimer’s disease. Despite its compelling preclinical record, no clinical trials have tested rapamycin or other mTOR inhibitors in patients with Alzheimer’s disease. We argue that such clinical trials should be undertaken.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/476/eaar4289?rss=1</href></item></alternate><published>1548269442000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>f99b1d26</fingerprint><link>http://stm.sciencemag.org/cgi/content/short/11/476/eaar4289?rss=1</link><engagement>35</engagement><title>[Perspectives] Rapamycin and Alzheimers disease: Time for a clinical trial?</title><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><description>&lt;p&gt;The drug rapamycin has beneficial effects in a number of animal models of neurodegeneration and aging including mouse models of Alzheimer’s disease. Despite its compelling preclinical record, no clinical trials have tested rapamycin or other mTOR inhibitors in patients with Alzheimer’s disease. We argue that such clinical trials should be undertaken.&lt;/p&gt;</description><originId>http://stm.sciencemag.org/cgi/content/short/11/476/eaar4289?rss=1</originId><crawled>1548270343644</crawled><canonicalUrl>http://stm.sciencemag.org/content/11/476/eaar4289.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1689a6b3fcd:435e7b:ad2b6584</id><published>1548720000000</published><unread>True</unread><summary><direction>ltr</direction><content>For organic semiconductors, the solid-state packings of the π-conjugated molecules or polymers dictate the material electronic, optical, and mechanical characteristics. Combinations of solution and solid-state investigations are often used to establish structure–function relationships, though these connections are often loosely correlated, and experiments in different laboratories can lead to widely variable interpretations. Hence, there remains a need to develop a deeper, more robust understanding of the connections between molecular and polymer chemistry, structure, processing, solid-state order, and materials properties to enable judicious materials design principles. Towards this goal, we employ fully-atomistic molecular dynamics (MD) simulations of poly[4,8-bis(5-(2-ethylhexyl)thiophen-2-yl)benzo[1,2-b;4,5-b’]dithiophene-2,6-diyl-alt-(4-(2-ethylhexyl)-3-fluorothieno[3,4-b]thiophene-)-2-carboxylate-2-6-diyl)] (PTB7), a donor–acceptor copolymer that has been widely investigated in the organic solar cell literature, to unravel some of these associations. The MD simulations make use of polymer lengths (masses) and solution concentrations that are consistent with those used in experiment, allowing for a detailed picture to arise as to how variations in the polymer environment can direct polymer structure. Comparisons between experiment and theory suggest that processing history can be an important factor in the polymer structures presumed experimentally that are used to interpret optical and electronic response. The results of these simulations provide specific information into the behavior of PTB7 under different conditions, and showcase how atomistic MD simulations that approach experimentally relevant sizes can be used to develop broader chemical insight that can aid in the design, processing, and characterization of polymer-based organic semiconductors.</content></summary><fingerprint>b306e35e</fingerprint><link>https://chemrxiv.org/articles/Deconstructing_the_Behavior_of_Donor-Acceptor_Copolymers_in_Solution_the_Melt_The_Case_of_PTB7/7637870</link><engagement>0</engagement><crawled>1548778946509</crawled><title>Deconstructing the Behavior of Donor-Acceptor Copolymers in Solution &amp; the Melt: The Case of PTB7</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>For organic semiconductors, the solid-state packings of the π-conjugated molecules or polymers dictate the material electronic, optical, and mechanical characteristics. Combinations of solution and solid-state investigations are often used to establish structure–function relationships, though these connections are often loosely correlated, and experiments in different laboratories can lead to widely variable interpretations. Hence, there remains a need to develop a deeper, more robust understanding of the connections between molecular and polymer chemistry, structure, processing, solid-state order, and materials properties to enable judicious materials design principles. Towards this goal, we employ fully-atomistic molecular dynamics (MD) simulations of poly[4,8-bis(5-(2-ethylhexyl)thiophen-2-yl)benzo[1,2-b;4,5-b’]dithiophene-2,6-diyl-alt-(4-(2-ethylhexyl)-3-fluorothieno[3,4-b]thiophene-)-2-carboxylate-2-6-diyl)] (PTB7), a donor–acceptor copolymer that has been widely investigated in the organic solar cell literature, to unravel some of these associations. The MD simulations make use of polymer lengths (masses) and solution concentrations that are consistent with those used in experiment, allowing for a detailed picture to arise as to how variations in the polymer environment can direct polymer structure. Comparisons between experiment and theory suggest that processing history can be an important factor in the polymer structures presumed experimentally that are used to interpret optical and electronic response. The results of these simulations provide specific information into the behavior of PTB7 under different conditions, and showcase how atomistic MD simulations that approach experimentally relevant sizes can be used to develop broader chemical insight that can aid in the design, processing, and characterization of polymer-based organic semiconductors.</description><originId>https://chemrxiv.org/articles/Deconstructing_the_Behavior_of_Donor-Acceptor_Copolymers_in_Solution_the_Melt_The_Case_of_PTB7/7637870</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Deconstructing_the_Behavior_of_Donor-Acceptor_Copolymers_in_Solution_the_Melt_The_Case_of_PTB7/7637870</href></item></alternate></item><item><author><name>Pekka Lappalainen</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>His73</text></item></mentions><label>His73</label><id>nlp/f/entity/en/-/his73</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>ATP</text></item></mentions><label>Adenosine triphosphate</label><id>nlp/f/entity/en/w/Adenosine triphosphate</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>ADP</text></item></mentions><label>Automatic Data Processing</label><id>nlp/f/entity/en/w/Automatic Data Processing</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Wilkinson et al</text></item></mentions><label>Wilkinson et al</label><id>nlp/f/entity/en/-/wilkinson et al</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>SETD3</text></item></mentions><label>SETD3</label><id>nlp/f/entity/en/w/SETD3 (gene)</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16833ca2c4e:d2b07a:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Protein modification fine-tunes the cell’s force producers&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Protein modification fine-tunes the cell’s force producers, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07882-0&quot;&gt;doi:10.1038/d41586-018-07882-0&lt;/a&gt;&lt;/p&gt;Identification of the enzyme that catalyses a site-specific modification of the protein actin reveals how this change modulates the function of the cell’s force-producing machinery.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07882-0</href></item></alternate><published>1547020800000</published><unread>True</unread><visual><height>450</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07882-0/d41586-018-07882-0_16375250.jpg</url><contentType>image/jpeg</contentType><width>800</width></visual><fingerprint>3c77a57</fingerprint><commonTopics><item><probability>0.996</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>0.995</probability><label>biochemistry</label><id>nlp/f/topic/257</id></item><item><probability>0.931</probability><label>proteomics</label><id>nlp/f/topic/1840</id></item><item><probability>0.914</probability><label>biology</label><id>nlp/f/topic/263</id></item><item><probability>0.799</probability><label>microscopy</label><id>nlp/f/topic/1457</id></item><item><probability>0.798</probability><label>fitness</label><id>nlp/f/topic/874</id></item><item><probability>0.772</probability><label>stem cells</label><id>nlp/f/topic/2185</id></item><item><probability>0.753</probability><label>bodybuilding</label><id>nlp/f/topic/294</id></item><item><probability>0.712</probability><label>immunology</label><id>nlp/f/topic/1145</id></item></commonTopics><link>https://www.nature.com/articles/d41586-018-07882-0</link><engagement>11</engagement><title>Protein modification fine-tunes the cell’s force producers</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Protein modification fine-tunes the cell’s force producers&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Protein modification fine-tunes the cell’s force producers, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07882-0&quot;&gt;doi:10.1038/d41586-018-07882-0&lt;/a&gt;&lt;/p&gt;Identification of the enzyme that catalyses a site-specific modification of the protein actin reveals how this change modulates the function of the cell’s force-producing machinery.</description><originId>https://www.nature.com/articles/d41586-018-07882-0</originId><crawled>1547057114190</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Dahye Lee, Haushabhau S. Pagire, Suvarna H. Pagire, Eun Jung Bae, Mahesh Dighe, Minhee Kim, Kyu Myung Lee, Yoon Kyung Jang, Ashok Kumar Jaladi, Kwan-Young Jung, Eun Kyung Yoo, Hee Eon Gim, Seungmi Lee, Won-Il Choi, Young-In Chi, Jin Sook Song, Myung Ae Bae, Yong Hyun Jeon, Ga-Hyun Lee, Kwang-Hyeon Liu, Taeho Lee, Sungmi Park, Jae-Han Jeon, In-Kyu Lee, Jin Hee Ahn</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_16832f5f720:b5ab3c:56b782f7</id><published>1547010000000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01168/20190108/images/medium/jm-2018-011682_0017.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01168&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=nWnboOg9Jf0:0rinHQjRc4Y:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/nWnboOg9Jf0&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>a6a13bb2</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01168</link><crawled>1547043206944</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01168</href></item></canonical><engagement>0</engagement><title>[ASAP] Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01168/20190108/images/medium/jm-2018-011682_0017.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01168&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=nWnboOg9Jf0:0rinHQjRc4Y:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/nWnboOg9Jf0&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01168</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/nWnboOg9Jf0/acs.jmedchem.8b01168</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Xuanxuan Xing</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1687515b28c:246a92b:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;A recurrent cancer-associated substitution in DNA polymerase ε produces a hyperactive enzyme&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A recurrent cancer-associated substitution in DNA polymerase ε produces a hyperactive enzyme, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08145-2&quot;&gt;doi:10.1038/s41467-018-08145-2&lt;/a&gt;&lt;/p&gt;Somatic alterations in the exonuclease domain of DNA polymerase ɛ have been linked to the development of highly mutated cancers. Here, the authors report that a major consequence of the most common cancer-associated Polɛ variant is a dramatically increased DNA polymerase activity.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/AG4gvs8mf2s&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/AG4gvs8mf2s/s41467-018-08145-2</href></item></alternate><published>1548144000000</published><unread>True</unread><fingerprint>fc3dc26d</fingerprint><link>https://www.nature.com/articles/s41467-018-08145-2</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08145-2</href></item></canonical><title>A recurrent cancer-associated substitution in DNA polymerase ε produces a hyperactive enzyme</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;A recurrent cancer-associated substitution in DNA polymerase ε produces a hyperactive enzyme&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A recurrent cancer-associated substitution in DNA polymerase ε produces a hyperactive enzyme, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08145-2&quot;&gt;doi:10.1038/s41467-018-08145-2&lt;/a&gt;&lt;/p&gt;Somatic alterations in the exonuclease domain of DNA polymerase ɛ have been linked to the development of highly mutated cancers. Here, the authors report that a major consequence of the most common cancer-associated Polɛ variant is a dramatically increased DNA polymerase activity.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/AG4gvs8mf2s&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-08145-2</originId><crawled>1548152582796</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Carsten T. Charlesworth</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Cas9</text></item></mentions><label>Cas9</label><id>nlp/f/entity/en/w/Cas9</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>CRISPR</text></item></mentions><label>CRISPR</label><id>nlp/f/entity/en/w/CRISPR</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>vivo</text></item></mentions><label>vivo</label><id>nlp/f/entity/en/-/vivo</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>O</text></item></mentions><label>O</label><id>nlp/f/entity/en/-/o</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Dever</text></item></mentions><label>Dever</label><id>nlp/f/entity/en/-/dever</id></item></entities><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_16895383fb5:4fc2f1d:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Identification of preexisting adaptive immunity to Cas9 proteins in humans&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Identification of preexisting adaptive immunity to Cas9 proteins in humans, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0326-x&quot;&gt;doi:10.1038/s41591-018-0326-x&lt;/a&gt;&lt;/p&gt;Cas9-specific antibodies and reactive T cells are found in the majority of healthy adult human serum samples analyzed. Such preexisting adaptive immunity should be taken into consideration as the CRISPR–Cas9 system moves toward clinical trials.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/6wHagP8ukLA&quot; height=&quot;1&quot;&gt;</content></content><engagementRate>1.17</engagementRate><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/6wHagP8ukLA/s41591-018-0326-x</href></item></alternate><published>1548662400000</published><unread>True</unread><visual><height>566</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-018-0326-x/MediaObjects/41591_2018_326_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>24075dfc</fingerprint><commonTopics><item><probability>1.0</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>1.0</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.994</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.99</probability><label>stem cells</label><id>nlp/f/topic/2185</id></item><item><probability>0.875</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item><item><probability>0.821</probability><label>neurology</label><id>nlp/f/topic/1563</id></item><item><probability>0.711</probability><label>bioinformatics</label><id>nlp/f/topic/262</id></item></commonTopics><link>https://www.nature.com/articles/s41591-018-0326-x</link><engagement>21</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41591-018-0326-x</href></item></canonical><title>Identification of preexisting adaptive immunity to Cas9 proteins in humans</title><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Identification of preexisting adaptive immunity to Cas9 proteins in humans&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Identification of preexisting adaptive immunity to Cas9 proteins in humans, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0326-x&quot;&gt;doi:10.1038/s41591-018-0326-x&lt;/a&gt;&lt;/p&gt;Cas9-specific antibodies and reactive T cells are found in the majority of healthy adult human serum samples analyzed. Such preexisting adaptive immunity should be taken into consideration as the CRISPR–Cas9 system moves toward clinical trials.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/6wHagP8ukLA&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41591-018-0326-x</originId><crawled>1548691718069</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Mikhail V. Mesitov</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1683c74bb16:1a14eee:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Pentatricopeptide repeat poly(A) binding protein KPAF4 stabilizes mitochondrial mRNAs in &lt;i&gt;Trypanosoma brucei&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Pentatricopeptide repeat poly(A) binding protein KPAF4 stabilizes mitochondrial mRNAs in &amp;lt;i&gt;Trypanosoma brucei&amp;lt;/i&gt;, Published online: 11 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08137-2&quot;&gt;doi:10.1038/s41467-018-08137-2&lt;/a&gt;&lt;/p&gt;Polyadenylation stabilizes edited mitochondrial mRNAs in Trypanosoma brucei, but the involved poly(A) binding protein is unknown. Here, Mesitov et al. show that a pentatricopeptide repeat factor KPAF4 binds to A-tail and prevents exonucleolytic degradation as well as translation of incompletely edited mRNAs.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/zwbidnSUrb4&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/zwbidnSUrb4/s41467-018-08137-2</href></item></alternate><published>1547193600000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08137-2/MediaObjects/41467_2018_8137_Fig1_HTML.png</url><contentType>image/png</contentType><width>520</width></visual><fingerprint>7ec79e3c</fingerprint><link>https://www.nature.com/articles/s41467-018-08137-2</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08137-2</href></item></canonical><title>Pentatricopeptide repeat poly(A) binding protein KPAF4 stabilizes mitochondrial mRNAs in Trypanosoma brucei</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Pentatricopeptide repeat poly(A) binding protein KPAF4 stabilizes mitochondrial mRNAs in &lt;i&gt;Trypanosoma brucei&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Pentatricopeptide repeat poly(A) binding protein KPAF4 stabilizes mitochondrial mRNAs in &amp;lt;i&gt;Trypanosoma brucei&amp;lt;/i&gt;, Published online: 11 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08137-2&quot;&gt;doi:10.1038/s41467-018-08137-2&lt;/a&gt;&lt;/p&gt;Polyadenylation stabilizes edited mitochondrial mRNAs in Trypanosoma brucei, but the involved poly(A) binding protein is unknown. Here, Mesitov et al. show that a pentatricopeptide repeat factor KPAF4 binds to A-tail and prevents exonucleolytic degradation as well as translation of incompletely edited mRNAs.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/zwbidnSUrb4&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-08137-2</originId><crawled>1547202509590</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Smith, K. T.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168a5541f68:15080a3:3a104d3b</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6426/494-n?rss=1</href></item></alternate><published>1548959829000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>92b8d063</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6426/494-n?rss=1</link><engagement>0</engagement><title>Oscillating x-rays reveal black hole spin</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6426/494-n?rss=1</originId><crawled>1548961980264</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6426/494.14.full</canonicalUrl><keywords><item>Astronomy, Physics</item></keywords></item><item><author><name>Nathalia D. de Moura Sperotto, Candida Deves Roth, Valnês S. Rodrigues-Junior, Christiano Ev Neves, Fávero Reisdorfer Paula, Adilio da Silva Dadda, Pedro Bergo, Talita Freitas de Freitas, Fernanda Souza Macchi, Sidnei Moura, Ana Paula Duarte de Souza, Maria Martha Campos, Cristiano Valim Bizarro, Diógenes Santiago Santos, Luiz Augusto Basso, Pablo Machado</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_1685e8483fd:112c07:1451c985</id><published>1547701200000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01305/20190117/images/medium/jm-2018-01305w_0009.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01305&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=6XYcrIEeAJ4:A_88tSO4KZU:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/6XYcrIEeAJ4&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>26000795</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01305</link><crawled>1547773969405</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01305</href></item></canonical><engagement>0</engagement><title>[ASAP] Design of Novel Inhibitors of Human Thymidine Phosphorylase: Synthesis, Enzyme Inhibition, in Vitro Toxicity, and Impact on Human Glioblastoma Cancer</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01305/20190117/images/medium/jm-2018-01305w_0009.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01305&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=6XYcrIEeAJ4:A_88tSO4KZU:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/6XYcrIEeAJ4&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01305</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/6XYcrIEeAJ4/acs.jmedchem.8b01305</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Zhang, Y.-z.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16898aef4f6:167da1:ad2b6584</id><content><direction>ltr</direction><content>Structure variants (SVs) are complex genomic alterations with affected genome sizes larger than 50 nucleotides. They have been found in both healthy individuals and patients, which contribute to phenotypic traits and are highly correlated with diseases, such as cancer. With the advance of sequencing technologies, more precise profiling of SVs becomes available. It is still a challenging task to determine SVs in nucleotide-resolution with satisfying both high accuracy and coverage for a single sample. In this paper, we proposed a novel nucleotide-resolution SV detection method for determining SV fragments inside of bin with base-pair read-depth (RD) information. Distinguished from traditional RD based SV detectors, which usually require grouping and smoothing RD signals at the scale of a bin, we used a U-net model to directly process base-pair RD signals inside of a bin and learn feature representations for intra-bin SV segmentation. The proposed method can be used solely for searching target SVs with RD signature or integrated with previous bin-based SV detection methods to exceed the bin-size limitation. We did a systematic evaluation of the method using WGS data from 1000 Genomes Project. In both single-sample and cross-sample experiments, the U-net model achieves significantly better performances on detecting intra-bin SV fragments, when compared with convolutional neural networks (CNN). Furthermore, the model shows a good ability to detect specific SV subtypes, such as ALU deletion.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/503649v2?rss=1</href></item></alternate><published>1548662400000</published><unread>True</unread><fingerprint>91fd9405</fingerprint><link>http://biorxiv.org/cgi/content/short/503649v2?rss=1</link><engagement>0</engagement><title>Intra-bin structural variant segmentation for whole-genome sequencing data using U-net [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Structure variants (SVs) are complex genomic alterations with affected genome sizes larger than 50 nucleotides. They have been found in both healthy individuals and patients, which contribute to phenotypic traits and are highly correlated with diseases, such as cancer. With the advance of sequencing technologies, more precise profiling of SVs becomes available. It is still a challenging task to determine SVs in nucleotide-resolution with satisfying both high accuracy and coverage for a single sample. In this paper, we proposed a novel nucleotide-resolution SV detection method for determining SV fragments inside of bin with base-pair read-depth (RD) information. Distinguished from traditional RD based SV detectors, which usually require grouping and smoothing RD signals at the scale of a bin, we used a U-net model to directly process base-pair RD signals inside of a bin and learn feature representations for intra-bin SV segmentation. The proposed method can be used solely for searching target SVs with RD signature or integrated with previous bin-based SV detection methods to exceed the bin-size limitation. We did a systematic evaluation of the method using WGS data from 1000 Genomes Project. In both single-sample and cross-sample experiments, the U-net model achieves significantly better performances on detecting intra-bin SV fragments, when compared with convolutional neural networks (CNN). Furthermore, the model shows a good ability to detect specific SV subtypes, such as ALU deletion.</description><originId>http://biorxiv.org/cgi/content/short/503649v2?rss=1</originId><crawled>1548749829366</crawled><canonicalUrl>https://www.biorxiv.org/content/10.1101/503649v2</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Osato, N.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1682fc1b2bd:7222c8:3a104d3b</id><content><direction>ltr</direction><content>Chromatin interactions have important roles for enhancer-promoter interactions (EPI) and regulating the transcription of genes. CTCF and cohesin proteins are located at the anchors of chromatin interactions, forming their loop structures. CTCF has insulator function limiting the activity of enhancers into the loops. DNA binding sequences of CTCF indicate their orientation bias at chromatin interaction anchors - forward-reverse (FR) orientation is frequently observed. DNA binding sequences of CTCF were found in open chromatin regions at about 40% - 80% of chromatin interaction anchors in Hi-C and in situ Hi-C experimental data. It has been reported that long range of chromatin interactions tends to include less CTCF at their anchors. It is still unclear what proteins are associated with chromatin interactions. To find DNA binding motif sequences of transcription factors (TF), such as CTCF, and repeat DNA sequences affecting the interaction between enhancers and promoters of genes and their expression, first I predicted TF bound in enhancers and promoters using DNA motif sequences of TF and experimental data of open chromatin regions in monocytes and other cell types, which were obtained from public and commercial databases. Second, transcriptional target genes of each TF were predicted based on enhancer-promoter association (EPA). EPA was shortened at the genomic locations of FR or reverse-forward (RF) orientation of DNA motif sequence of a TF, which were supposed to be at chromatin interaction anchors and acted as insulator sites like CTCF. The expression levels of the transcriptional target genes predicted based on the EPA were compared with those predicted from only promoters. Total 287 biased orientation of DNA motifs (159 FR and 153 RF orientation, the reverse complement sequences of some DNA motifs were also registered in databases, so the total number was smaller than the number of FR and RF) affected the expression level of putative transcriptional target genes significantly in CD14+ monocytes of four people in common. The same analysis was conducted in CD4+ T cells of four people. DNA motif sequences of CTCF, cohesin and other transcription factors involved in chromatin interactions were found to be a biased orientation. Transposon sequences, which are known to be involved in insulators and enhancers, showed a biased orientation. The biased orientation of DNA motif sequences tended to be co-localized in the same open chromatin regions. Moreover, for ~85% of FR and RF orientations of DNA motif sequences, EPI predicted from EPA that were shortened at the genomic locations of the biased orientation of DNA motif sequence were overlapped with chromatin interaction data (Hi-C and HiChIP) significantly more than other types of EPAs.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/290825v10?rss=1</href></item></alternate><published>1546934400000</published><unread>True</unread><fingerprint>245e7631</fingerprint><link>http://biorxiv.org/cgi/content/short/290825v10?rss=1</link><engagement>0</engagement><title>Discovery of biased orientation of human DNA motif sequences affecting enhancer-promoter interactions and transcription of genes [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Chromatin interactions have important roles for enhancer-promoter interactions (EPI) and regulating the transcription of genes. CTCF and cohesin proteins are located at the anchors of chromatin interactions, forming their loop structures. CTCF has insulator function limiting the activity of enhancers into the loops. DNA binding sequences of CTCF indicate their orientation bias at chromatin interaction anchors - forward-reverse (FR) orientation is frequently observed. DNA binding sequences of CTCF were found in open chromatin regions at about 40% - 80% of chromatin interaction anchors in Hi-C and in situ Hi-C experimental data. It has been reported that long range of chromatin interactions tends to include less CTCF at their anchors. It is still unclear what proteins are associated with chromatin interactions. To find DNA binding motif sequences of transcription factors (TF), such as CTCF, and repeat DNA sequences affecting the interaction between enhancers and promoters of genes and their expression, first I predicted TF bound in enhancers and promoters using DNA motif sequences of TF and experimental data of open chromatin regions in monocytes and other cell types, which were obtained from public and commercial databases. Second, transcriptional target genes of each TF were predicted based on enhancer-promoter association (EPA). EPA was shortened at the genomic locations of FR or reverse-forward (RF) orientation of DNA motif sequence of a TF, which were supposed to be at chromatin interaction anchors and acted as insulator sites like CTCF. The expression levels of the transcriptional target genes predicted based on the EPA were compared with those predicted from only promoters. Total 287 biased orientation of DNA motifs (159 FR and 153 RF orientation, the reverse complement sequences of some DNA motifs were also registered in databases, so the total number was smaller than the number of FR and RF) affected the expression level of putative transcriptional target genes significantly in CD14+ monocytes of four people in common. The same analysis was conducted in CD4+ T cells of four people. DNA motif sequences of CTCF, cohesin and other transcription factors involved in chromatin interactions were found to be a biased orientation. Transposon sequences, which are known to be involved in insulators and enhancers, showed a biased orientation. The biased orientation of DNA motif sequences tended to be co-localized in the same open chromatin regions. Moreover, for ~85% of FR and RF orientations of DNA motif sequences, EPI predicted from EPA that were shortened at the genomic locations of the biased orientation of DNA motif sequence were overlapped with chromatin interaction data (Hi-C and HiChIP) significantly more than other types of EPAs.</description><originId>http://biorxiv.org/cgi/content/short/290825v10?rss=1</originId><crawled>1546989449917</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/08/290825</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Elizabeth Gibney</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Pablo Jarillo - Herrero</text></item><item><text>Jarillo - Herrero</text></item></mentions><label>Pablo Jarillo - Herrero</label><id>nlp/f/entity/en/-/pablo jarillo - herrero</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Massachusetts Institute of Technology</text></item><item><text>MIT group</text></item><item><text>MIT</text></item></mentions><label>Massachusetts Institute of Technology</label><id>nlp/f/entity/en/w/Massachusetts Institute of Technology</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Young</text></item><item><text>Andrea Young</text></item></mentions><label>Andrea Young</label><id>nlp/f/entity/en/-/andrea young</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>2D</text></item></mentions><label>2D</label><id>nlp/f/entity/en/-/2d</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Juliette Halsey</text></item></mentions><label>Juliette Halsey</label><id>nlp/f/entity/en/-/juliette halsey</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1680e41d037:5f46bbf:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;How ‘magic angle’ graphene is stirring up physics&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How ‘magic angle’ graphene is stirring up physics, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07848-2&quot;&gt;doi:10.1038/d41586-018-07848-2&lt;/a&gt;&lt;/p&gt;Misaligned stacks of the wonder material exhibit superconductivity and other curious properties.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07848-2</href></item></alternate><published>1546416000000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07848-2/d41586-018-07848-2_16349610.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>8118d35</fingerprint><link>https://www.nature.com/articles/d41586-018-07848-2</link><engagement>6</engagement><title>How ‘magic angle’ graphene is stirring up physics</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;How ‘magic angle’ graphene is stirring up physics&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How ‘magic angle’ graphene is stirring up physics, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07848-2&quot;&gt;doi:10.1038/d41586-018-07848-2&lt;/a&gt;&lt;/p&gt;Misaligned stacks of the wonder material exhibit superconductivity and other curious properties.</description><originId>https://www.nature.com/articles/d41586-018-07848-2</originId><crawled>1546427420727</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>Saxon State Railways</text></item></mentions><label>Saxon State Railways</label><id>nlp/f/entity/en/-/saxon state railways</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>daily Nature Briefing</text></item></mentions><label>daily Nature Briefing</label><id>nlp/f/entity/en/-/daily nature briefing</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Dubois ergograph</text></item></mentions><label>Dubois ergograph</label><id>nlp/f/entity/en/-/dubois ergograph</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Dresden</text></item></mentions><label>Dresden</label><id>nlp/f/entity/en/w/Dresden</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1682dd7e14e:41314d:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;From the archive&lt;/b&gt;&lt;/p&gt;&lt;p&gt;From the archive, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00028-w&quot;&gt;doi:10.1038/d41586-019-00028-w&lt;/a&gt;&lt;/p&gt;How Nature reported psychometric testing in 1919, and its own hundredth anniversary in 1969.</content></content><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00028-w</href></item></alternate><published>1546934400000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00028-w/d41586-019-00028-w_15948436.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>bf80c35b</fingerprint><link>https://www.nature.com/articles/d41586-019-00028-w</link><engagement>0</engagement><title>From the archive</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;From the archive&lt;/b&gt;&lt;/p&gt;&lt;p&gt;From the archive, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00028-w&quot;&gt;doi:10.1038/d41586-019-00028-w&lt;/a&gt;&lt;/p&gt;How Nature reported psychometric testing in 1919, and its own hundredth anniversary in 1969.</description><originId>https://www.nature.com/articles/d41586-019-00028-w</originId><crawled>1546957349198</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1689a6b3fcd:435e7d:ad2b6584</id><published>1548720000000</published><unread>True</unread><summary><direction>ltr</direction><content>The interactions among fluid species such as H2O, CO2, and CH4 confined in nano- and meso-pores in shales and other rocks is of central concern to understanding the chemical behavior and transport properties of these species in the earth’s subsurface and is of special concern to geological C-sequestration and enhanced production of oil and natural gas. The behavior of CO2, and CH4 are less well understood than that of H2O. This paper presents theresults of a computational modeling study of the partitioning of CO2 and CH4 between bulk fluid and nano- and meso-pores bounded by the common clay mineral montmorillonite. The calculations were done at 323 K and a total fluid pressure of 124 bars using a novel approach (constant reservoir composition molecular dynamics, CRC-MD) that uses bias forces to maintain a constant composition in the fluid external to the pore. This purely MD approach overcomes the difficulties in making stochastic particle insertion-deletion moves in dense fluids encountered in grand canonical Monte Carlo and related hybrid approaches. The results show that both the basal siloxane surfaces and protonated broken edge surfaces of montmorillonite both prefer CO2 relative to CH4 suggesting that methods of enhanced oil and gas production using CO2 will readily displace CH4 from such pores. This preference for CO2 is due to its preferred interaction with the surfaces and extends to approximately 20 Å from them.</content></summary><fingerprint>d561dcaf</fingerprint><link>https://chemrxiv.org/articles/Methane_Carbon_Dioxide_Partitioning_in_Clay_Nano-_and_Meso-Pores_Molecular_Dynamics_Modeling_with_Constant_Reservoir_Composition/7638035</link><engagement>0</engagement><crawled>1548778946509</crawled><title>Methane/Carbon Dioxide Partitioning in Clay Nano- and Meso-Pores: Molecular Dynamics Modeling with Constant Reservoir Composition</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>The interactions among fluid species such as H2O, CO2, and CH4 confined in nano- and meso-pores in shales and other rocks is of central concern to understanding the chemical behavior and transport properties of these species in the earth’s subsurface and is of special concern to geological C-sequestration and enhanced production of oil and natural gas. The behavior of CO2, and CH4 are less well understood than that of H2O. This paper presents theresults of a computational modeling study of the partitioning of CO2 and CH4 between bulk fluid and nano- and meso-pores bounded by the common clay mineral montmorillonite. The calculations were done at 323 K and a total fluid pressure of 124 bars using a novel approach (constant reservoir composition molecular dynamics, CRC-MD) that uses bias forces to maintain a constant composition in the fluid external to the pore. This purely MD approach overcomes the difficulties in making stochastic particle insertion-deletion moves in dense fluids encountered in grand canonical Monte Carlo and related hybrid approaches. The results show that both the basal siloxane surfaces and protonated broken edge surfaces of montmorillonite both prefer CO2 relative to CH4 suggesting that methods of enhanced oil and gas production using CO2 will readily displace CH4 from such pores. This preference for CO2 is due to its preferred interaction with the surfaces and extends to approximately 20 Å from them.</description><originId>https://chemrxiv.org/articles/Methane_Carbon_Dioxide_Partitioning_in_Clay_Nano-_and_Meso-Pores_Molecular_Dynamics_Modeling_with_Constant_Reservoir_Composition/7638035</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Methane_Carbon_Dioxide_Partitioning_in_Clay_Nano-_and_Meso-Pores_Molecular_Dynamics_Modeling_with_Constant_Reservoir_Composition/7638035</href></item></alternate></item><item><author><name>Shuang-Shuang Wan, Lu Zhang, Xian-Zheng Zhang</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>1TYkl+7D2jbCAjv6kqe9qy39+K76tsp7YKV/mQVt7ps=_1682f640884:682b30:b77f238b</id><published>1546923600000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00822/20190108/images/medium/oc-2018-00822y_0009.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00822&lt;/div&gt;</content></summary><fingerprint>dce35aab</fingerprint><link>http://dx.doi.org/10.1021/acscentsci.8b00822</link><engagement>0</engagement><crawled>1546983311492</crawled><title>[ASAP] An ATP-Regulated Ion Transport Nanosystem for Homeostatic Perturbation Therapy and Sensitizing Photodynamic Therapy by Autophagy Inhibition of Tumors</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acscii</streamId><title>ACS Central Science: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00822/20190108/images/medium/oc-2018-00822y_0009.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00822&lt;/div&gt;</description><originId>http://dx.doi.org/10.1021/acscentsci.8b00822</originId><alternate><item><type>text/html</type><href>http://dx.doi.org/10.1021/acscentsci.8b00822</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Fangqun Yu</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>SOA</text></item></mentions><label>SOA</label><id>nlp/f/entity/en/-/soa</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>VOCs</text></item></mentions><label>Volatile organic compound</label><id>nlp/f/entity/en/w/Volatile organic compound</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>SOAs</text></item></mentions><label>SOAS, University of London</label><id>nlp/f/entity/en/w/SOAS, University of London</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>McFiggans et al</text></item><item><text>McFiggans</text></item></mentions><label>McFiggans et al</label><id>nlp/f/entity/en/-/mcfiggans et al</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Monoterpene</text></item><item><text>monoterpenes</text></item></mentions><label>Monoterpene</label><id>nlp/f/entity/en/w/Monoterpene</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ff99aeb:c7ac5b:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Atmospheric reaction networks affecting climate are more complex than was thought&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Atmospheric reaction networks affecting climate are more complex than was thought, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00263-1&quot;&gt;doi:10.1038/d41586-019-00263-1&lt;/a&gt;&lt;/p&gt;Experiments show that the amount of atmospheric particles produced from plant emissions could be lower than was thought — challenging our understanding of the processes that affect air quality and climate.</content></content><engagementRate>0.13</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00263-1</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><height>450</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00263-1/d41586-019-00263-1_16423372.jpg</url><contentType>image/jpeg</contentType><width>800</width></visual><fingerprint>e4cdf91c</fingerprint><commonTopics><item><probability>0.873</probability><label>climate</label><id>nlp/f/topic/482</id></item><item><probability>0.749</probability><label>biochemistry</label><id>nlp/f/topic/257</id></item><item><probability>0.721</probability><label>environment</label><id>nlp/f/topic/780</id></item><item><probability>0.705</probability><label>energy</label><id>nlp/f/topic/772</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00263-1</link><engagement>1</engagement><title>Atmospheric reaction networks affecting climate are more complex than was thought</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Atmospheric reaction networks affecting climate are more complex than was thought&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Atmospheric reaction networks affecting climate are more complex than was thought, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00263-1&quot;&gt;doi:10.1038/d41586-019-00263-1&lt;/a&gt;&lt;/p&gt;Experiments show that the amount of atmospheric particles produced from plant emissions could be lower than was thought — challenging our understanding of the processes that affect air quality and climate.</description><originId>https://www.nature.com/articles/d41586-019-00263-1</originId><crawled>1548872162027</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Dogyun Byeon</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1682d035c6a:2a73e3:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Discovery of colossal Seebeck effect in metallic Cu&lt;sub&gt;2&lt;/sub&gt;Se&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Discovery of colossal Seebeck effect in metallic Cu&amp;lt;sub&gt;2&amp;lt;/sub&gt;Se, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07877-5&quot;&gt;doi:10.1038/s41467-018-07877-5&lt;/a&gt;&lt;/p&gt;Recent research efforts have aimed at discovering thermoelectric materials with high efficiency in the middle-low temperature range, where a majority of waste heat is lost to the ambient. Here, the authors discover colossal Seebeck coefficient values in metallic copper selenide from 340 K to 400 K.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/2NBlDTCJFNI&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/2NBlDTCJFNI/s41467-018-07877-5</href></item></alternate><published>1546934400000</published><unread>True</unread><visual><height>201</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-07877-5/MediaObjects/41467_2018_7877_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>2e56b44e</fingerprint><link>https://www.nature.com/articles/s41467-018-07877-5</link><engagement>21</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-07877-5</href></item></canonical><title>Discovery of colossal Seebeck effect in metallic Cu2Se</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Discovery of colossal Seebeck effect in metallic Cu&lt;sub&gt;2&lt;/sub&gt;Se&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Discovery of colossal Seebeck effect in metallic Cu&amp;lt;sub&gt;2&amp;lt;/sub&gt;Se, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07877-5&quot;&gt;doi:10.1038/s41467-018-07877-5&lt;/a&gt;&lt;/p&gt;Recent research efforts have aimed at discovering thermoelectric materials with high efficiency in the middle-low temperature range, where a majority of waste heat is lost to the ambient. Here, the authors discover colossal Seebeck coefficient values in metallic copper selenide from 340 K to 400 K.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/2NBlDTCJFNI&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-07877-5</originId><crawled>1546943421546</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Reed, E.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16830362b68:7e1a5a:8675cc2c</id><content><direction>ltr</direction><content>The need to reduce per sample cost of RNA-seq profiling for scalable data generation has led to the emergence of highly multiplexed RNA-seq. These technologies utilize barcoding of cDNA sequences in order to combine samples into single sequencing lane to be separated during data processing. In this study, we report the performance of one such technique denoted as sparse full length sequencing (SFL), a ribosomal RNA depletion-based RNA sequencing approach that allows for the simultaneous sequencing of 96 samples and higher. We offer comparisons to well established single-sample techniques, including: full coverage Poly-A capture RNA-seq and microarray, as well as another low-cost highly multiplexed technique known as 3&apos; digital gene expression (3&apos;DGE). Data was generated for a set of exposure experiments on immortalized human lung epithelial (AALE) cells in a two-by-two study design, in which samples received both genetic and chemical perturbations of known oncogenes/tumor suppressors and lung carcinogens. SFL demonstrated improved performance over 3&apos;DGE in terms of coverage, power to detect differential gene expression, and biological recapitulation of patterns of differential gene expression from in vivo lung cancer mutation signatures.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/419838v2?rss=1</href></item></alternate><published>1546934400000</published><unread>True</unread><fingerprint>e5f8defe</fingerprint><link>http://biorxiv.org/cgi/content/short/419838v2?rss=1</link><engagement>0</engagement><title>Assessment of a highly multiplexed RNA sequencing platform and comparison to existing high-throughput gene expression profiling techniques [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>The need to reduce per sample cost of RNA-seq profiling for scalable data generation has led to the emergence of highly multiplexed RNA-seq. These technologies utilize barcoding of cDNA sequences in order to combine samples into single sequencing lane to be separated during data processing. In this study, we report the performance of one such technique denoted as sparse full length sequencing (SFL), a ribosomal RNA depletion-based RNA sequencing approach that allows for the simultaneous sequencing of 96 samples and higher. We offer comparisons to well established single-sample techniques, including: full coverage Poly-A capture RNA-seq and microarray, as well as another low-cost highly multiplexed technique known as 3&apos; digital gene expression (3&apos;DGE). Data was generated for a set of exposure experiments on immortalized human lung epithelial (AALE) cells in a two-by-two study design, in which samples received both genetic and chemical perturbations of known oncogenes/tumor suppressors and lung carcinogens. SFL demonstrated improved performance over 3&apos;DGE in terms of coverage, power to detect differential gene expression, and biological recapitulation of patterns of differential gene expression from in vivo lung cancer mutation signatures.</description><originId>http://biorxiv.org/cgi/content/short/419838v2?rss=1</originId><crawled>1546997082984</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/08/419838</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Busia, A.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16897df452a:3adf7:ad2b6584</id><content><direction>ltr</direction><content>Motivation: Inferring properties of biological sequences--such as determining the species-of-origin of a DNA sequence or the function of an amino-acid sequence--is a core task in many bioinformatics applications. These tasks are often solved using string-matching to map query sequences to labeled database sequences or via Hidden Markov Model-like pattern matching. In the current work we describe and assess an deep learning approach which trains a deep neural network (DNN) to predict database-derived labels directly from query sequences. Results: We demonstrate this DNN performs at state-of-the-art or above levels on a difficult, practically important problem: predicting species-of-origin from short reads of 16S ribosomal DNA. When trained on 16S sequences of over 13,000 distinct species, our DNN achieves read-level species classification accuracy within 2.0% of perfect memorization of training data, and produces more accurate genus-level assignments for reads from held-out species than k-mer, alignment, and taxonomic binning baselines. Moreover, our models exhibit greater robustness than these existing approaches to increasing noise in the query sequences. Finally, we show that these DNNs perform well on experimental 16S mock community dataset. Overall, our results constitute a first step towards our long-term goal of developing a general-purpose deep learning approach to predicting meaningful labels from short biological sequences. Availability: TensorFlow training code is available through GitHub (https://github.com/tensorflow/models/tree/master/research). Data in TensorFlow TFRecord format is available on Google Cloud Storage (gs://brain-genomics-public/research/seq2species/). Contact: seq2species-interest@google.com. Supplementary information: Supplementary data are available in a separate document.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/353474v2?rss=1</href></item></alternate><published>1548662400000</published><unread>True</unread><fingerprint>d1ce7f40</fingerprint><link>http://biorxiv.org/cgi/content/short/353474v2?rss=1</link><engagement>0</engagement><title>A deep learning approach to pattern recognition for short DNA sequences [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Motivation: Inferring properties of biological sequences--such as determining the species-of-origin of a DNA sequence or the function of an amino-acid sequence--is a core task in many bioinformatics applications. These tasks are often solved using string-matching to map query sequences to labeled database sequences or via Hidden Markov Model-like pattern matching. In the current work we describe and assess an deep learning approach which trains a deep neural network (DNN) to predict database-derived labels directly from query sequences. Results: We demonstrate this DNN performs at state-of-the-art or above levels on a difficult, practically important problem: predicting species-of-origin from short reads of 16S ribosomal DNA. When trained on 16S sequences of over 13,000 distinct species, our DNN achieves read-level species classification accuracy within 2.0% of perfect memorization of training data, and produces more accurate genus-level assignments for reads from held-out species than k-mer, alignment, and taxonomic binning baselines. Moreover, our models exhibit greater robustness than these existing approaches to increasing noise in the query sequences. Finally, we show that these DNNs perform well on experimental 16S mock community dataset. Overall, our results constitute a first step towards our long-term goal of developing a general-purpose deep learning approach to predicting meaningful labels from short biological sequences. Availability: TensorFlow training code is available through GitHub (https://github.com/tensorflow/models/tree/master/research). Data in TensorFlow TFRecord format is available on Google Cloud Storage (gs://brain-genomics-public/research/seq2species/). Contact: seq2species-interest@google.com. Supplementary information: Supplementary data are available in a separate document.</description><originId>http://biorxiv.org/cgi/content/short/353474v2?rss=1</originId><crawled>1548736218410</crawled><canonicalUrl>https://www.biorxiv.org/content/10.1101/353474v2</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Jeffrey T. Morgan</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Biol</text></item><item><text>J. Biol</text></item></mentions><label>J. Biol</label><id>nlp/f/entity/en/-/j. biol</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>R.</text></item></mentions><label>R.</label><id>nlp/f/entity/en/-/r.</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>J.</text></item><item><text>J. M.</text></item><item><text>J</text></item></mentions><label>John Milton</label><id>nlp/f/entity/en/w/John Milton</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>S.</text></item></mentions><label>S.</label><id>nlp/f/entity/en/-/s.</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Koonin</text></item></mentions><label>Eugene Koonin</label><id>nlp/f/entity/en/w/Eugene Koonin</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16857ddbaa0:3dd05e9:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Excised linear introns regulate growth in yeast&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Excised linear introns regulate growth in yeast, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0828-1&quot;&gt;doi:10.1038/s41586-018-0828-1&lt;/a&gt;&lt;/p&gt;A set of 34 excised introns in Saccharomyces cerevisiae, characterized by having a short distance between the lariat branch point and the 3′ splice site, have a biological function within the TOR growth-signalling network.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0828-1</href></item></alternate><published>1547625600000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0828-1/MediaObjects/41586_2018_828_Fig1_HTML.png</url><contentType>image/png</contentType><width>679</width></visual><fingerprint>829754de</fingerprint><commonTopics><item><probability>0.98</probability><label>classics</label><id>nlp/f/topic/477</id></item><item><probability>0.948</probability><label>bioinformatics</label><id>nlp/f/topic/262</id></item><item><probability>0.919</probability><label>genetics</label><id>nlp/f/topic/955</id></item><item><probability>0.842</probability><label>mp3</label><id>nlp/f/topic/1508</id></item><item><probability>0.764</probability><label>emergency medicine</label><id>nlp/f/topic/764</id></item><item><probability>0.705</probability><label>data science</label><id>nlp/f/topic/618</id></item></commonTopics><link>https://www.nature.com/articles/s41586-018-0828-1</link><engagement>8</engagement><title>Excised linear introns regulate growth in yeast</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Excised linear introns regulate growth in yeast&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Excised linear introns regulate growth in yeast, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0828-1&quot;&gt;doi:10.1038/s41586-018-0828-1&lt;/a&gt;&lt;/p&gt;A set of 34 excised introns in Saccharomyces cerevisiae, characterized by having a short distance between the lariat branch point and the 3′ splice site, have a biological function within the TOR growth-signalling network.</description><originId>https://www.nature.com/articles/s41586-018-0828-1</originId><crawled>1547662375584</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Derek Lowe</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Target</text></item></mentions><label>Target Corporation</label><id>nlp/f/entity/en/w/Target Corporation</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>PNP</text></item><item><text>PNP enzyme</text></item></mentions><label>PNP enzyme</label><id>nlp/f/entity/en/-/pnp enzyme</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>SPR</text></item></mentions><label>SPR</label><id>nlp/f/entity/en/-/spr</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Plasmodium</text></item></mentions><label>Plasmodium</label><id>nlp/f/entity/en/w/Plasmodium</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>mal aria</text></item></mentions><label>mal aria</label><id>nlp/f/entity/en/-/mal aria</id></item></entities><id>2k24/TFePIh3MUUJr/vqRk++EkKG/RZ2TtOvsKiJXX4=_168763aff30:2596e6a:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;Every “history of pharmaceuticals” article ever written probably mentions &lt;a href=&quot;https://en.wikipedia.org/wiki/Quinine&quot;&gt;quinine&lt;/a&gt;, and well they should. (I certainly reserved an entry for it while writing my own &lt;a href=&quot;https://amzn.to/2T6vOUn&quot;&gt;chemical history book&lt;/a&gt;). It’s a classic example of a natural product drug, one that was not known to the classical Mediterranean world but was only appreciated by Europeans after they came into contact with the New World civilizations. Malaria was &lt;a href=&quot;https://en.wikipedia.org/wiki/History_of_malaria&quot;&gt;most certainly known&lt;/a&gt; to them – it was a disease thought to be cause by harmful vapors (&lt;em&gt;mal aria&lt;/em&gt;) particularly in warm, humid areas, but there was no effective treatment in the Old World pharmacopeia. The bark of the cinchona tree, though, was something new. It had been used by natives of the Inca Empire to treat shivering, and since that was a notable feature of malaria cases, the Spanish Jesuits who brought the bark to Europe tried it for that with notable success.&lt;/p&gt;
&lt;p&gt;And as the idea of active natural products began to take hold, quinine itself was isolated as a pure substance in 1820. Later in the 19th century, with the &lt;em&gt;Plasmodium&lt;/em&gt; parasites were identified as the cause of the disease, it was clear that quinine was affecting the organisms directly. But how? It may come as a surprise, but despite a great deal of work that’s still been unclear – if you’re looking for one, it’s a pretty good example of how tricky drug research can be. The mode of action of any of the antimalarial drugs (of any class) has been hard to pin down, for that matter, and it’s not for lack of trying. Chloroquine is perhaps the &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057915/&quot;&gt;best worked-out&lt;/a&gt; of the bunch, but quinine doesn’t quite seem to share its proposed mode of action.&lt;/p&gt;
&lt;p&gt;Here, though, is a &lt;a href=&quot;http://stm.sciencemag.org/content/11/473/eaau3174&quot;&gt;new paper&lt;/a&gt; with what might be an answer. A Singapore-Karolinska collaboration tackled the problem with one of the best target ID technologies available, MS-CETSA. The Nordlund lab, which spans both locations, was the source of the &lt;a href=&quot;https://blogs.sciencemag.org/pipeline/archives/2014/04/02/binding_assays_inside_the_actual_cells&quot;&gt;first CETSA paper&lt;/a&gt;, and they’ve continued to develop the technique. The idea is that when a ligand binds to a protein target, it stabilizes it – the complex has to be lower-energy overall, or it wouldn’t form in the first place. And if you heat up a protein with and without such a ligand, you can see the effect on its melting and denaturation (that’s the DSF assay, differential scanning fluorimetry).&lt;/p&gt;
&lt;p&gt;Wildly, this even works in living cells, which is the CETSA assay. Heat is a real stress situation on them, since proteins get misfolded/denatured under those conditions and tend to turn insoluble. If you lyse the cells, with and without compound treatment, and look for how much soluble protein target is left, it’s a measure of how much a compound stabilized it under the heat. Combining this with modern mass spec proteomics, you can do this trick and then &lt;em&gt;monitor the whole proteome&lt;/em&gt; (OK, a lot of it) to see which proteins were stabilized, and thus identify targets from scratch: MS-CETSA. No labels needed, real cells, whatever dosages and time points you want to try.&lt;/p&gt;
&lt;p&gt;Doing that with &lt;em&gt;Plasmodium falciparum&lt;/em&gt; (and with infected red blood cells) after treatment with both quinine and &lt;a href=&quot;https://en.wikipedia.org/wiki/Mefloquine&quot;&gt;mefloquine&lt;/a&gt; identified the organism’s &lt;a href=&quot;https://en.wikipedia.org/wiki/Purine_nucleoside_phosphorylase&quot;&gt;purine nucleoside phosphorylase&lt;/a&gt; enzyme (PfPNP) as a target of both drugs. These assays weren’t trivial to set up, but after a good deal of optimization they’ve provided a new look at the proteomes of both the malaria parasites and of erythrocytes. That will be an excellent baseline for further CETSA work in either system. The troubleshooting and validation took place with &lt;a href=&quot;https://en.wikipedia.org/wiki/Pyrimethamine&quot;&gt;pyrimethamine&lt;/a&gt; (famous these days as Daraprim), which is largely useless in the field these days against malaria, but whose target (dihydrofolate reductase) is well characterized.&lt;/p&gt;
&lt;p&gt;Interestingly, resistance to mefloquine isn’t mediated by mutations in that enzyme; that’s instead via a changed transporter protein that becomes available to pump them out of the organism’s cytosol. And it turns out that mefloquine is a much weaker binder than quinine itself (40 micromolar versus 30 nanomolar, in an SPR assay), so the PNP enzyme is probably mainly relevant just for quinine’s effects. A DSF screen  showed that &lt;a href=&quot;https://en.wikipedia.org/wiki/Quinidine&quot;&gt;quinidine&lt;/a&gt; (a quinine stereoisomer) is an even weaker binder, while &lt;a href=&quot;https://en.wikipedia.org/wiki/Chloroquine&quot;&gt;chloroquine&lt;/a&gt;, &lt;a href=&quot;https://en.wikipedia.org/wiki/Primaquine&quot;&gt;primaquine&lt;/a&gt; and another antimalarial (&lt;a href=&quot;https://en.wikipedia.org/wiki/Lumefantrine&quot;&gt;lumefantrine)&lt;/a&gt; don’t even seem to bind to PfPNP at all. No wonder it’s been taking so long to unravel all this.&lt;/p&gt;
&lt;p&gt;The team was able to obtain a very nice X-ray structure of quinine bound to PfPNP itself, and that picture alone (quinine bound to its target!) is something that many people in the field wondered when (and if) they’d ever see. As it turns out, though, it isn’t a new target itself. PNP inhibitors have &lt;a href=&quot;https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026916&quot;&gt;already been pursued&lt;/a&gt; as antimalarials from first principles, with the idea of targeting the parasite’s purine salvage pathway. But no one realized that the first antimalarial of them all was working through the same mechanism! Quinine itself may still have some other modes of action (all of these compounds are a mess, and if you think this is bad you should see the MOA work on &lt;a href=&quot;https://en.wikipedia.org/wiki/Artemisinin&quot;&gt;artemisinin&lt;/a&gt;). But this certainly appears to be the main one, and I think that case can finally be closed, after hundreds of years.&lt;/p&gt;</content></content><updateCount>6</updateCount><alternate><item><type>text/html</type><href>https://blogs.sciencemag.org/pipeline/archives/2019/01/22/quinines-target</href></item></alternate><published>1548171681000</published><unread>True</unread><origin><htmlUrl>https://blogs.sciencemag.org/pipeline</htmlUrl><streamId>feed/http://blogs.sciencemag.org/pipeline/feed</streamId><title>Sciencemag</title></origin><fingerprint>51506cdc</fingerprint><commonTopics><item><probability>0.928</probability><label>drug discovery</label><id>nlp/f/topic/697</id></item><item><probability>0.83</probability><label>proteomics</label><id>nlp/f/topic/1840</id></item></commonTopics><link>http://blogs.sciencemag.org/pipeline/?p=14120</link><recrawled>1548961812937</recrawled><engagement>28</engagement><title>Quinine’s Target</title><summary><direction>ltr</direction><content>Every “history of pharmaceuticals” article ever written probably mentions quinine, and well they should. (I certainly reserved an entry for it while writing my own chemical history book). It’s a classic example of a natural product drug, one that was not known to the classical Mediterranean world but was only appreciated by Europeans after they</content></summary><description>Every “history of pharmaceuticals” article ever written probably mentions quinine, and well they should. (I certainly reserved an entry for it while writing my own chemical history book). It’s a classic example of a natural product drug, one that was not known to the classical Mediterranean world but was only appreciated by Europeans after they</description><originId>http://blogs.sciencemag.org/pipeline/?p=14120</originId><crawled>1548171804464</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><keywords><item>Biological News</item><item>Chemical Biology</item><item>Infectious Diseases</item></keywords></item><item><author><name>Han, A. X.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16863cda9d5:fb24eb:3a104d3b</id><content><direction>ltr</direction><content>Sub-species nomenclature systems of pathogens are increasingly based on sequence data. The use of phylogenetics to identify and differentiate between clusters of genetically similar pathogens is particularly prevalent in virology from the nomenclature of human papillomaviruses to highly pathogenic avian influenza (HPAI) H5Nx viruses. These nomenclature systems rely on absolute genetic distance thresholds to define the maximum genetic divergence tolerated between viruses designated as closely related. However, the phylogenetic clustering methods used in these nomenclature systems are limited by the arbitrariness of setting intra- and inter-cluster diversity thresholds. The lack of a consensus ground truth to define well-delineated, meaningful phylogenetic subpopulations amplifies the difficulties in identifying an informative distance threshold. Consequently, phylogenetic clustering often becomes an exploratory, ad-hoc exercise. Phylogenetic Clustering by Linear Integer Programming (PhyCLIP) was developed to provide a statistically-principled phylogenetic clustering framework that negates the need for an arbitrarily-defined distance threshold. Using the pairwise patristic distance distributions of an input phylogeny, PhyCLIP parameterises the intra- and inter-cluster divergence limits as statistical bounds in an integer linear programming model which is subsequently optimised to cluster as many sequences as possible. When applied to the hemagglutinin phylogeny of HPAI H5Nx viruses, PhyCLIP was not only able to recapitulate the current WHO/OIE/FAO H5 nomenclature system but also further delineated informative higher resolution clusters that capture geographically-distinct subpopulations of viruses. PhyCLIP is pathogen-agnostic and can be generalised to a wide variety of research questions concerning the identification of biologically informative clusters in pathogen phylogenies. PhyCLIP is freely available at http://github.com/alvinxhan/PhyCLIP.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/446716v3?rss=1</href></item></alternate><published>1547798400000</published><unread>True</unread><fingerprint>81e0215c</fingerprint><link>http://biorxiv.org/cgi/content/short/446716v3?rss=1</link><engagement>0</engagement><title>Phylogenetic Clustering by Linear Integer Programming (PhyCLIP) [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Sub-species nomenclature systems of pathogens are increasingly based on sequence data. The use of phylogenetics to identify and differentiate between clusters of genetically similar pathogens is particularly prevalent in virology from the nomenclature of human papillomaviruses to highly pathogenic avian influenza (HPAI) H5Nx viruses. These nomenclature systems rely on absolute genetic distance thresholds to define the maximum genetic divergence tolerated between viruses designated as closely related. However, the phylogenetic clustering methods used in these nomenclature systems are limited by the arbitrariness of setting intra- and inter-cluster diversity thresholds. The lack of a consensus ground truth to define well-delineated, meaningful phylogenetic subpopulations amplifies the difficulties in identifying an informative distance threshold. Consequently, phylogenetic clustering often becomes an exploratory, ad-hoc exercise. Phylogenetic Clustering by Linear Integer Programming (PhyCLIP) was developed to provide a statistically-principled phylogenetic clustering framework that negates the need for an arbitrarily-defined distance threshold. Using the pairwise patristic distance distributions of an input phylogeny, PhyCLIP parameterises the intra- and inter-cluster divergence limits as statistical bounds in an integer linear programming model which is subsequently optimised to cluster as many sequences as possible. When applied to the hemagglutinin phylogeny of HPAI H5Nx viruses, PhyCLIP was not only able to recapitulate the current WHO/OIE/FAO H5 nomenclature system but also further delineated informative higher resolution clusters that capture geographically-distinct subpopulations of viruses. PhyCLIP is pathogen-agnostic and can be generalised to a wide variety of research questions concerning the identification of biologically informative clusters in pathogen phylogenies. PhyCLIP is freely available at http://github.com/alvinxhan/PhyCLIP.</description><originId>http://biorxiv.org/cgi/content/short/446716v3?rss=1</originId><crawled>1547862649301</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/18/446716</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Vinson, V.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a65:c2ce2e2e</id><published>1548355045000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>782445f</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6425/361-f?rss=1</link><engagement>0</engagement><crawled>1548357093757</crawled><title>Turning on the clock</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6425/361-f?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/361-f?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6425/361.6.full</canonicalUrl></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_168290d10df:162ecf9:c2ce2e2e</id><published>1546819200000</published><unread>True</unread><summary><direction>ltr</direction><content>Biodegradable poly lactic-co-glycolic acid (PLGA) microspheres can be used to encapsulate peptide and offer a promising drug delivery vehicle. In this work we investigate the dynamics of PLGA microspheres prepared by freeze-drying and the molecular mobility at lower temperatures leading to the glass transition temperature, using temperature-variable terahertz time-domain spectroscopy (THz-TDS) experiments. The microspheres were prepared using a water-in-oil-in-water (w/o/w) double emulsion technique and subsequent freeze-drying of the samples. Physical characterisation was performed by morphology measurements, scanning electron microscopy (SEM), and helium pycnometry. The THz-TDS data show two distinct transition processes, Tg,β in the range of 167-219 K, associated with local motions, and Tg,α in the range of 313-330 K associated with large-scale motions, for the microspheres examined. Using FTIR measurements in the mid-infrared we were able to characterise the interactions between a model polypeptide, exendin-4, and the PLGA copolymer. We observe a relationship between the experimentally determined Tg,β and Tg,α and free volume and microsphere dynamics.</content></summary><fingerprint>39fb0ca8</fingerprint><link>https://chemrxiv.org/articles/Terahertz_Spectroscopy_An_investigation_of_the_Structural_Dynamics_of_Freeze-Dried_PLGA_Microspheres/7547222</link><engagement>0</engagement><crawled>1546876948703</crawled><title>Terahertz Spectroscopy: An investigation of the  Structural Dynamics of Freeze-Dried PLGA Microspheres</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>Biodegradable poly lactic-co-glycolic acid (PLGA) microspheres can be used to encapsulate peptide and offer a promising drug delivery vehicle. In this work we investigate the dynamics of PLGA microspheres prepared by freeze-drying and the molecular mobility at lower temperatures leading to the glass transition temperature, using temperature-variable terahertz time-domain spectroscopy (THz-TDS) experiments. The microspheres were prepared using a water-in-oil-in-water (w/o/w) double emulsion technique and subsequent freeze-drying of the samples. Physical characterisation was performed by morphology measurements, scanning electron microscopy (SEM), and helium pycnometry. The THz-TDS data show two distinct transition processes, Tg,β in the range of 167-219 K, associated with local motions, and Tg,α in the range of 313-330 K associated with large-scale motions, for the microspheres examined. Using FTIR measurements in the mid-infrared we were able to characterise the interactions between a model polypeptide, exendin-4, and the PLGA copolymer. We observe a relationship between the experimentally determined Tg,β and Tg,α and free volume and microsphere dynamics.</description><originId>https://chemrxiv.org/articles/Terahertz_Spectroscopy_An_investigation_of_the_Structural_Dynamics_of_Freeze-Dried_PLGA_Microspheres/7547222</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Terahertz_Spectroscopy_An_investigation_of_the_Structural_Dynamics_of_Freeze-Dried_PLGA_Microspheres/7547222</href></item></alternate></item><item><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Chinese</text></item></mentions><label>Chinese</label><id>nlp/f/entity/en/-/chinese</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Ebola</text></item></mentions><label>Ebola virus disease</label><id>nlp/f/entity/en/w/Ebola virus disease</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Anna Balazs</text></item></mentions><label>Anna Balazs</label><id>nlp/f/entity/en/-/anna balazs</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>University of Pittsburgh</text></item></mentions><label>University of Pittsburgh</label><id>nlp/f/entity/en/w/University of Pittsburgh</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Pennsylvania</text></item></mentions><label>Pennsylvania</label><id>nlp/f/entity/en/w/Pennsylvania</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1682976e704:16d834f:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;New Ebola-like virus found in a Chinese bat’s liver&lt;/b&gt;&lt;/p&gt;&lt;p&gt;New Ebola-like virus found in a Chinese bat’s liver, Published online: 07 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00022-2&quot;&gt;doi:10.1038/d41586-019-00022-2&lt;/a&gt;&lt;/p&gt;The Měnglà virus can infect human cells but the risk of its transmission from bats to humans is unknown.</content></content><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00022-2</href></item></alternate><published>1546848000000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00022-2/d41586-019-00022-2_16380156.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>3a1f76c3</fingerprint><commonTopics><item><probability>0.969</probability><label>robotics</label><id>nlp/f/topic/1955</id></item><item><probability>0.862</probability><label>swimming</label><id>nlp/f/topic/2220</id></item><item><probability>0.852</probability><label>biochemistry</label><id>nlp/f/topic/257</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00022-2</link><engagement>8</engagement><title>New Ebola-like virus found in a Chinese bat’s liver</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;New Ebola-like virus found in a Chinese bat’s liver&lt;/b&gt;&lt;/p&gt;&lt;p&gt;New Ebola-like virus found in a Chinese bat’s liver, Published online: 07 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00022-2&quot;&gt;doi:10.1038/d41586-019-00022-2&lt;/a&gt;&lt;/p&gt;The Měnglà virus can infect human cells but the risk of its transmission from bats to humans is unknown.</description><originId>https://www.nature.com/articles/d41586-019-00022-2</originId><crawled>1546883884804</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Yilan Ouyang, Yanlei Yu, Fuming Zhang, Jianle Chen, Xiaorui Han, Ke Xia, Yiming Yao, Zhenqing Zhang, Robert J. Linhardt</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_1684d6d1d93:1030911:eba6efc8</id><published>1547442000000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01551/20190114/images/medium/jm-2018-01551r_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01551&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=ohRML5C8J4I:MV-Gvp6JiMU:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/ohRML5C8J4I&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>3ce745c5</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01551</link><crawled>1547487223187</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01551</href></item></canonical><engagement>0</engagement><title>[ASAP] Non-Anticoagulant Low Molecular Weight Heparins for Pharmaceutical Applications</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01551/20190114/images/medium/jm-2018-01551r_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01551&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=ohRML5C8J4I:MV-Gvp6JiMU:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/ohRML5C8J4I&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01551</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/ohRML5C8J4I/acs.jmedchem.8b01551</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Ashuach, T.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1687e8dc9e5:32cbf3f:3a104d3b</id><content><direction>ltr</direction><content>Massively parallel reporter assays (MPRAs) are a technique that enables testing thousands of regulatory DNA sequences and their variants in a single, quantitative experiment. Despite growing popularity, there is lack of statistical methods that account for the different sources of uncertainty inherent to these assays, thus effectively leveraging their promise. Development of such methods could help enhance our ability to identify regulatory sequences in the genome, understand their function under various setting, and ultimately gain a better understanding of how the regulatory code and its alteration lead to phenotypic consequence. Here we present MPRAnalyze: a statistical framework dedicated to analyzing MPRA count data. MPRAnalyze addresses the major questions that are posed in the context of MPRA experiments: estimating the magnitude of the effect of a regulatory sequence in a single condition setting, and comparing differential activity of regulatory sequences across multiple conditions. The framework uses a nested construction of generalized linear models to account for uncertainty in both DNA and RNA observations, controls for various sources of unwanted variation, and incorporates negative controls for robust hypothesis testing, thereby providing clear quantitative answers in complex experimental settings. We demonstrate the robustness, accuracy and applicability of MPRAnalyze on simulated data and published data sets and compare it against the existing analysis methodologies. MPRAnalyze is implemented as an R package and is publicly available through Bioconductor.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/527887v1?rss=1</href></item></alternate><published>1548230400000</published><unread>True</unread><fingerprint>1693446d</fingerprint><link>http://biorxiv.org/cgi/content/short/527887v1?rss=1</link><engagement>0</engagement><title>MPRAnalyze - A statistical framework for Massively Parallel Reporter Assays [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Massively parallel reporter assays (MPRAs) are a technique that enables testing thousands of regulatory DNA sequences and their variants in a single, quantitative experiment. Despite growing popularity, there is lack of statistical methods that account for the different sources of uncertainty inherent to these assays, thus effectively leveraging their promise. Development of such methods could help enhance our ability to identify regulatory sequences in the genome, understand their function under various setting, and ultimately gain a better understanding of how the regulatory code and its alteration lead to phenotypic consequence. Here we present MPRAnalyze: a statistical framework dedicated to analyzing MPRA count data. MPRAnalyze addresses the major questions that are posed in the context of MPRA experiments: estimating the magnitude of the effect of a regulatory sequence in a single condition setting, and comparing differential activity of regulatory sequences across multiple conditions. The framework uses a nested construction of generalized linear models to account for uncertainty in both DNA and RNA observations, controls for various sources of unwanted variation, and incorporates negative controls for robust hypothesis testing, thereby providing clear quantitative answers in complex experimental settings. We demonstrate the robustness, accuracy and applicability of MPRAnalyze on simulated data and published data sets and compare it against the existing analysis methodologies. MPRAnalyze is implemented as an R package and is publicly available through Bioconductor.</description><originId>http://biorxiv.org/cgi/content/short/527887v1?rss=1</originId><crawled>1548311448037</crawled><canonicalUrl>https://www.biorxiv.org/content/10.1101/527887v1</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Jiantao Hu, Biao Hu, Mingliang Wang, Fuming Xu, Bukeyan Miao, Chao-Yie Yang, Mi Wang, Zhaomin Liu, Daniel F. Hayes, Krishnapriya Chinnaswamy, James Delproposto, Jeanne Stuckey, Shaomeng Wang</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_168611c4e4a:13b2a7:1451c985</id><published>1547787600000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01572/20190117/images/medium/jm-2018-015727_0017.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01572&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=gbL8C_X5h30:E7r0sdneegw:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/gbL8C_X5h30&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>f81f0b45</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01572</link><crawled>1547817471562</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01572</href></item></canonical><engagement>0</engagement><title>[ASAP] Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER)</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01572/20190117/images/medium/jm-2018-015727_0017.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01572&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=gbL8C_X5h30:E7r0sdneegw:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/gbL8C_X5h30&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01572</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/gbL8C_X5h30/acs.jmedchem.8b01572</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Hasan Tükenmez</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_16837450b1a:120d155:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;&lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; virulence inhibitors discovered by &lt;i&gt;Mycobacterium marinum&lt;/i&gt; high-throughput screening&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&amp;lt;i&gt;Mycobacterium tuberculosis&amp;lt;/i&gt; virulence inhibitors discovered by &amp;lt;i&gt;Mycobacterium marinum&amp;lt;/i&gt; high-throughput screening, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37176-4&quot;&gt;doi:10.1038/s41598-018-37176-4&lt;/a&gt;&lt;/p&gt;&lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; virulence inhibitors discovered by &lt;i&gt;Mycobacterium marinum&lt;/i&gt; high-throughput screening&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/nFKh9tFJl2c&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/nFKh9tFJl2c/s41598-018-37176-4</href></item></alternate><published>1547107200000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37176-4/MediaObjects/41598_2018_37176_Fig1_HTML.png</url><contentType>image/png</contentType><width>411</width></visual><fingerprint>56b84278</fingerprint><link>https://www.nature.com/articles/s41598-018-37176-4</link><engagement>224</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37176-4</href></item></canonical><title>Mycobacterium tuberculosis virulence inhibitors discovered by Mycobacterium marinum high-throughput screening</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;&lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; virulence inhibitors discovered by &lt;i&gt;Mycobacterium marinum&lt;/i&gt; high-throughput screening&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&amp;lt;i&gt;Mycobacterium tuberculosis&amp;lt;/i&gt; virulence inhibitors discovered by &amp;lt;i&gt;Mycobacterium marinum&amp;lt;/i&gt; high-throughput screening, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37176-4&quot;&gt;doi:10.1038/s41598-018-37176-4&lt;/a&gt;&lt;/p&gt;&lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; virulence inhibitors discovered by &lt;i&gt;Mycobacterium marinum&lt;/i&gt; high-throughput screening&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/nFKh9tFJl2c&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-37176-4</originId><crawled>1547115498266</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Yeston, J.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce088:ad2b6584</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/241-p?rss=1</href></item></alternate><published>1547750305000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>22b9055b</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6424/241-p?rss=1</link><engagement>0</engagement><title>Journey to jorumycin</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6424/241-p?rss=1</originId><crawled>1547752389672</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6424/241.16.full</canonicalUrl><keywords><item>Chemistry</item></keywords></item><item><author><name>Yifei Qi, 
Jumin Lee, 
Jeffery B. Klauda, 
Wonpil Im</name></author><id>6wY2EtDmLbeMr9WopopAzS1SKiHs2ogsOuunEriW7zs=_168841432dd:3aff3d0:3a104d3b</id><content><direction>ltr</direction><content>&lt;img alt=&quot;Journal of Computational Chemistry CHARMM‐GUI Nanodisc Builder for modeling and simulation of various nanodisc systems&quot; src=&quot;https://onlinelibrary.wiley.com/cms/attachment/476ceec6-c50d-429f-8f1a-fad87bc361d1/jcc25773-toc-0001-m.png&quot;&gt;
&lt;p&gt;Modeling and simulation of nanodiscs are challenging due to the absence of structures of many membrane scaffold proteins (MSPs) that wrap around the membrane bilayer. The authors have developed the CHARMM‐GUI &lt;i&gt;Nanodisc Builder&lt;/i&gt; (&lt;a href=&quot;http://www.charmm-gui.org/input/nanodisc&quot; title=&quot;Link to external resource&quot; target=&quot;_blank&quot;&gt;http://www.charmm-gui.org/input/nanodisc&lt;/a&gt;) to facilitate the setup of nanodisc simulation systems by modeling the MSPs with defined size and known structural features.
&lt;/p&gt;
&lt;br&gt;
&lt;p&gt;Nanodiscs are discoidal protein–lipid complexes that have wide applications in membrane protein studies. Modeling and simulation of nanodiscs are challenging due to the absence of structures of many membrane scaffold proteins (MSPs) that wrap around the membrane bilayer. We have developed CHARMM‐GUI &lt;i&gt;Nanodisc Builder&lt;/i&gt; (&lt;a href=&quot;http://www.charmm-gui.org/input/nanodisc&quot; title=&quot;Link to external resource&quot; target=&quot;_blank&quot;&gt;http://www.charmm-gui.org/input/nanodisc&lt;/a&gt;) to facilitate the setup of nanodisc simulation systems by modeling the MSPs with defined size and known structural features. A total of 11 different nanodiscs with a diameter from 80 to 180 Å are made available in both the all‐atom CHARMM and two coarse‐grained (PACE and Martini) force fields. The usage of the &lt;i&gt;Nanodisc Builder&lt;/i&gt; is demonstrated with various simulation systems. The structures and dynamics of proteins and lipids in these systems were analyzed, showing similar behaviors to those from previous all‐atom and coarse‐grained nanodisc simulations. We expect the &lt;i&gt;Nanodisc Builder&lt;/i&gt; to be a convenient and reliable tool for modeling and simulation of nanodisc systems. © 2019 Wiley Periodicals, Inc.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25773?af=R</href></item></alternate><published>1548357860000</published><unread>True</unread><summary><direction>ltr</direction><content>Modeling and simulation of nanodiscs are challenging due to the absence of structures of many membrane scaffold proteins (MSPs) that wrap around the membrane bilayer. The authors have developed the CHARMM‐GUI Nanodisc Builder (http://www.charmm-gui.org/input/nanodisc) to facilitate the setup of nanodisc simulation systems by modeling the MSPs with defined size and known structural features.
Nanodiscs are discoidal protein–lipid complexes that have wide applications in membrane protein studies. Modeling and simulation of nanodiscs are challenging due to the absence of structures of many membrane scaffold proteins (MSPs) that wrap around the membrane bilayer. We have developed CHARMM‐GUI Nanodisc Builder (http://www.charmm-gui.org/input/nanodisc) to facilitate the setup of nanodisc simulation systems by modeling the MSPs with defined size and known structural features. A total of 11 different nanodiscs with a diameter from 80 to 180 Å are made available in both the all‐atom CHARMM and two coarse‐grained (PACE and Martini) force fields. The usage of the Nanodisc Builder is demonstrated with various simulation systems. The structures and dynamics of proteins and lipids in these systems were analyzed, showing similar behaviors to those from previous all‐atom and coarse‐grained nanodisc simulations. We expect the Nanodisc Builder to be a convenient and reliable tool for modeling and simulation of nanodisc systems. © 2019 Wiley Periodicals, Inc.</content></summary><fingerprint>e86df5e1</fingerprint><link>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25773?af=R</link><title>CHARMM‐GUI Nanodisc Builder for modeling and simulation of various nanodisc systems</title><origin><htmlUrl>https://onlinelibrary.wiley.com/journal/1096987x?af=R</htmlUrl><streamId>feed/https://onlinelibrary.wiley.com/action/showFeed?jc=1096987x&amp;type=etoc&amp;feed=rss</streamId><title>Wiley: Journal of Computational Chemistry: Table of Contents</title></origin><description>Modeling and simulation of nanodiscs are challenging due to the absence of structures of many membrane scaffold proteins (MSPs) that wrap around the membrane bilayer. The authors have developed the CHARMM‐GUI Nanodisc Builder (http://www.charmm-gui.org/input/nanodisc) to facilitate the setup of nanodisc simulation systems by modeling the MSPs with defined size and known structural features.
Nanodiscs are discoidal protein–lipid complexes that have wide applications in membrane protein studies. Modeling and simulation of nanodiscs are challenging due to the absence of structures of many membrane scaffold proteins (MSPs) that wrap around the membrane bilayer. We have developed CHARMM‐GUI Nanodisc Builder (http://www.charmm-gui.org/input/nanodisc) to facilitate the setup of nanodisc simulation systems by modeling the MSPs with defined size and known structural features. A total of 11 different nanodiscs with a diameter from 80 to 180 Å are made available in both the all‐atom CHARMM and two coarse‐grained (PACE and Martini) force fields. The usage of the Nanodisc Builder is demonstrated with various simulation systems. The structures and dynamics of proteins and lipids in these systems were analyzed, showing similar behaviors to those from previous all‐atom and coarse‐grained nanodisc simulations. We expect the Nanodisc Builder to be a convenient and reliable tool for modeling and simulation of nanodisc systems. © 2019 Wiley Periodicals, Inc.</description><originId>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25773?af=R</originId><crawled>1548404142813</crawled><visual><height>259</height><processor>feedly-nikon-v3.1</processor><url>https://onlinelibrary.wiley.com/cms/attachment/476ceec6-c50d-429f-8f1a-fad87bc361d1/jcc25773-toc-0001-m.png</url><contentType>image/png; charset=UTF-8</contentType><width>394</width></visual><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Magdalena Śmiech</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Japan</text></item><item><text>Japanese</text></item></mentions><label>Japan</label><id>nlp/f/entity/en/w/Japan</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Europeans</text></item><item><text>Europe</text></item><item><text>European</text></item></mentions><label>Europe</label><id>nlp/f/entity/en/w/Europe</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>CBS</text></item></mentions><label>CBS</label><id>nlp/f/entity/en/w/CBS</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>RIKEN CBS Summer Program</text></item><item><text>RIKEN CBS</text></item></mentions><label>RIKEN CBS Summer Program</label><id>nlp/f/entity/en/-/riken cbs summer program</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>RIKEN</text></item></mentions><label>Riken</label><id>nlp/f/entity/en/w/Riken</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168863a9c00:3e51601:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Dispatch: a visit to Japan from Europe&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Dispatch: a visit to Japan from Europe, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07869-x&quot;&gt;doi:10.1038/d41586-018-07869-x&lt;/a&gt;&lt;/p&gt;PhD student Magdalena Śmiech describes her experience of switching continents and cultures.</content></content><engagementRate>2.45</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07869-x</href></item></alternate><published>1548403200000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07869-x/d41586-018-07869-x_16411716.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>d936f49a</fingerprint><commonTopics><item><probability>1.0</probability><label>japan</label><id>nlp/f/topic/1222</id></item><item><probability>0.996</probability><label>anime</label><id>nlp/f/topic/104</id></item><item><probability>0.903</probability><label>science policy</label><id>nlp/f/topic/2019</id></item></commonTopics><link>https://www.nature.com/articles/d41586-018-07869-x</link><engagement>27</engagement><title>Dispatch: a visit to Japan from Europe</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Dispatch: a visit to Japan from Europe&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Dispatch: a visit to Japan from Europe, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07869-x&quot;&gt;doi:10.1038/d41586-018-07869-x&lt;/a&gt;&lt;/p&gt;PhD student Magdalena Śmiech describes her experience of switching continents and cultures.</description><originId>https://www.nature.com/articles/d41586-018-07869-x</originId><crawled>1548440214528</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Foley, J. F.</name></author><id>RuJRIXzN26JgDGk9YhlIBfh4YrPi0r+1c4exm9G1IBw=_1689b0ef677:533ffb:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;Loss of mitochondrial complex III in regulatory T cells reduces their suppressive activity without affecting their survival.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stke.sciencemag.org/cgi/content/short/12/566/eaaw7886?rss=1</href></item></alternate><published>1548787889000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>11bd7283</fingerprint><link>http://stke.sciencemag.org/cgi/content/short/12/566/eaaw7886?rss=1</link><engagement>0</engagement><title>Immune suppression with complex III</title><origin><htmlUrl>http://stke.sciencemag.org</htmlUrl><streamId>feed/http://stke.sciencemag.org/rss/current.xml</streamId><title>Science Signaling current issue</title></origin><description>&lt;p&gt;Loss of mitochondrial complex III in regulatory T cells reduces their suppressive activity without affecting their survival.&lt;/p&gt;</description><originId>http://stke.sciencemag.org/cgi/content/short/12/566/eaaw7886?rss=1</originId><crawled>1548789675639</crawled><canonicalUrl>http://stke.sciencemag.org/content/12/566/eaaw7886.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Karine F. Ferri-Lagneau</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1686fec8cb7:1d0f713:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Rescue of hematopoietic stem/progenitor cells formation in &lt;i&gt;plcg1&lt;/i&gt; zebrafish mutant&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Rescue of hematopoietic stem/progenitor cells formation in &amp;lt;i&gt;plcg1&amp;lt;/i&gt; zebrafish mutant, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36338-8&quot;&gt;doi:10.1038/s41598-018-36338-8&lt;/a&gt;&lt;/p&gt;Rescue of hematopoietic stem/progenitor cells formation in &lt;i&gt;plcg1&lt;/i&gt; zebrafish mutant&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/8ikzz7dbICw&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/8ikzz7dbICw/s41598-018-36338-8</href></item></alternate><published>1548057600000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36338-8/MediaObjects/41598_2018_36338_Fig1_HTML.png</url><contentType>image/png</contentType><width>439</width></visual><fingerprint>bdb37d7e</fingerprint><link>https://www.nature.com/articles/s41598-018-36338-8</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36338-8</href></item></canonical><title>Rescue of hematopoietic stem/progenitor cells formation in plcg1 zebrafish mutant</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Rescue of hematopoietic stem/progenitor cells formation in &lt;i&gt;plcg1&lt;/i&gt; zebrafish mutant&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Rescue of hematopoietic stem/progenitor cells formation in &amp;lt;i&gt;plcg1&amp;lt;/i&gt; zebrafish mutant, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36338-8&quot;&gt;doi:10.1038/s41598-018-36338-8&lt;/a&gt;&lt;/p&gt;Rescue of hematopoietic stem/progenitor cells formation in &lt;i&gt;plcg1&lt;/i&gt; zebrafish mutant&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/8ikzz7dbICw&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-36338-8</originId><crawled>1548066000055</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Sünnje L. Basedow</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1687f5d8127:341e60d:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Remote sensing of zooplankton swarms&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Remote sensing of zooplankton swarms, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37129-x&quot;&gt;doi:10.1038/s41598-018-37129-x&lt;/a&gt;&lt;/p&gt;Remote sensing of zooplankton swarms&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/3uMW17nXWBQ&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/3uMW17nXWBQ/s41598-018-37129-x</href></item></alternate><published>1548316800000</published><unread>True</unread><visual><height>594</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37129-x/MediaObjects/41598_2018_37129_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>790cddae</fingerprint><link>https://www.nature.com/articles/s41598-018-37129-x</link><engagement>42</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37129-x</href></item></canonical><title>Remote sensing of zooplankton swarms</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Remote sensing of zooplankton swarms&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Remote sensing of zooplankton swarms, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37129-x&quot;&gt;doi:10.1038/s41598-018-37129-x&lt;/a&gt;&lt;/p&gt;Remote sensing of zooplankton swarms&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/3uMW17nXWBQ&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-37129-x</originId><crawled>1548325060903</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Takeshi Tanoue</name></author><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1687be0093d:2e2c1c2:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;A defined commensal consortium elicits CD8 T cells and anti-cancer immunity&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A defined commensal consortium elicits CD8 T cells and anti-cancer immunity, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0878-z&quot;&gt;doi:10.1038/s41586-019-0878-z&lt;/a&gt;&lt;/p&gt;A consortium of 11 bacterial strains from the healthy human gut microbiota can strongly induce interferon-γ-producing CD8 T cells in the intestine, and enhance both resistance to bacterial infection and the therapeutic efficacy of immune checkpoint inhibitors.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0878-z</href></item></alternate><published>1548230400000</published><unread>True</unread><visual><height>449</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-019-0878-z/MediaObjects/41586_2019_878_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>8156bc29</fingerprint><link>https://www.nature.com/articles/s41586-019-0878-z</link><engagement>11</engagement><title>A defined commensal consortium elicits CD8 T cells and anti-cancer immunity</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;A defined commensal consortium elicits CD8 T cells and anti-cancer immunity&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A defined commensal consortium elicits CD8 T cells and anti-cancer immunity, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0878-z&quot;&gt;doi:10.1038/s41586-019-0878-z&lt;/a&gt;&lt;/p&gt;A consortium of 11 bacterial strains from the healthy human gut microbiota can strongly induce interferon-γ-producing CD8 T cells in the intestine, and enhance both resistance to bacterial infection and the therapeutic efficacy of immune checkpoint inhibitors.</description><originId>https://www.nature.com/articles/s41586-019-0878-z</originId><crawled>1548266506557</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Baccini, A., Walker, W., Carvalho, L., Farina, M., Houghton, R. A.</name></author><content><direction>ltr</direction><content>&lt;p&gt;The Hansen &lt;i&gt;et al&lt;/i&gt;. critique centers on the lack of spatial agreement between two very different datasets. Nonetheless, properly constructed comparisons designed to reconcile the two datasets yield up to 90% agreement (e.g., in South America).&lt;/p&gt;</content></content><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:157088d:8675cc2c</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/eaat1205?rss=1</href></item></alternate><published>1547145461000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>7a0e4a62</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6423/eaat1205?rss=1</link><engagement>1</engagement><title>Response to Comment on &quot;Tropical forests are a net carbon source based on aboveground measurements of gain and loss&quot;</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><description>&lt;p&gt;The Hansen &lt;i&gt;et al&lt;/i&gt;. critique centers on the lack of spatial agreement between two very different datasets. Nonetheless, properly constructed comparisons designed to reconcile the two datasets yield up to 90% agreement (e.g., in South America).&lt;/p&gt;</description><originId>http://science.sciencemag.org/cgi/content/short/363/6423/eaat1205?rss=1</originId><crawled>1547147463250</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6423/eaat1205.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><keywords><item>Ecology</item></keywords></item><item><author><name>Sugden, A. M.</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>AAAS</text></item></mentions><label>American Association for the Advancement of Science</label><id>nlp/f/entity/en/w/American Association for the Advancement of Science</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Science</text></item></mentions><label>Science</label><id>nlp/f/entity/en/w/Science</id></item></entities><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:15708b4:8675cc2c</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/137-f?rss=1</href></item></alternate><published>1547145461000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>fa6be211</fingerprint><commonTopics><item><probability>0.976</probability><label>ecology</label><id>nlp/f/topic/725</id></item></commonTopics><link>http://science.sciencemag.org/cgi/content/short/363/6423/137-f?rss=1</link><engagement>0</engagement><title>Forest termites mitigate the effects of drought</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6423/137-f?rss=1</originId><crawled>1547147463250</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6423/137.6.full</canonicalUrl><keywords><item>Ecology</item></keywords></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1689a4fb4ec:3d1039:c2ce2e2e</id><published>1548720000000</published><unread>True</unread><summary><direction>ltr</direction><content>The addition of a trifunctional silicon alkoxide methyltrimethoxysilane (MTMS) to aluminum oxide hydroxide pseudoboehmite nanorod (PBNR) aqueous dispersions resulted in adhesion between the PBNR colloids to form macroporous monoliths. The use of greater amounts of MTMS led to coarsening of the skeleton and strengthening of the skeletal structure, and the monoliths got water resistance. When a dispersion of zirconium oxide nanoparticles and MTMS was used as a starting material, a macroporous monolith was also obtained by the same simple process. The colloidal gelation occurs because the silanol moiety is more likely to react with the colloid surface of ceramic materials than with other silanols derived from MTMS and their oligomer. Due to the development of material chemistry, colloidal dispersions having various shapes and compositions are becoming available as products. Based on this mechanism, it is expected to be feasible to fabricate various porous monoliths with characteristic morphologies and properties depending on the colloid.</content></summary><fingerprint>fe53f8ff</fingerprint><link>https://chemrxiv.org/articles/Pseudoboehmite_Nanorod_Polymethylsilsesquioxane_Monoliths_Formed_by_Colloidal_Gelation/7637405</link><engagement>0</engagement><crawled>1548777141484</crawled><title>Pseudoboehmite Nanorod–Polymethylsilsesquioxane Monoliths Formed by Colloidal Gelation</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>The addition of a trifunctional silicon alkoxide methyltrimethoxysilane (MTMS) to aluminum oxide hydroxide pseudoboehmite nanorod (PBNR) aqueous dispersions resulted in adhesion between the PBNR colloids to form macroporous monoliths. The use of greater amounts of MTMS led to coarsening of the skeleton and strengthening of the skeletal structure, and the monoliths got water resistance. When a dispersion of zirconium oxide nanoparticles and MTMS was used as a starting material, a macroporous monolith was also obtained by the same simple process. The colloidal gelation occurs because the silanol moiety is more likely to react with the colloid surface of ceramic materials than with other silanols derived from MTMS and their oligomer. Due to the development of material chemistry, colloidal dispersions having various shapes and compositions are becoming available as products. Based on this mechanism, it is expected to be feasible to fabricate various porous monoliths with characteristic morphologies and properties depending on the colloid.</description><originId>https://chemrxiv.org/articles/Pseudoboehmite_Nanorod_Polymethylsilsesquioxane_Monoliths_Formed_by_Colloidal_Gelation/7637405</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Pseudoboehmite_Nanorod_Polymethylsilsesquioxane_Monoliths_Formed_by_Colloidal_Gelation/7637405</href></item></alternate></item><item><author><name>Fatma Z. Guerfali</name></author><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_16895c50117:243ded1:56b782f7</id><content><direction>ltr</direction><content>&lt;p&gt;by Fatma Z. Guerfali, Dhafer Laouini, Abdellatif Boudabous, Fredj Tekaia&lt;/p&gt;
Genome data, with underlying new knowledge, are accumulating at exponential rate thanks to ever-improving sequencing technologies and the parallel development of dedicated efficient Bioinformatics methods and tools. Advanced Education in Bioinformatics and Genome Analyses is to a large extent not accessible to students in developing countries where endeavors to set up Bioinformatics courses concern most often only basic levels. Here, we report a pioneering pilot experience concerning the design and implementation, from scratch, of a three-months advanced and extensive course in Bioinformatics and Genome Analyses in the Institut Pasteur de Tunis. Most significantly the outcome of the course was upgrading the participants’ skills in Bioinformatics and Genome Analyses to recognized international standards. Here we detail the different steps involved in the implementation of this course as well as the topics covered in the program. The description of this pilot experience might be helpful for the implementation of other similar educational projects, notably in developing countries, aiming to go beyond basics and providing young researchers with high-level skills.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/jk3OXkDl4KM&quot; height=&quot;1&quot;&gt;</content></content><updateCount>1</updateCount><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/jk3OXkDl4KM/article</href></item></alternate><published>1548712800000</published><unread>True</unread><visual><height>410</height><processor>feedly-nikon-v3.1</processor><url>https://journals.plos.org/ploscompbiol/article/figure/image?size=inline&amp;id=10.1371/journal.pcbi.1006373.g001</url><contentType>image/png</contentType><width>320</width></visual><fingerprint>fbe29034</fingerprint><engagementRate>1.67</engagementRate><link>10.1371/journal.pcbi.1006373</link><recrawled>1548710822648</recrawled><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006373</href></item></canonical><updated>1548712800000</updated><engagement>10</engagement><title>Designing and running an advanced Bioinformatics and genome analyses course in Tunisia</title><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><description>&lt;p&gt;by Fatma Z. Guerfali, Dhafer Laouini, Abdellatif Boudabous, Fredj Tekaia&lt;/p&gt;
Genome data, with underlying new knowledge, are accumulating at exponential rate thanks to ever-improving sequencing technologies and the parallel development of dedicated efficient Bioinformatics methods and tools. Advanced Education in Bioinformatics and Genome Analyses is to a large extent not accessible to students in developing countries where endeavors to set up Bioinformatics courses concern most often only basic levels. Here, we report a pioneering pilot experience concerning the design and implementation, from scratch, of a three-months advanced and extensive course in Bioinformatics and Genome Analyses in the Institut Pasteur de Tunis. Most significantly the outcome of the course was upgrading the participants’ skills in Bioinformatics and Genome Analyses to recognized international standards. Here we detail the different steps involved in the implementation of this course as well as the topics covered in the program. The description of this pilot experience might be helpful for the implementation of other similar educational projects, notably in developing countries, aiming to go beyond basics and providing young researchers with high-level skills.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/jk3OXkDl4KM&quot; height=&quot;1&quot;&gt;</description><originId>10.1371/journal.pcbi.1006373</originId><crawled>1548700942615</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>Hubble Space Telescope</text></item></mentions><label>Hubble Space Telescope</label><id>nlp/f/entity/en/w/Hubble Space Telescope</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Stockholm University</text></item></mentions><label>Stockholm University</label><id>nlp/f/entity/en/w/Stockholm University</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Jesper Sollerman</text></item></mentions><label>Jesper Sollerman</label><id>nlp/f/entity/en/-/jesper sollerman</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1687810c18f:28a8953:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Ants build superhighways without bosses or blueprints&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Ants build superhighways without bosses or blueprints, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00227-5&quot;&gt;doi:10.1038/d41586-019-00227-5&lt;/a&gt;&lt;/p&gt;Hard-working insects ﻿achieve engineering marvels despite lack of cooperation.</content></content><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00227-5</href></item></alternate><published>1548230400000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00227-5/d41586-019-00227-5_16411400.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>8e13ffaf</fingerprint><commonTopics><item><probability>0.952</probability><label>astrophysics</label><id>nlp/f/topic/173</id></item><item><probability>0.924</probability><label>space</label><id>nlp/f/topic/2140</id></item><item><probability>0.804</probability><label>gossip</label><id>nlp/f/topic/989</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00227-5</link><engagement>3</engagement><title>Ants build superhighways without bosses or blueprints</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Ants build superhighways without bosses or blueprints&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Ants build superhighways without bosses or blueprints, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00227-5&quot;&gt;doi:10.1038/d41586-019-00227-5&lt;/a&gt;&lt;/p&gt;Hard-working insects ﻿achieve engineering marvels despite lack of cooperation.</description><originId>https://www.nature.com/articles/d41586-019-00227-5</originId><crawled>1548202590607</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1680fbb85b0:615f868:c2ce2e2e</id><published>1546387200000</published><unread>True</unread><summary><direction>ltr</direction><content>Porous catalysts have garnered substantial interest as potential platforms for
group-transfer catalysis due to the ability to site-isolate catalysts and to non-covalently co-
localize substrates in proximity to reactive intermediates. In contrast to soluble molecular
catalysts, the limited synthetic toolbox available to prepare porous catalysts presents a
formidable challenge to controlling the primary coordination sphere of lattice-confined
catalysts and thus modulating the electronic structures of reactive catalyst intermediates.
Here, we utilize Sonogashira cross-coupling chemistry to prepare a family of porous
metallopolymers, in which the primary coordination sphere of Ru2 sites is systematically
varied. The newly synthesized materials are characterized by IR, elemental analysis, gas
sorption, powder X-ray diffraction, thermogravimetric analysis, X-ray absorption
spectroscopy, and diffuse-reflectance UV-vis-NIR spectroscopy. The resulting porous
materials are catalysts for nitrene-transfer chemistry and the chemoselectivty for allylic
amination of olefin aziridination can be tuned by modulating the primary coordination
sphere of the catalyst sites. The demonstration of metallopolymerization as a rational
synthetic strategy allows to translate ligand-modulated chemoselectivity to porous
catalysts, which represents a new opportunity to tailor the functionality of heterogeneous
analogues of molecular complexes.</content></summary><fingerprint>448cdeea</fingerprint><link>https://chemrxiv.org/articles/Metallopolymerization_as_a_Strategy_to_Translate_Ligand-Modulated_Chemoselectivity_to_Porous_Catalysts/7538747</link><engagement>1</engagement><crawled>1546452174256</crawled><title>Metallopolymerization as a Strategy to Translate Ligand-Modulated Chemoselectivity to Porous Catalysts</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>Porous catalysts have garnered substantial interest as potential platforms for
group-transfer catalysis due to the ability to site-isolate catalysts and to non-covalently co-
localize substrates in proximity to reactive intermediates. In contrast to soluble molecular
catalysts, the limited synthetic toolbox available to prepare porous catalysts presents a
formidable challenge to controlling the primary coordination sphere of lattice-confined
catalysts and thus modulating the electronic structures of reactive catalyst intermediates.
Here, we utilize Sonogashira cross-coupling chemistry to prepare a family of porous
metallopolymers, in which the primary coordination sphere of Ru2 sites is systematically
varied. The newly synthesized materials are characterized by IR, elemental analysis, gas
sorption, powder X-ray diffraction, thermogravimetric analysis, X-ray absorption
spectroscopy, and diffuse-reflectance UV-vis-NIR spectroscopy. The resulting porous
materials are catalysts for nitrene-transfer chemistry and the chemoselectivty for allylic
amination of olefin aziridination can be tuned by modulating the primary coordination
sphere of the catalyst sites. The demonstration of metallopolymerization as a rational
synthetic strategy allows to translate ligand-modulated chemoselectivity to porous
catalysts, which represents a new opportunity to tailor the functionality of heterogeneous
analogues of molecular complexes.</description><originId>https://chemrxiv.org/articles/Metallopolymerization_as_a_Strategy_to_Translate_Ligand-Modulated_Chemoselectivity_to_Porous_Catalysts/7538747</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Metallopolymerization_as_a_Strategy_to_Translate_Ligand-Modulated_Chemoselectivity_to_Porous_Catalysts/7538747</href></item></alternate><visual><height>324</height><processor>feedly-nikon-v3.1</processor><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14014484/thumb.png</url><contentType>image/png</contentType><width>250</width></visual></item><item><author><name>Yonggi Jo</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1687f5d8127:341e60e:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Enhanced Bell state measurement for efficient measurement-device-independent quantum key distribution using 3-dimensional quantum states&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Enhanced Bell state measurement for efficient measurement-device-independent quantum key distribution using 3-dimensional quantum states, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36513-x&quot;&gt;doi:10.1038/s41598-018-36513-x&lt;/a&gt;&lt;/p&gt;Enhanced Bell state measurement for efficient measurement-device-independent quantum key distribution using 3-dimensional quantum states&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/XQJpG9ZrbZo&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/XQJpG9ZrbZo/s41598-018-36513-x</href></item></alternate><published>1548316800000</published><unread>True</unread><visual><height>225</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36513-x/MediaObjects/41598_2018_36513_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>1664c22a</fingerprint><link>https://www.nature.com/articles/s41598-018-36513-x</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36513-x</href></item></canonical><title>Enhanced Bell state measurement for efficient measurement-device-independent quantum key distribution using 3-dimensional quantum states</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Enhanced Bell state measurement for efficient measurement-device-independent quantum key distribution using 3-dimensional quantum states&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Enhanced Bell state measurement for efficient measurement-device-independent quantum key distribution using 3-dimensional quantum states, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36513-x&quot;&gt;doi:10.1038/s41598-018-36513-x&lt;/a&gt;&lt;/p&gt;Enhanced Bell state measurement for efficient measurement-device-independent quantum key distribution using 3-dimensional quantum states&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/XQJpG9ZrbZo&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-36513-x</originId><crawled>1548325060903</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>D&apos;Angelo, E.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce0a1:ad2b6584</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/229?rss=1</href></item></alternate><published>1547750305000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>6b980137</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6424/229?rss=1</link><engagement>0</engagement><title>The cerebellum gets social</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6424/229?rss=1</originId><crawled>1547752389672</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6424/229.full</canonicalUrl><keywords><item>Neuroscience</item></keywords></item><item><author><name>Marti-Juan, G.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16819100f47:3d548a:ad2b6584</id><content><direction>ltr</direction><content>Alzheimer&apos;s disease (AD) affects millions of people and is a major rising problem in health care worldwide. Recent research suggests that AD could have different subtypes, presenting differences in how the disease develops. Characterizing those subtypes could be key to deepen the understanding of this complex disease. In this paper, we used a multivariate, non-supervised clustering method over blood-based markers to find subgroups of patients defined by distinctive blood profiles. Our analysis on ADNI database identified 4 possible subgroups, each with a different blood profile. More importantly, we show that subgroups with different profiles have a different relationship between brain phenotypes detected in magnetic resonance imaging and disease condition.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/339614v3?rss=1</href></item></alternate><published>1546588800000</published><unread>True</unread><fingerprint>d50cd060</fingerprint><link>http://biorxiv.org/cgi/content/short/339614v3?rss=1</link><engagement>0</engagement><title>Revealing heterogeneity of brain imaging phenotypes in Alzheimer&apos;s disease based on unsupervised clustering of blood marker profiles [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Alzheimer&apos;s disease (AD) affects millions of people and is a major rising problem in health care worldwide. Recent research suggests that AD could have different subtypes, presenting differences in how the disease develops. Characterizing those subtypes could be key to deepen the understanding of this complex disease. In this paper, we used a multivariate, non-supervised clustering method over blood-based markers to find subgroups of patients defined by distinctive blood profiles. Our analysis on ADNI database identified 4 possible subgroups, each with a different blood profile. More importantly, we show that subgroups with different profiles have a different relationship between brain phenotypes detected in magnetic resonance imaging and disease condition.</description><originId>http://biorxiv.org/cgi/content/short/339614v3?rss=1</originId><crawled>1546608709447</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/04/339614</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Craig, S.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168a5541f68:15080c3:3a104d3b</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6426/451?rss=1</href></item></alternate><published>1548959829000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>77dca15f</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6426/451?rss=1</link><engagement>0</engagement><title>Hydrogels muscle their way into new territory</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6426/451?rss=1</originId><crawled>1548961980264</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6426/451.full</canonicalUrl><keywords><item>Materials Science</item></keywords></item><item><author><name>Wang, L., Zhou, H., Hu, J., Huang, B., Sun, M., Dong, B., Zheng, G., Huang, Y., Chen, Y., Li, L., Xu, Z., Li, N., Liu, Z., Chen, Q., Sun, L.-D., Yan, C.-H.</name></author><content><direction>ltr</direction><content>&lt;p&gt;The components with soft nature in the metal halide perovskite absorber usually generate lead (Pb)&lt;sup&gt;0&lt;/sup&gt; and iodine (I)&lt;sup&gt;0&lt;/sup&gt; defects during device fabrication and operation. These defects serve as not only recombination centers to deteriorate device efficiency but also degradation initiators to hamper device lifetimes. We show that the europium ion pair Eu&lt;sup&gt;3+&lt;/sup&gt;-Eu&lt;sup&gt;2+&lt;/sup&gt; acts as the &amp;quot;redox shuttle&amp;quot; that selectively oxidized Pb&lt;sup&gt;0&lt;/sup&gt; and reduced I&lt;sup&gt;0&lt;/sup&gt; defects simultaneously in a cyclical transition. The resultant device achieves a power conversion efficiency (PCE) of 21.52% (certified 20.52%) with substantially improved long-term durability. The devices retained 92% and 89% of the peak PCE under 1-sun continuous illumination or heating at 85°C for 1500 hours and 91% of the original stable PCE after maximum power point tracking for 500 hours, respectively.&lt;/p&gt;</content></content><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce077:ad2b6584</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/265?rss=1</href></item></alternate><published>1547750305000</published><unread>True</unread><fingerprint>6713bd09</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6424/265?rss=1</link><engagement>0</engagement><title>A Eu3+-Eu2+ ion redox shuttle imparts operational durability to Pb-I perovskite solar cells</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><description>&lt;p&gt;The components with soft nature in the metal halide perovskite absorber usually generate lead (Pb)&lt;sup&gt;0&lt;/sup&gt; and iodine (I)&lt;sup&gt;0&lt;/sup&gt; defects during device fabrication and operation. These defects serve as not only recombination centers to deteriorate device efficiency but also degradation initiators to hamper device lifetimes. We show that the europium ion pair Eu&lt;sup&gt;3+&lt;/sup&gt;-Eu&lt;sup&gt;2+&lt;/sup&gt; acts as the &amp;quot;redox shuttle&amp;quot; that selectively oxidized Pb&lt;sup&gt;0&lt;/sup&gt; and reduced I&lt;sup&gt;0&lt;/sup&gt; defects simultaneously in a cyclical transition. The resultant device achieves a power conversion efficiency (PCE) of 21.52% (certified 20.52%) with substantially improved long-term durability. The devices retained 92% and 89% of the peak PCE under 1-sun continuous illumination or heating at 85°C for 1500 hours and 91% of the original stable PCE after maximum power point tracking for 500 hours, respectively.&lt;/p&gt;</description><originId>http://science.sciencemag.org/cgi/content/short/363/6424/265?rss=1</originId><crawled>1547752389672</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6424/265.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><keywords><item>Physics, Applied</item></keywords></item><item><author><name>Starr, D.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a92:c2ce2e2e</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/334?rss=1</href></item></alternate><published>1548355045000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>c3c9318f</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6425/334?rss=1</link><engagement>17</engagement><title>Bearing witness</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6425/334?rss=1</originId><crawled>1548357093757</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6425/334.full</canonicalUrl><keywords><item>Science and Business, Scientific Community</item></keywords></item><item><author><name>Ilda Theka</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1689e477777:9c5975:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Wnt/β-catenin signaling pathway safeguards epigenetic stability and homeostasis of mouse embryonic stem cells&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Wnt/β-catenin signaling pathway safeguards epigenetic stability and homeostasis of mouse embryonic stem cells, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37442-5&quot;&gt;doi:10.1038/s41598-018-37442-5&lt;/a&gt;&lt;/p&gt;Wnt/β-catenin signaling pathway safeguards epigenetic stability and homeostasis of mouse embryonic stem cells&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/VccVlonu93Y&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/VccVlonu93Y/s41598-018-37442-5</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37442-5/MediaObjects/41598_2018_37442_Fig1_HTML.png</url><contentType>image/png</contentType><width>621</width></visual><fingerprint>4a414588</fingerprint><link>https://www.nature.com/articles/s41598-018-37442-5</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37442-5</href></item></canonical><title>Wnt/β-catenin signaling pathway safeguards epigenetic stability and homeostasis of mouse embryonic stem cells</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Wnt/β-catenin signaling pathway safeguards epigenetic stability and homeostasis of mouse embryonic stem cells&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Wnt/β-catenin signaling pathway safeguards epigenetic stability and homeostasis of mouse embryonic stem cells, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37442-5&quot;&gt;doi:10.1038/s41598-018-37442-5&lt;/a&gt;&lt;/p&gt;Wnt/β-catenin signaling pathway safeguards epigenetic stability and homeostasis of mouse embryonic stem cells&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/VccVlonu93Y&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-37442-5</originId><crawled>1548843710327</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Benson, P. J.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:15708b9:8675cc2c</id><published>1547145461000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>2d32a5ff</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6423/137-a?rss=1</link><engagement>0</engagement><crawled>1547147463250</crawled><title>Advancing 3D imaging of organs</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6423/137-a?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/137-a?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6423/137.1.full</canonicalUrl><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>AAAS</text></item></mentions><label>American Association for the Advancement of Science</label><id>nlp/f/entity/en/w/American Association for the Advancement of Science</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Science</text></item></mentions><label>Science</label><id>nlp/f/entity/en/w/Science</id></item></entities></item><item><author><name>Jianbin Zheng, Sohee Jeon, Weilan Jiang, Lena F. Burbulla, Daniel Ysselstein, Kristine Oevel, Dimitri Krainc, Richard B. Silverman</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_168543dd3c0:72e2d7:56b782f7</id><published>1547528400000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01294/20190115/images/medium/jm-2018-01294p_0018.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01294&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=F_C1w6VVbFQ:2H_oOmGfgpc:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/F_C1w6VVbFQ&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>ca526452</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01294</link><crawled>1547601564608</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01294</href></item></canonical><engagement>0</engagement><title>[ASAP] Conversion of Quinazoline Modulators from Inhibitors to Activators of ß-Glucocerebrosidase</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01294/20190115/images/medium/jm-2018-01294p_0018.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01294&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=F_C1w6VVbFQ:2H_oOmGfgpc:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/F_C1w6VVbFQ&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01294</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/F_C1w6VVbFQ/acs.jmedchem.8b01294</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Declan Butler</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Republic of Ireland</text></item><item><text>Ireland</text></item><item><text>Irish</text></item></mentions><label>Republic of Ireland</label><id>nlp/f/entity/en/w/Republic of Ireland</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Brexit</text></item></mentions><label>Brexit</label><id>nlp/f/entity/en/w/Brexit</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>EU</text></item><item><text>European Union</text></item></mentions><label>European Union</label><id>nlp/f/entity/en/w/European Union</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Ohlmeyer</text></item></mentions><label>Don Ohlmeyer</label><id>nlp/f/entity/en/w/Don Ohlmeyer</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Jane Ohlmeyer</text></item></mentions><label>Jane Ohlmeyer</label><id>nlp/f/entity/en/w/Jane Ohlmeyer</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ff99aeb:c7ac56:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;How Brexit threatens Irish science’s cross-border collaboration&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How Brexit threatens Irish science’s cross-border collaboration, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00339-y&quot;&gt;doi:10.1038/d41586-019-00339-y&lt;/a&gt;&lt;/p&gt;Peace and common membership of the European Union have allowed scientists in the Republic of Ireland and Northern Ireland to build a unique, cross-border research system.</content></content><engagementRate>0.38</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00339-y</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>282e2ecc</fingerprint><commonTopics><item><probability>0.986</probability><label>europe</label><id>nlp/f/topic/807</id></item><item><probability>0.922</probability><label>science policy</label><id>nlp/f/topic/2019</id></item><item><probability>0.886</probability><label>uk</label><id>nlp/f/topic/2368</id></item><item><probability>0.741</probability><label>migration</label><id>nlp/f/topic/1464</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00339-y</link><engagement>3</engagement><title>How Brexit threatens Irish science’s cross-border collaboration</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;How Brexit threatens Irish science’s cross-border collaboration&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How Brexit threatens Irish science’s cross-border collaboration, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00339-y&quot;&gt;doi:10.1038/d41586-019-00339-y&lt;/a&gt;&lt;/p&gt;Peace and common membership of the European Union have allowed scientists in the Republic of Ireland and Northern Ireland to build a unique, cross-border research system.</description><originId>https://www.nature.com/articles/d41586-019-00339-y</originId><crawled>1548872162027</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Alison Abbott</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Rony Paz</text></item><item><text>Paz</text></item></mentions><label>Rony Paz</label><id>nlp/f/entity/en/-/rony paz</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Getty</text></item></mentions><label>Getty Images</label><id>nlp/f/entity/en/w/Getty Images</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>BSIP</text></item></mentions><label>BSIP</label><id>nlp/f/entity/en/-/bsip</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Itzhak Fried</text></item><item><text>Fried</text></item></mentions><label>Itzhak Fried</label><id>nlp/f/entity/en/-/itzhak fried</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>University of Freiburg</text></item></mentions><label>University of Freiburg</label><id>nlp/f/entity/en/w/University of Freiburg</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1686687c354:12bc0e9:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Pioneering brain study reveals ‘software’ differences between humans and monkeys&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Pioneering brain study reveals ‘software’ differences between humans and monkeys, Published online: 19 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00198-7&quot;&gt;doi:10.1038/d41586-019-00198-7&lt;/a&gt;&lt;/p&gt;Neuroscientists tracked the activity of single neurons deep in the brain and suggest the findings could explain humans’ intelligence — and susceptibility to psychiatric disorders.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00198-7</href></item></alternate><published>1547884800000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00198-7/d41586-019-00198-7_16405502.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>fbd4fe66</fingerprint><commonTopics><item><probability>0.999</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item><item><probability>0.984</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.951</probability><label>psychiatry</label><id>nlp/f/topic/1844</id></item><item><probability>0.939</probability><label>psychology</label><id>nlp/f/topic/1847</id></item><item><probability>0.907</probability><label>neurology</label><id>nlp/f/topic/1563</id></item><item><probability>0.862</probability><label>biology</label><id>nlp/f/topic/263</id></item><item><probability>0.82</probability><label>autism</label><id>nlp/f/topic/192</id></item><item><probability>0.796</probability><label>epidemiology</label><id>nlp/f/topic/783</id></item><item><probability>0.794</probability><label>anthropology</label><id>nlp/f/topic/109</id></item><item><probability>0.773</probability><label>ted</label><id>nlp/f/topic/2261</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00198-7</link><engagement>11</engagement><title>Pioneering brain study reveals ‘software’ differences between humans and monkeys</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Pioneering brain study reveals ‘software’ differences between humans and monkeys&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Pioneering brain study reveals ‘software’ differences between humans and monkeys, Published online: 19 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00198-7&quot;&gt;doi:10.1038/d41586-019-00198-7&lt;/a&gt;&lt;/p&gt;Neuroscientists tracked the activity of single neurons deep in the brain and suggest the findings could explain humans’ intelligence — and susceptibility to psychiatric disorders.</description><originId>https://www.nature.com/articles/d41586-019-00198-7</originId><crawled>1547908399956</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Martin Hsu</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1685620d6e4:3ad9595:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Neuroinflammation-induced lymphangiogenesis near the cribriform plate contributes to drainage of CNS-derived antigens and immune cells&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Neuroinflammation-induced lymphangiogenesis near the cribriform plate contributes to drainage of CNS-derived antigens and immune cells, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08163-0&quot;&gt;doi:10.1038/s41467-018-08163-0&lt;/a&gt;&lt;/p&gt;Lymphangiogenesis occurs in the context of systemic inflammation and development but has not been reported for the lymphatics that surround the CNS. Here the authors show that in the context of experimental autoimmune encephatlitis, lymphangiogenesis occurs at the cribriform plate, but not the meninges, and contributes to immune cell and antigen drainage.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/tYlqeP4JtaI&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/tYlqeP4JtaI/s41467-018-08163-0</href></item></alternate><published>1547625600000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08163-0/MediaObjects/41467_2018_8163_Fig2_HTML.png</url><contentType>image/png</contentType><width>610</width></visual><fingerprint>36c2bb3f</fingerprint><link>https://www.nature.com/articles/s41467-018-08163-0</link><engagement>134</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08163-0</href></item></canonical><title>Neuroinflammation-induced lymphangiogenesis near the cribriform plate contributes to drainage of CNS-derived antigens and immune cells</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Neuroinflammation-induced lymphangiogenesis near the cribriform plate contributes to drainage of CNS-derived antigens and immune cells&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Neuroinflammation-induced lymphangiogenesis near the cribriform plate contributes to drainage of CNS-derived antigens and immune cells, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08163-0&quot;&gt;doi:10.1038/s41467-018-08163-0&lt;/a&gt;&lt;/p&gt;Lymphangiogenesis occurs in the context of systemic inflammation and development but has not been reported for the lymphatics that surround the CNS. Here the authors show that in the context of experimental autoimmune encephatlitis, lymphangiogenesis occurs at the cribriform plate, but not the meninges, and contributes to immune cell and antigen drainage.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/tYlqeP4JtaI&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-08163-0</originId><crawled>1547633219300</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Li, G.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1685ce02dff:51ba64:c2ce2e2e</id><content><direction>ltr</direction><content>The optimal growth temperature (OGT) of organisms is an important index to estimate the stability of enzymes encoded in their genomes. However, experimental determination of OGT for microorganisms that cannot be cultivated is difficult. Here, we report on the development of a machine learning model that can accurately predict OGT directly from proteome-wide 2-mer amino acid composition. We make use of this model to predict OGTs for 1,438 microorganisms. In a subsequent step we combine OGT data with amino acid composition of individual enzymes to develop a second machine learning model for prediction of enzyme temperature optima (Topt). The resulting model is far superior to using OGT alone for estimating Topt in a dataset of 2,609 enzymes. Finally, we predict Topt for 6.5 million enzymes, covering 4,447 EC numbers, and make the resulting dataset available for researchers, enabling simple identification of enzymes that are potentially functional at extreme temperatures.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/522342v2?rss=1</href></item></alternate><published>1547712000000</published><unread>True</unread><fingerprint>b1b35952</fingerprint><link>http://biorxiv.org/cgi/content/short/522342v2?rss=1</link><engagement>4</engagement><title>Machine learning applied to predicting microorganism growth temperatures and enzyme catalytic optima [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>The optimal growth temperature (OGT) of organisms is an important index to estimate the stability of enzymes encoded in their genomes. However, experimental determination of OGT for microorganisms that cannot be cultivated is difficult. Here, we report on the development of a machine learning model that can accurately predict OGT directly from proteome-wide 2-mer amino acid composition. We make use of this model to predict OGTs for 1,438 microorganisms. In a subsequent step we combine OGT data with amino acid composition of individual enzymes to develop a second machine learning model for prediction of enzyme temperature optima (Topt). The resulting model is far superior to using OGT alone for estimating Topt in a dataset of 2,609 enzymes. Finally, we predict Topt for 6.5 million enzymes, covering 4,447 EC numbers, and make the resulting dataset available for researchers, enabling simple identification of enzymes that are potentially functional at extreme temperatures.</description><originId>http://biorxiv.org/cgi/content/short/522342v2?rss=1</originId><crawled>1547746422271</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/17/522342</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Brett R. Goldsmith</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_16874a0b853:23176ce:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Digital Biosensing by Foundry-Fabricated Graphene Sensors&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Digital Biosensing by Foundry-Fabricated Graphene Sensors, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-019-38700-w&quot;&gt;doi:10.1038/s41598-019-38700-w&lt;/a&gt;&lt;/p&gt;Digital Biosensing by Foundry-Fabricated Graphene Sensors&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/X0eBdFGo6uI&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/X0eBdFGo6uI/s41598-019-38700-w</href></item></alternate><published>1548144000000</published><unread>True</unread><visual><height>476</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-38700-w/MediaObjects/41598_2019_38700_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>6d7f3fdf</fingerprint><link>https://www.nature.com/articles/s41598-019-38700-w</link><engagement>23</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-019-38700-w</href></item></canonical><title>Digital Biosensing by Foundry-Fabricated Graphene Sensors</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Digital Biosensing by Foundry-Fabricated Graphene Sensors&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Digital Biosensing by Foundry-Fabricated Graphene Sensors, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-019-38700-w&quot;&gt;doi:10.1038/s41598-019-38700-w&lt;/a&gt;&lt;/p&gt;Digital Biosensing by Foundry-Fabricated Graphene Sensors&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/X0eBdFGo6uI&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-019-38700-w</originId><crawled>1548144916563</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:157088f:8675cc2c</id><published>1547145461000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>1ab9cb40</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6423/193?rss=1</link><engagement>0</engagement><crawled>1547147463250</crawled><title>New Products</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6423/193?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/193?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6423/193.full</canonicalUrl></item><item><author><name>F. Peter Guengerich, Gunda I. Georg, Shaomeng Wang</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_1683ef2a450:205d49:875042c9</id><published>1547182800000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.9b00005&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=rUlVNwKwM98:Agw6_ARV6Q8:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/rUlVNwKwM98&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>8783fb8c</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.9b00005</link><crawled>1547244315728</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.9b00005</href></item></canonical><engagement>0</engagement><title>[ASAP] Drug Metabolism and Toxicology Special Issue Call for Papers</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.9b00005&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=rUlVNwKwM98:Agw6_ARV6Q8:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/rUlVNwKwM98&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.9b00005</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/rUlVNwKwM98/acs.jmedchem.9b00005</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Kiberstis, P. A.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce07c:ad2b6584</id><published>1547750305000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>8ea4e9a9</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6424/242-g?rss=1</link><engagement>0</engagement><crawled>1547752389672</crawled><title>Addressing a hairy problem</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6424/242-g?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/242-g?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6424/242.7.full</canonicalUrl></item><item><author><name>Carlos Moreno-Cinos, Elisa Sassetti, Irene G. Salado, Gesa Witt, Siham Benramdane, Laura Reinhardt, Cristina D. Cruz, Jurgen Joossens, Pieter Van der Veken, Heike Brötz-Oesterhelt, Päivi Tammela, Mathias Winterhalter, Philip Gribbon, Björn Windshügel, Koen Augustyns</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_1683e06bbd2:1b419a4:b77f238b</id><published>1547182800000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01466/20190111/images/medium/jm-2018-01466s_0023.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01466&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=4DdwASndLcQ:ntS_MDV9nj4:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/4DdwASndLcQ&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>6935a082</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01466</link><crawled>1547228855250</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01466</href></item></canonical><engagement>0</engagement><title>[ASAP] a-Amino Diphenyl Phosphonates as Novel Inhibitors of Escherichia coli ClpP Protease</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01466/20190111/images/medium/jm-2018-01466s_0023.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01466&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=4DdwASndLcQ:ntS_MDV9nj4:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/4DdwASndLcQ&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01466</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/4DdwASndLcQ/acs.jmedchem.8b01466</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Balasubramani, A.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168a5541f68:15080a2:3a104d3b</id><published>1548959829000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>4ba04a00</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6426/494-o?rss=1</link><engagement>0</engagement><crawled>1548961980264</crawled><title>Rescuing T cell glycolysis</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6426/494-o?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6426/494-o?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6426/494.15.full</canonicalUrl></item><item><author><name>Hsiau, T.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168501a7774:3183787:c2ce2e2e</id><content><direction>ltr</direction><content>Efficient precision genome editing requires a quick, quantitative, and inexpensive assay of editing outcomes. Here we present ICE (Inference of CRISPR Edits), which enables robust batch analysis of CRISPR edits using Sanger data. ICE proposes potential editing outcomes for single guide, multiplex editing, base editing, and homology-directed repair experiments and then determines which are supported by the data via regression. Additionally, we develop a score called ICE-D (Discordance) that can provide information on large or unexpected edits. We empirically confirm through over 1,800 edits that the ICE algorithm is robust, reproducible, and can analyze CRISPR experiments within days after transfection. We also confirm that ICE strongly correlates with NGS analysis (Amp-Seq). ICE is an improvement over current analysis tools in that it provides batch analysis, is free to use, and can detect a wider variety of edits. It provides investigators with a reliable editing tool that can significantly expedite CRISPR editing workflows. Our ICE tool is available online at ice.synthego.com and the source code is at github.com/synthego-open/ice</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/251082v2?rss=1</href></item></alternate><published>1547452800000</published><unread>True</unread><fingerprint>d84022d9</fingerprint><link>http://biorxiv.org/cgi/content/short/251082v2?rss=1</link><engagement>0</engagement><title>Inference of CRISPR Edits from Sanger Trace Data [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Efficient precision genome editing requires a quick, quantitative, and inexpensive assay of editing outcomes. Here we present ICE (Inference of CRISPR Edits), which enables robust batch analysis of CRISPR edits using Sanger data. ICE proposes potential editing outcomes for single guide, multiplex editing, base editing, and homology-directed repair experiments and then determines which are supported by the data via regression. Additionally, we develop a score called ICE-D (Discordance) that can provide information on large or unexpected edits. We empirically confirm through over 1,800 edits that the ICE algorithm is robust, reproducible, and can analyze CRISPR experiments within days after transfection. We also confirm that ICE strongly correlates with NGS analysis (Amp-Seq). ICE is an improvement over current analysis tools in that it provides batch analysis, is free to use, and can detect a wider variety of edits. It provides investigators with a reliable editing tool that can significantly expedite CRISPR editing workflows. Our ICE tool is available online at ice.synthego.com and the source code is at github.com/synthego-open/ice</description><originId>http://biorxiv.org/cgi/content/short/251082v2?rss=1</originId><crawled>1547532138356</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/14/251082</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Gayathri Vaidyanathan</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Indian</text></item><item><text>India</text></item></mentions><label>India</label><id>nlp/f/entity/en/w/India</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>GM</text></item></mentions><label>General Motors</label><id>nlp/f/entity/en/w/General Motors</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Monsanto</text></item></mentions><label>Monsanto</label><id>nlp/f/entity/en/w/Monsanto</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Bayer</text></item></mentions><label>Bayer</label><id>nlp/f/entity/en/w/Bayer</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Getty</text></item></mentions><label>Getty Images</label><id>nlp/f/entity/en/w/Getty Images</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689e29c7d9:999a8a:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Indian court’s decision to uphold GM cotton patent could boost industry research&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Indian court’s decision to uphold GM cotton patent could boost industry research, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00177-y&quot;&gt;doi:10.1038/d41586-019-00177-y&lt;/a&gt;&lt;/p&gt;But the ruling is not the end of the legal challenge.</content></content><engagementRate>0.67</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00177-y</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00177-y/d41586-019-00177-y_16398044.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>53edb675</fingerprint><commonTopics><item><probability>1.0</probability><label>ip</label><id>nlp/f/topic/1200</id></item><item><probability>0.989</probability><label>agriculture</label><id>nlp/f/topic/54</id></item><item><probability>0.977</probability><label>copyright</label><id>nlp/f/topic/546</id></item><item><probability>0.852</probability><label>science policy</label><id>nlp/f/topic/2019</id></item><item><probability>0.746</probability><label>india</label><id>nlp/f/topic/1149</id></item><item><probability>0.71</probability><label>pharma</label><id>nlp/f/topic/1734</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00177-y</link><engagement>6</engagement><title>Indian court’s decision to uphold GM cotton patent could boost industry research</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Indian court’s decision to uphold GM cotton patent could boost industry research&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Indian court’s decision to uphold GM cotton patent could boost industry research, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00177-y&quot;&gt;doi:10.1038/d41586-019-00177-y&lt;/a&gt;&lt;/p&gt;But the ruling is not the end of the legal challenge.</description><originId>https://www.nature.com/articles/d41586-019-00177-y</originId><crawled>1548841764825</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Barbara Casassus</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>French</text></item><item><text>France</text></item></mentions><label>France</label><id>nlp/f/entity/en/w/France</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Roundup Pro 360</text></item></mentions><label>Roundup Pro 360</label><id>nlp/f/entity/en/-/roundup pro 360</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Getty</text></item></mentions><label>Getty Images</label><id>nlp/f/entity/en/w/Getty Images</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>AFP</text></item></mentions><label>AFP</label><id>nlp/f/entity/en/-/afp</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>ANSES</text></item></mentions><label>ANSES</label><id>nlp/f/entity/en/-/anses</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16880ec7634:357fac5:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;French court bans sale of controversial weedkiller&lt;/b&gt;&lt;/p&gt;&lt;p&gt;French court bans sale of controversial weedkiller, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00259-x&quot;&gt;doi:10.1038/d41586-019-00259-x&lt;/a&gt;&lt;/p&gt;Ruling prohibits sale of a glyphosate product to professionals, citing arguments that chemical is potentially carcinogenic.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00259-x</href></item></alternate><published>1548316800000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00259-x/d41586-019-00259-x_16414864.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>b8f63e72</fingerprint><commonTopics><item><probability>0.936</probability><label>europe</label><id>nlp/f/topic/807</id></item><item><probability>0.77</probability><label>germany</label><id>nlp/f/topic/964</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00259-x</link><engagement>8</engagement><title>French court bans sale of controversial weedkiller</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;French court bans sale of controversial weedkiller&lt;/b&gt;&lt;/p&gt;&lt;p&gt;French court bans sale of controversial weedkiller, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00259-x&quot;&gt;doi:10.1038/d41586-019-00259-x&lt;/a&gt;&lt;/p&gt;Ruling prohibits sale of a glyphosate product to professionals, citing arguments that chemical is potentially carcinogenic.</description><originId>https://www.nature.com/articles/d41586-019-00259-x</originId><crawled>1548351206964</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Zahn, L. M.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a69:c2ce2e2e</id><published>1548355045000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>6b413726</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6425/361-b?rss=1</link><engagement>0</engagement><crawled>1548357093757</crawled><title>Minor veins are key to photosynthesis</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6425/361-b?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/361-b?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6425/361.2.full</canonicalUrl></item><item><author><name>Kai Zhang</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_16827dd5e9f:1470d47:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Manganese based layered oxides with modulated electronic and thermodynamic properties for sodium ion batteries&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Manganese based layered oxides with modulated electronic and thermodynamic properties for sodium ion batteries, Published online: 07 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07646-4&quot;&gt;doi:10.1038/s41467-018-07646-4&lt;/a&gt;&lt;/p&gt;Mn-based layered oxides are promising cathode materials for next generation sodium ion batteries. To address two existing issues facing the system, here the authors show that a simple zinc doping can suppress both Jahn–Teller distortion and phase separation, enabling enhanced cycling performance.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/-JU0bd8RsBE&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/-JU0bd8RsBE/s41467-018-07646-4</href></item></alternate><published>1546848000000</published><unread>True</unread><visual><height>326</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-07646-4/MediaObjects/41467_2018_7646_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>72307dee</fingerprint><link>https://www.nature.com/articles/s41467-018-07646-4</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-07646-4</href></item></canonical><title>Manganese based layered oxides with modulated electronic and thermodynamic properties for sodium ion batteries</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Manganese based layered oxides with modulated electronic and thermodynamic properties for sodium ion batteries&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Manganese based layered oxides with modulated electronic and thermodynamic properties for sodium ion batteries, Published online: 07 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07646-4&quot;&gt;doi:10.1038/s41467-018-07646-4&lt;/a&gt;&lt;/p&gt;Mn-based layered oxides are promising cathode materials for next generation sodium ion batteries. To address two existing issues facing the system, here the authors show that a simple zinc doping can suppress both Jahn–Teller distortion and phase separation, enabling enhanced cycling performance.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/-JU0bd8RsBE&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-07646-4</originId><crawled>1546857045663</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>AAAS</text></item></mentions><label>American Association for the Advancement of Science</label><id>nlp/f/entity/en/w/American Association for the Advancement of Science</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Science</text></item></mentions><label>Science</label><id>nlp/f/entity/en/w/Science</id></item></entities><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:15708cd:8675cc2c</id><author><name>NA</name></author><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/106?rss=1</href></item></alternate><published>1547145461000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>deb03a4d</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6423/106?rss=1</link><engagement>2</engagement><title>News at a glance</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6423/106?rss=1</originId><crawled>1547147463250</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6423/106.full</canonicalUrl><keywords><item>Scientific Community</item></keywords></item><item><author><name>Chen, L.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168409baea7:1f1be99:c2ce2e2e</id><content><direction>ltr</direction><content>Tissue/cell-specific marker genes (MGs) are defined as being exclusively and consistently expressed in a particular tissue/cell subtype across varying conditions. Detecting MGs plays a critical role in molecularly characterizing and conferring tissue/cell subtypes. Unfortunately, classic differential analysis assumes a convenient statistical distribution for the null hypothesis that however does not enforce MG definition and thus results in high false positives. Here we describe a statistically principled method, One Versus Everyone Subtype Exclusively-expressed Genes (OVESEG) test, and propose a mixture null distribution model estimated via novel permutation schemes. Validated with realistic synthetic data sets on both type 1 error and detection power, OVESEG-test applied to two benchmark gene expression data sets detects many known and de novo subtype-specific markers. The subsequent supervised deconvolution results, obtained using MGs detected by OVESEG-test, show superior performance as compared with that by peer methods.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/517961v1?rss=1</href></item></alternate><published>1547193600000</published><unread>True</unread><fingerprint>ac0b371c</fingerprint><link>http://biorxiv.org/cgi/content/short/517961v1?rss=1</link><engagement>0</engagement><title>Data-driven robust detection of tissue/cell-specific markers [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Tissue/cell-specific marker genes (MGs) are defined as being exclusively and consistently expressed in a particular tissue/cell subtype across varying conditions. Detecting MGs plays a critical role in molecularly characterizing and conferring tissue/cell subtypes. Unfortunately, classic differential analysis assumes a convenient statistical distribution for the null hypothesis that however does not enforce MG definition and thus results in high false positives. Here we describe a statistically principled method, One Versus Everyone Subtype Exclusively-expressed Genes (OVESEG) test, and propose a mixture null distribution model estimated via novel permutation schemes. Validated with realistic synthetic data sets on both type 1 error and detection power, OVESEG-test applied to two benchmark gene expression data sets detects many known and de novo subtype-specific markers. The subsequent supervised deconvolution results, obtained using MGs detected by OVESEG-test, show superior performance as compared with that by peer methods.</description><originId>http://biorxiv.org/cgi/content/short/517961v1?rss=1</originId><crawled>1547272171175</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/11/517961</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1687650ea7b:2671251:3a104d3b</id><published>1548115200000</published><unread>True</unread><summary><direction>ltr</direction><content>We report a modular synthetic strategy for accessing heteroatom-containing polycyclic aromatic hydrocarbons (PAHs) that relies on the controlled generation of transient heterocyclic alkynes and arynes. The strained intermediates undergo in situ trapping with readily accessible oxadiazinones. Four sequential pericyclic reactions occur, namely two Diels–Alder / retro-Diels–Alder sequences, which can be performed in a stepwise or one-pot fashion to assemble four new carbon–carbon (C–C) bonds.</content></summary><fingerprint>5137d4c6</fingerprint><link>https://chemrxiv.org/articles/Cyclic_Alkyne_Approach_to_Heteroatom-Containing_Polycyclic_Aromatic_Hydrocarbon_Scaffolds/7613027</link><engagement>2</engagement><crawled>1548173240955</crawled><title>Cyclic Alkyne Approach to Heteroatom-Containing Polycyclic Aromatic Hydrocarbon Scaffolds</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>We report a modular synthetic strategy for accessing heteroatom-containing polycyclic aromatic hydrocarbons (PAHs) that relies on the controlled generation of transient heterocyclic alkynes and arynes. The strained intermediates undergo in situ trapping with readily accessible oxadiazinones. Four sequential pericyclic reactions occur, namely two Diels–Alder / retro-Diels–Alder sequences, which can be performed in a stepwise or one-pot fashion to assemble four new carbon–carbon (C–C) bonds.</description><originId>https://chemrxiv.org/articles/Cyclic_Alkyne_Approach_to_Heteroatom-Containing_Polycyclic_Aromatic_Hydrocarbon_Scaffolds/7613027</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Cyclic_Alkyne_Approach_to_Heteroatom-Containing_Polycyclic_Aromatic_Hydrocarbon_Scaffolds/7613027</href></item></alternate><visual><height>324</height><processor>feedly-nikon-v3.1</processor><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14137436/thumb.png</url><contentType>image/png</contentType><width>250</width></visual></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1684d406641:2dbff58:3a104d3b</id><published>1547424000000</published><unread>True</unread><summary><direction>ltr</direction><content>Self-standing macrocellular titanosilicate monolith foams are obtained using a one-pot sol-gel route and show excellent performance in the epoxidation of cyclohexene. Thanks to the High Internal Phase Emulsion (HIPE) templating method, the materials feature a high void fraction, a hierarchically porous texture and good mechanical strength. Highly dispersed Ti species can be incorporated in tetrahedral coordination the silica matrix. These characteristics allow the obtained ‘SiTi(HIPE)’ materials to reach high catalytic turnover in the epoxidation of cyclohexene. The monoliths can advantageously be used to run the reaction in continuous flow mode.</content></summary><fingerprint>472aa07d</fingerprint><link>https://chemrxiv.org/articles/Macrocellular_Titanosilicate_Monoliths_as_Highly_Efficient_Structured_Olefin_Epoxidation_Catalysts/7578599</link><engagement>0</engagement><crawled>1547484292673</crawled><title>Macrocellular Titanosilicate Monoliths as Highly Efficient Structured Olefin Epoxidation Catalysts</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>Self-standing macrocellular titanosilicate monolith foams are obtained using a one-pot sol-gel route and show excellent performance in the epoxidation of cyclohexene. Thanks to the High Internal Phase Emulsion (HIPE) templating method, the materials feature a high void fraction, a hierarchically porous texture and good mechanical strength. Highly dispersed Ti species can be incorporated in tetrahedral coordination the silica matrix. These characteristics allow the obtained ‘SiTi(HIPE)’ materials to reach high catalytic turnover in the epoxidation of cyclohexene. The monoliths can advantageously be used to run the reaction in continuous flow mode.</description><originId>https://chemrxiv.org/articles/Macrocellular_Titanosilicate_Monoliths_as_Highly_Efficient_Structured_Olefin_Epoxidation_Catalysts/7578599</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Macrocellular_Titanosilicate_Monoliths_as_Highly_Efficient_Structured_Olefin_Epoxidation_Catalysts/7578599</href></item></alternate><visual><height>354</height><processor>feedly-nikon-v3.1</processor><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14076065/thumb.png</url><contentType>image/png</contentType><width>250</width></visual></item><item><author><name>Srinivasan, S.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1681998498c:49e4e3:ad2b6584</id><content><direction>ltr</direction><content>Single-cell RNA sequencing (scRNA-seq) is a recent technology that enables fine-grained discovery of cellular subtypes and specific cell states. It routinely uses machine learning methods, such as feature learning, clustering, and classification, to assist in uncovering novel information from scRNA-seq data. However, current methods are not well suited to deal with the substantial amounts of noise that is created by the experiments or the variation that occurs due to differences in the cells of the same type. Here, we develop a new hybrid approach, Deep Unsupervised Single-cell Clustering (DUSC), that integrates feature generation based on a deep learning architecture with a model-based clustering algorithm, to find a compact and informative representation of the single-cell transcriptomic data generating robust clusters. We also include a technique to estimate an efficient number of latent features in the deep learning model. Our method outperforms both classical and state-of-the-art feature learning and clustering methods, approaching the accuracy of supervised learning. The method is freely available to the community and will hopefully facilitate our understanding of the cellular atlas of living organisms as well as provide the means to improve patient diagnostics and treatment.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/511626v1?rss=1</href></item></alternate><published>1546588800000</published><unread>True</unread><fingerprint>a9d6c66b</fingerprint><link>http://biorxiv.org/cgi/content/short/511626v1?rss=1</link><engagement>13</engagement><title>A Hybrid Deep Clustering Approach for Robust Cell Type Profiling Using Single-cell RNA-seq Data [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Single-cell RNA sequencing (scRNA-seq) is a recent technology that enables fine-grained discovery of cellular subtypes and specific cell states. It routinely uses machine learning methods, such as feature learning, clustering, and classification, to assist in uncovering novel information from scRNA-seq data. However, current methods are not well suited to deal with the substantial amounts of noise that is created by the experiments or the variation that occurs due to differences in the cells of the same type. Here, we develop a new hybrid approach, Deep Unsupervised Single-cell Clustering (DUSC), that integrates feature generation based on a deep learning architecture with a model-based clustering algorithm, to find a compact and informative representation of the single-cell transcriptomic data generating robust clusters. We also include a technique to estimate an efficient number of latent features in the deep learning model. Our method outperforms both classical and state-of-the-art feature learning and clustering methods, approaching the accuracy of supervised learning. The method is freely available to the community and will hopefully facilitate our understanding of the cellular atlas of living organisms as well as provide the means to improve patient diagnostics and treatment.</description><originId>http://biorxiv.org/cgi/content/short/511626v1?rss=1</originId><crawled>1546617637260</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/04/511626</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Tim Radford</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Primo Levi</text></item></mentions><label>Primo Levi</label><id>nlp/f/entity/en/w/Primo Levi</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Levi</text></item></mentions><label>Levi Strauss &amp; Co.</label><id>nlp/f/entity/en/w/Levi Strauss &amp; Co.</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Periodic Table</text></item><item><text>The Periodic Table</text></item></mentions><label>Periodic table</label><id>nlp/f/entity/en/w/Periodic table</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Bridgeman</text></item></mentions><label>Bridgeman</label><id>nlp/f/entity/en/-/bridgeman</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Jewish</text></item></mentions><label>Jews</label><id>nlp/f/entity/en/w/Jews</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16893f5cc58:4de9b91:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;In his element: looking back on Primo Levi’s &lt;i&gt;The Periodic Table&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;In his element: looking back on Primo Levi’s &amp;lt;i&gt;The Periodic Table&amp;lt;/i&gt;, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00288-6&quot;&gt;doi:10.1038/d41586-019-00288-6&lt;/a&gt;&lt;/p&gt;Tim Radford celebrates an extraordinary short-story collection.</content></content><engagementRate>0.44</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00288-6</href></item></alternate><published>1548662400000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00288-6/d41586-019-00288-6_16420130.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>500d25a8</fingerprint><commonTopics><item><probability>0.916</probability><label>books</label><id>nlp/f/topic/303</id></item><item><probability>0.78</probability><label>germany</label><id>nlp/f/topic/964</id></item><item><probability>0.758</probability><label>jewish</label><id>nlp/f/topic/1235</id></item><item><probability>0.752</probability><label>peak oil</label><id>nlp/f/topic/1712</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00288-6</link><engagement>4</engagement><title>In his element: looking back on Primo Levi’s The Periodic Table</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;In his element: looking back on Primo Levi’s &lt;i&gt;The Periodic Table&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;In his element: looking back on Primo Levi’s &amp;lt;i&gt;The Periodic Table&amp;lt;/i&gt;, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00288-6&quot;&gt;doi:10.1038/d41586-019-00288-6&lt;/a&gt;&lt;/p&gt;Tim Radford celebrates an extraordinary short-story collection.</description><originId>https://www.nature.com/articles/d41586-019-00288-6</originId><crawled>1548670585944</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Changsong Zou</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1688482b6e0:3b9c08a:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;The genome of broomcorn millet&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The genome of broomcorn millet, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08409-5&quot;&gt;doi:10.1038/s41467-019-08409-5&lt;/a&gt;&lt;/p&gt;Broomcorn millet is one of the earliest domesticated plants and has the highest water use efficiency among cereals. Here, the authors report its genome assembly and annotation, which provides a valuable resource for breeders and paves the way for studying plant drought tolerance and C4 photosynthesis.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/u0Jpn2pcVWc&quot; height=&quot;1&quot;&gt;</content></content><engagementRate>0.45</engagementRate><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/u0Jpn2pcVWc/s41467-019-08409-5</href></item></alternate><published>1548403200000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-019-08409-5/MediaObjects/41467_2019_8409_Fig1_HTML.png</url><contentType>image/png</contentType><width>629</width></visual><fingerprint>90be21dc</fingerprint><link>https://www.nature.com/articles/s41467-019-08409-5</link><engagement>5</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-019-08409-5</href></item></canonical><title>The genome of broomcorn millet</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;The genome of broomcorn millet&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The genome of broomcorn millet, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08409-5&quot;&gt;doi:10.1038/s41467-019-08409-5&lt;/a&gt;&lt;/p&gt;Broomcorn millet is one of the earliest domesticated plants and has the highest water use efficiency among cereals. Here, the authors report its genome assembly and annotation, which provides a valuable resource for breeders and paves the way for studying plant drought tolerance and C4 photosynthesis.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/u0Jpn2pcVWc&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-019-08409-5</originId><crawled>1548411385568</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Servick, K.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3d0:ad2b6584</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/14?rss=1</href></item></alternate><published>1546540591000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>1493039d</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6422/14?rss=1</link><engagement>67</engagement><title>Computers turn neural signals into speech</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6422/14?rss=1</originId><crawled>1546542450273</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6422/14.full</canonicalUrl><keywords><item>Medicine, Diseases, Neuroscience</item></keywords></item><item><author><name>Huang, Q.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1685006f7f1:32ac812:8675cc2c</id><content><direction>ltr</direction><content>For a variety of human malignancies, incidence, treatment effi- cacy and overall prognosis show considerable variation between different populations and ethnic groups. Disentangling the ef- fects related to particular population backgrounds can help in both understanding cancer biology and in tailoring therapeu- tic interventions. Because self-reported or inferred patient data can be incomplete or misleading due to migration and genomic admixture, a data-driven ancestry estimation should be pre- ferred. While algorithms to analyze ancestry structure from healthy individuals have been developed, an easy-to-use tool to assign population groups based on genotyping data from SNP profiles is still missing and benchmarking for the validity of pop- ulation assignment strategy for aberrant cancer genomes was not tested. We benchmarked the consistency and accuracy of cross- platform population assignment. We also demonstrated its high accuracy to process unaltered as well as cancer genomes. De- spite widespread and extensive somatic mutations of cancer pro- filing data, population assignment consistency between germline and highly mutated samples from cancer patients reached of 97% and 92% for assignment into 5 and 26 populations re- spectively. Comparison of our benchmarked results with self- reported meta-data estimated a matching rate between 88 % to 92%. Despite a relatively high matching rate, the ethnicity labels indicated in meta-data are vague compared to the stan- dardized output from our tool. We have developed a bioinformatics tool to assign the popula- tions from genome profiling data and validated its performance in healthy as well as aberrant cancer genomes. It is ready-to-use for genotyping data from nine commercial SNP array platforms or sequencing data. This tool is effective to scrutinize the popu- lation structure in cancer genomes and provides better measure to integrate genotyping data from various platforms instead of self-reported information. It will facilitate research on inter- play between ethnicity related genetic background and molecu- lar patterns in cancer entities and disentangling possible hered- itary contributions. The docker image of the tool is provided in DockerHub as &amp;quot;baudisgroup/snp2pop&amp;quot;.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/368647v2?rss=1</href></item></alternate><published>1547452800000</published><unread>True</unread><fingerprint>3412de7f</fingerprint><link>http://biorxiv.org/cgi/content/short/368647v2?rss=1</link><engagement>0</engagement><title>Enabling population assignment from cancer genomes with SNP2pop [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>For a variety of human malignancies, incidence, treatment effi- cacy and overall prognosis show considerable variation between different populations and ethnic groups. Disentangling the ef- fects related to particular population backgrounds can help in both understanding cancer biology and in tailoring therapeu- tic interventions. Because self-reported or inferred patient data can be incomplete or misleading due to migration and genomic admixture, a data-driven ancestry estimation should be pre- ferred. While algorithms to analyze ancestry structure from healthy individuals have been developed, an easy-to-use tool to assign population groups based on genotyping data from SNP profiles is still missing and benchmarking for the validity of pop- ulation assignment strategy for aberrant cancer genomes was not tested. We benchmarked the consistency and accuracy of cross- platform population assignment. We also demonstrated its high accuracy to process unaltered as well as cancer genomes. De- spite widespread and extensive somatic mutations of cancer pro- filing data, population assignment consistency between germline and highly mutated samples from cancer patients reached of 97% and 92% for assignment into 5 and 26 populations re- spectively. Comparison of our benchmarked results with self- reported meta-data estimated a matching rate between 88 % to 92%. Despite a relatively high matching rate, the ethnicity labels indicated in meta-data are vague compared to the stan- dardized output from our tool. We have developed a bioinformatics tool to assign the popula- tions from genome profiling data and validated its performance in healthy as well as aberrant cancer genomes. It is ready-to-use for genotyping data from nine commercial SNP array platforms or sequencing data. This tool is effective to scrutinize the popu- lation structure in cancer genomes and provides better measure to integrate genotyping data from various platforms instead of self-reported information. It will facilitate research on inter- play between ethnicity related genetic background and molecu- lar patterns in cancer entities and disentangling possible hered- itary contributions. The docker image of the tool is provided in DockerHub as &amp;quot;baudisgroup/snp2pop&amp;quot;.</description><originId>http://biorxiv.org/cgi/content/short/368647v2?rss=1</originId><crawled>1547530860529</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/14/368647</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Ming-Hsiang Lee</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Publisher Correction : Somatic</text></item></mentions><label>Publisher Correction : Somatic</label><id>nlp/f/entity/en/-/publisher correction : somatic</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Alzheimer</text></item></mentions><label>Alzheimer&apos;s disease</label><id>nlp/f/entity/en/w/Alzheimer&apos;s disease</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>CSS</text></item></mentions><label>Cascading Style Sheets</label><id>nlp/f/entity/en/w/Cascading Style Sheets</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Explorer</text></item></mentions><label>Explorer</label><id>nlp/f/entity/en/-/explorer</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>WEBSITEnature_com</text></item></mentions><label>WEBSITEnature_com</label><id>nlp/f/entity/en/-/websitenature_com</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168768f3dc0:262c68a:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Publisher Correction: Somatic &lt;i&gt;APP&lt;/i&gt; gene recombination in Alzheimer’s disease and normal neurons&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Publisher Correction: Somatic &amp;lt;i&gt;APP&amp;lt;/i&gt; gene recombination in Alzheimer’s disease and normal neurons, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0905-0&quot;&gt;doi:10.1038/s41586-019-0905-0&lt;/a&gt;&lt;/p&gt;Publisher Correction: Somatic &lt;i&gt;APP&lt;/i&gt; gene recombination in Alzheimer’s disease and normal neurons</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0905-0</href></item></alternate><published>1548144000000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>b584e331</fingerprint><commonTopics><item><probability>0.948</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item><item><probability>0.703</probability><label>journals</label><id>nlp/f/topic/1241</id></item></commonTopics><link>https://www.nature.com/articles/s41586-019-0905-0</link><engagement>0</engagement><title>Publisher Correction: Somatic APP gene recombination in Alzheimer’s disease and normal neurons</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Publisher Correction: Somatic &lt;i&gt;APP&lt;/i&gt; gene recombination in Alzheimer’s disease and normal neurons&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Publisher Correction: Somatic &amp;lt;i&gt;APP&amp;lt;/i&gt; gene recombination in Alzheimer’s disease and normal neurons, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0905-0&quot;&gt;doi:10.1038/s41586-019-0905-0&lt;/a&gt;&lt;/p&gt;Publisher Correction: Somatic &lt;i&gt;APP&lt;/i&gt; gene recombination in Alzheimer’s disease and normal neurons</description><originId>https://www.nature.com/articles/s41586-019-0905-0</originId><crawled>1548177325504</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Nicola Fenderico</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1686ff3b71e:1d335eb:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08172-z&quot;&gt;doi:10.1038/s41467-018-08172-z&lt;/a&gt;&lt;/p&gt;Enhanced Wnt receptor activity is a major cause of cancer development. Here the authors identify camelid single-domain antibody fragments (VHHs) that bind to the Wnt receptor LRP5/6 ectodomain, determine the crystal structures and show that these VHHs selectively inhibit Wnt3- mediated cellular responses and block the growth of mutant Wnt-hypersensitive intestinal tumor organoids.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/8pjq12ql1hM&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/8pjq12ql1hM/s41467-018-08172-z</href></item></alternate><published>1548057600000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08172-z/MediaObjects/41467_2018_8172_Fig1_HTML.png</url><contentType>image/png</contentType><width>496</width></visual><fingerprint>ed91e88e</fingerprint><link>https://www.nature.com/articles/s41467-018-08172-z</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08172-z</href></item></canonical><title>Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08172-z&quot;&gt;doi:10.1038/s41467-018-08172-z&lt;/a&gt;&lt;/p&gt;Enhanced Wnt receptor activity is a major cause of cancer development. Here the authors identify camelid single-domain antibody fragments (VHHs) that bind to the Wnt receptor LRP5/6 ectodomain, determine the crystal structures and show that these VHHs selectively inhibit Wnt3- mediated cellular responses and block the growth of mutant Wnt-hypersensitive intestinal tumor organoids.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/8pjq12ql1hM&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-08172-z</originId><crawled>1548066469662</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1689abddb96:4b6008:3a104d3b</id><published>1548720000000</published><unread>True</unread><summary><direction>ltr</direction><content>Corrosion inhibition offered by unfunctionalized exfoliated graphite polymer composite coatings for protection of aluminum alloy 7075 substrates is described.</content></summary><fingerprint>9881ced6</fingerprint><link>https://chemrxiv.org/articles/Tortuosity_but_not_Percolation_Design_of_Graphene_Nanocomposite_Coatings_for_the_Extended_Corrosion_Protection_of_Aluminum_Alloys/7635980</link><engagement>0</engagement><crawled>1548784360342</crawled><title>Tortuosity but not Percolation: Design of Graphene Nanocomposite Coatings for the Extended Corrosion Protection of Aluminum Alloys</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>Corrosion inhibition offered by unfunctionalized exfoliated graphite polymer composite coatings for protection of aluminum alloy 7075 substrates is described.</description><originId>https://chemrxiv.org/articles/Tortuosity_but_not_Percolation_Design_of_Graphene_Nanocomposite_Coatings_for_the_Extended_Corrosion_Protection_of_Aluminum_Alloys/7635980</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Tortuosity_but_not_Percolation_Design_of_Graphene_Nanocomposite_Coatings_for_the_Extended_Corrosion_Protection_of_Aluminum_Alloys/7635980</href></item></alternate><visual><height>324</height><processor>feedly-nikon-v3.1</processor><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14202656/thumb.png</url><contentType>image/png</contentType><width>250</width></visual></item><item><author><name>Oliver Preische</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Alzheimer disease</text></item><item><text>Alzheimer</text></item></mentions><label>Alzheimer&apos;s disease</label><id>nlp/f/entity/en/w/Alzheimer&apos;s disease</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Presymptomatic</text></item><item><text>presymptomatic Alzheimer</text></item></mentions><label>presymptomatic Alzheimer</label><id>nlp/f/entity/en/-/presymptomatic alzheimer</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Lancet Neurol</text></item></mentions><label>The Lancet</label><id>nlp/f/entity/en/w/The Lancet</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>A. et al</text></item></mentions><label>A. et al</label><id>nlp/f/entity/en/-/a. et al</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>CSF</text></item></mentions><label>CSF</label><id>nlp/f/entity/en/-/csf</id></item></entities><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_168713e9936:1f197cf:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0304-3&quot;&gt;doi:10.1038/s41591-018-0304-3&lt;/a&gt;&lt;/p&gt;In a longitudinal cohort of familial Alzheimer’s disease patients, the rate of change of blood biomarker levels identifies disease carriers much earlier than absolute levels and predicts both neurodegeneration and cognitive decline.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/Cic-rFxhSVo&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/Cic-rFxhSVo/s41591-018-0304-3</href></item></alternate><published>1548057600000</published><unread>True</unread><visual><height>652</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-018-0304-3/MediaObjects/41591_2018_304_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>4d489311</fingerprint><commonTopics><item><probability>0.989</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.951</probability><label>neurology</label><id>nlp/f/topic/1563</id></item><item><probability>0.912</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item><item><probability>0.897</probability><label>classics</label><id>nlp/f/topic/477</id></item><item><probability>0.886</probability><label>emergency medicine</label><id>nlp/f/topic/764</id></item><item><probability>0.873</probability><label>rationality</label><id>nlp/f/topic/1895</id></item><item><probability>0.788</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.752</probability><label>ecology</label><id>nlp/f/topic/725</id></item><item><probability>0.729</probability><label>aging</label><id>nlp/f/topic/53</id></item><item><probability>0.721</probability><label>mp3</label><id>nlp/f/topic/1508</id></item></commonTopics><link>https://www.nature.com/articles/s41591-018-0304-3</link><engagement>12</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41591-018-0304-3</href></item></canonical><title>Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease</title><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0304-3&quot;&gt;doi:10.1038/s41591-018-0304-3&lt;/a&gt;&lt;/p&gt;In a longitudinal cohort of familial Alzheimer’s disease patients, the rate of change of blood biomarker levels identifies disease carriers much earlier than absolute levels and predicts both neurodegeneration and cognitive decline.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/Cic-rFxhSVo&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41591-018-0304-3</originId><crawled>1548088154422</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Obinna N. Obianom, Yong Ai, Yingjun Li, Wei Yang, Dong Guo, Hong Yang, Srilatha Sakamuru, Menghang Xia, Fengtian Xue, Yan Shu</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_16838d9f7a3:1402b0b:b77f238b</id><published>1547096400000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01408/20190109/images/medium/jm-2018-01408x_0010.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01408&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=EsNxexbJz6Y:a1W7QOv1UOg:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/EsNxexbJz6Y&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>e8a07e33</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01408</link><crawled>1547142035363</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01408</href></item></canonical><engagement>0</engagement><title>[ASAP] Triazole-Based Inhibitors of the Wnt/ß-Catenin Signaling Pathway Improve Glucose and Lipid Metabolisms in Diet-Induced Obese Mice</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01408/20190109/images/medium/jm-2018-01408x_0010.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01408&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=EsNxexbJz6Y:a1W7QOv1UOg:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/EsNxexbJz6Y&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01408</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/EsNxexbJz6Y/acs.jmedchem.8b01408</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Vignieri, S.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a77:c2ce2e2e</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/360-j?rss=1</href></item></alternate><published>1548355045000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>9129ef35</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6425/360-j?rss=1</link><engagement>0</engagement><title>Ocean recoveries are moving targets</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6425/360-j?rss=1</originId><crawled>1548357093757</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6425/360.10.full</canonicalUrl><keywords><item>Ecology</item></keywords></item><item><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>twining</text></item></mentions><label>twining</label><id>nlp/f/entity/en/-/twining</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Indrek</text></item></mentions><label>Indrek</label><id>nlp/f/entity/en/-/indrek</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Edoardo Sinibaldi</text></item></mentions><label>Edoardo Sinibaldi</label><id>nlp/f/entity/en/-/edoardo sinibaldi</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Barbara Mazzolai</text></item></mentions><label>Barbara Mazzolai</label><id>nlp/f/entity/en/-/barbara mazzolai</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Italian Institute of Technology</text></item></mentions><label>Istituto Italiano di Tecnologia</label><id>nlp/f/entity/en/w/Istituto Italiano di Tecnologia</id></item></entities><author><name>NA</name></author><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689a861fbc:42b9b0:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;A ﻿robotic vine that can coil itself around the real thing&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A ﻿robotic vine that can coil itself around the real thing, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00308-5&quot;&gt;doi:10.1038/d41586-019-00308-5&lt;/a&gt;&lt;/p&gt;Artificial device imitates plants that rely on osmosis to power their tendrils.</content></content><engagementRate>0.56</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00308-5</href></item></alternate><published>1548748800000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00308-5/d41586-019-00308-5_16417502.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>e2f7667b</fingerprint><commonTopics><item><probability>0.971</probability><label>robotics</label><id>nlp/f/topic/1955</id></item><item><probability>0.763</probability><label>electronics</label><id>nlp/f/topic/750</id></item><item><probability>0.723</probability><label>permaculture</label><id>nlp/f/topic/1728</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00308-5</link><engagement>5</engagement><title>A ﻿robotic vine that can coil itself around the real thing</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;A ﻿robotic vine that can coil itself around the real thing&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A ﻿robotic vine that can coil itself around the real thing, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00308-5&quot;&gt;doi:10.1038/d41586-019-00308-5&lt;/a&gt;&lt;/p&gt;Artificial device imitates plants that rely on osmosis to power their tendrils.</description><originId>https://www.nature.com/articles/d41586-019-00308-5</originId><crawled>1548780707772</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Davide Castelvecchi</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Taylor</text></item><item><text>Hayden Taylor</text></item></mentions><label>Hayden Taylor</label><id>nlp/f/entity/en/-/hayden taylor</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Star Trek</text></item></mentions><label>Star Trek</label><id>nlp/f/entity/en/w/Star Trek</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>UC Berkeley</text></item></mentions><label>University of California, Berkeley</label><id>nlp/f/entity/en/w/University of California, Berkeley</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Science 1</text></item></mentions><label>Science 1</label><id>nlp/f/entity/en/-/science 1</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Joseph DeSimone</text></item></mentions><label>Joseph DeSimone</label><id>nlp/f/entity/en/w/Joseph DeSimone</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168a54edd4b:147b208:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Forget everything you know about 3D printing — the ‘replicator’ is here&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Forget everything you know about 3D printing — the ‘replicator’ is here, Published online: 31 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07798-9&quot;&gt;doi:10.1038/d41586-018-07798-9&lt;/a&gt;&lt;/p&gt;Rather ﻿than building objects layer by layer, the printer creates whole structures by projecting light into a resin that solidifies.</content></content><engagementRate>3.5</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07798-9</href></item></alternate><published>1548921600000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07798-9/d41586-018-07798-9_16433618.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>648ff816</fingerprint><commonTopics><item><probability>1.0</probability><label>3d printing</label><id>nlp/f/topic/4</id></item><item><probability>0.786</probability><label>manufacturing</label><id>nlp/f/topic/1404</id></item><item><probability>0.719</probability><label>nano</label><id>nlp/f/topic/1532</id></item></commonTopics><link>https://www.nature.com/articles/d41586-018-07798-9</link><engagement>7</engagement><title>Forget everything you know about 3D printing — the ‘replicator’ is here</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Forget everything you know about 3D printing — the ‘replicator’ is here&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Forget everything you know about 3D printing — the ‘replicator’ is here, Published online: 31 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07798-9&quot;&gt;doi:10.1038/d41586-018-07798-9&lt;/a&gt;&lt;/p&gt;Rather ﻿than building objects layer by layer, the printer creates whole structures by projecting light into a resin that solidifies.</description><originId>https://www.nature.com/articles/d41586-018-07798-9</originId><crawled>1548961635659</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>J. Benjamin Hurlbut</name></author><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>CRISPR</text></item></mentions><label>CRISPR</label><id>nlp/f/entity/en/w/CRISPR</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>first International Summit on Human Gene</text></item></mentions><label>first International Summit on Human Gene</label><id>nlp/f/entity/en/-/first international summit on human gene</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Asilomar Conference on Recombinant DNA</text></item><item><text>Asilomar</text></item></mentions><label>Asilomar Conference on Recombinant DNA</label><id>nlp/f/entity/en/w/Asilomar Conference on Recombinant DNA</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Edward Kennedy</text></item></mentions><label>Ted Kennedy</label><id>nlp/f/entity/en/w/Ted Kennedy</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Oviedo Convention</text></item></mentions><label>Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine</label><id>nlp/f/entity/en/w/Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1680fa3cabf:6141419:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Human genome editing: ask whether, not how&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Human genome editing: ask whether, not how, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07881-1&quot;&gt;doi:10.1038/d41586-018-07881-1&lt;/a&gt;&lt;/p&gt;The scientific community’s response to the CRISPR twins should not pre-empt broader discussion across society, warns J. Benjamin Hurlbut.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07881-1</href></item></alternate><published>1546416000000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07881-1/d41586-018-07881-1_16369436.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>835a36fb</fingerprint><link>https://www.nature.com/articles/d41586-018-07881-1</link><engagement>5</engagement><title>Human genome editing: ask whether, not how</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Human genome editing: ask whether, not how&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Human genome editing: ask whether, not how, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07881-1&quot;&gt;doi:10.1038/d41586-018-07881-1&lt;/a&gt;&lt;/p&gt;The scientific community’s response to the CRISPR twins should not pre-empt broader discussion across society, warns J. Benjamin Hurlbut.</description><originId>https://www.nature.com/articles/d41586-018-07881-1</originId><crawled>1546450619071</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Yeston, J.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce08b:ad2b6584</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/241-m?rss=1</href></item></alternate><published>1547750305000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>f7039ccb</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6424/241-m?rss=1</link><engagement>1</engagement><title>Predicting catalyst selectivity</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6424/241-m?rss=1</originId><crawled>1547752389672</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6424/241.13.full</canonicalUrl><keywords><item>Chemistry</item></keywords></item><item><author><name>Lucey, B. P., McCullough, A., Landsness, E. C., Toedebusch, C. D., McLeland, J. S., Zaza, A. M., Fagan, A. M., McCue, L., Xiong, C., Morris, J. C., Benzinger, T. L. S., Holtzman, D. M.</name></author><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_168340336d8:d6f30e:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;In Alzheimer’s disease (AD), deposition of insoluble amyloid-β (Aβ) is followed by intracellular aggregation of tau in the neocortex and subsequent neuronal cell loss, synaptic loss, brain atrophy, and cognitive impairment. By the time even the earliest clinical symptoms are detectable, Aβ accumulation is close to reaching its peak and neocortical tau pathology is frequently already present. The period in which AD pathology is accumulating in the absence of cognitive symptoms represents a clinically relevant time window for therapeutic intervention. Sleep is increasingly recognized as a potential marker for AD pathology and future risk of cognitive impairment. Previous studies in animal models and humans have associated decreased non–rapid eye movement (NREM) sleep slow wave activity (SWA) with Aβ deposition. In this study, we analyzed cognitive performance, brain imaging, and cerebrospinal fluid (CSF) AD biomarkers in participants enrolled in longitudinal studies of aging. In addition, we monitored their sleep using a single-channel electroencephalography (EEG) device worn on the forehead. After adjusting for multiple covariates such as age and sex, we found that NREM SWA showed an inverse relationship with AD pathology, particularly tauopathy, and that this association was most evident at the lowest frequencies of NREM SWA. Given that our study participants were predominantly cognitively normal, this suggested that changes in NREM SWA, especially at 1 to 2 Hz, might be able to discriminate tau pathology and cognitive impairment either before or at the earliest stages of symptomatic AD.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/474/eaau6550?rss=1</href></item></alternate><published>1547059839000</published><unread>True</unread><fingerprint>1dfda22a</fingerprint><link>http://stm.sciencemag.org/cgi/content/short/11/474/eaau6550?rss=1</link><engagement>282</engagement><title>[Research Articles] Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimers disease</title><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><description>&lt;p&gt;In Alzheimer’s disease (AD), deposition of insoluble amyloid-β (Aβ) is followed by intracellular aggregation of tau in the neocortex and subsequent neuronal cell loss, synaptic loss, brain atrophy, and cognitive impairment. By the time even the earliest clinical symptoms are detectable, Aβ accumulation is close to reaching its peak and neocortical tau pathology is frequently already present. The period in which AD pathology is accumulating in the absence of cognitive symptoms represents a clinically relevant time window for therapeutic intervention. Sleep is increasingly recognized as a potential marker for AD pathology and future risk of cognitive impairment. Previous studies in animal models and humans have associated decreased non–rapid eye movement (NREM) sleep slow wave activity (SWA) with Aβ deposition. In this study, we analyzed cognitive performance, brain imaging, and cerebrospinal fluid (CSF) AD biomarkers in participants enrolled in longitudinal studies of aging. In addition, we monitored their sleep using a single-channel electroencephalography (EEG) device worn on the forehead. After adjusting for multiple covariates such as age and sex, we found that NREM SWA showed an inverse relationship with AD pathology, particularly tauopathy, and that this association was most evident at the lowest frequencies of NREM SWA. Given that our study participants were predominantly cognitively normal, this suggested that changes in NREM SWA, especially at 1 to 2 Hz, might be able to discriminate tau pathology and cognitive impairment either before or at the earliest stages of symptomatic AD.&lt;/p&gt;</description><originId>http://stm.sciencemag.org/cgi/content/short/11/474/eaau6550?rss=1</originId><crawled>1547060852440</crawled><canonicalUrl>http://stm.sciencemag.org/content/11/474/eaau6550.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>V. Gopalaswamy</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>L.</text></item></mentions><label>Carl Linnaeus</label><id>nlp/f/entity/en/w/Carl Linnaeus</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>J.</text></item></mentions><label>J.</label><id>nlp/f/entity/en/-/j.</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>CTR</text></item></mentions><label>CTR</label><id>nlp/f/entity/en/-/ctr</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Nuckolls</text></item></mentions><label>Nuckolls</label><id>nlp/f/entity/en/-/nuckolls</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Nat</text></item></mentions><label>Nat</label><id>nlp/f/entity/en/-/nat</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ff99aeb:c7ac4e:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Tripled yield in direct-drive laser fusion through statistical modelling&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Tripled yield in direct-drive laser fusion through statistical modelling, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0877-0&quot;&gt;doi:10.1038/s41586-019-0877-0&lt;/a&gt;&lt;/p&gt;A statistical approach to designing and predicting the fusion yield of cryogenic deuterium–tritium implosions leads to tripled yield in direct-drive laser fusion of deuterium–tritium layered targets.</content></content><engagementRate>0.13</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0877-0</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-019-0877-0/MediaObjects/41586_2019_877_Fig1_HTML.png</url><contentType>image/png</contentType><width>591</width></visual><fingerprint>a918696b</fingerprint><commonTopics><item><probability>0.903</probability><label>physics</label><id>nlp/f/topic/1753</id></item><item><probability>0.823</probability><label>aps</label><id>nlp/f/topic/127</id></item></commonTopics><link>https://www.nature.com/articles/s41586-019-0877-0</link><engagement>1</engagement><title>Tripled yield in direct-drive laser fusion through statistical modelling</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Tripled yield in direct-drive laser fusion through statistical modelling&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Tripled yield in direct-drive laser fusion through statistical modelling, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0877-0&quot;&gt;doi:10.1038/s41586-019-0877-0&lt;/a&gt;&lt;/p&gt;A statistical approach to designing and predicting the fusion yield of cryogenic deuterium–tritium implosions leads to tripled yield in direct-drive laser fusion of deuterium–tritium layered targets.</description><originId>https://www.nature.com/articles/s41586-019-0877-0</originId><crawled>1548872162027</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Wanchisen, B. A.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b399:ad2b6584</id><published>1546540591000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>36c268d5</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6422/98?rss=1</link><engagement>0</engagement><crawled>1546542450273</crawled><title>Lessons from the &apos;real world</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6422/98?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/98?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6422/98.full</canonicalUrl></item><item><author><name>Tamames, J.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168575362d6:3cd71a4:3a104d3b</id><content><direction>ltr</direction><content>Metagenomes can be analysed using different approaches and tools. One of the most important distinctions is the way to perform taxonomic and functional assignment, choosing between the usage of assemblies or the direct analysis of raw sequence reads instead. Many instances of each approach can be found in the literature, but to the best of our knowledge no evaluation of their different performances has been carried on, and we question if their results are comparable. We have studied this point by analysing several real and mock metagenomes using different methodologies and tools, and comparing the resulting taxonomic and functional profiles. Our results show that database completeness is the main factor determining the performance of the methods relying on direct read assignment either by homology, k-mer composition or similarity to marker genes, while methods relying on assembly and assignment of predicted genes are most influenced by sequencing depth, that in turn determines the completeness of the assembly. Although differences exist, taxonomic profiles are rather similar between raw read assignment and assembly assignment methods, while they are more divergent for methods based on k-mers and marker genes. Regarding functional annotation, analysis of raw reads retrieves more functions, but it also makes a significant number of over-predictions. Assembly methods are more advantageous as the size of the metagenome grows bigger.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/522292v1?rss=1</href></item></alternate><published>1547625600000</published><unread>True</unread><fingerprint>e6fd77b3</fingerprint><link>http://biorxiv.org/cgi/content/short/522292v1?rss=1</link><engagement>22</engagement><title>Assessing the performance of different approaches for functional and taxonomic annotation of metagenomes [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Metagenomes can be analysed using different approaches and tools. One of the most important distinctions is the way to perform taxonomic and functional assignment, choosing between the usage of assemblies or the direct analysis of raw sequence reads instead. Many instances of each approach can be found in the literature, but to the best of our knowledge no evaluation of their different performances has been carried on, and we question if their results are comparable. We have studied this point by analysing several real and mock metagenomes using different methodologies and tools, and comparing the resulting taxonomic and functional profiles. Our results show that database completeness is the main factor determining the performance of the methods relying on direct read assignment either by homology, k-mer composition or similarity to marker genes, while methods relying on assembly and assignment of predicted genes are most influenced by sequencing depth, that in turn determines the completeness of the assembly. Although differences exist, taxonomic profiles are rather similar between raw read assignment and assembly assignment methods, while they are more divergent for methods based on k-mers and marker genes. Regarding functional annotation, analysis of raw reads retrieves more functions, but it also makes a significant number of over-predictions. Assembly methods are more advantageous as the size of the metagenome grows bigger.</description><originId>http://biorxiv.org/cgi/content/short/522292v1?rss=1</originId><crawled>1547653309142</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/16/522292</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Schick, R. S.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:157088e:8675cc2c</id><published>1547145461000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>15c0be4b</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6423/198?rss=1</link><engagement>28</engagement><crawled>1547147463250</crawled><title>The scars we bear</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6423/198?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/198?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6423/198.full</canonicalUrl></item><item><author><name>Sarah Marktel</name></author><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>L. Ex vivo</text></item><item><text>vivo</text></item></mentions><label>L. Ex vivo</label><id>nlp/f/entity/en/-/l. ex vivo</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>EMBO Mol</text></item><item><text>Mol</text></item></mentions><label>EMBO Mol</label><id>nlp/f/entity/en/-/embo mol</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>European Society for Blood and Marrow Transplantation</text></item><item><text>European Society for Blood</text></item></mentions><label>European Society for Blood and Marrow Transplantation</label><id>nlp/f/entity/en/-/european society for blood and marrow transplantation</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>A. T.</text></item></mentions><label>Ataxia-telangiectasia</label><id>nlp/f/entity/en/w/Ataxia-telangiectasia</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>D. J</text></item></mentions><label>D. J</label><id>nlp/f/entity/en/-/d. j</id></item></entities><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_168713e9936:1f197d0:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0301-6&quot;&gt;doi:10.1038/s41591-018-0301-6&lt;/a&gt;&lt;/p&gt;In a phase 1/2 clinical trial, gene therapy with autologous hematopoietic stem cells significantly reduced transfusion requirement in adults and children with transfusion dependent ß-thalassemia.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/po6364CvX_0&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/po6364CvX_0/s41591-018-0301-6</href></item></alternate><published>1548057600000</published><unread>True</unread><visual><height>551</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-018-0301-6/MediaObjects/41591_2018_301_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>20253fe1</fingerprint><commonTopics><item><probability>0.999</probability><label>stem cells</label><id>nlp/f/topic/2185</id></item><item><probability>0.994</probability><label>hematology</label><id>nlp/f/topic/1058</id></item><item><probability>0.992</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>0.961</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.871</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.866</probability><label>bioinformatics</label><id>nlp/f/topic/262</id></item><item><probability>0.833</probability><label>rationality</label><id>nlp/f/topic/1895</id></item><item><probability>0.831</probability><label>emergency medicine</label><id>nlp/f/topic/764</id></item><item><probability>0.831</probability><label>ecology</label><id>nlp/f/topic/725</id></item><item><probability>0.777</probability><label>classics</label><id>nlp/f/topic/477</id></item></commonTopics><link>https://www.nature.com/articles/s41591-018-0301-6</link><engagement>4</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41591-018-0301-6</href></item></canonical><title>Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia</title><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0301-6&quot;&gt;doi:10.1038/s41591-018-0301-6&lt;/a&gt;&lt;/p&gt;In a phase 1/2 clinical trial, gene therapy with autologous hematopoietic stem cells significantly reduced transfusion requirement in adults and children with transfusion dependent ß-thalassemia.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/po6364CvX_0&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41591-018-0301-6</originId><crawled>1548088154422</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Miguel C. Coelho</name></author><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>Biol</text></item></mentions><label>Biol</label><id>nlp/f/entity/en/-/biol</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>T. et al</text></item></mentions><label>T. et al</label><id>nlp/f/entity/en/-/t. et al</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Nat</text></item></mentions><label>Nat</label><id>nlp/f/entity/en/-/nat</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>e22939</text></item></mentions><label>e22939</label><id>nlp/f/entity/en/-/e22939</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>ASTRA</text></item></mentions><label>ASTRA</label><id>nlp/f/entity/en/-/astra</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ff99aeb:c7ac61:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Heterozygous mutations cause genetic instability in a yeast model of cancer evolution&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Heterozygous mutations cause genetic instability in a yeast model of cancer evolution, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0887-y&quot;&gt;doi:10.1038/s41586-019-0887-y&lt;/a&gt;&lt;/p&gt;Repeated selection for adaptive mutations in a diploid yeast model results in increased genetic instability and sheds light on mechanisms of genetic instability that might contribute to tumorigenesis.</content></content><engagementRate>1.63</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0887-y</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><height>537</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-019-0887-y/MediaObjects/41586_2019_887_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>170392c4</fingerprint><commonTopics><item><probability>1.0</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>1.0</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.996</probability><label>genetics</label><id>nlp/f/topic/955</id></item><item><probability>0.987</probability><label>evolution</label><id>nlp/f/topic/815</id></item><item><probability>0.981</probability><label>bioinformatics</label><id>nlp/f/topic/262</id></item><item><probability>0.966</probability><label>cancer</label><id>nlp/f/topic/377</id></item><item><probability>0.946</probability><label>stem cells</label><id>nlp/f/topic/2185</id></item><item><probability>0.904</probability><label>zoology</label><id>nlp/f/topic/2543</id></item><item><probability>0.902</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.866</probability><label>biology</label><id>nlp/f/topic/263</id></item></commonTopics><link>https://www.nature.com/articles/s41586-019-0887-y</link><engagement>13</engagement><title>Heterozygous mutations cause genetic instability in a yeast model of cancer evolution</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Heterozygous mutations cause genetic instability in a yeast model of cancer evolution&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Heterozygous mutations cause genetic instability in a yeast model of cancer evolution, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0887-y&quot;&gt;doi:10.1038/s41586-019-0887-y&lt;/a&gt;&lt;/p&gt;Repeated selection for adaptive mutations in a diploid yeast model results in increased genetic instability and sheds light on mechanisms of genetic instability that might contribute to tumorigenesis.</description><originId>https://www.nature.com/articles/s41586-019-0887-y</originId><crawled>1548872162027</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Yi-Wei Chen</name></author><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1687be0093d:2e2c1c0:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Southward propagation of Nazca subduction along the Andes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Southward propagation of Nazca subduction along the Andes, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0860-1&quot;&gt;doi:10.1038/s41586-018-0860-1&lt;/a&gt;&lt;/p&gt;The current phase of subduction of the Nazca slab was established in the Peruvian Andes after a plate reorganization around 80 million years ago and then propagated progressively southwards.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0860-1</href></item></alternate><published>1548230400000</published><unread>True</unread><visual><height>508</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0860-1/MediaObjects/41586_2018_860_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>a11f470a</fingerprint><link>https://www.nature.com/articles/s41586-018-0860-1</link><engagement>23</engagement><title>Southward propagation of Nazca subduction along the Andes</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Southward propagation of Nazca subduction along the Andes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Southward propagation of Nazca subduction along the Andes, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0860-1&quot;&gt;doi:10.1038/s41586-018-0860-1&lt;/a&gt;&lt;/p&gt;The current phase of subduction of the Nazca slab was established in the Peruvian Andes after a plate reorganization around 80 million years ago and then propagated progressively southwards.</description><originId>https://www.nature.com/articles/s41586-018-0860-1</originId><crawled>1548266506557</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Conway, C.</name></author><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1687c1a95dc:2f6433b:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;Wireless, biodegradable pressure sensors provide continuous short-term monitoring of arterial pulse in rats.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/476/eaaw5315?rss=1</href></item></alternate><published>1548269442000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>5468e5a4</fingerprint><link>http://stm.sciencemag.org/cgi/content/short/11/476/eaaw5315?rss=1</link><engagement>0</engagement><title>[Editors&apos; Choice] Disappearing pressure cuffs</title><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><description>&lt;p&gt;Wireless, biodegradable pressure sensors provide continuous short-term monitoring of arterial pulse in rats.&lt;/p&gt;</description><originId>http://stm.sciencemag.org/cgi/content/short/11/476/eaaw5315?rss=1</originId><crawled>1548270343644</crawled><canonicalUrl>http://stm.sciencemag.org/content/11/476/eaaw5315.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Shengming Cheng, Bin Shen, Wei Yuan, Xiaobo Zhou, Qingyun Liu, Mengya Kong, Yibing Shi, Pengyuan Yang, Wei Feng, Fuyou Li</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>1TYkl+7D2jbCAjv6kqe9qy39+K76tsp7YKV/mQVt7ps=_1684d8e4af6:1069c05:b77f238b</id><published>1547442000000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00763/20190114/images/medium/oc-2018-00763c_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00763&lt;/div&gt;</content></summary><fingerprint>a8178a77</fingerprint><link>http://dx.doi.org/10.1021/acscentsci.8b00763</link><engagement>0</engagement><crawled>1547489397494</crawled><title>[ASAP] Time-Gated Ratiometric Detection with the Same Working Wavelength To Minimize the Interferences from Photon Attenuation for Accurate in Vivo Detection</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acscii</streamId><title>ACS Central Science: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00763/20190114/images/medium/oc-2018-00763c_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00763&lt;/div&gt;</description><originId>http://dx.doi.org/10.1021/acscentsci.8b00763</originId><alternate><item><type>text/html</type><href>http://dx.doi.org/10.1021/acscentsci.8b00763</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Lin, J. J. Y., Low-Nam, S. T., Alfieri, K. N., McAffee, D. B., Fay, N. C., Groves, J. T.</name></author><id>RuJRIXzN26JgDGk9YhlIBfh4YrPi0r+1c4exm9G1IBw=_16852fd9a71:365ade7:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;T cell receptor (TCR) binding to agonist peptide major histocompatibility complex (pMHC) triggers signaling events that initiate T cell responses. This system is remarkably sensitive, requiring only a few binding events to successfully activate a cellular response. On average, activating pMHC ligands exhibit mean dwell times of at least a few seconds when bound to the TCR. However, a T cell accumulates pMHC-TCR interactions as a stochastic series of discrete, single-molecule binding events whose individual dwell times are broadly distributed. With activation occurring in response to only a handful of such binding events, individual cells are unlikely to experience the average binding time. Here, we mapped the ensemble of pMHC-TCR binding events in space and time while simultaneously monitoring cellular activation. Our findings revealed that T cell activation hinges on rare, long–dwell time binding events that are an order of magnitude longer than the average agonist pMHC-TCR dwell time. Furthermore, we observed that short pMHC-TCR binding events that were spatially correlated and temporally sequential led to cellular activation. These observations indicate that T cell antigen discrimination likely occurs by sensing the tail end of the pMHC-TCR binding dwell time distribution rather than its average properties.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stke.sciencemag.org/cgi/content/short/12/564/eaat8715?rss=1</href></item></alternate><published>1547578510000</published><unread>True</unread><fingerprint>af8405bb</fingerprint><link>http://stke.sciencemag.org/cgi/content/short/12/564/eaat8715?rss=1</link><engagement>0</engagement><title>Mapping the stochastic sequence of individual ligand-receptor binding events to cellular activation: T cells act on the rare events</title><origin><htmlUrl>http://stke.sciencemag.org</htmlUrl><streamId>feed/http://stke.sciencemag.org/rss/current.xml</streamId><title>Science Signaling current issue</title></origin><description>&lt;p&gt;T cell receptor (TCR) binding to agonist peptide major histocompatibility complex (pMHC) triggers signaling events that initiate T cell responses. This system is remarkably sensitive, requiring only a few binding events to successfully activate a cellular response. On average, activating pMHC ligands exhibit mean dwell times of at least a few seconds when bound to the TCR. However, a T cell accumulates pMHC-TCR interactions as a stochastic series of discrete, single-molecule binding events whose individual dwell times are broadly distributed. With activation occurring in response to only a handful of such binding events, individual cells are unlikely to experience the average binding time. Here, we mapped the ensemble of pMHC-TCR binding events in space and time while simultaneously monitoring cellular activation. Our findings revealed that T cell activation hinges on rare, long–dwell time binding events that are an order of magnitude longer than the average agonist pMHC-TCR dwell time. Furthermore, we observed that short pMHC-TCR binding events that were spatially correlated and temporally sequential led to cellular activation. These observations indicate that T cell antigen discrimination likely occurs by sensing the tail end of the pMHC-TCR binding dwell time distribution rather than its average properties.&lt;/p&gt;</description><originId>http://stke.sciencemag.org/cgi/content/short/12/564/eaat8715?rss=1</originId><crawled>1547580578417</crawled><canonicalUrl>http://stke.sciencemag.org/content/12/564/eaat8715.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Yang, H., Zhang, D.-C., Liu, L., Liu, Y.-X., Nan, J., Zhao, B., Pan, J.-W.</name></author><content><direction>ltr</direction><content>&lt;p&gt;Resonances in ultracold collisions involving heavy molecules are difficult to simulate theoretically and have proven challenging to detect. Here we report the observation of magnetically tunable Feshbach resonances in ultracold collisions between potassium-40 (&lt;sup&gt;40&lt;/sup&gt;K) atoms and sodium-23–potassium-40 (&lt;sup&gt;23&lt;/sup&gt;Na&lt;sup&gt;40&lt;/sup&gt;K) molecules in the rovibrational ground state. We prepare the atoms and molecules in various hyperfine levels of their ground states and observe the loss of molecules as a function of the magnetic field. The atom-molecule Feshbach resonances are identified by observing an enhancement of the loss. We have observed 11 resonances in the magnetic field range of 43 to 120 gauss. The observed atom-molecule Feshbach resonances at ultralow temperatures probe the three-body potential energy surface with exceptional resolution and will help to improve understanding of ultracold collisions.&lt;/p&gt;</content></content><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce078:ad2b6584</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/261?rss=1</href></item></alternate><published>1547750305000</published><unread>True</unread><fingerprint>61e2285d</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6424/261?rss=1</link><engagement>0</engagement><title>Observation of magnetically tunable Feshbach resonances in ultracold 23Na40K + 40K collisions</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><description>&lt;p&gt;Resonances in ultracold collisions involving heavy molecules are difficult to simulate theoretically and have proven challenging to detect. Here we report the observation of magnetically tunable Feshbach resonances in ultracold collisions between potassium-40 (&lt;sup&gt;40&lt;/sup&gt;K) atoms and sodium-23–potassium-40 (&lt;sup&gt;23&lt;/sup&gt;Na&lt;sup&gt;40&lt;/sup&gt;K) molecules in the rovibrational ground state. We prepare the atoms and molecules in various hyperfine levels of their ground states and observe the loss of molecules as a function of the magnetic field. The atom-molecule Feshbach resonances are identified by observing an enhancement of the loss. We have observed 11 resonances in the magnetic field range of 43 to 120 gauss. The observed atom-molecule Feshbach resonances at ultralow temperatures probe the three-body potential energy surface with exceptional resolution and will help to improve understanding of ultracold collisions.&lt;/p&gt;</description><originId>http://science.sciencemag.org/cgi/content/short/363/6424/261?rss=1</originId><crawled>1547752389672</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6424/261.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><keywords><item>Chemistry, Physics</item></keywords></item><item><author><name>Giovanni Tangherlini, Dmitrii V. Kalinin, Dirk Schepmann, Tao Che, Nadine Mykicki, Sonja Ständer, Karin Loser, Bernhard Wünsch</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_1683494eecb:e1d3fb:56b782f7</id><published>1547010000000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01609/20190109/images/medium/jm-2018-01609h_0009.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01609&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=kD3Bi9_oAbU:Uw_jQHMyeWo:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/kD3Bi9_oAbU&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>922ba42b</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01609</link><crawled>1547070402251</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01609</href></item></canonical><engagement>0</engagement><title>[ASAP] Development of Novel Quinoxaline-Based ?-Opioid Receptor Agonists for the Treatment of Neuroinflammation</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01609/20190109/images/medium/jm-2018-01609h_0009.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01609&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=kD3Bi9_oAbU:Uw_jQHMyeWo:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/kD3Bi9_oAbU&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01609</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/kD3Bi9_oAbU/acs.jmedchem.8b01609</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Zahn, L. M.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a76:c2ce2e2e</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/360-k?rss=1</href></item></alternate><published>1548355045000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>c03f8e84</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6425/360-k?rss=1</link><engagement>0</engagement><title>Human recombination and mutation mapped</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6425/360-k?rss=1</originId><crawled>1548357093757</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6425/360.11.full</canonicalUrl><keywords><item>Genetics</item></keywords></item><item><author><name>Poos, A.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1684975f368:28d9793:3a104d3b</id><content><direction>ltr</direction><content>Background: Reactivation of the telomerase reverse transcriptase gene TERT is a central feature for the unlimited proliferation potential of the majority of cancers but the underlying regulatory processes are only partly understood. Results: We assembled regulator binding information from different sources to construct a generic human and mouse regulatory network. Advancing our Mixed Integer linear Programming based Regulatory Interaction Predictor (MIPRIP) approach, we identified the most common and cancer-type specific regulators of TERT across 19 different human cancers. The results were validated by using the well-known TERT regulation by the ETS1 transcription factor in a subset of melanomas with mutations in the TERT promoter. Conclusion: Our improved MIPRIP2 R-package and the associated generic regulatory networks are freely available at https://github.com/network-modeling/MIPRIP. MIPRIP 2.0 identified both common as well as tumor type specific regulators of TERT. The software can be easily applied to transcriptome datasets to predict gene regulation for any gene and disease/condition under investigation.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/513259v1?rss=1</href></item></alternate><published>1547366400000</published><unread>True</unread><fingerprint>b783e24e</fingerprint><link>http://biorxiv.org/cgi/content/short/513259v1?rss=1</link><engagement>0</engagement><title>Modelling TERT regulation across 19 different cancer types based on the MIPRIP 2.0 gene regulatory network approach [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Background: Reactivation of the telomerase reverse transcriptase gene TERT is a central feature for the unlimited proliferation potential of the majority of cancers but the underlying regulatory processes are only partly understood. Results: We assembled regulator binding information from different sources to construct a generic human and mouse regulatory network. Advancing our Mixed Integer linear Programming based Regulatory Interaction Predictor (MIPRIP) approach, we identified the most common and cancer-type specific regulators of TERT across 19 different human cancers. The results were validated by using the well-known TERT regulation by the ETS1 transcription factor in a subset of melanomas with mutations in the TERT promoter. Conclusion: Our improved MIPRIP2 R-package and the associated generic regulatory networks are freely available at https://github.com/network-modeling/MIPRIP. MIPRIP 2.0 identified both common as well as tumor type specific regulators of TERT. The software can be easily applied to transcriptome datasets to predict gene regulation for any gene and disease/condition under investigation.</description><originId>http://biorxiv.org/cgi/content/short/513259v1?rss=1</originId><crawled>1547420693352</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/13/513259</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Seiya Yamayoshi</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>O</text></item></mentions><label>O</label><id>nlp/f/entity/en/-/o</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>X</text></item></mentions><label>X</label><id>nlp/f/entity/en/-/x</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Neumann</text></item></mentions><label>Neumann</label><id>nlp/f/entity/en/-/neumann</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>G.</text></item></mentions><label>G.</label><id>nlp/f/entity/en/-/g.</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Noda</text></item></mentions><label>Noda</label><id>nlp/f/entity/en/-/noda</id></item></entities><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_16895383fb5:4fc2f20:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Current and future influenza vaccines&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Current and future influenza vaccines, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0340-z&quot;&gt;doi:10.1038/s41591-018-0340-z&lt;/a&gt;&lt;/p&gt;The universal flu vaccine remains elusive, but there are several strategies that scientists can take to develop one, including closer monitoring of viral evolution.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/3Ph8pAddcKs&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/3Ph8pAddcKs/s41591-018-0340-z</href></item></alternate><published>1548662400000</published><unread>True</unread><visual><height>521</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-018-0340-z/MediaObjects/41591_2018_340_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>5a339c7b</fingerprint><commonTopics><item><probability>1.0</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>1.0</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>0.976</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.895</probability><label>stem cells</label><id>nlp/f/topic/2185</id></item><item><probability>0.851</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item><item><probability>0.845</probability><label>neurology</label><id>nlp/f/topic/1563</id></item><item><probability>0.761</probability><label>epidemiology</label><id>nlp/f/topic/783</id></item></commonTopics><link>https://www.nature.com/articles/s41591-018-0340-z</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41591-018-0340-z</href></item></canonical><title>Current and future influenza vaccines</title><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Current and future influenza vaccines&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Current and future influenza vaccines, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0340-z&quot;&gt;doi:10.1038/s41591-018-0340-z&lt;/a&gt;&lt;/p&gt;The universal flu vaccine remains elusive, but there are several strategies that scientists can take to develop one, including closer monitoring of viral evolution.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/3Ph8pAddcKs&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41591-018-0340-z</originId><crawled>1548691718069</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Daniel-Adriano Silva</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>de novo</text></item><item><text>novo</text></item><item><text>De novo</text></item></mentions><label>De novo</label><id>nlp/f/entity/en/-/de novo</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>IL</text></item></mentions><label>IL</label><id>nlp/f/entity/en/-/il</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>IL - 2</text></item></mentions><label>IL - 2</label><id>nlp/f/entity/en/-/il - 2</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Immunol</text></item><item><text>J. Immunol</text></item></mentions><label>J. Immunol</label><id>nlp/f/entity/en/-/j. immunol</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>O</text></item></mentions><label>O</label><id>nlp/f/entity/en/-/o</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16833d253bc:d1b58f:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;De novo design of potent and selective mimics of IL-2 and IL-15&lt;/b&gt;&lt;/p&gt;&lt;p&gt;De novo design of potent and selective mimics of IL-2 and IL-15, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0830-7&quot;&gt;doi:10.1038/s41586-018-0830-7&lt;/a&gt;&lt;/p&gt;A hyper-stable de novo protein mimic of interleukin-2 computationally designed to not interact with a regulatory T-cell specific receptor subunit has improved therapeutic activity in mouse models of melanoma and colon cancer.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0830-7</href></item></alternate><published>1547020800000</published><unread>True</unread><visual><height>568</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0830-7/MediaObjects/41586_2018_830_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>6ef256f3</fingerprint><commonTopics><item><probability>0.985</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.974</probability><label>classics</label><id>nlp/f/topic/477</id></item><item><probability>0.914</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.888</probability><label>mp3</label><id>nlp/f/topic/1508</id></item><item><probability>0.877</probability><label>emergency medicine</label><id>nlp/f/topic/764</id></item><item><probability>0.872</probability><label>coupons</label><id>nlp/f/topic/560</id></item><item><probability>0.822</probability><label>rationality</label><id>nlp/f/topic/1895</id></item><item><probability>0.808</probability><label>car design</label><id>nlp/f/topic/385</id></item><item><probability>0.743</probability><label>bioinformatics</label><id>nlp/f/topic/262</id></item><item><probability>0.703</probability><label>nlp</label><id>nlp/f/topic/1585</id></item></commonTopics><link>https://www.nature.com/articles/s41586-018-0830-7</link><engagement>2</engagement><title>De novo design of potent and selective mimics of IL-2 and IL-15</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;De novo design of potent and selective mimics of IL-2 and IL-15&lt;/b&gt;&lt;/p&gt;&lt;p&gt;De novo design of potent and selective mimics of IL-2 and IL-15, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0830-7&quot;&gt;doi:10.1038/s41586-018-0830-7&lt;/a&gt;&lt;/p&gt;A hyper-stable de novo protein mimic of interleukin-2 computationally designed to not interact with a regulatory T-cell specific receptor subunit has improved therapeutic activity in mouse models of melanoma and colon cancer.</description><originId>https://www.nature.com/articles/s41586-018-0830-7</originId><crawled>1547057648572</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Spinney, L.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce0aa:ad2b6584</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/213?rss=1</href></item></alternate><published>1547750305000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>208a517e</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6424/213?rss=1</link><engagement>0</engagement><title>In Congo, fighting a virus and a groundswell of fake news</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6424/213?rss=1</originId><crawled>1547752389672</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6424/213.full</canonicalUrl><keywords><item>Medicine, Diseases, Scientific Community</item></keywords></item><item><author><name>Jordao, M. J. C., Sankowski, R., Brendecke, S. M., Sagar,  , Locatelli, G., Tai, Y.-H., Tay, T. L., Schramm, E., Armbruster, S., Hagemeyer, N., Gross, O., Mai, D., Cicek, O., Falk, T., Kerschensteiner, M., Grün, D., Prinz, M.</name></author><content><direction>ltr</direction><content>&lt;p&gt;The innate immune cell compartment is highly diverse in the healthy central nervous system (CNS), including parenchymal and non-parenchymal macrophages. However, this complexity is increased in inflammatory settings by the recruitment of circulating myeloid cells. It is unclear which disease-specific myeloid subsets exist and what their transcriptional profiles and dynamics during CNS pathology are. Combining deep single-cell transcriptome analysis, fate mapping, in vivo imaging, clonal analysis, and transgenic mouse lines, we comprehensively characterized unappreciated myeloid subsets in several CNS compartments during neuroinflammation. During inflammation, CNS macrophage subsets undergo self-renewal, and random proliferation shifts toward clonal expansion. Last, functional studies demonstrated that endogenous CNS tissue macrophages are redundant for antigen presentation. Our results highlight myeloid cell diversity and provide insights into the brain’s innate immune system.&lt;/p&gt;</content></content><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a52:c2ce2e2e</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/eaat7554?rss=1</href></item></alternate><published>1548355045000</published><unread>True</unread><fingerprint>7bf80c0b</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6425/eaat7554?rss=1</link><engagement>0</engagement><title>Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><description>&lt;p&gt;The innate immune cell compartment is highly diverse in the healthy central nervous system (CNS), including parenchymal and non-parenchymal macrophages. However, this complexity is increased in inflammatory settings by the recruitment of circulating myeloid cells. It is unclear which disease-specific myeloid subsets exist and what their transcriptional profiles and dynamics during CNS pathology are. Combining deep single-cell transcriptome analysis, fate mapping, in vivo imaging, clonal analysis, and transgenic mouse lines, we comprehensively characterized unappreciated myeloid subsets in several CNS compartments during neuroinflammation. During inflammation, CNS macrophage subsets undergo self-renewal, and random proliferation shifts toward clonal expansion. Last, functional studies demonstrated that endogenous CNS tissue macrophages are redundant for antigen presentation. Our results highlight myeloid cell diversity and provide insights into the brain’s innate immune system.&lt;/p&gt;</description><originId>http://science.sciencemag.org/cgi/content/short/363/6425/eaat7554?rss=1</originId><crawled>1548357093757</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6425/eaat7554.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><keywords><item>Immunology, Online Only</item></keywords></item><item><author><name>Francesco Merlino, Étienne Billard, Ali M. Yousif, Salvatore Di Maro, Diego Brancaccio, Luigi Abate, Alfonso Carotenuto, Rosa Bellavita, Roberta d’Emmanuele di Villa Bianca, Paolo Santicioli, Luciana Marinelli, Ettore Novellino, Terence E. Hébert, William D. Lubell, David Chatenet, Paolo Grieco</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_1687c8dac31:58e3ab:b77f238b</id><published>1548219600000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01601/20190123/images/medium/jm-2018-01601a_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01601&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=16hR9QS33cQ:zPVTXO4jGFc:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/16hR9QS33cQ&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>30ef75a3</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01601</link><crawled>1548277886001</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01601</href></item></canonical><engagement>0</engagement><title>[ASAP] Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01601/20190123/images/medium/jm-2018-01601a_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01601&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=16hR9QS33cQ:zPVTXO4jGFc:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/16hR9QS33cQ&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01601</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/16hR9QS33cQ/acs.jmedchem.8b01601</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Hao Chen, Sumana Venkat, Denver Hudson, Tony Wang, Qinglei Gan, Chenguang Fan</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>ofNPcmQ46PpGzt1nO49W9STAvkUsM7jssLxNXMp09ME=_1689abb4453:2b14cc8:b77f238b</id><published>1548738000000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b01013/20190128/images/medium/cb-2018-01013n_0004.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b01013&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=DNFHeGE3yr8:ZpaWaUWg9Ak:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/DNFHeGE3yr8&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>459bce1d</fingerprint><link>http://dx.doi.org/10.1021/acschembio.8b01013</link><crawled>1548784190547</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acschembio.8b01013</href></item></canonical><engagement>0</engagement><title>[ASAP] Site-Specifically Studying Lysine Acetylation of Aminoacyl-tRNA Synthetases</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acbcct</streamId><title>ACS Chemical Biology: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b01013/20190128/images/medium/cb-2018-01013n_0004.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b01013&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=DNFHeGE3yr8:ZpaWaUWg9Ak:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/DNFHeGE3yr8&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acschembio.8b01013</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/acbcct/~3/DNFHeGE3yr8/acschembio.8b01013</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Chen, R.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16870fd8bf4:1e410cb:c2ce2e2e</id><content><direction>ltr</direction><content>Image-based transcriptomics involves determining spatial patterns in gene expression across cells and tissues. Image registration is a necessary component of data analysis pipelines that study gene expression levels across different cells and intracellular structures. We consider images from multiplexed single molecule fluorescent in situ hybridization (smFISH) and multiplexed in situ sequencing (ISS) datasets from the Human Cell Atlas project and demonstrate a novel approach to groupwise image registration using a parametric representation of images based on finite rate of innovation sampling, together with practical optimization of empirical multivariate information measures.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/521898v1?rss=1</href></item></alternate><published>1548057600000</published><unread>True</unread><fingerprint>75f451d3</fingerprint><link>http://biorxiv.org/cgi/content/short/521898v1?rss=1</link><engagement>0</engagement><title>Registration for Image-Based Transcriptomics: Parametric Signal Features and Multivariate Information Measures [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Image-based transcriptomics involves determining spatial patterns in gene expression across cells and tissues. Image registration is a necessary component of data analysis pipelines that study gene expression levels across different cells and intracellular structures. We consider images from multiplexed single molecule fluorescent in situ hybridization (smFISH) and multiplexed in situ sequencing (ISS) datasets from the Human Cell Atlas project and demonstrate a novel approach to groupwise image registration using a parametric representation of images based on finite rate of innovation sampling, together with practical optimization of empirical multivariate information measures.</description><originId>http://biorxiv.org/cgi/content/short/521898v1?rss=1</originId><crawled>1548083891188</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/21/521898</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Amodio, M.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16816203c5f:6d19:3a104d3b</id><content><direction>ltr</direction><content>Biomedical researchers are generating high-throughput, high-dimensional single-cell data at a staggering rate. As costs of data generation decrease, experimental design is moving towards measurement of many different single-cell samples in the same dataset. These samples can correspond to different patients, conditions, or treatments. While scalability of methods to datasets of these sizes is a challenge on its own, dealing with large-scale experimental design presents a whole new set of problems, including batch effects and sample comparison issues. Currently, there are no computational tools that can both handle large amounts of data in a scalable manner (many cells) and at the same time deal with many samples (many patients or conditions). Moreover, data analysis currently involves the use of different tools that each operate on their own data representation, not guaranteeing a synchronized analysis pipeline. For instance, data visualization methods can be disjoint and mismatched with the clustering method. For this purpose, we present SAUCIE, a deep neural network that leverages the high degree of parallelization and scalability offered by neural networks, as well as the deep representation of data that can be learned by them to perform many single-cell data analysis tasks, all on a unified representation. A well-known limitation of neural networks is their interpretability. Our key contribution here are newly formulated regularizations (penalties) that render features learned in hidden layers of the neural network interpretable. When large multi-patient datasets are fed into SAUCIE, the various hidden layers contain denoised and batch-corrected data, a low dimensional visualization, unsupervised clustering, as well as other information that can be used to explore the data. We show this capability by analyzing a newly generated 180-sample dataset consisting of T cells from dengue patients in India, measured with mass cytometry. We show that SAUCIE, for the first time, can batch correct and process this 11-million cell data to identify cluster-based signatures of acute dengue infection and create a patient manifold, stratifying immune response to dengue on the basis of single-cell measurements.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/237065v4?rss=1</href></item></alternate><published>1546502400000</published><unread>True</unread><fingerprint>19aafae6</fingerprint><link>http://biorxiv.org/cgi/content/short/237065v4?rss=1</link><engagement>0</engagement><title>Exploring Single-Cell Data with Deep Multitasking Neural Networks [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Biomedical researchers are generating high-throughput, high-dimensional single-cell data at a staggering rate. As costs of data generation decrease, experimental design is moving towards measurement of many different single-cell samples in the same dataset. These samples can correspond to different patients, conditions, or treatments. While scalability of methods to datasets of these sizes is a challenge on its own, dealing with large-scale experimental design presents a whole new set of problems, including batch effects and sample comparison issues. Currently, there are no computational tools that can both handle large amounts of data in a scalable manner (many cells) and at the same time deal with many samples (many patients or conditions). Moreover, data analysis currently involves the use of different tools that each operate on their own data representation, not guaranteeing a synchronized analysis pipeline. For instance, data visualization methods can be disjoint and mismatched with the clustering method. For this purpose, we present SAUCIE, a deep neural network that leverages the high degree of parallelization and scalability offered by neural networks, as well as the deep representation of data that can be learned by them to perform many single-cell data analysis tasks, all on a unified representation. A well-known limitation of neural networks is their interpretability. Our key contribution here are newly formulated regularizations (penalties) that render features learned in hidden layers of the neural network interpretable. When large multi-patient datasets are fed into SAUCIE, the various hidden layers contain denoised and batch-corrected data, a low dimensional visualization, unsupervised clustering, as well as other information that can be used to explore the data. We show this capability by analyzing a newly generated 180-sample dataset consisting of T cells from dengue patients in India, measured with mass cytometry. We show that SAUCIE, for the first time, can batch correct and process this 11-million cell data to identify cluster-based signatures of acute dengue infection and create a patient manifold, stratifying immune response to dengue on the basis of single-cell measurements.</description><originId>http://biorxiv.org/cgi/content/short/237065v4?rss=1</originId><crawled>1546559437919</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/03/237065</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Heidi Ledford</name></author><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>Shibutani</text></item><item><text>Chris Shibutani</text></item></mentions><label>Chris Shibutani</label><id>nlp/f/entity/en/-/chris shibutani</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Luc Morris</text></item><item><text>Morris</text></item></mentions><label>Luc Morris</label><id>nlp/f/entity/en/-/luc morris</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Science Photo Library</text></item></mentions><label>Science Photo Library</label><id>nlp/f/entity/en/w/Science Photo Library</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Steve Gschmeissner</text></item></mentions><label>Steve Gschmeissner</label><id>nlp/f/entity/en/-/steve gschmeissner</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Nature Genetics</text></item></mentions><label>Nature Genetics</label><id>nlp/f/entity/en/w/Nature Genetics</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1684d43cc94:2ea5ced:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Highly mutated cancers respond better to immune therapy&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Highly mutated cancers respond better to immune therapy, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00143-8&quot;&gt;doi:10.1038/d41586-019-00143-8&lt;/a&gt;&lt;/p&gt;The complex tests that gauge mutation levels will pose a challenge in the clinic.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00143-8</href></item></alternate><published>1547452800000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00143-8/d41586-019-00143-8_16392502.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>d7e49d57</fingerprint><commonTopics><item><probability>0.981</probability><label>cancer</label><id>nlp/f/topic/377</id></item><item><probability>0.958</probability><label>hematology</label><id>nlp/f/topic/1058</id></item><item><probability>0.872</probability><label>genetics</label><id>nlp/f/topic/955</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00143-8</link><engagement>10</engagement><title>Highly mutated cancers respond better to immune therapy</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Highly mutated cancers respond better to immune therapy&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Highly mutated cancers respond better to immune therapy, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00143-8&quot;&gt;doi:10.1038/d41586-019-00143-8&lt;/a&gt;&lt;/p&gt;The complex tests that gauge mutation levels will pose a challenge in the clinic.</description><originId>https://www.nature.com/articles/d41586-019-00143-8</originId><crawled>1547484515476</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Bain, N., Bartolo, D.</name></author><content><direction>ltr</direction><content>&lt;p&gt;Modeling crowd motion is central to situations as diverse as risk prevention in mass events and visual effects rendering in the motion picture industry. The difficulty of performing quantitative measurements in model experiments has limited our ability to model pedestrian flows. We use tens of thousands of road-race participants in starting corrals to elucidate the flowing behavior of polarized crowds by probing its response to boundary motion. We establish that speed information propagates over system-spanning scales through polarized crowds, whereas orientational fluctuations are locally suppressed. Building on these observations, we lay out a hydrodynamic theory of polarized crowds and demonstrate its predictive power. We expect this description of human groups as active continua to provide quantitative guidelines for crowd management.&lt;/p&gt;</content></content><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3a5:ad2b6584</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/46?rss=1</href></item></alternate><published>1546540591000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>a5436116</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6422/46?rss=1</link><engagement>89</engagement><title>Dynamic response and hydrodynamics of polarized crowds</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><description>&lt;p&gt;Modeling crowd motion is central to situations as diverse as risk prevention in mass events and visual effects rendering in the motion picture industry. The difficulty of performing quantitative measurements in model experiments has limited our ability to model pedestrian flows. We use tens of thousands of road-race participants in starting corrals to elucidate the flowing behavior of polarized crowds by probing its response to boundary motion. We establish that speed information propagates over system-spanning scales through polarized crowds, whereas orientational fluctuations are locally suppressed. Building on these observations, we lay out a hydrodynamic theory of polarized crowds and demonstrate its predictive power. We expect this description of human groups as active continua to provide quantitative guidelines for crowd management.&lt;/p&gt;</description><originId>http://science.sciencemag.org/cgi/content/short/363/6422/46?rss=1</originId><crawled>1546542450273</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6422/46.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><keywords><item>Physics, Applied, Physics</item></keywords></item><item><author><name>Shin, H.-T.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168577a45e1:3ce7c6e:c2ce2e2e</id><content><direction>ltr</direction><content>Accurate detection of genomic fusions by high-throughput sequencing in clinical samples with inadequate tumor purity and formalin-fixed paraffin embedded (FFPE) tissue is an essential task in precise oncology. We developed the fusion detection algorithm Junction Location Identifier (JuLI) for optimization of high-depth clinical sequencing. We implemented novel filtering steps to minimize false positives and a joint calling function to increase sensitivity in clinical setting. We comprehensively validated the algorithm using high-depth sequencing data from cancer cell lines and clinical samples and whole genome sequencing data from NA12878. We showed that JuLI outperformed state-of-the-art fusion callers in cases with high-depth clinical sequencing and rescued a driver fusion from false negative in plasma cell-free DNA. JuLI is freely available via GitHub (https://github.com/sgilab/JuLI).</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/521039v1?rss=1</href></item></alternate><published>1547625600000</published><unread>True</unread><fingerprint>f66c5630</fingerprint><link>http://biorxiv.org/cgi/content/short/521039v1?rss=1</link><engagement>0</engagement><title>JuLI: accurate detection of DNA fusions in clinical sequencing for precision oncology [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Accurate detection of genomic fusions by high-throughput sequencing in clinical samples with inadequate tumor purity and formalin-fixed paraffin embedded (FFPE) tissue is an essential task in precise oncology. We developed the fusion detection algorithm Junction Location Identifier (JuLI) for optimization of high-depth clinical sequencing. We implemented novel filtering steps to minimize false positives and a joint calling function to increase sensitivity in clinical setting. We comprehensively validated the algorithm using high-depth sequencing data from cancer cell lines and clinical samples and whole genome sequencing data from NA12878. We showed that JuLI outperformed state-of-the-art fusion callers in cases with high-depth clinical sequencing and rescued a driver fusion from false negative in plasma cell-free DNA. JuLI is freely available via GitHub (https://github.com/sgilab/JuLI).</description><originId>http://biorxiv.org/cgi/content/short/521039v1?rss=1</originId><crawled>1547655857633</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/16/521039</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Matías Fuentealba</name></author><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_16834134ba8:d376a7:b77f238b</id><content><direction>ltr</direction><content>&lt;p&gt;by Matías Fuentealba, Handan Melike Dönertaş, Rhianna Williams, Johnathan Labbadia, Janet M. Thornton, Linda Partridge&lt;/p&gt;
Advancing age is the dominant risk factor for most of the major killer diseases in developed countries. Hence, ameliorating the effects of ageing may prevent multiple diseases simultaneously. Drugs licensed for human use against specific diseases have proved to be effective in extending lifespan and healthspan in animal models, suggesting that there is scope for drug repurposing in humans. New bioinformatic methods to identify and prioritise potential anti-ageing compounds for humans are therefore of interest. In this study, we first used drug-protein interaction information, to rank 1,147 drugs by their likelihood of targeting ageing-related gene products in humans. Among 19 statistically significant drugs, 6 have already been shown to have pro-longevity properties in animal models (p &amp;lt; 0.001). Using the targets of each drug, we established their association with ageing at multiple levels of biological action including pathways, functions and protein interactions. Finally, combining all the data, we calculated a ranked list of drugs that identified tanespimycin, an inhibitor of HSP-90, as the top-ranked novel anti-ageing candidate. We experimentally validated the pro-longevity effect of tanespimycin through its HSP-90 target in &lt;i&gt;Caenorhabditis elegans&lt;/i&gt;.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/Yjtn-ZF7ak8&quot; height=&quot;1&quot;&gt;</content></content><updateCount>1</updateCount><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/Yjtn-ZF7ak8/article</href></item></alternate><published>1547071200000</published><unread>True</unread><visual><height>619</height><processor>feedly-nikon-v3.1</processor><url>https://journals.plos.org/ploscompbiol/article/figure/image?size=inline&amp;id=10.1371/journal.pcbi.1006639.g001</url><contentType>image/png</contentType><width>320</width></visual><fingerprint>884c16e</fingerprint><link>10.1371/journal.pcbi.1006639</link><recrawled>1547069228337</recrawled><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006639</href></item></canonical><updated>1547071200000</updated><engagement>252</engagement><title>Using the drug-protein interactome to identify anti-ageing compounds for humans</title><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><description>&lt;p&gt;by Matías Fuentealba, Handan Melike Dönertaş, Rhianna Williams, Johnathan Labbadia, Janet M. Thornton, Linda Partridge&lt;/p&gt;
Advancing age is the dominant risk factor for most of the major killer diseases in developed countries. Hence, ameliorating the effects of ageing may prevent multiple diseases simultaneously. Drugs licensed for human use against specific diseases have proved to be effective in extending lifespan and healthspan in animal models, suggesting that there is scope for drug repurposing in humans. New bioinformatic methods to identify and prioritise potential anti-ageing compounds for humans are therefore of interest. In this study, we first used drug-protein interaction information, to rank 1,147 drugs by their likelihood of targeting ageing-related gene products in humans. Among 19 statistically significant drugs, 6 have already been shown to have pro-longevity properties in animal models (p &amp;lt; 0.001). Using the targets of each drug, we established their association with ageing at multiple levels of biological action including pathways, functions and protein interactions. Finally, combining all the data, we calculated a ranked list of drugs that identified tanespimycin, an inhibitor of HSP-90, as the top-ranked novel anti-ageing candidate. We experimentally validated the pro-longevity effect of tanespimycin through its HSP-90 target in &lt;i&gt;Caenorhabditis elegans&lt;/i&gt;.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/Yjtn-ZF7ak8&quot; height=&quot;1&quot;&gt;</description><originId>10.1371/journal.pcbi.1006639</originId><crawled>1547061906344</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Katherine M. Bruner</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Ho</text></item></mentions><label>Ho</label><id>nlp/f/entity/en/-/ho</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Finzi</text></item></mentions><label>Finzi</label><id>nlp/f/entity/en/-/finzi</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>D. et al</text></item></mentions><label>D. et al</label><id>nlp/f/entity/en/-/d. et al</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Proc</text></item></mentions><label>Proc</label><id>nlp/f/entity/en/-/proc</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Nat</text></item></mentions><label>Nat</label><id>nlp/f/entity/en/-/nat</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ff99aeb:c7ac5c:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;A quantitative approach for measuring the reservoir of latent HIV-1 proviruses&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A quantitative approach for measuring the reservoir of latent HIV-1 proviruses, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0898-8&quot;&gt;doi:10.1038/s41586-019-0898-8&lt;/a&gt;&lt;/p&gt;An assay to measure the latent HIV-1 reservoir that separately quantifies intact and defective proviruses will facilitate evaluation of HIV-1 cure strategies by measuring the provirues that pose a barrier to cure.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0898-8</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><height>640</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-019-0898-8/MediaObjects/41586_2019_898_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>89c9b0b</fingerprint><commonTopics><item><probability>1.0</probability><label>hiv</label><id>nlp/f/topic/1069</id></item><item><probability>1.0</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.999</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>0.997</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.925</probability><label>global health</label><id>nlp/f/topic/977</id></item><item><probability>0.91</probability><label>stem cells</label><id>nlp/f/topic/2185</id></item><item><probability>0.836</probability><label>epidemiology</label><id>nlp/f/topic/783</id></item><item><probability>0.824</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item><item><probability>0.803</probability><label>neurology</label><id>nlp/f/topic/1563</id></item><item><probability>0.754</probability><label>bioinformatics</label><id>nlp/f/topic/262</id></item></commonTopics><link>https://www.nature.com/articles/s41586-019-0898-8</link><engagement>0</engagement><title>A quantitative approach for measuring the reservoir of latent HIV-1 proviruses</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;A quantitative approach for measuring the reservoir of latent HIV-1 proviruses&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A quantitative approach for measuring the reservoir of latent HIV-1 proviruses, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0898-8&quot;&gt;doi:10.1038/s41586-019-0898-8&lt;/a&gt;&lt;/p&gt;An assay to measure the latent HIV-1 reservoir that separately quantifies intact and defective proviruses will facilitate evaluation of HIV-1 cure strategies by measuring the provirues that pose a barrier to cure.</description><originId>https://www.nature.com/articles/s41586-019-0898-8</originId><crawled>1548872162027</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Bolognini, D.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168334d34c6:c6d886:8675cc2c</id><content><direction>ltr</direction><content>MinION and GridION X5 from Oxford Nanopore Technologies are devices for real-time DNA and RNA sequencing. While MinION is the only real-time, low cost and portable sequencing device and, thanks to its unique properties, is becoming more and more popular among biologists, GridION X5, mainly for its costs, is less widespread but highly suitable for researchers with large sequencing projects. Despite the fact that Oxford Nanopore Technologies devices have been increasingly used in the last few years, there is a lack of high-performing and user-friendly tools to handle the data outputted by both MinION and GridION X5 platforms. Here we present NanoR, a cross-platform R package designed with the purpose to simplify and improve nanopore data visualization. Indeed, NanoR is built on few functions but overcomes the capabilities of existing tools to extract meaningful informations from MinION sequencing data; in addition, as exclusive features, NanoR can deal with GridION X5 sequencing outputs and allows comparison of both MinION and GridION X5 sequencing data in one command. NanoR is released as free package for R at https://github.com/davidebolo1993/NanoR.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/514232v1?rss=1</href></item></alternate><published>1547020800000</published><unread>True</unread><fingerprint>73b024e8</fingerprint><link>http://biorxiv.org/cgi/content/short/514232v1?rss=1</link><engagement>7</engagement><title>NanoR: An user-friendly R package to analyze and compare nanopore sequencing data [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>MinION and GridION X5 from Oxford Nanopore Technologies are devices for real-time DNA and RNA sequencing. While MinION is the only real-time, low cost and portable sequencing device and, thanks to its unique properties, is becoming more and more popular among biologists, GridION X5, mainly for its costs, is less widespread but highly suitable for researchers with large sequencing projects. Despite the fact that Oxford Nanopore Technologies devices have been increasingly used in the last few years, there is a lack of high-performing and user-friendly tools to handle the data outputted by both MinION and GridION X5 platforms. Here we present NanoR, a cross-platform R package designed with the purpose to simplify and improve nanopore data visualization. Indeed, NanoR is built on few functions but overcomes the capabilities of existing tools to extract meaningful informations from MinION sequencing data; in addition, as exclusive features, NanoR can deal with GridION X5 sequencing outputs and allows comparison of both MinION and GridION X5 sequencing data in one command. NanoR is released as free package for R at https://github.com/davidebolo1993/NanoR.</description><originId>http://biorxiv.org/cgi/content/short/514232v1?rss=1</originId><crawled>1547048924358</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/09/514232</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Andreas Lange, Johannes Heidrich, Markus O. Zimmermann, Thomas E. Exner, Frank M. Boeckler</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>bE0mPve90xtDW7Mgx9+xm/gIKXt54qktoOvefuUy0ZI=_16895741f3d:23b710d:56b782f7</id><published>1548651600000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00621/20190128/images/medium/ci-2018-00621m_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00621&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=ldu3UR-c4N0:_cst98YUhWk:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/ldu3UR-c4N0&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>b3b3061a</fingerprint><link>http://dx.doi.org/10.1021/acs.jcim.8b00621</link><crawled>1548695641917</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jcim.8b00621</href></item></canonical><engagement>0</engagement><title>[ASAP] Scaffold Effects on Halogen Bonding Strength</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jcisd8</streamId><title>Journal of Chemical Information and Modeling: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00621/20190128/images/medium/ci-2018-00621m_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00621&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=ldu3UR-c4N0:_cst98YUhWk:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/ldu3UR-c4N0&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jcim.8b00621</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jcisd8/~3/ldu3UR-c4N0/acs.jcim.8b00621</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Julia Leventon</name></author><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>Mama</text></item></mentions><label>Mama</label><id>nlp/f/entity/en/-/mama</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Hero / Getty</text></item></mentions><label>Hero / Getty</label><id>nlp/f/entity/en/-/hero / getty</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>daily Nature Briefing</text></item></mentions><label>daily Nature Briefing</label><id>nlp/f/entity/en/-/daily nature briefing</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1684b9f1b23:2c192c0:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;An academic mother’s wish list: 12 things universities need&lt;/b&gt;&lt;/p&gt;&lt;p&gt;An academic mother’s wish list: 12 things universities need, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00019-x&quot;&gt;doi:10.1038/d41586-019-00019-x&lt;/a&gt;&lt;/p&gt;There are many ways to create an inclusive workplace, say Julia Leventon, Katy Roelich and Lucie Middlemiss.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00019-x</href></item></alternate><published>1547452800000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00019-x/d41586-019-00019-x_16349532.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>6a7f7453</fingerprint><commonTopics><item><probability>1.0</probability><label>phd</label><id>nlp/f/topic/1737</id></item><item><probability>1.0</probability><label>academic</label><id>nlp/f/topic/17</id></item><item><probability>0.959</probability><label>research</label><id>nlp/f/topic/1931</id></item><item><probability>0.942</probability><label>sociology</label><id>nlp/f/topic/2122</id></item><item><probability>0.767</probability><label>career</label><id>nlp/f/topic/388</id></item><item><probability>0.758</probability><label>leadership</label><id>nlp/f/topic/1309</id></item><item><probability>0.74</probability><label>higher ed</label><id>nlp/f/topic/1063</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00019-x</link><engagement>7</engagement><title>An academic mother’s wish list: 12 things universities need</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;An academic mother’s wish list: 12 things universities need&lt;/b&gt;&lt;/p&gt;&lt;p&gt;An academic mother’s wish list: 12 things universities need, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00019-x&quot;&gt;doi:10.1038/d41586-019-00019-x&lt;/a&gt;&lt;/p&gt;There are many ways to create an inclusive workplace, say Julia Leventon, Katy Roelich and Lucie Middlemiss.</description><originId>https://www.nature.com/articles/d41586-019-00019-x</originId><crawled>1547456944931</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Toda, H., Williams, J. A., Gulledge, M., Sehgal, A.</name></author><content><direction>ltr</direction><content>&lt;p&gt;Sleep remains a major mystery of biology. In particular, little is known about the mechanisms that account for the drive to sleep. In an unbiased screen of more than 12,000 &lt;i&gt;Drosophila&lt;/i&gt; lines, we identified a single gene, &lt;i&gt;nemuri&lt;/i&gt;, that induces sleep. The NEMURI protein is an antimicrobial peptide that can be secreted ectopically to drive prolonged sleep (with resistance to arousal) and to promote survival after infection. Loss of &lt;i&gt;nemuri&lt;/i&gt; increased arousability during daily sleep and attenuated the acute increase in sleep induced by sleep deprivation or bacterial infection. Conditions that increase sleep drive induced expression of &lt;i&gt;nemuri&lt;/i&gt; in a small number of fly brain neurons and targeted it to the sleep-promoting, dorsal fan-shaped body. We propose that NEMURI is a bona fide sleep homeostasis factor that is particularly important under conditions of high sleep need; because these conditions include sickness, our findings provide a link between sleep and immune function.&lt;/p&gt;</content></content><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168a5541f68:1508096:3a104d3b</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6426/509?rss=1</href></item></alternate><published>1548959829000</published><unread>True</unread><fingerprint>6d86e687</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6426/509?rss=1</link><engagement>0</engagement><title>A sleep-inducing gene, nemuri, links sleep and immune function in Drosophila</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><description>&lt;p&gt;Sleep remains a major mystery of biology. In particular, little is known about the mechanisms that account for the drive to sleep. In an unbiased screen of more than 12,000 &lt;i&gt;Drosophila&lt;/i&gt; lines, we identified a single gene, &lt;i&gt;nemuri&lt;/i&gt;, that induces sleep. The NEMURI protein is an antimicrobial peptide that can be secreted ectopically to drive prolonged sleep (with resistance to arousal) and to promote survival after infection. Loss of &lt;i&gt;nemuri&lt;/i&gt; increased arousability during daily sleep and attenuated the acute increase in sleep induced by sleep deprivation or bacterial infection. Conditions that increase sleep drive induced expression of &lt;i&gt;nemuri&lt;/i&gt; in a small number of fly brain neurons and targeted it to the sleep-promoting, dorsal fan-shaped body. We propose that NEMURI is a bona fide sleep homeostasis factor that is particularly important under conditions of high sleep need; because these conditions include sickness, our findings provide a link between sleep and immune function.&lt;/p&gt;</description><originId>http://science.sciencemag.org/cgi/content/short/363/6426/509?rss=1</originId><crawled>1548961980264</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6426/509.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><keywords><item>Neuroscience, Physiology</item></keywords></item><item><author><name>Zahn, L. M.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3ab:ad2b6584</id><published>1546540591000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>97976863</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6422/40-b?rss=1</link><engagement>0</engagement><crawled>1546542450273</crawled><title>Alzheimer&apos;s disease in admixed people</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6422/40-b?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/40-b?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6422/40.2.full</canonicalUrl></item><item><author><name>Quirin Schiermeier</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Estonian</text></item><item><text>Estonia</text></item></mentions><label>Estonia</label><id>nlp/f/entity/en/w/Estonia</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Niinemets</text></item><item><text>Ülo Niinemets</text></item></mentions><label>Ülo Niinemets</label><id>nlp/f/entity/en/-/ülo niinemets</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>EU</text></item><item><text>European Union</text></item></mentions><label>European Union</label><id>nlp/f/entity/en/w/European Union</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>University of Tartu</text></item></mentions><label>University of Tartu</label><id>nlp/f/entity/en/w/University of Tartu</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Science</text></item></mentions><label>Science</label><id>nlp/f/entity/en/w/Science</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16875b16558:24afe40:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;How Estonia blazed a trail in science&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How Estonia blazed a trail in science, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00209-7&quot;&gt;doi:10.1038/d41586-019-00209-7&lt;/a&gt;&lt;/p&gt;A small nation found strength in research after joining the European Union.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00209-7</href></item></alternate><published>1548144000000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00209-7/d41586-019-00209-7_16408500.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>2f55f7c5</fingerprint><commonTopics><item><probability>0.982</probability><label>science policy</label><id>nlp/f/topic/2019</id></item><item><probability>0.97</probability><label>research</label><id>nlp/f/topic/1931</id></item><item><probability>0.97</probability><label>academic</label><id>nlp/f/topic/17</id></item><item><probability>0.939</probability><label>phd</label><id>nlp/f/topic/1737</id></item><item><probability>0.923</probability><label>market research</label><id>nlp/f/topic/1408</id></item><item><probability>0.893</probability><label>ted</label><id>nlp/f/topic/2261</id></item><item><probability>0.865</probability><label>anthropology</label><id>nlp/f/topic/109</id></item><item><probability>0.804</probability><label>security intel</label><id>nlp/f/topic/2038</id></item><item><probability>0.802</probability><label>epidemiology</label><id>nlp/f/topic/783</id></item><item><probability>0.761</probability><label>psychiatry</label><id>nlp/f/topic/1844</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00209-7</link><engagement>16</engagement><title>How Estonia blazed a trail in science</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;How Estonia blazed a trail in science&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How Estonia blazed a trail in science, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00209-7&quot;&gt;doi:10.1038/d41586-019-00209-7&lt;/a&gt;&lt;/p&gt;A small nation found strength in research after joining the European Union.</description><originId>https://www.nature.com/articles/d41586-019-00209-7</originId><crawled>1548162786648</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce0ad:ad2b6584</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/208?rss=1</href></item></alternate><published>1547750305000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>1d9669d5</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6424/208?rss=1</link><engagement>0</engagement><title>News at a glance</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6424/208?rss=1</originId><crawled>1547752389672</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6424/208.full</canonicalUrl><keywords><item>Scientific Community</item></keywords></item><item><author><name>Keesha E. Erickson</name></author><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_1685d421ebd:fe257:1451c985</id><content><direction>ltr</direction><content>&lt;p&gt;by Keesha E. Erickson, Oleksii S. Rukhlenko, Md Shahinuzzaman, Kalina P. Slavkova, Yen Ting Lin, Ryan Suderman, Edward C. Stites, Marian Anghel, Richard G. Posner, Dipak Barua, Boris N. Kholodenko, William S. Hlavacek&lt;/p&gt;
Receptor tyrosine kinases (RTKs) typically contain multiple autophosphorylation sites in their cytoplasmic domains. Once activated, these autophosphorylation sites can recruit downstream signaling proteins containing Src homology 2 (SH2) and phosphotyrosine-binding (PTB) domains, which recognize phosphotyrosine-containing short linear motifs (SLiMs). These domains and SLiMs have polyspecific or promiscuous binding activities. Thus, multiple signaling proteins may compete for binding to a common SLiM and vice versa. To investigate the effects of competition on RTK signaling, we used a rule-based modeling approach to develop and analyze models for ligand-induced recruitment of SH2/PTB domain-containing proteins to autophosphorylation sites in the insulin-like growth factor 1 (IGF1) receptor (IGF1R). Models were parameterized using published datasets reporting protein copy numbers and site-specific binding affinities. Simulations were facilitated by a novel application of model restructuration, to reduce redundancy in rule-derived equations. We compare predictions obtained via numerical simulation of the model to those obtained through simple prediction methods, such as through an analytical approximation, or ranking by copy number and/or K&lt;sub&gt;D&lt;/sub&gt; value, and find that the simple methods are unable to recapitulate the predictions of numerical simulations. We created 45 cell line-specific models that demonstrate how early events in IGF1R signaling depend on the protein abundance profile of a cell. Simulations, facilitated by model restructuration, identified pairs of IGF1R binding partners that are recruited in anti-correlated and correlated fashions, despite no inclusion of cooperativity in our models. This work shows that the outcome of competition depends on the physicochemical parameters that characterize pairwise interactions, as well as network properties, including network connectivity and the relative abundances of competitors.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/FF8MbA9TfH8&quot; height=&quot;1&quot;&gt;</content></content><updateCount>1</updateCount><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/FF8MbA9TfH8/article</href></item></alternate><published>1547762400000</published><unread>True</unread><visual><height>150</height><processor>feedly-nikon-v3.1</processor><url>https://journals.plos.org/ploscompbiol/article/figure/image?size=inline&amp;id=10.1371/journal.pcbi.1006706.g001</url><contentType>image/png</contentType><width>320</width></visual><fingerprint>7ea7bfa</fingerprint><link>10.1371/journal.pcbi.1006706</link><recrawled>1547760425467</recrawled><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006706</href></item></canonical><updated>1547762400000</updated><engagement>0</engagement><title>Modeling cell line-specific recruitment of signaling proteins to the insulin-like growth factor 1 receptor</title><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><description>&lt;p&gt;by Keesha E. Erickson, Oleksii S. Rukhlenko, Md Shahinuzzaman, Kalina P. Slavkova, Yen Ting Lin, Ryan Suderman, Edward C. Stites, Marian Anghel, Richard G. Posner, Dipak Barua, Boris N. Kholodenko, William S. Hlavacek&lt;/p&gt;
Receptor tyrosine kinases (RTKs) typically contain multiple autophosphorylation sites in their cytoplasmic domains. Once activated, these autophosphorylation sites can recruit downstream signaling proteins containing Src homology 2 (SH2) and phosphotyrosine-binding (PTB) domains, which recognize phosphotyrosine-containing short linear motifs (SLiMs). These domains and SLiMs have polyspecific or promiscuous binding activities. Thus, multiple signaling proteins may compete for binding to a common SLiM and vice versa. To investigate the effects of competition on RTK signaling, we used a rule-based modeling approach to develop and analyze models for ligand-induced recruitment of SH2/PTB domain-containing proteins to autophosphorylation sites in the insulin-like growth factor 1 (IGF1) receptor (IGF1R). Models were parameterized using published datasets reporting protein copy numbers and site-specific binding affinities. Simulations were facilitated by a novel application of model restructuration, to reduce redundancy in rule-derived equations. We compare predictions obtained via numerical simulation of the model to those obtained through simple prediction methods, such as through an analytical approximation, or ranking by copy number and/or K&lt;sub&gt;D&lt;/sub&gt; value, and find that the simple methods are unable to recapitulate the predictions of numerical simulations. We created 45 cell line-specific models that demonstrate how early events in IGF1R signaling depend on the protein abundance profile of a cell. Simulations, facilitated by model restructuration, identified pairs of IGF1R binding partners that are recruited in anti-correlated and correlated fashions, despite no inclusion of cooperativity in our models. This work shows that the outcome of competition depends on the physicochemical parameters that characterize pairwise interactions, as well as network properties, including network connectivity and the relative abundances of competitors.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/FF8MbA9TfH8&quot; height=&quot;1&quot;&gt;</description><originId>10.1371/journal.pcbi.1006706</originId><crawled>1547752840893</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Guillaume Salomon</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Hubbard</text></item></mentions><label>Hubbard</label><id>nlp/f/entity/en/-/hubbard</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>CSS</text></item></mentions><label>Cascading Style Sheets</label><id>nlp/f/entity/en/w/Cascading Style Sheets</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Explorer</text></item></mentions><label>Explorer</label><id>nlp/f/entity/en/-/explorer</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>JavaScript</text></item></mentions><label>JavaScript</label><id>nlp/f/entity/en/w/JavaScript</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>WEBSITEnature_com</text></item></mentions><label>WEBSITEnature_com</label><id>nlp/f/entity/en/-/websitenature_com</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16876d0b8d9:275fdec:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Author Correction: Direct observation of incommensurate magnetism in Hubbard chains&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Author Correction: Direct observation of incommensurate magnetism in Hubbard chains, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0906-z&quot;&gt;doi:10.1038/s41586-019-0906-z&lt;/a&gt;&lt;/p&gt;Author Correction: Direct observation of incommensurate magnetism in Hubbard chains</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0906-z</href></item></alternate><published>1548144000000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>a394ac1f</fingerprint><commonTopics><item><probability>0.933</probability><label>web design</label><id>nlp/f/topic/2461</id></item><item><probability>0.933</probability><label>css</label><id>nlp/f/topic/590</id></item></commonTopics><link>https://www.nature.com/articles/s41586-019-0906-z</link><engagement>0</engagement><title>Author Correction: Direct observation of incommensurate magnetism in Hubbard chains</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Author Correction: Direct observation of incommensurate magnetism in Hubbard chains&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Author Correction: Direct observation of incommensurate magnetism in Hubbard chains, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0906-z&quot;&gt;doi:10.1038/s41586-019-0906-z&lt;/a&gt;&lt;/p&gt;Author Correction: Direct observation of incommensurate magnetism in Hubbard chains</description><originId>https://www.nature.com/articles/s41586-019-0906-z</originId><crawled>1548181616857</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Matteo Rosati</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_168510df8ce:3410aee:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Author Correction: Narrow bounds for the quantum capacity of thermal attenuators&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Author Correction: Narrow bounds for the quantum capacity of thermal attenuators, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08338-3&quot;&gt;doi:10.1038/s41467-019-08338-3&lt;/a&gt;&lt;/p&gt;Author Correction: Narrow bounds for the quantum capacity of thermal attenuators&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/kaQTXvfT7nU&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/kaQTXvfT7nU/s41467-019-08338-3</href></item></alternate><published>1547539200000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>b320a15a</fingerprint><link>https://www.nature.com/articles/s41467-019-08338-3</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-019-08338-3</href></item></canonical><title>Author Correction: Narrow bounds for the quantum capacity of thermal attenuators</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Author Correction: Narrow bounds for the quantum capacity of thermal attenuators&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Author Correction: Narrow bounds for the quantum capacity of thermal attenuators, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08338-3&quot;&gt;doi:10.1038/s41467-019-08338-3&lt;/a&gt;&lt;/p&gt;Author Correction: Narrow bounds for the quantum capacity of thermal attenuators&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/kaQTXvfT7nU&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-019-08338-3</originId><crawled>1547548096718</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Seiya Yamayoshi</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Ebola</text></item></mentions><label>Ebola virus disease</label><id>nlp/f/entity/en/w/Ebola virus disease</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>NP</text></item></mentions><label>NP</label><id>nlp/f/entity/en/-/np</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Batra</text></item><item><text>Batra et al</text></item></mentions><label>Batra et al</label><id>nlp/f/entity/en/-/batra et al</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>VP30</text></item></mentions><label>VP30</label><id>nlp/f/entity/en/-/vp30</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>RBBP6</text></item></mentions><label>RBBP6</label><id>nlp/f/entity/en/-/rbbp6</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168708470a5:1e0dac7:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Host protein mimics viral protein to hinder infection by Ebola virus&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Host protein mimics viral protein to hinder infection by Ebola virus, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00182-1&quot;&gt;doi:10.1038/d41586-019-00182-1&lt;/a&gt;&lt;/p&gt;Infection by Ebola virus can be fatal. The discovery of a human protein that mimics one type of Ebola protein and binds to another to suppress viral RNA production might aid the development of clinical treatments for the disease.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00182-1</href></item></alternate><published>1548057600000</published><unread>True</unread><visual><height>450</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00182-1/d41586-019-00182-1_16408306.jpg</url><contentType>image/jpeg</contentType><width>800</width></visual><fingerprint>ed275ee0</fingerprint><commonTopics><item><probability>0.972</probability><label>proteomics</label><id>nlp/f/topic/1840</id></item><item><probability>0.942</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>0.934</probability><label>microbiology</label><id>nlp/f/topic/1455</id></item><item><probability>0.917</probability><label>biology</label><id>nlp/f/topic/263</id></item><item><probability>0.864</probability><label>global health</label><id>nlp/f/topic/977</id></item><item><probability>0.845</probability><label>biochemistry</label><id>nlp/f/topic/257</id></item><item><probability>0.827</probability><label>fitness</label><id>nlp/f/topic/874</id></item><item><probability>0.809</probability><label>public health</label><id>nlp/f/topic/1850</id></item><item><probability>0.791</probability><label>bodybuilding</label><id>nlp/f/topic/294</id></item><item><probability>0.767</probability><label>immunology</label><id>nlp/f/topic/1145</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00182-1</link><engagement>11</engagement><title>Host protein mimics viral protein to hinder infection by Ebola virus</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Host protein mimics viral protein to hinder infection by Ebola virus&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Host protein mimics viral protein to hinder infection by Ebola virus, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00182-1&quot;&gt;doi:10.1038/d41586-019-00182-1&lt;/a&gt;&lt;/p&gt;Infection by Ebola virus can be fatal. The discovery of a human protein that mimics one type of Ebola protein and binds to another to suppress viral RNA production might aid the development of clinical treatments for the disease.</description><originId>https://www.nature.com/articles/d41586-019-00182-1</originId><crawled>1548075954341</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>NA</name></author><id>6wY2EtDmLbeMr9WopopAzS1SKiHs2ogsOuunEriW7zs=_168841432dd:3aff3cf:3a104d3b</id><content><direction>ltr</direction><content>Journal of Computational Chemistry, Volume 40, Issue 7, Page 849-853, March 15, 2019.</content></content><alternate><item><type>text/html</type><href>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25406?af=R</href></item></alternate><published>1548357860000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>5e2657d1</fingerprint><link>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25406?af=R</link><title>Issue Information</title><origin><htmlUrl>https://onlinelibrary.wiley.com/journal/1096987x?af=R</htmlUrl><streamId>feed/https://onlinelibrary.wiley.com/action/showFeed?jc=1096987x&amp;type=etoc&amp;feed=rss</streamId><title>Wiley: Journal of Computational Chemistry: Table of Contents</title></origin><description>Journal of Computational Chemistry, Volume 40, Issue 7, Page 849-853, March 15, 2019.</description><originId>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25406?af=R</originId><crawled>1548404142813</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Hamblin, J. D.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce09b:ad2b6584</id><published>1547750305000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>5af44999</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6424/237?rss=1</link><engagement>0</engagement><crawled>1547752389672</crawled><title>Nuclear power and promise</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6424/237?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/237?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6424/237.full</canonicalUrl></item><item><author><name>Rabesandratana, T.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3d2:ad2b6584</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/11?rss=1</href></item></alternate><published>1546540591000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>6afa4b1f</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6422/11?rss=1</link><engagement>25</engagement><title>The world debates open-access mandates</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6422/11?rss=1</originId><crawled>1546542450273</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6422/11.full</canonicalUrl><keywords><item>European News, Scientific Community</item></keywords></item><item><author><name>Ma, F.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1689500a144:4f6a8b6:3a104d3b</id><content><direction>ltr</direction><content>Cell type identification is one of the major goals in single cell RNA sequencing (scRNA-seq). Current methods for assigning cell types typically involve the use of unsupervised clustering, the identification of signature genes in each cluster, followed by a manual lookup of these genes in the literature and databases to assign cell types. However, there are several limitations associated with these approaches, such as unwanted sources of variation that influence clustering and a lack of canonical markers for certain cell types. Here, we present ACTINN (Automated Cell Type Identification using Neural Networks), which employs a neural network with 3 hidden layers, trains on datasets with predefined cell types, and predicts cell types for other datasets based on the trained parameters. We trained the neural network on a mouse cell type atlas (Tabula Muris Atlas) and a human immune cell dataset, and used it to predict cell types for mouse leukocytes, human PBMCs and human T cell sub types. The results showed that our neural network is fast and accurate, and should therefore be a useful tool to complement existing scRNA-seq pipelines.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/532093v1?rss=1</href></item></alternate><published>1548662400000</published><unread>True</unread><fingerprint>8cfd930b</fingerprint><link>http://biorxiv.org/cgi/content/short/532093v1?rss=1</link><engagement>0</engagement><title>Automated identification of Cell Types in Single Cell RNA Sequencing [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Cell type identification is one of the major goals in single cell RNA sequencing (scRNA-seq). Current methods for assigning cell types typically involve the use of unsupervised clustering, the identification of signature genes in each cluster, followed by a manual lookup of these genes in the literature and databases to assign cell types. However, there are several limitations associated with these approaches, such as unwanted sources of variation that influence clustering and a lack of canonical markers for certain cell types. Here, we present ACTINN (Automated Cell Type Identification using Neural Networks), which employs a neural network with 3 hidden layers, trains on datasets with predefined cell types, and predicts cell types for other datasets based on the trained parameters. We trained the neural network on a mouse cell type atlas (Tabula Muris Atlas) and a human immune cell dataset, and used it to predict cell types for mouse leukocytes, human PBMCs and human T cell sub types. The results showed that our neural network is fast and accurate, and should therefore be a useful tool to complement existing scRNA-seq pipelines.</description><originId>http://biorxiv.org/cgi/content/short/532093v1?rss=1</originId><crawled>1548688073028</crawled><canonicalUrl>https://www.biorxiv.org/content/10.1101/532093v1</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Yang, M.</name></author><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1687c1a95dc:2f6433a:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;The IL-6 receptor antibody tocilizumab abolished the ability of exercise to reduce visceral fat and cholesterol levels in obese individuals.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/476/eaaw5316?rss=1</href></item></alternate><published>1548269442000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>e75c4fdb</fingerprint><link>http://stm.sciencemag.org/cgi/content/short/11/476/eaaw5316?rss=1</link><engagement>0</engagement><title>[Editors&apos; Choice] IL-6: A hack to body fat and exercise?</title><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><description>&lt;p&gt;The IL-6 receptor antibody tocilizumab abolished the ability of exercise to reduce visceral fat and cholesterol levels in obese individuals.&lt;/p&gt;</description><originId>http://stm.sciencemag.org/cgi/content/short/11/476/eaaw5316?rss=1</originId><crawled>1548270343644</crawled><canonicalUrl>http://stm.sciencemag.org/content/11/476/eaaw5316.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Lubba, C. H.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16897069d79:529f571:ad2b6584</id><content><direction>ltr</direction><content>Capturing the dynamical properties of time series concisely as interpretable feature vectors can enable efficient clustering and classification for time-series applications across science and industry. Selecting an appropriate feature-based representation of time series for a given application can be achieved through systematic comparison across a comprehensive time-series feature library, such as those in the hctsa toolbox. However, this approach is computationally expensive and involves evaluating many similar features, limiting the widespread adoption of feature-based representations of time series for real-world applications. In this work, we introduce a method to infer small sets of time-series features that (i) exhibit strong classification performance across a given collection of time-series problems, and (ii) are minimally redundant. Applying our method to a set of 93 time-series classification datasets (containing over 147\,000 time series, including biomedical datasets) and using a filtered version of the hctsa feature library (4791 features), we introduce a generically useful set of 22 CAnonical Time-series CHaracteristics, catch22. This dimensionality reduction, from 4791 to 22, is associated with an approximately 1000-fold reduction in computation time and near linear scaling with time-series length, despite an average reduction in classification accuracy of just 7%. catch22 captures a diverse and interpretable signature of time series in terms of their properties, including linear and non-linear autocorrelation, successive differences, value distributions and outliers, and fluctuation scaling properties. We provide an efficient implementation of catch22, accessible from many programming environments, that facilitates feature-based time-series analysis for scientific, industrial, financial and medical applications using a common language of interpretable time-series properties.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/532259v1?rss=1</href></item></alternate><published>1548662400000</published><unread>True</unread><fingerprint>4a31afbf</fingerprint><link>http://biorxiv.org/cgi/content/short/532259v1?rss=1</link><engagement>0</engagement><title>catch22: CAnonical Time-series CHaracteristics [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Capturing the dynamical properties of time series concisely as interpretable feature vectors can enable efficient clustering and classification for time-series applications across science and industry. Selecting an appropriate feature-based representation of time series for a given application can be achieved through systematic comparison across a comprehensive time-series feature library, such as those in the hctsa toolbox. However, this approach is computationally expensive and involves evaluating many similar features, limiting the widespread adoption of feature-based representations of time series for real-world applications. In this work, we introduce a method to infer small sets of time-series features that (i) exhibit strong classification performance across a given collection of time-series problems, and (ii) are minimally redundant. Applying our method to a set of 93 time-series classification datasets (containing over 147\,000 time series, including biomedical datasets) and using a filtered version of the hctsa feature library (4791 features), we introduce a generically useful set of 22 CAnonical Time-series CHaracteristics, catch22. This dimensionality reduction, from 4791 to 22, is associated with an approximately 1000-fold reduction in computation time and near linear scaling with time-series length, despite an average reduction in classification accuracy of just 7%. catch22 captures a diverse and interpretable signature of time series in terms of their properties, including linear and non-linear autocorrelation, successive differences, value distributions and outliers, and fluctuation scaling properties. We provide an efficient implementation of catch22, accessible from many programming environments, that facilitates feature-based time-series analysis for scientific, industrial, financial and medical applications using a common language of interpretable time-series properties.</description><originId>http://biorxiv.org/cgi/content/short/532259v1?rss=1</originId><crawled>1548722019705</crawled><canonicalUrl>https://www.biorxiv.org/content/10.1101/532259v1</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Natalie B. Vinh, Nyssa Drinkwater, Tess R. Malcolm, Michael Kassiou, Leonardo Lucantoni, Peter M. Grin, Georgina S. Butler, Sandra Duffy, Christopher M. Overall, Vicky M. Avery, Peter J. Scammells, Sheena McGowan</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_1681adbea07:5c6b5f:56b782f7</id><published>1546578000000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01310/20190104/images/medium/jm-2018-01310w_0002.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01310&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=J-fWUzr-2rQ:sLTo5vmG9Sc:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/J-fWUzr-2rQ&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>d94e5e3</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01310</link><crawled>1546638846471</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01310</href></item></canonical><engagement>0</engagement><title>[ASAP] Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01310/20190104/images/medium/jm-2018-01310w_0002.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01310&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=J-fWUzr-2rQ:sLTo5vmG9Sc:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/J-fWUzr-2rQ&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01310</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/J-fWUzr-2rQ/acs.jmedchem.8b01310</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Sharma, R., Khristov, V., Rising, A., Jha, B. S., Dejene, R., Hotaling, N., Li, Y., Stoddard, J., Stankewicz, C., Wan, Q., Zhang, C., Campos, M. M., Miyagishima, K. J., McGaughey, D., Villasmil, R., Mattapallil, M., Stanzel, B., Qian, H., Wong, W., Chase, L., Charles, S., McGill, T., Miller, S., Maminishkis, A., Amaral, J., Bharti, K.</name></author><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1685811db3f:3e26697:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;Considerable progress has been made in testing stem cell–derived retinal pigment epithelium (RPE) as a potential therapy for age-related macular degeneration (AMD). However, the recent reports of oncogenic mutations in induced pluripotent stem cells (iPSCs) underlie the need for robust manufacturing and functional validation of clinical-grade iPSC-derived RPE before transplantation. Here, we developed oncogenic mutation-free clinical-grade iPSCs from three AMD patients and differentiated them into clinical-grade iPSC-RPE patches on biodegradable scaffolds. Functional validation of clinical-grade iPSC-RPE patches revealed specific features that distinguished transplantable from nontransplantable patches. Compared to RPE cells in suspension, our biodegradable scaffold approach improved integration and functionality of RPE patches in rats and in a porcine laser-induced RPE injury model that mimics AMD-like eye conditions. Our results suggest that the in vitro and in vivo preclinical functional validation of iPSC-RPE patches developed here might ultimately be useful for evaluation and optimization of autologous iPSC-based therapies.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/475/eaat5580?rss=1</href></item></alternate><published>1547664692000</published><unread>True</unread><fingerprint>35a66eb7</fingerprint><link>http://stm.sciencemag.org/cgi/content/short/11/475/eaat5580?rss=1</link><engagement>142</engagement><title>[Research Articles] Clinical-grade stem cell-derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs</title><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><description>&lt;p&gt;Considerable progress has been made in testing stem cell–derived retinal pigment epithelium (RPE) as a potential therapy for age-related macular degeneration (AMD). However, the recent reports of oncogenic mutations in induced pluripotent stem cells (iPSCs) underlie the need for robust manufacturing and functional validation of clinical-grade iPSC-derived RPE before transplantation. Here, we developed oncogenic mutation-free clinical-grade iPSCs from three AMD patients and differentiated them into clinical-grade iPSC-RPE patches on biodegradable scaffolds. Functional validation of clinical-grade iPSC-RPE patches revealed specific features that distinguished transplantable from nontransplantable patches. Compared to RPE cells in suspension, our biodegradable scaffold approach improved integration and functionality of RPE patches in rats and in a porcine laser-induced RPE injury model that mimics AMD-like eye conditions. Our results suggest that the in vitro and in vivo preclinical functional validation of iPSC-RPE patches developed here might ultimately be useful for evaluation and optimization of autologous iPSC-based therapies.&lt;/p&gt;</description><originId>http://stm.sciencemag.org/cgi/content/short/11/475/eaat5580?rss=1</originId><crawled>1547665791807</crawled><canonicalUrl>http://stm.sciencemag.org/content/11/475/eaat5580.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Xie, X.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16898338664:a571c:3a104d3b</id><content><direction>ltr</direction><content>Identification of functional non-coding variants (polymorphisms) and their mechanistic interpretation is a major challenge of modern genomics, especially for precision medicine. Transcription factor (TF) binding profiles and epigenomic landscapes in reference samples can help us functionally annotate the genome, but do not provide ready answers regarding the effects of non-coding variants. A promising computational approach is to build models that predict TF-DNA binding from sequence, and use such models to score a variant&apos;s impact on TF binding strength. Here, we asked if this mechanistic approach to variant interpretation can be combined with information on genotype-phenotype associations to discover important transcription factors regulating phenotypic variation among individuals. We developed a statistical approach that integrates phenotype, genotype, gene expression, TF ChIP-seq and Hi-C chromatin interaction data to answer this question. Using drug sensitivity measured in lymphoblastoid cell lines as the phenotype of interest, we tested if the non-coding variants statistically linked to the phenotype are enriched for strong predicted impact on DNA-binding strength of a TF, and used this test to identify TFs regulating individual differences in the phenotype. Our method relies on a new method for predicting variant impact on TF-DNA binding, that uses a combination of biophysical modelling and machine learning. We report statistical and literature-based support for many of the TFs discovered here as regulators of drug response variation. We show that the use of mechanistically driven variant impact predictors can identify TF-drug associations that would otherwise be missed. We examined in depth the evidence underlying one reported association - that of the transcription factor ELF1 with the drug doxorubicin - and identified several genes that may mediate this regulatory relationship.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/503458v2?rss=1</href></item></alternate><published>1548662400000</published><unread>True</unread><fingerprint>cfb666b9</fingerprint><link>http://biorxiv.org/cgi/content/short/503458v2?rss=1</link><engagement>0</engagement><title>Mechanistic interpretation of non-coding variants helps discover transcriptional regulators of drug response [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Identification of functional non-coding variants (polymorphisms) and their mechanistic interpretation is a major challenge of modern genomics, especially for precision medicine. Transcription factor (TF) binding profiles and epigenomic landscapes in reference samples can help us functionally annotate the genome, but do not provide ready answers regarding the effects of non-coding variants. A promising computational approach is to build models that predict TF-DNA binding from sequence, and use such models to score a variant&apos;s impact on TF binding strength. Here, we asked if this mechanistic approach to variant interpretation can be combined with information on genotype-phenotype associations to discover important transcription factors regulating phenotypic variation among individuals. We developed a statistical approach that integrates phenotype, genotype, gene expression, TF ChIP-seq and Hi-C chromatin interaction data to answer this question. Using drug sensitivity measured in lymphoblastoid cell lines as the phenotype of interest, we tested if the non-coding variants statistically linked to the phenotype are enriched for strong predicted impact on DNA-binding strength of a TF, and used this test to identify TFs regulating individual differences in the phenotype. Our method relies on a new method for predicting variant impact on TF-DNA binding, that uses a combination of biophysical modelling and machine learning. We report statistical and literature-based support for many of the TFs discovered here as regulators of drug response variation. We show that the use of mechanistically driven variant impact predictors can identify TF-drug associations that would otherwise be missed. We examined in depth the evidence underlying one reported association - that of the transcription factor ELF1 with the drug doxorubicin - and identified several genes that may mediate this regulatory relationship.</description><originId>http://biorxiv.org/cgi/content/short/503458v2?rss=1</originId><crawled>1548741740132</crawled><canonicalUrl>https://www.biorxiv.org/content/10.1101/503458v2</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Gökcen Eraslan</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1687c2d8177:2f7efe3:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Single-cell RNA-seq denoising using a deep count autoencoder&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Single-cell RNA-seq denoising using a deep count autoencoder, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07931-2&quot;&gt;doi:10.1038/s41467-018-07931-2&lt;/a&gt;&lt;/p&gt;Single-cell RNA sequencing is a powerful method to study gene expression, but noise in the data can obstruct analysis. Here the authors develop a denoising method based on a deep count autoencoder network that scales linearly with the number of cells, and therefore is compatible with large data sets.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/DusL33Ftc4E&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/DusL33Ftc4E/s41467-018-07931-2</href></item></alternate><published>1548230400000</published><unread>True</unread><visual><height>527</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-07931-2/MediaObjects/41467_2018_7931_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>5964d7cd</fingerprint><link>https://www.nature.com/articles/s41467-018-07931-2</link><engagement>1</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-07931-2</href></item></canonical><title>Single-cell RNA-seq denoising using a deep count autoencoder</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Single-cell RNA-seq denoising using a deep count autoencoder&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Single-cell RNA-seq denoising using a deep count autoencoder, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07931-2&quot;&gt;doi:10.1038/s41467-018-07931-2&lt;/a&gt;&lt;/p&gt;Single-cell RNA sequencing is a powerful method to study gene expression, but noise in the data can obstruct analysis. Here the authors develop a denoising method based on a deep count autoencoder network that scales linearly with the number of cells, and therefore is compatible with large data sets.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/DusL33Ftc4E&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-07931-2</originId><crawled>1548271583607</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Pazokitoroudi, A.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16857c82f49:3da0663:3a104d3b</id><content><direction>ltr</direction><content>A central question in human genetics is to find the proportion of variation in a trait that can be explained by genetic variation. A number of methods have been developed to estimate this quantity, termed narrow-sense heritability, from genome-wide SNP data. Recently, it has become clear that estimates of narrow-sense heritability are sensitive to modeling assumptions that relate the effect sizes of a SNP to its minor allele frequency (MAF) and linkage disequilibrium (LD) patterns. A principled approach to estimate heritability while accounting for variation in SNP effect sizes involves the application of linear Mixed Models (LMMs) with multiple variance components where each variance component represents the fraction of genetic variance explained by SNPs that belong to a given range of MAF and LD values. Beyond their importance in accurately estimating genome-wide SNP heritability, multiple variance component LMMs are useful in partitioning the contribution of genomic annotations to trait heritability which, in turn, can provide insights into biological processes that are associated with the trait. Existing methods for fitting multi-component LMMs rely on maximizing the likelihood of the variance components. These methods pose major computational bottlenecks that makes it challenging to apply them to large-scale genomic datasets such as the UK Biobank which contains half a million individuals genotyped at tens of millions of SNPs. We propose a scalable algorithm, RHE-reg-mc, to jointly estimate multiple variance components in LMMs. Our algorithm is a randomized method-of-moments estimator that has a runtime that is observed to scale as O(NMB/max(log3(N),log3(M)) +K3) for N individuals, M SNPs, K variance components, and B {approx} 10 being a parameter that controls the number of random matrix-vector multiplication. RHE-reg-mc also efficiently computes standard errors. We evaluate the accuracy and scalability of RHE-reg-mc for estimating the total heritability as well as in partitioning heritability. The ability to fit multiple variance components to SNPs partitioned according to their MAF and local LD allows RHE reg-mc to obtain relatively unbiased estimates of SNP heritability under a wide range of models of genetic architecture. On the UK Biobank dataset consisting of {approx} 300, 000 individuals and {approx} 500, 000 SNPs, RHE-reg-mc can fit 250 variance components, corresponding to genetic variance explained by 1 MB blocks, in {approx} 40 minutes on standard hardware.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/522003v1?rss=1</href></item></alternate><published>1547625600000</published><unread>True</unread><fingerprint>ea6a0ea</fingerprint><link>http://biorxiv.org/cgi/content/short/522003v1?rss=1</link><engagement>0</engagement><title>Scalable multi-component linear mixed models with application to SNP heritability estimation [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>A central question in human genetics is to find the proportion of variation in a trait that can be explained by genetic variation. A number of methods have been developed to estimate this quantity, termed narrow-sense heritability, from genome-wide SNP data. Recently, it has become clear that estimates of narrow-sense heritability are sensitive to modeling assumptions that relate the effect sizes of a SNP to its minor allele frequency (MAF) and linkage disequilibrium (LD) patterns. A principled approach to estimate heritability while accounting for variation in SNP effect sizes involves the application of linear Mixed Models (LMMs) with multiple variance components where each variance component represents the fraction of genetic variance explained by SNPs that belong to a given range of MAF and LD values. Beyond their importance in accurately estimating genome-wide SNP heritability, multiple variance component LMMs are useful in partitioning the contribution of genomic annotations to trait heritability which, in turn, can provide insights into biological processes that are associated with the trait. Existing methods for fitting multi-component LMMs rely on maximizing the likelihood of the variance components. These methods pose major computational bottlenecks that makes it challenging to apply them to large-scale genomic datasets such as the UK Biobank which contains half a million individuals genotyped at tens of millions of SNPs. We propose a scalable algorithm, RHE-reg-mc, to jointly estimate multiple variance components in LMMs. Our algorithm is a randomized method-of-moments estimator that has a runtime that is observed to scale as O(NMB/max(log3(N),log3(M)) +K3) for N individuals, M SNPs, K variance components, and B {approx} 10 being a parameter that controls the number of random matrix-vector multiplication. RHE-reg-mc also efficiently computes standard errors. We evaluate the accuracy and scalability of RHE-reg-mc for estimating the total heritability as well as in partitioning heritability. The ability to fit multiple variance components to SNPs partitioned according to their MAF and local LD allows RHE reg-mc to obtain relatively unbiased estimates of SNP heritability under a wide range of models of genetic architecture. On the UK Biobank dataset consisting of {approx} 300, 000 individuals and {approx} 500, 000 SNPs, RHE-reg-mc can fit 250 variance components, corresponding to genetic variance explained by 1 MB blocks, in {approx} 40 minutes on standard hardware.</description><originId>http://biorxiv.org/cgi/content/short/522003v1?rss=1</originId><crawled>1547660963657</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/16/522003</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Johnson, T. S.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168780c3ba1:294b469:3a104d3b</id><content><direction>ltr</direction><content>Technical advances have enabled the identification of high-resolution cell types within tissues based on single-cell transcriptomics. However, such analyses are restricted in human brain tissue due to the limited number of brain donors. In this study, we integrate mouse and human data to predict cell-type proportions in human brain tissue, and spatially map the resulting cellular composition. By applying feature selection and linear modeling, combinations of human and mouse brain single-cell transcriptomics profiles can be integrated to &amp;quot;fill in&amp;quot; missing information. These combined &amp;quot;in silico chimeric&amp;quot; datasets are used to model the composition of nine cell types in 3,702 human brain samples in six Allen Human Brain Atlas (AHBA) donors. Cell types were spatially consistent regardless of the scRNA-Seq dataset (91% significantly correlated) or AHBA donor (p-value = 4.43E-20 by t-test) used in the model. Importantly, neuron nuclei location and neuron mRNA location were correlated only after accounting for neural connectivity (p-value = 1.26E-10), which supports the notion that gene expression is a better indicator than nuclei location of cellular localization for cells with large and irregularly shaped cell bodies, such as neurons. These results advocate for the integration of mouse and human data in models of brain tissue heterogeneity.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/527499v1?rss=1</href></item></alternate><published>1548144000000</published><unread>True</unread><fingerprint>e420d1e1</fingerprint><link>http://biorxiv.org/cgi/content/short/527499v1?rss=1</link><engagement>0</engagement><title>Integration of Mouse and Human Single-cell RNA Sequencing Infers Spatial Cell-type Composition in Human Brains [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Technical advances have enabled the identification of high-resolution cell types within tissues based on single-cell transcriptomics. However, such analyses are restricted in human brain tissue due to the limited number of brain donors. In this study, we integrate mouse and human data to predict cell-type proportions in human brain tissue, and spatially map the resulting cellular composition. By applying feature selection and linear modeling, combinations of human and mouse brain single-cell transcriptomics profiles can be integrated to &amp;quot;fill in&amp;quot; missing information. These combined &amp;quot;in silico chimeric&amp;quot; datasets are used to model the composition of nine cell types in 3,702 human brain samples in six Allen Human Brain Atlas (AHBA) donors. Cell types were spatially consistent regardless of the scRNA-Seq dataset (91% significantly correlated) or AHBA donor (p-value = 4.43E-20 by t-test) used in the model. Importantly, neuron nuclei location and neuron mRNA location were correlated only after accounting for neural connectivity (p-value = 1.26E-10), which supports the notion that gene expression is a better indicator than nuclei location of cellular localization for cells with large and irregularly shaped cell bodies, such as neurons. These results advocate for the integration of mouse and human data in models of brain tissue heterogeneity.</description><originId>http://biorxiv.org/cgi/content/short/527499v1?rss=1</originId><crawled>1548202294177</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/22/527499</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Stajic, J.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a7f:c2ce2e2e</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/360-b?rss=1</href></item></alternate><published>1548355045000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>26466ee6</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6425/360-b?rss=1</link><engagement>0</engagement><title>Simulating transport with cold atoms</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6425/360-b?rss=1</originId><crawled>1548357093757</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6425/360.2.full</canonicalUrl><keywords><item>Physics</item></keywords></item><item><author><name>Annemieke Milks</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_168848de9d4:3bb247f:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;External ballistics of Pleistocene hand-thrown spears: experimental performance data and implications for human evolution&lt;/b&gt;&lt;/p&gt;&lt;p&gt;External ballistics of Pleistocene hand-thrown spears: experimental performance data and implications for human evolution, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37904-w&quot;&gt;doi:10.1038/s41598-018-37904-w&lt;/a&gt;&lt;/p&gt;External ballistics of Pleistocene hand-thrown spears: experimental performance data and implications for human evolution&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/2Q5DjUKhJDs&quot; height=&quot;1&quot;&gt;</content></content><engagementRate>2.33</engagementRate><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/2Q5DjUKhJDs/s41598-018-37904-w</href></item></alternate><published>1548403200000</published><unread>True</unread><visual><height>546</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37904-w/MediaObjects/41598_2018_37904_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>27af89c0</fingerprint><link>https://www.nature.com/articles/s41598-018-37904-w</link><engagement>7</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37904-w</href></item></canonical><title>External ballistics of Pleistocene hand-thrown spears: experimental performance data and implications for human evolution</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;External ballistics of Pleistocene hand-thrown spears: experimental performance data and implications for human evolution&lt;/b&gt;&lt;/p&gt;&lt;p&gt;External ballistics of Pleistocene hand-thrown spears: experimental performance data and implications for human evolution, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37904-w&quot;&gt;doi:10.1038/s41598-018-37904-w&lt;/a&gt;&lt;/p&gt;External ballistics of Pleistocene hand-thrown spears: experimental performance data and implications for human evolution&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/2Q5DjUKhJDs&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-37904-w</originId><crawled>1548412119508</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Maria Cantarella</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1689e477777:9c5978:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Mechanical milling: a sustainable route to induce structural transformations in MoS&lt;sub&gt;2&lt;/sub&gt; for applications in the treatment of contaminated water&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Mechanical milling: a sustainable route to induce structural transformations in MoS&amp;lt;sub&gt;2&amp;lt;/sub&gt; for applications in the treatment of contaminated water, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37798-8&quot;&gt;doi:10.1038/s41598-018-37798-8&lt;/a&gt;&lt;/p&gt;Mechanical milling: a sustainable route to induce structural transformations in MoS&lt;sub&gt;2&lt;/sub&gt; for applications in the treatment of contaminated water&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/9YBPRZ08kQA&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/9YBPRZ08kQA/s41598-018-37798-8</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37798-8/MediaObjects/41598_2018_37798_Fig1_HTML.png</url><contentType>image/png</contentType><width>343</width></visual><fingerprint>251af397</fingerprint><link>https://www.nature.com/articles/s41598-018-37798-8</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37798-8</href></item></canonical><title>Mechanical milling: a sustainable route to induce structural transformations in MoS2 for applications in the treatment of contaminated water</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Mechanical milling: a sustainable route to induce structural transformations in MoS&lt;sub&gt;2&lt;/sub&gt; for applications in the treatment of contaminated water&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Mechanical milling: a sustainable route to induce structural transformations in MoS&amp;lt;sub&gt;2&amp;lt;/sub&gt; for applications in the treatment of contaminated water, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37798-8&quot;&gt;doi:10.1038/s41598-018-37798-8&lt;/a&gt;&lt;/p&gt;Mechanical milling: a sustainable route to induce structural transformations in MoS&lt;sub&gt;2&lt;/sub&gt; for applications in the treatment of contaminated water&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/9YBPRZ08kQA&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-37798-8</originId><crawled>1548843710327</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Ana Mincholé</name></author><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>CSS</text></item></mentions><label>Cascading Style Sheets</label><id>nlp/f/entity/en/w/Cascading Style Sheets</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>WEBSITEnature_com</text></item></mentions><label>WEBSITEnature_com</label><id>nlp/f/entity/en/-/websitenature_com</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Explorer</text></item></mentions><label>Explorer</label><id>nlp/f/entity/en/-/explorer</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>JavaScript</text></item></mentions><label>JavaScript</label><id>nlp/f/entity/en/w/JavaScript</id></item></entities><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_1682910372d:1629682:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Artificial intelligence for the electrocardiogram&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Artificial intelligence for the electrocardiogram, Published online: 07 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0306-1&quot;&gt;doi:10.1038/s41591-018-0306-1&lt;/a&gt;&lt;/p&gt;Deep-learning algorithms can be applied to large datasets of electrocardiograms, are capable of identifying abnormal heart rhythms and mechanical dysfunction, and could aid healthcare decisions.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/xF6BsdGWPJo&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/xF6BsdGWPJo/s41591-018-0306-1</href></item></alternate><published>1546848000000</published><unread>True</unread><visual><height>251</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-018-0306-1/MediaObjects/41591_2018_306_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>9994c635</fingerprint><commonTopics><item><probability>0.825</probability><label>deep learning</label><id>nlp/f/topic/630</id></item></commonTopics><link>https://www.nature.com/articles/s41591-018-0306-1</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41591-018-0306-1</href></item></canonical><title>Artificial intelligence for the electrocardiogram</title><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Artificial intelligence for the electrocardiogram&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Artificial intelligence for the electrocardiogram, Published online: 07 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0306-1&quot;&gt;doi:10.1038/s41591-018-0306-1&lt;/a&gt;&lt;/p&gt;Deep-learning algorithms can be applied to large datasets of electrocardiograms, are capable of identifying abnormal heart rhythms and mechanical dysfunction, and could aid healthcare decisions.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/xF6BsdGWPJo&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41591-018-0306-1</originId><crawled>1546877155117</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>T.V. Padma</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Indian</text></item><item><text>India</text></item></mentions><label>India</label><id>nlp/f/entity/en/w/India</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>LIGO</text></item><item><text>Laser Interferometer Gravitational - Wave Observatory</text></item></mentions><label>LIGO</label><id>nlp/f/entity/en/w/LIGO</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Universe</text></item></mentions><label>Universe</label><id>nlp/f/entity/en/w/Universe</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>aLIGO</text></item></mentions><label>aLIGO</label><id>nlp/f/entity/en/-/aligo</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>LIGO Laboratory</text></item></mentions><label>LIGO Laboratory</label><id>nlp/f/entity/en/-/ligo laboratory</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168771244b9:270e014:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;India’s LIGO gravitational-wave observatory gets green light&lt;/b&gt;&lt;/p&gt;&lt;p&gt;India’s LIGO gravitational-wave observatory gets green light, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00184-z&quot;&gt;doi:10.1038/d41586-019-00184-z&lt;/a&gt;&lt;/p&gt;The US$177-million observatory will join a global network of sensors and should improve sensitivity.</content></content><updateCount>1</updateCount><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00184-z</href></item></alternate><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00184-z/d41586-019-00184-z_16400364.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>29ccaaf7</fingerprint><commonTopics><item><probability>0.99</probability><label>aps</label><id>nlp/f/topic/127</id></item><item><probability>0.906</probability><label>astrophysics</label><id>nlp/f/topic/173</id></item><item><probability>0.793</probability><label>physics</label><id>nlp/f/topic/1753</id></item><item><probability>0.791</probability><label>india</label><id>nlp/f/topic/1149</id></item><item><probability>0.778</probability><label>mrunal</label><id>nlp/f/topic/1510</id></item><item><probability>0.764</probability><label>surf</label><id>nlp/f/topic/2209</id></item><item><probability>0.725</probability><label>economy</label><id>nlp/f/topic/731</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00184-z</link><recrawled>1548246751843</recrawled><engagement>32</engagement><title>India’s LIGO gravitational-wave observatory gets green light</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;India’s LIGO gravitational-wave observatory gets green light&lt;/b&gt;&lt;/p&gt;&lt;p&gt;India’s LIGO gravitational-wave observatory gets green light, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00184-z&quot;&gt;doi:10.1038/d41586-019-00184-z&lt;/a&gt;&lt;/p&gt;The US$177-million observatory will join a global network of sensors and should improve sensitivity.</description><originId>https://www.nature.com/articles/d41586-019-00184-z</originId><crawled>1548185912505</crawled><published>1548144000000</published><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Roth, L., Wakim, J., Wasserman, E., Shalev, M., Arman, E., Stein, M., Brumfeld, V., Sagum, C. A., Bedford, M. T., Tuckermann, J., Elson, A.</name></author><id>RuJRIXzN26JgDGk9YhlIBfh4YrPi0r+1c4exm9G1IBw=_1682ee938a9:5d2d1f:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;Bone resorption by osteoclasts is essential for bone homeostasis. The kinase Src promotes osteoclast activity and is activated in osteoclasts by the receptor-type tyrosine phosphatase PTPROt. In other contexts, however, PTPROt can inhibit Src activity. Through in vivo and in vitro experiments, we show that PTPROt is bifunctional and can dephosphorylate Src both at its inhibitory residue Tyr&lt;sup&gt;527&lt;/sup&gt; and its activating residue Tyr&lt;sup&gt;416&lt;/sup&gt;. Whereas wild-type and PTPROt knockout mice exhibited similar bone masses, mice in which a putative C-terminal phosphorylation site, Tyr&lt;sup&gt;399&lt;/sup&gt;, in endogenous PTPROt was replaced with phenylalanine had increased bone mass and reduced osteoclast activity. Osteoclasts from the knock-in mice also showed reduced Src activity. Experiments in cultured cells and in osteoclasts derived from both mouse strains demonstrated that the absence of phosphorylation at Tyr&lt;sup&gt;399&lt;/sup&gt; caused PTPROt to dephosphorylate Src at the activating site pTyr&lt;sup&gt;416&lt;/sup&gt;. In contrast, phosphorylation of PTPROt at Tyr&lt;sup&gt;399&lt;/sup&gt; enabled PTPROt to recruit Src through Grb2 and to dephosphorylate Src at the inhibitory site Tyr&lt;sup&gt;527&lt;/sup&gt;, thus stimulating Src activity. We conclude that reversible phosphorylation of PTPROt at Tyr&lt;sup&gt;399&lt;/sup&gt; is a molecular switch that selects between its opposing activities toward Src and maintains a coherent signaling output, and that blocking this phosphorylation event can induce physiological effects in vivo. Because most receptor-type tyrosine phosphatases contain potential phosphorylation sites at their C termini, we propose that preventing phosphorylation at these sites or its consequences may offer an alternative to inhibiting their catalytic activity to achieve therapeutic benefit.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stke.sciencemag.org/cgi/content/short/12/563/eaau0240?rss=1</href></item></alternate><published>1546973708000</published><unread>True</unread><fingerprint>2edb8f4e</fingerprint><link>http://stke.sciencemag.org/cgi/content/short/12/563/eaau0240?rss=1</link><engagement>0</engagement><title>Phosphorylation of the phosphatase PTPROt at Tyr399 is a molecular switch that controls osteoclast activity and bone mass in vivo</title><origin><htmlUrl>http://stke.sciencemag.org</htmlUrl><streamId>feed/http://stke.sciencemag.org/rss/current.xml</streamId><title>Science Signaling current issue</title></origin><description>&lt;p&gt;Bone resorption by osteoclasts is essential for bone homeostasis. The kinase Src promotes osteoclast activity and is activated in osteoclasts by the receptor-type tyrosine phosphatase PTPROt. In other contexts, however, PTPROt can inhibit Src activity. Through in vivo and in vitro experiments, we show that PTPROt is bifunctional and can dephosphorylate Src both at its inhibitory residue Tyr&lt;sup&gt;527&lt;/sup&gt; and its activating residue Tyr&lt;sup&gt;416&lt;/sup&gt;. Whereas wild-type and PTPROt knockout mice exhibited similar bone masses, mice in which a putative C-terminal phosphorylation site, Tyr&lt;sup&gt;399&lt;/sup&gt;, in endogenous PTPROt was replaced with phenylalanine had increased bone mass and reduced osteoclast activity. Osteoclasts from the knock-in mice also showed reduced Src activity. Experiments in cultured cells and in osteoclasts derived from both mouse strains demonstrated that the absence of phosphorylation at Tyr&lt;sup&gt;399&lt;/sup&gt; caused PTPROt to dephosphorylate Src at the activating site pTyr&lt;sup&gt;416&lt;/sup&gt;. In contrast, phosphorylation of PTPROt at Tyr&lt;sup&gt;399&lt;/sup&gt; enabled PTPROt to recruit Src through Grb2 and to dephosphorylate Src at the inhibitory site Tyr&lt;sup&gt;527&lt;/sup&gt;, thus stimulating Src activity. We conclude that reversible phosphorylation of PTPROt at Tyr&lt;sup&gt;399&lt;/sup&gt; is a molecular switch that selects between its opposing activities toward Src and maintains a coherent signaling output, and that blocking this phosphorylation event can induce physiological effects in vivo. Because most receptor-type tyrosine phosphatases contain potential phosphorylation sites at their C termini, we propose that preventing phosphorylation at these sites or its consequences may offer an alternative to inhibiting their catalytic activity to achieve therapeutic benefit.&lt;/p&gt;</description><originId>http://stke.sciencemag.org/cgi/content/short/12/563/eaau0240?rss=1</originId><crawled>1546975262889</crawled><canonicalUrl>http://stke.sciencemag.org/content/12/563/eaau0240.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Hewitt, S. L., Bai, A., Bailey, D., Ichikawa, K., Zielinski, J., Karp, R., Apte, A., Arnold, K., Zacharek, S. J., Iliou, M. S., Bhatt, K., Garnaas, M., Musenge, F., Davis, A., Khatwani, N., Su, S. V., MacLean, G., Farlow, S. J., Burke, K., Frederick, J. P.</name></author><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_168a028b953:cc891a:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;Many solid cancers contain dysfunctional immune microenvironments. Immune system modulators that initiate responses to foreign pathogens could be promising candidates for reigniting productive responses toward tumors. Interleukin-1 (IL-1) and IL-12 cytokine family members cooperate at barrier tissues after microbial invasion, in human inflammatory diseases, and in antitumoral immunity. IL-36, in classic alarmin fashion, acts in damaged tissues, whereas IL-23 centrally coordinates immune responses to danger signals. In this study, direct intratumoral delivery of messenger RNAs (mRNAs) encoding these cytokines produced robust anticancer responses in a broad range of tumor microenvironments. The addition of mRNA encoding the T cell costimulator OX40L increased complete response rates in treated and untreated distal tumors compared to the cytokine mRNAs alone. Mice exhibiting complete responses were subsequently protected from tumor rechallenge. Treatments with these mRNA mixtures induced downstream cytokine and chemokine expression, and also activated multiple dendritic cell (DC) and T cell types. Consistent with this, efficacy was dependent on Batf3-dependent cross-presenting DCs and cytotoxic CD8&lt;sup&gt;+&lt;/sup&gt; T cells. IL-23/IL-36/OX40L triplet mRNA mixture triggered substantial immune cell recruitment into tumors, enabling effective tumor destruction irrespective of previous tumoral immune infiltrates. Last, combining triplet mRNA with checkpoint blockade led to efficacy in models otherwise resistant to systemic immune checkpoint inhibition. Human cell studies showed similar cytokine responses to the individual components of this mRNA mixture, suggesting translatability of immunomodulatory activity to human patients.&lt;/p&gt;</content></content><engagementRate>4.0</engagementRate><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/477/eaat9143?rss=1</href></item></alternate><published>1548874208000</published><unread>True</unread><fingerprint>51d73b9c</fingerprint><link>http://stm.sciencemag.org/cgi/content/short/11/477/eaat9143?rss=1</link><engagement>40</engagement><title>[Research Articles] Durable anticancer immunity from intratumoral administration of IL-23, IL-36{gamma}, and OX40L mRNAs</title><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><description>&lt;p&gt;Many solid cancers contain dysfunctional immune microenvironments. Immune system modulators that initiate responses to foreign pathogens could be promising candidates for reigniting productive responses toward tumors. Interleukin-1 (IL-1) and IL-12 cytokine family members cooperate at barrier tissues after microbial invasion, in human inflammatory diseases, and in antitumoral immunity. IL-36, in classic alarmin fashion, acts in damaged tissues, whereas IL-23 centrally coordinates immune responses to danger signals. In this study, direct intratumoral delivery of messenger RNAs (mRNAs) encoding these cytokines produced robust anticancer responses in a broad range of tumor microenvironments. The addition of mRNA encoding the T cell costimulator OX40L increased complete response rates in treated and untreated distal tumors compared to the cytokine mRNAs alone. Mice exhibiting complete responses were subsequently protected from tumor rechallenge. Treatments with these mRNA mixtures induced downstream cytokine and chemokine expression, and also activated multiple dendritic cell (DC) and T cell types. Consistent with this, efficacy was dependent on Batf3-dependent cross-presenting DCs and cytotoxic CD8&lt;sup&gt;+&lt;/sup&gt; T cells. IL-23/IL-36/OX40L triplet mRNA mixture triggered substantial immune cell recruitment into tumors, enabling effective tumor destruction irrespective of previous tumoral immune infiltrates. Last, combining triplet mRNA with checkpoint blockade led to efficacy in models otherwise resistant to systemic immune checkpoint inhibition. Human cell studies showed similar cytokine responses to the individual components of this mRNA mixture, suggesting translatability of immunomodulatory activity to human patients.&lt;/p&gt;</description><originId>http://stm.sciencemag.org/cgi/content/short/11/477/eaat9143?rss=1</originId><crawled>1548875250003</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Temple, S., Goldstein, L. S. B.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce0ae:ad2b6584</id><published>1547750305000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>6c50bbee</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6424/207?rss=1</link><engagement>941</engagement><crawled>1547752389672</crawled><title>Why we need fetal tissue research</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6424/207?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/207?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6424/207.full</canonicalUrl></item><item><author><name>Lei Xiong</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_16860820a59:a55ff7:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming, Published online: 18 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08245-z&quot;&gt;doi:10.1038/s41467-018-08245-z&lt;/a&gt;&lt;/p&gt;There are distinct hypermethylation patterns in gene promoters in hepatocellular carcinomas (HCCs). Here, the authors show that the enhancer of C/EBPβ is recurrently hypomethylated in human HCCs, recapitulating this in a transgenic murine model and linking aberrant enhancer hypomethylation to hepatocarcinogenesis.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/2uB15o68czs&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/2uB15o68czs/s41467-018-08245-z</href></item></alternate><published>1547798400000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08245-z/MediaObjects/41467_2018_8245_Fig1_HTML.png</url><contentType>image/png</contentType><width>495</width></visual><fingerprint>110a3b5f</fingerprint><link>https://www.nature.com/articles/s41467-018-08245-z</link><engagement>1</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08245-z</href></item></canonical><title>Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming, Published online: 18 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08245-z&quot;&gt;doi:10.1038/s41467-018-08245-z&lt;/a&gt;&lt;/p&gt;There are distinct hypermethylation patterns in gene promoters in hepatocellular carcinomas (HCCs). Here, the authors show that the enhancer of C/EBPβ is recurrently hypomethylated in human HCCs, recapitulating this in a transgenic murine model and linking aberrant enhancer hypomethylation to hepatocarcinogenesis.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/2uB15o68czs&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-08245-z</originId><crawled>1547807361625</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Michael J. Serpe</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>windows</text></item></mentions><label>Microsoft Windows</label><id>nlp/f/entity/en/w/Microsoft Windows</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Li</text></item></mentions><label>Li</label><id>nlp/f/entity/en/-/li</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Li et al</text></item></mentions><label>Li et al</label><id>nlp/f/entity/en/-/li et al</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>NIR</text></item></mentions><label>NIR</label><id>nlp/f/entity/en/-/nir</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Joule</text></item></mentions><label>Joule</label><id>nlp/f/entity/en/w/Joule</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1684d157a77:2e52ee2:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Fine-tuned gel particles enable smart windows for energy efficiency&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Fine-tuned gel particles enable smart windows for energy efficiency, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00084-2&quot;&gt;doi:10.1038/d41586-019-00084-2&lt;/a&gt;&lt;/p&gt;Polymeric gel particles have been used to make windows that highly effectively allow or block heat-generating wavelengths of sunlight in response to temperature. Such windows might increase the energy efficiency of buildings.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00084-2</href></item></alternate><published>1547452800000</published><unread>True</unread><visual><height>450</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00084-2/d41586-019-00084-2_16395608.jpg</url><contentType>image/jpeg</contentType><width>800</width></visual><fingerprint>f848cd96</fingerprint><commonTopics><item><probability>0.713</probability><label>energy</label><id>nlp/f/topic/772</id></item><item><probability>0.705</probability><label>materials</label><id>nlp/f/topic/1419</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00084-2</link><engagement>21</engagement><title>Fine-tuned gel particles enable smart windows for energy efficiency</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Fine-tuned gel particles enable smart windows for energy efficiency&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Fine-tuned gel particles enable smart windows for energy efficiency, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00084-2&quot;&gt;doi:10.1038/d41586-019-00084-2&lt;/a&gt;&lt;/p&gt;Polymeric gel particles have been used to make windows that highly effectively allow or block heat-generating wavelengths of sunlight in response to temperature. Such windows might increase the energy efficiency of buildings.</description><originId>https://www.nature.com/articles/d41586-019-00084-2</originId><crawled>1547481479799</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Katie Kingwell</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>FNDC5</text></item><item><text>irisin</text></item></mentions><label>FNDC5</label><id>nlp/f/entity/en/w/FNDC5</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Aβ</text></item></mentions><label>Amyloid beta</label><id>nlp/f/entity/en/w/Amyloid beta</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>LTP</text></item></mentions><label>Long-term potentiation</label><id>nlp/f/entity/en/w/Long-term potentiation</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Myokines</text></item></mentions><label>Myokine</label><id>nlp/f/entity/en/w/Myokine</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Alzheimer disease</text></item></mentions><label>Alzheimer&apos;s disease</label><id>nlp/f/entity/en/w/Alzheimer&apos;s disease</id></item></entities><id>YLwIhSxZAzQIEnJq1FGGcXUQMCbQUlr9cyNMExMVeyY=_1683913d1a7:14f6d20:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;An exercise-linked mediator of memory protection&lt;/b&gt;&lt;/p&gt;&lt;p&gt;An exercise-linked mediator of memory protection, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41573-019-00006-x&quot;&gt;doi:10.1038/d41573-019-00006-x&lt;/a&gt;&lt;/p&gt;An exercise-linked mediator of memory protection&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/c6kAYtkl5JA&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nrd/rss/current/~3/c6kAYtkl5JA/d41573-019-00006-x</href></item></alternate><published>1547107200000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>d22eee28</fingerprint><commonTopics><item><probability>0.958</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.952</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item><item><probability>0.881</probability><label>pharmacology</label><id>nlp/f/topic/1735</id></item><item><probability>0.811</probability><label>sports medicine</label><id>nlp/f/topic/2154</id></item><item><probability>0.792</probability><label>cell</label><id>nlp/f/topic/403</id></item></commonTopics><link>https://www.nature.com/articles/d41573-019-00006-x</link><engagement>3</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/d41573-019-00006-x</href></item></canonical><title>An exercise-linked mediator of memory protection</title><origin><htmlUrl>http://feeds.nature.com/nrd/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nrd/rss/current</streamId><title>Nature Reviews Drug Discovery - Issue - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;An exercise-linked mediator of memory protection&lt;/b&gt;&lt;/p&gt;&lt;p&gt;An exercise-linked mediator of memory protection, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41573-019-00006-x&quot;&gt;doi:10.1038/d41573-019-00006-x&lt;/a&gt;&lt;/p&gt;An exercise-linked mediator of memory protection&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/c6kAYtkl5JA&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/d41573-019-00006-x</originId><crawled>1547145826727</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Striedter, G. F., Burley, N. T.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:15708c5:8675cc2c</id><published>1547145461000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>41104b53</fingerprint><commonTopics><item><probability>0.987</probability><label>birds</label><id>nlp/f/topic/268</id></item><item><probability>0.972</probability><label>zoology</label><id>nlp/f/topic/2543</id></item><item><probability>0.96</probability><label>evolution</label><id>nlp/f/topic/815</id></item><item><probability>0.826</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.788</probability><label>ecology</label><id>nlp/f/topic/725</id></item></commonTopics><link>http://science.sciencemag.org/cgi/content/short/363/6423/120?rss=1</link><engagement>191</engagement><crawled>1547147463250</crawled><title>Are clever males preferred as mates?</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6423/120?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/120?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6423/120.full</canonicalUrl><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>Chen et al</text></item></mentions><label>Chen et al</label><id>nlp/f/entity/en/-/chen et al</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Australian</text></item></mentions><label>Australia</label><id>nlp/f/entity/en/w/Australia</id></item></entities></item><item><author><name>Chen-Jie Shen</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Publisher Correction</text></item></mentions><label>Publisher Correction</label><id>nlp/f/entity/en/-/publisher correction</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Cannabinoid CB1</text></item></mentions><label>Cannabinoid receptor type 1</label><id>nlp/f/entity/en/w/Cannabinoid receptor type 1</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Cannabinoid CB</text></item><item><text>Cannabinoid CB 1</text></item></mentions><label>Cannabinoid CB 1</label><id>nlp/f/entity/en/-/cannabinoid cb 1</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>amygdalar cholecystokinin</text></item></mentions><label>amygdalar cholecystokinin</label><id>nlp/f/entity/en/-/amygdalar cholecystokinin</id></item></entities><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_1689ef0e749:a8ee4f:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Publisher Correction: Cannabinoid CB&lt;sub&gt;1&lt;/sub&gt; receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Publisher Correction: Cannabinoid CB&amp;lt;sub&gt;1&amp;lt;/sub&gt; receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-019-0372-z&quot;&gt;doi:10.1038/s41591-019-0372-z&lt;/a&gt;&lt;/p&gt;Publisher Correction: Cannabinoid CB&lt;sub&gt;1&lt;/sub&gt; receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/iwggGsdAwwI&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/iwggGsdAwwI/s41591-019-0372-z</href></item></alternate><published>1548835200000</published><unread>True</unread><fingerprint>a1d90805</fingerprint><link>https://www.nature.com/articles/s41591-019-0372-z</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41591-019-0372-z</href></item></canonical><title>Publisher Correction: Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior</title><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Publisher Correction: Cannabinoid CB&lt;sub&gt;1&lt;/sub&gt; receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Publisher Correction: Cannabinoid CB&amp;lt;sub&gt;1&amp;lt;/sub&gt; receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-019-0372-z&quot;&gt;doi:10.1038/s41591-019-0372-z&lt;/a&gt;&lt;/p&gt;Publisher Correction: Cannabinoid CB&lt;sub&gt;1&lt;/sub&gt; receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/iwggGsdAwwI&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41591-019-0372-z</originId><crawled>1548854814537</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Allen T. Hopper, Adam Brockman, Andy Wise, Julie Gould, Jennifer Barks, Joshua B. Radke, L. David Sibley, Yongmao Zou, Stephen Thomas</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_16880d96d90:b754ce:56b782f7</id><published>1548306000000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01754/20190123/images/medium/jm-2018-01754k_0013.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01754&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=Hu1WsaFW64Y:-x4cZ9F97qY:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/Hu1WsaFW64Y&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>c4e4b0d8</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01754</link><crawled>1548349959568</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01754</href></item></canonical><engagement>0</engagement><title>[ASAP] Discovery of Selective Toxoplasma gondii Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01754/20190123/images/medium/jm-2018-01754k_0013.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01754&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=Hu1WsaFW64Y:-x4cZ9F97qY:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/Hu1WsaFW64Y&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01754</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/Hu1WsaFW64Y/acs.jmedchem.8b01754</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Vivek K. Mutalik</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_16860820a59:a55ff2:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Dual-barcoded shotgun expression library sequencing for high-throughput characterization of functional traits in bacteria&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Dual-barcoded shotgun expression library sequencing for high-throughput characterization of functional traits in bacteria, Published online: 18 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08177-8&quot;&gt;doi:10.1038/s41467-018-08177-8&lt;/a&gt;&lt;/p&gt;Gain of function methods based on gene overexpression are not easily applied to high-throughput screening across different experimental conditions. Here, the authors present Dub-seq, which separates overexpression library characterization from functional screening and uses random DNA barcodes to increase the experimental throughput.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/qLADecslZOw&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/qLADecslZOw/s41467-018-08177-8</href></item></alternate><published>1547798400000</published><unread>True</unread><visual><height>359</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08177-8/MediaObjects/41467_2018_8177_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>1e0264b4</fingerprint><link>https://www.nature.com/articles/s41467-018-08177-8</link><engagement>1</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08177-8</href></item></canonical><title>Dual-barcoded shotgun expression library sequencing for high-throughput characterization of functional traits in bacteria</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Dual-barcoded shotgun expression library sequencing for high-throughput characterization of functional traits in bacteria&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Dual-barcoded shotgun expression library sequencing for high-throughput characterization of functional traits in bacteria, Published online: 18 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08177-8&quot;&gt;doi:10.1038/s41467-018-08177-8&lt;/a&gt;&lt;/p&gt;Gain of function methods based on gene overexpression are not easily applied to high-throughput screening across different experimental conditions. Here, the authors present Dub-seq, which separates overexpression library characterization from functional screening and uses random DNA barcodes to increase the experimental throughput.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/qLADecslZOw&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-08177-8</originId><crawled>1547807361625</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Beug, S. T., Cheung, H. H., Sanda, T., St-Jean, M., Beauregard, C. E., Mamady, H., Baird, S. D., LaCasse, E. C., Korneluk, R. G.</name></author><id>RuJRIXzN26JgDGk9YhlIBfh4YrPi0r+1c4exm9G1IBw=_1689b0ef677:533ffa:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;The controlled production and downstream signaling of the inflammatory cytokine tumor necrosis factor–α (TNF-α) are important for immunity and its anticancer effects. Although chronic stimulation with TNF-α is detrimental to the health of the host in several autoimmune and inflammatory disorders, TNF-α—contrary to what its name implies—leads to cancer formation by promoting cell proliferation and survival. Smac mimetic compounds (SMCs), small-molecule antagonists of inhibitor of apoptosis proteins (IAPs), switch the TNF-α signal from promoting survival to promoting death in cancer cells. Using a genome-wide siRNA screen to identify factors required for SMC–to–TNF-α–mediated cancer cell death, we identified the transcription factor SP3 as a critical molecule in both basal and SMC-induced production of TNF-α by engaging the nuclear factor B (NF-B) transcriptional pathway. Moreover, the promotion of TNF-α expression by SP3 activity confers differential sensitivity of cancer versus normal cells to SMC treatment. The key role of SP3 in TNF-α production and signaling will help us further understand TNF-α biology and provide insight into mechanisms relevant to cancer and inflammatory disease.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stke.sciencemag.org/cgi/content/short/12/566/eaat9563?rss=1</href></item></alternate><published>1548787889000</published><unread>True</unread><fingerprint>86db5da8</fingerprint><link>http://stke.sciencemag.org/cgi/content/short/12/566/eaat9563?rss=1</link><engagement>0</engagement><title>The transcription factor SP3 drives TNF-{alpha} expression in response to Smac mimetics</title><origin><htmlUrl>http://stke.sciencemag.org</htmlUrl><streamId>feed/http://stke.sciencemag.org/rss/current.xml</streamId><title>Science Signaling current issue</title></origin><description>&lt;p&gt;The controlled production and downstream signaling of the inflammatory cytokine tumor necrosis factor–α (TNF-α) are important for immunity and its anticancer effects. Although chronic stimulation with TNF-α is detrimental to the health of the host in several autoimmune and inflammatory disorders, TNF-α—contrary to what its name implies—leads to cancer formation by promoting cell proliferation and survival. Smac mimetic compounds (SMCs), small-molecule antagonists of inhibitor of apoptosis proteins (IAPs), switch the TNF-α signal from promoting survival to promoting death in cancer cells. Using a genome-wide siRNA screen to identify factors required for SMC–to–TNF-α–mediated cancer cell death, we identified the transcription factor SP3 as a critical molecule in both basal and SMC-induced production of TNF-α by engaging the nuclear factor B (NF-B) transcriptional pathway. Moreover, the promotion of TNF-α expression by SP3 activity confers differential sensitivity of cancer versus normal cells to SMC treatment. The key role of SP3 in TNF-α production and signaling will help us further understand TNF-α biology and provide insight into mechanisms relevant to cancer and inflammatory disease.&lt;/p&gt;</description><originId>http://stke.sciencemag.org/cgi/content/short/12/566/eaat9563?rss=1</originId><crawled>1548789675639</crawled><canonicalUrl>http://stke.sciencemag.org/content/12/566/eaat9563.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Maksim Kunitski</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_168108cd0f1:6372acc:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Double-slit photoelectron interference in strong-field ionization of the neon dimer&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Double-slit photoelectron interference in strong-field ionization of the neon dimer, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07882-8&quot;&gt;doi:10.1038/s41467-018-07882-8&lt;/a&gt;&lt;/p&gt;The wave nature of light and particles is of interest to the fundamental quantum mechanics. Here the authors show the double-slit interference effect in the strong-field ionization of neon dimers by employing COLTRIMS method to record the momentum distribution of the photoelectrons in the molecular frame&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/mwRPGh7w8k0&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/mwRPGh7w8k0/s41467-018-07882-8</href></item></alternate><published>1546416000000</published><unread>True</unread><visual><height>342</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-07882-8/MediaObjects/41467_2018_7882_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>a0f5e70e</fingerprint><link>https://www.nature.com/articles/s41467-018-07882-8</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-07882-8</href></item></canonical><title>Double-slit photoelectron interference in strong-field ionization of the neon dimer</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Double-slit photoelectron interference in strong-field ionization of the neon dimer&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Double-slit photoelectron interference in strong-field ionization of the neon dimer, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07882-8&quot;&gt;doi:10.1038/s41467-018-07882-8&lt;/a&gt;&lt;/p&gt;The wave nature of light and particles is of interest to the fundamental quantum mechanics. Here the authors show the double-slit interference effect in the strong-field ionization of neon dimers by employing COLTRIMS method to record the momentum distribution of the photoelectrons in the molecular frame&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/mwRPGh7w8k0&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-07882-8</originId><crawled>1546465890545</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Majarian, T. D.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16881e58094:37f8152:3a104d3b</id><content><direction>ltr</direction><content>Within influenza virus infected cells, viral genomic RNA are selectively packed into progeny virions, which predominantly contain a single copy of 8 viral RNA segments. Intersegmental RNA-RNA interactions are thought to mediate selective packaging of each viral ribonucleoprotein complex (vRNP). Clear evidence of a specific interaction network culminating in the full genomic set has yet to be identified. Using multi-color fluorescence in situ hybridization to visualize four vRNP segments within a single cell, we developed image-based models of vRNP-vRNP spatial dependence. These models were used to construct likely sequences of vRNP associations resulting in the full genomic set. Our results support the notion that selective packaging occurs during cytoplasmic transport and identifies the formation of multiple distinct vRNP sub-complexes that likely form as intermediate steps toward full genomic inclusion into a progeny virion. The methods employed demonstrate a statistically driven, model based approach applicable to other interaction and assembly problems.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/322966v2?rss=1</href></item></alternate><published>1548316800000</published><unread>True</unread><fingerprint>7507b8ed</fingerprint><link>http://biorxiv.org/cgi/content/short/322966v2?rss=1</link><engagement>0</engagement><title>Learning the sequence of influenza A genome assembly during viral replication using point process models and fluorescence in situ hybridization [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Within influenza virus infected cells, viral genomic RNA are selectively packed into progeny virions, which predominantly contain a single copy of 8 viral RNA segments. Intersegmental RNA-RNA interactions are thought to mediate selective packaging of each viral ribonucleoprotein complex (vRNP). Clear evidence of a specific interaction network culminating in the full genomic set has yet to be identified. Using multi-color fluorescence in situ hybridization to visualize four vRNP segments within a single cell, we developed image-based models of vRNP-vRNP spatial dependence. These models were used to construct likely sequences of vRNP associations resulting in the full genomic set. Our results support the notion that selective packaging occurs during cytoplasmic transport and identifies the formation of multiple distinct vRNP sub-complexes that likely form as intermediate steps toward full genomic inclusion into a progeny virion. The methods employed demonstrate a statistically driven, model based approach applicable to other interaction and assembly problems.</description><originId>http://biorxiv.org/cgi/content/short/322966v2?rss=1</originId><crawled>1548367528084</crawled><canonicalUrl>https://www.biorxiv.org/content/10.1101/322966v2</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Edward B. Barbier</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Green New Deal</text></item></mentions><label>Green New Deal</label><id>nlp/f/entity/en/w/Green New Deal</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>UN</text></item></mentions><label>United Nations</label><id>nlp/f/entity/en/w/United Nations</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Global Green New Deal</text></item></mentions><label>Global Green New Deal</label><id>nlp/f/entity/en/-/global green new deal</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>IMF</text></item><item><text>International Monetary Fund</text></item></mentions><label>International Monetary Fund</label><id>nlp/f/entity/en/w/International Monetary Fund</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>House of Representatives committee</text></item></mentions><label>House of Representatives committee</label><id>nlp/f/entity/en/-/house of representatives committee</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1680e00cbf2:5ff01c9:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;How to make the next Green New Deal work&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How to make the next Green New Deal work, Published online: 01 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07845-5&quot;&gt;doi:10.1038/d41586-018-07845-5&lt;/a&gt;&lt;/p&gt;To make green investments pay off, policymakers must learn from past mistakes and stop subsidizing polluters, urges Edward B. Barbier.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07845-5</href></item></alternate><published>1546329600000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07845-5/d41586-018-07845-5_16357100.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>9da52951</fingerprint><link>https://www.nature.com/articles/d41586-018-07845-5</link><engagement>12</engagement><title>How to make the next Green New Deal work</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;How to make the next Green New Deal work&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How to make the next Green New Deal work, Published online: 01 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07845-5&quot;&gt;doi:10.1038/d41586-018-07845-5&lt;/a&gt;&lt;/p&gt;To make green investments pay off, policymakers must learn from past mistakes and stop subsidizing polluters, urges Edward B. Barbier.</description><originId>https://www.nature.com/articles/d41586-018-07845-5</originId><crawled>1546423159794</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Giang T. H. Nguyen, Thinh N. Tran, Matthew N. Podgorski, Stephen G. Bell, Claudiu T. Supuran, William A. Donald</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>1TYkl+7D2jbCAjv6kqe9qy39+K76tsp7YKV/mQVt7ps=_1684d8e4af6:1069c04:b77f238b</id><published>1547442000000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00787/20190114/images/medium/oc-2018-00787d_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00787&lt;/div&gt;</content></summary><fingerprint>2e5c25fd</fingerprint><link>http://dx.doi.org/10.1021/acscentsci.8b00787</link><engagement>0</engagement><crawled>1547489397494</crawled><title>[ASAP] Nanoscale Ion Emitters in Native Mass Spectrometry for Measuring Ligand–Protein Binding Affinities</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acscii</streamId><title>ACS Central Science: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00787/20190114/images/medium/oc-2018-00787d_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00787&lt;/div&gt;</description><originId>http://dx.doi.org/10.1021/acscentsci.8b00787</originId><alternate><item><type>text/html</type><href>http://dx.doi.org/10.1021/acscentsci.8b00787</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Christopher D. Davidson</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_16832228f3e:a8de42:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Cell force-mediated matrix reorganization underlies multicellular network assembly&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Cell force-mediated matrix reorganization underlies multicellular network assembly, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37044-1&quot;&gt;doi:10.1038/s41598-018-37044-1&lt;/a&gt;&lt;/p&gt;Cell force-mediated matrix reorganization underlies multicellular network assembly&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/jOm6tOO3Ixc&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/jOm6tOO3Ixc/s41598-018-37044-1</href></item></alternate><published>1547020800000</published><unread>True</unread><visual><height>522</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37044-1/MediaObjects/41598_2018_37044_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>ed373b4a</fingerprint><link>https://www.nature.com/articles/s41598-018-37044-1</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37044-1</href></item></canonical><title>Cell force-mediated matrix reorganization underlies multicellular network assembly</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Cell force-mediated matrix reorganization underlies multicellular network assembly&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Cell force-mediated matrix reorganization underlies multicellular network assembly, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37044-1&quot;&gt;doi:10.1038/s41598-018-37044-1&lt;/a&gt;&lt;/p&gt;Cell force-mediated matrix reorganization underlies multicellular network assembly&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/jOm6tOO3Ixc&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-37044-1</originId><crawled>1547029352254</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Rice, H. C., de Malmazet, D., Schreurs, A., Frere, S., Van Molle, I., Volkov, A. N., Creemers, E., Vertkin, I., Nys, J., Ranaivoson, F. M., Comoletti, D., Savas, J. N., Remaut, H., Balschun, D., Wierda, K. D., Slutsky, I., Farrow, K., De Strooper, B., de Wit, J.</name></author><content><direction>ltr</direction><content>&lt;p&gt;Amyloid-β precursor protein (APP) is central to the pathogenesis of Alzheimer’s disease, yet its physiological function remains unresolved. Accumulating evidence suggests that APP has a synaptic function mediated by an unidentified receptor for secreted APP (sAPP). Here we show that the sAPP extension domain directly bound the sushi 1 domain specific to the -aminobutyric acid type B receptor subunit 1a (GABA&lt;sub&gt;B&lt;/sub&gt;R1a). sAPP-GABA&lt;sub&gt;B&lt;/sub&gt;R1a binding suppressed synaptic transmission and enhanced short-term facilitation in mouse hippocampal synapses via inhibition of synaptic vesicle release. A 17–amino acid peptide corresponding to the GABA&lt;sub&gt;B&lt;/sub&gt;R1a binding region within APP suppressed in vivo spontaneous neuronal activity in the hippocampus of anesthetized Thy1-GCaMP6s mice. Our findings identify GABA&lt;sub&gt;B&lt;/sub&gt;R1a as a synaptic receptor for sAPP and reveal a physiological role for sAPP in regulating GABA&lt;sub&gt;B&lt;/sub&gt;R1a function to modulate synaptic transmission.&lt;/p&gt;</content></content><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:1570889:8675cc2c</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/eaao4827?rss=1</href></item></alternate><published>1547145461000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>101d92b2</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6423/eaao4827?rss=1</link><engagement>592</engagement><title>Secreted amyloid-{beta} precursor protein functions as a GABABR1a ligand to modulate synaptic transmission</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><description>&lt;p&gt;Amyloid-β precursor protein (APP) is central to the pathogenesis of Alzheimer’s disease, yet its physiological function remains unresolved. Accumulating evidence suggests that APP has a synaptic function mediated by an unidentified receptor for secreted APP (sAPP). Here we show that the sAPP extension domain directly bound the sushi 1 domain specific to the -aminobutyric acid type B receptor subunit 1a (GABA&lt;sub&gt;B&lt;/sub&gt;R1a). sAPP-GABA&lt;sub&gt;B&lt;/sub&gt;R1a binding suppressed synaptic transmission and enhanced short-term facilitation in mouse hippocampal synapses via inhibition of synaptic vesicle release. A 17–amino acid peptide corresponding to the GABA&lt;sub&gt;B&lt;/sub&gt;R1a binding region within APP suppressed in vivo spontaneous neuronal activity in the hippocampus of anesthetized Thy1-GCaMP6s mice. Our findings identify GABA&lt;sub&gt;B&lt;/sub&gt;R1a as a synaptic receptor for sAPP and reveal a physiological role for sAPP in regulating GABA&lt;sub&gt;B&lt;/sub&gt;R1a function to modulate synaptic transmission.&lt;/p&gt;</description><originId>http://science.sciencemag.org/cgi/content/short/363/6423/eaao4827?rss=1</originId><crawled>1547147463250</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6423/eaao4827.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><keywords><item>Medicine, Diseases, Neuroscience, Online Only</item></keywords></item><item><author><name>Philip Ball</name></author><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>GSI</text></item></mentions><label>GSI Helmholtz Centre for Heavy Ion Research</label><id>nlp/f/entity/en/w/GSI Helmholtz Centre for Heavy Ion Research</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>RIKEN</text></item></mentions><label>Riken</label><id>nlp/f/entity/en/w/Riken</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Getty</text></item></mentions><label>Getty Images</label><id>nlp/f/entity/en/w/Getty Images</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Mendeleev</text></item><item><text>Dmitri Mendeleev</text></item></mentions><label>Dmitri Mendeleev</label><id>nlp/f/entity/en/w/Dmitri Mendeleev</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>AFP</text></item></mentions><label>AFP</label><id>nlp/f/entity/en/-/afp</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689e3d8589:9b60b3:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Extreme chemistry: experiments at the edge of the periodic table&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Extreme chemistry: experiments at the edge of the periodic table, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00285-9&quot;&gt;doi:10.1038/d41586-019-00285-9&lt;/a&gt;&lt;/p&gt;As the chase for new elements slows, scientists focus on deepening their understanding of the superheavy ones they already know.</content></content><engagementRate>0.44</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00285-9</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00285-9/d41586-019-00285-9_16423730.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>8edb2948</fingerprint><commonTopics><item><probability>0.979</probability><label>acs</label><id>nlp/f/topic/26</id></item><item><probability>0.815</probability><label>browsers</label><id>nlp/f/topic/334</id></item><item><probability>0.813</probability><label>chemistry</label><id>nlp/f/topic/437</id></item><item><probability>0.784</probability><label>css</label><id>nlp/f/topic/590</id></item><item><probability>0.738</probability><label>biochemistry</label><id>nlp/f/topic/257</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00285-9</link><engagement>4</engagement><title>Extreme chemistry: experiments at the edge of the periodic table</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Extreme chemistry: experiments at the edge of the periodic table&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Extreme chemistry: experiments at the edge of the periodic table, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00285-9&quot;&gt;doi:10.1038/d41586-019-00285-9&lt;/a&gt;&lt;/p&gt;As the chase for new elements slows, scientists focus on deepening their understanding of the superheavy ones they already know.</description><originId>https://www.nature.com/articles/d41586-019-00285-9</originId><crawled>1548843058569</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Mungall, C. J.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1689a16df5d:3781ef:c2ce2e2e</id><content><direction>ltr</direction><content>One strategy for building ontologies covering domains such as disease or anatomy is to weave together existing knowledge sources (databases, vocabularies and ontologies) into single cohesive whole. A first step in this process is to generate mappings between the elements of these different sources. There are a number of well-known techniques for generating mappings, both manual and automatic. Sometimes mappings are seen as an end in themselves, with the sources remaining in a loosely connected state. However, if we want to take the next step and use the mappings to weave together the different sources into a cohesive reference ontology, then we need to translate the mappings into precise logical relationships. This will allow us to safely merge equivalent concepts, creating a unified ontology. This translation is a non-trivial step, as each mapping can be interpreted as multiple different logical relationships, with each interpretation affecting the likelihood of the others. There is a lack of automated methods to assist with this last step; this resolution is typically performed by expert ontologists. Here we describe an ontology construction technique that takes two or more ontologies linked by hypothetical axioms, and estimates the most likely unified logical ontology. Hypothetical axioms can themselves be derived from semantically loose mappings. The method combines deductive reasoning and probabilistic inference and is called Bayesian OWL Ontology Merging (BOOM). We describe a special form k-BOOM that works by factorizing the probabilistic ontology into k submodules. We also briefly describe a supplemental lexical and knowledge-based technique for generating a set of hypothetical axioms from loose mappings. We are currently using this technique to build a merged disease ontology (Monarch Disease Ontology; MonDO) that unifies a broad range of vocabularies into a consistent and coherent whole.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/048843v3?rss=1</href></item></alternate><published>1548748800000</published><unread>True</unread><fingerprint>7ec981c5</fingerprint><link>http://biorxiv.org/cgi/content/short/048843v3?rss=1</link><engagement>0</engagement><title>k-BOOM: A Bayesian approach to ontology structure inference, with applications in disease ontology construction [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>One strategy for building ontologies covering domains such as disease or anatomy is to weave together existing knowledge sources (databases, vocabularies and ontologies) into single cohesive whole. A first step in this process is to generate mappings between the elements of these different sources. There are a number of well-known techniques for generating mappings, both manual and automatic. Sometimes mappings are seen as an end in themselves, with the sources remaining in a loosely connected state. However, if we want to take the next step and use the mappings to weave together the different sources into a cohesive reference ontology, then we need to translate the mappings into precise logical relationships. This will allow us to safely merge equivalent concepts, creating a unified ontology. This translation is a non-trivial step, as each mapping can be interpreted as multiple different logical relationships, with each interpretation affecting the likelihood of the others. There is a lack of automated methods to assist with this last step; this resolution is typically performed by expert ontologists. Here we describe an ontology construction technique that takes two or more ontologies linked by hypothetical axioms, and estimates the most likely unified logical ontology. Hypothetical axioms can themselves be derived from semantically loose mappings. The method combines deductive reasoning and probabilistic inference and is called Bayesian OWL Ontology Merging (BOOM). We describe a special form k-BOOM that works by factorizing the probabilistic ontology into k submodules. We also briefly describe a supplemental lexical and knowledge-based technique for generating a set of hypothetical axioms from loose mappings. We are currently using this technique to build a merged disease ontology (Monarch Disease Ontology; MonDO) that unifies a broad range of vocabularies into a consistent and coherent whole.</description><originId>http://biorxiv.org/cgi/content/short/048843v3?rss=1</originId><crawled>1548773416797</crawled><canonicalUrl>https://www.biorxiv.org/content/10.1101/048843v3</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Jahae Kim</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1689e477777:9c5974:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37244-9&quot;&gt;doi:10.1038/s41598-018-37244-9&lt;/a&gt;&lt;/p&gt;Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Mv2aN0OYYxc&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/Mv2aN0OYYxc/s41598-018-37244-9</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><height>390</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37244-9/MediaObjects/41598_2018_37244_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>ce2ede7d</fingerprint><link>https://www.nature.com/articles/s41598-018-37244-9</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37244-9</href></item></canonical><title>Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37244-9&quot;&gt;doi:10.1038/s41598-018-37244-9&lt;/a&gt;&lt;/p&gt;Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Mv2aN0OYYxc&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-37244-9</originId><crawled>1548843710327</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Vignieri, S.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce097:ad2b6584</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/241-a?rss=1</href></item></alternate><published>1547750305000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>dc2d064b</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6424/241-a?rss=1</link><engagement>0</engagement><title>Ancestral history matters</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6424/241-a?rss=1</originId><crawled>1547752389672</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6424/241.1.full</canonicalUrl><keywords><item>Ecology, Evolution</item></keywords></item><item><author><name>Roman T. Kellenberger</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1682d035c6a:2a73e0:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Emergence of a floral colour polymorphism by pollinator-mediated overdominance&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Emergence of a floral colour polymorphism by pollinator-mediated overdominance, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07936-x&quot;&gt;doi:10.1038/s41467-018-07936-x&lt;/a&gt;&lt;/p&gt;Examples of overdominance are usually explained by deleterious effects in homozygotes. Here, Kellenberger et al. describe a case of overdominance in the floral color of the Alpine orchid Gymnadenia rhellicani apparently maintained by pollinator preferences without deleterious effects in homozygotes.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/hPLDqG8AH98&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/hPLDqG8AH98/s41467-018-07936-x</href></item></alternate><published>1546934400000</published><unread>True</unread><visual><height>628</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-07936-x/MediaObjects/41467_2018_7936_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>8022c4f</fingerprint><link>https://www.nature.com/articles/s41467-018-07936-x</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-07936-x</href></item></canonical><title>Emergence of a floral colour polymorphism by pollinator-mediated overdominance</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Emergence of a floral colour polymorphism by pollinator-mediated overdominance&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Emergence of a floral colour polymorphism by pollinator-mediated overdominance, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07936-x&quot;&gt;doi:10.1038/s41467-018-07936-x&lt;/a&gt;&lt;/p&gt;Examples of overdominance are usually explained by deleterious effects in homozygotes. Here, Kellenberger et al. describe a case of overdominance in the floral color of the Alpine orchid Gymnadenia rhellicani apparently maintained by pollinator preferences without deleterious effects in homozygotes.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/hPLDqG8AH98&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-07936-x</originId><crawled>1546943421546</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Shraddha Chakradhar</name></author><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>Baker</text></item><item><text>Darren Baker</text></item></mentions><label>Darren Baker</label><id>nlp/f/entity/en/-/darren baker</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Schmitt</text></item><item><text>Clemens Schmitt</text></item></mentions><label>Clemens Schmitt</label><id>nlp/f/entity/en/-/clemens schmitt</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Mayo Clinic</text></item></mentions><label>Mayo Clinic</label><id>nlp/f/entity/en/w/Mayo Clinic</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Max Delbruck Center for Molecular Medicine</text></item></mentions><label>Max Delbrück Center for Molecular Medicine in the Helmholtz Association</label><id>nlp/f/entity/en/w/Max Delbrück Center for Molecular Medicine in the Helmholtz Association</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Max Delbruck Center</text></item></mentions><label>Max Delbruck Center</label><id>nlp/f/entity/en/-/max delbruck center</id></item></entities><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_16852653735:355fd3d:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;&lt;i&gt;Arrested cells may awaken yet &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&amp;lt;i&gt;Arrested cells may awaken yet &amp;lt;/i&gt;, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41591-019-00004-x&quot;&gt;doi:10.1038/d41591-019-00004-x&lt;/a&gt;&lt;/p&gt;The revived cells might spell further trouble for diseases such as cancer.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/kAW4EEs1YOA&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/kAW4EEs1YOA/d41591-019-00004-x</href></item></alternate><published>1547539200000</published><unread>True</unread><visual><height>527</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41591-019-00004-x/d41591-019-00004-x_16398770.png</url><contentType>image/png</contentType><width>1024</width></visual><fingerprint>860c5d1b</fingerprint><commonTopics><item><probability>0.99</probability><label>stem cells</label><id>nlp/f/topic/2185</id></item><item><probability>0.981</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>0.977</probability><label>singularity</label><id>nlp/f/topic/2074</id></item><item><probability>0.976</probability><label>microscopy</label><id>nlp/f/topic/1457</id></item><item><probability>0.948</probability><label>biochemistry</label><id>nlp/f/topic/257</id></item><item><probability>0.941</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.93</probability><label>biology</label><id>nlp/f/topic/263</id></item><item><probability>0.869</probability><label>synthetic biology</label><id>nlp/f/topic/2228</id></item><item><probability>0.708</probability><label>south africa</label><id>nlp/f/topic/2136</id></item></commonTopics><link>https://www.nature.com/articles/d41591-019-00004-x</link><engagement>2</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/d41591-019-00004-x</href></item></canonical><title>Arrested cells may awaken yet</title><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;&lt;i&gt;Arrested cells may awaken yet &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&amp;lt;i&gt;Arrested cells may awaken yet &amp;lt;/i&gt;, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41591-019-00004-x&quot;&gt;doi:10.1038/d41591-019-00004-x&lt;/a&gt;&lt;/p&gt;The revived cells might spell further trouble for diseases such as cancer.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/kAW4EEs1YOA&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/d41591-019-00004-x</originId><crawled>1547570591541</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Malakoff, D.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce0a8:ad2b6584</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/216?rss=1</href></item></alternate><published>1547750305000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>13bea634</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6424/216?rss=1</link><engagement>0</engagement><title>Pain spreads from shutdown</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6424/216?rss=1</originId><crawled>1547752389672</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6424/216.full</canonicalUrl><keywords><item>Scientific Community, Science and Policy</item></keywords></item><item><author><name>Sergei F. Vyboishchikov, 
Alexander A. Voityuk</name></author><id>6wY2EtDmLbeMr9WopopAzS1SKiHs2ogsOuunEriW7zs=_16828338c3d:14d5d09:3a104d3b</id><content><direction>ltr</direction><content>&lt;img alt=&quot;Journal of Computational Chemistry Iterative Atomic Charge Partitioning of Valence Electron Density&quot; src=&quot;https://onlinelibrary.wiley.com/cms/attachment/31ee0e12-03b9-4ddc-bd35-acc7eb031370/jcc25771-toc-0001-m.png&quot;&gt;
&lt;p&gt;An atomic charge scheme, &lt;i&gt;I‐ACP&lt;/i&gt;, is based on partitioning of the valence electron density using a Slater‐type weighting factors &lt;i&gt;c&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;A&lt;/i&gt;
&lt;/sub&gt;
&lt;i&gt;r&lt;/i&gt;
&lt;sup&gt;2&lt;i&gt;n–&lt;/i&gt;2&lt;/sup&gt;exp(–&lt;i&gt;α&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;A&lt;/i&gt;
&lt;/sub&gt;
&lt;i&gt;r&lt;/i&gt;). I‐ACP produces chemically meaningful atomic charges and accurately reproduces molecular dipole moments.
&lt;/p&gt;
&lt;br&gt;
&lt;p&gt;We propose an atomic charge partitioning scheme, &lt;i&gt;iterative adjusted charge partitioning (I‐ACP)&lt;/i&gt;, belonging to the stockholder family and based on partitioning of the valence molecular electron density. The method uses a Slater‐type weighting factor &lt;i&gt;c&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;A&lt;/i&gt;
&lt;/sub&gt;
&lt;i&gt;r&lt;/i&gt;
&lt;sup&gt;2&lt;i&gt;n–&lt;/i&gt;2&lt;/sup&gt;exp(–&lt;i&gt;α&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;A&lt;/i&gt;
&lt;/sub&gt;
&lt;i&gt;r&lt;/i&gt;), where &lt;i&gt;α&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;A&lt;/i&gt;
&lt;/sub&gt; is a fixed parameter and &lt;i&gt;c&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;A&lt;/i&gt;
&lt;/sub&gt; is determined iteratively. The parameters &lt;i&gt;α&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;A&lt;/i&gt;
&lt;/sub&gt; were fitted for 17 main‐group elements. The I‐ACP scheme is shown to produce consistent, chemically meaningful atomic charges. Several stockholder‐type charge‐partitioning are compared. Extensive numerical tests demonstrate that in most cases, I‐ACP surpasses most other methods by reproducing more accurately molecular dipole moments. © 2018 Wiley Periodicals, Inc.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25771?af=R</href></item></alternate><unread>True</unread><origin><htmlUrl>https://onlinelibrary.wiley.com/journal/1096987x?af=R</htmlUrl><streamId>feed/https://onlinelibrary.wiley.com/action/showFeed?jc=1096987x&amp;type=etoc&amp;feed=rss</streamId><title>Wiley: Journal of Computational Chemistry: Table of Contents</title></origin><fingerprint>2a872ec0</fingerprint><link>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25771?af=R</link><summary><direction>ltr</direction><content>An atomic charge scheme, I‐ACP, is based on partitioning of the valence electron density using a Slater‐type weighting factors cAr2n–2exp(–αAr). I‐ACP produces chemically meaningful atomic charges and accurately reproduces molecular dipole moments.
We propose an atomic charge partitioning scheme, iterative adjusted charge partitioning (I‐ACP), belonging to the stockholder family and based on partitioning of the valence molecular electron density. The method uses a Slater‐type weighting factor cAr2n–2exp(–αAr), where αA is a fixed parameter and cA is determined iteratively. The parameters αA were fitted for 17 main‐group elements. The I‐ACP scheme is shown to produce consistent, chemically meaningful atomic charges. Several stockholder‐type charge‐partitioning are compared. Extensive numerical tests demonstrate that in most cases, I‐ACP surpasses most other methods by reproducing more accurately molecular dipole moments. © 2018 Wiley Periodicals, Inc.</content></summary><title>Iterative Atomic Charge Partitioning of Valence Electron Density</title><published>1546862073000</published><description>An atomic charge scheme, I‐ACP, is based on partitioning of the valence electron density using a Slater‐type weighting factors cAr2n–2exp(–αAr). I‐ACP produces chemically meaningful atomic charges and accurately reproduces molecular dipole moments.
We propose an atomic charge partitioning scheme, iterative adjusted charge partitioning (I‐ACP), belonging to the stockholder family and based on partitioning of the valence molecular electron density. The method uses a Slater‐type weighting factor cAr2n–2exp(–αAr), where αA is a fixed parameter and cA is determined iteratively. The parameters αA were fitted for 17 main‐group elements. The I‐ACP scheme is shown to produce consistent, chemically meaningful atomic charges. Several stockholder‐type charge‐partitioning are compared. Extensive numerical tests demonstrate that in most cases, I‐ACP surpasses most other methods by reproducing more accurately molecular dipole moments. © 2018 Wiley Periodicals, Inc.</description><originId>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25771?af=R</originId><crawled>1546862693437</crawled><visual><height>215</height><processor>feedly-nikon-v3.1</processor><url>https://onlinelibrary.wiley.com/cms/attachment/31ee0e12-03b9-4ddc-bd35-acc7eb031370/jcc25771-toc-0001-m.png</url><contentType>image/png; charset=UTF-8</contentType><width>395</width></visual><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Christopher R. Fielding</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1687c2d8177:2f7efdc:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Age and pattern of the southern high-latitude continental end-Permian extinction constrained by multiproxy analysis&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Age and pattern of the southern high-latitude continental end-Permian extinction constrained by multiproxy analysis, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07934-z&quot;&gt;doi:10.1038/s41467-018-07934-z&lt;/a&gt;&lt;/p&gt;The continental record of the end Permian mass extinction is limited, especially from high paleolatitudes. Here, Fielding et al. report a multi-proxy Permo-Triassic record from Australia, resolving the timing of local terrestrial plant extinction and the relationship with environmental changes.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/tPO_FmU4UFg&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/tPO_FmU4UFg/s41467-018-07934-z</href></item></alternate><published>1548230400000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-07934-z/MediaObjects/41467_2018_7934_Fig1_HTML.png</url><contentType>image/png</contentType><width>388</width></visual><fingerprint>d61eea19</fingerprint><link>https://www.nature.com/articles/s41467-018-07934-z</link><engagement>6</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-07934-z</href></item></canonical><title>Age and pattern of the southern high-latitude continental end-Permian extinction constrained by multiproxy analysis</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Age and pattern of the southern high-latitude continental end-Permian extinction constrained by multiproxy analysis&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Age and pattern of the southern high-latitude continental end-Permian extinction constrained by multiproxy analysis, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07934-z&quot;&gt;doi:10.1038/s41467-018-07934-z&lt;/a&gt;&lt;/p&gt;The continental record of the end Permian mass extinction is limited, especially from high paleolatitudes. Here, Fielding et al. report a multi-proxy Permo-Triassic record from Australia, resolving the timing of local terrestrial plant extinction and the relationship with environmental changes.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/tPO_FmU4UFg&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-07934-z</originId><crawled>1548271583607</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Thomas  Gersdorf</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Novartis</text></item></mentions><label>Novartis</label><id>nlp/f/entity/en/w/Novartis</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Supplementary Box 1</text></item></mentions><label>Supplementary Box 1</label><id>nlp/f/entity/en/-/supplementary box 1</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Supplementary Box 2</text></item></mentions><label>Supplementary Box 2</label><id>nlp/f/entity/en/-/supplementary box 2</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>n.s.</text></item></mentions><label>Nova Scotia</label><id>nlp/f/entity/en/w/Nova Scotia</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Foster</text></item></mentions><label>Foster</label><id>nlp/f/entity/en/-/foster</id></item></entities><id>YLwIhSxZAzQIEnJq1FGGcXUQMCbQUlr9cyNMExMVeyY=_168569792c7:3ba3da3:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Demystifying industry–academia collaboration&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Demystifying industry–academia collaboration, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41573-019-00001-2&quot;&gt;doi:10.1038/d41573-019-00001-2&lt;/a&gt;&lt;/p&gt;Demystifying industry–academia collaboration&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/IwAjwgK3v4Y&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nrd/rss/current/~3/IwAjwgK3v4Y/d41573-019-00001-2</href></item></alternate><published>1547625600000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>f5b324e1</fingerprint><commonTopics><item><probability>0.957</probability><label>phd</label><id>nlp/f/topic/1737</id></item><item><probability>0.94</probability><label>km</label><id>nlp/f/topic/1269</id></item><item><probability>0.933</probability><label>academic</label><id>nlp/f/topic/17</id></item><item><probability>0.905</probability><label>project management</label><id>nlp/f/topic/1833</id></item><item><probability>0.877</probability><label>success</label><id>nlp/f/topic/2202</id></item><item><probability>0.856</probability><label>behavioral economics</label><id>nlp/f/topic/237</id></item><item><probability>0.753</probability><label>science policy</label><id>nlp/f/topic/2019</id></item><item><probability>0.727</probability><label>manga</label><id>nlp/f/topic/1402</id></item></commonTopics><link>https://www.nature.com/articles/d41573-019-00001-2</link><engagement>4</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/d41573-019-00001-2</href></item></canonical><title>Demystifying industry–academia collaboration</title><origin><htmlUrl>http://feeds.nature.com/nrd/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nrd/rss/current</streamId><title>Nature Reviews Drug Discovery - Issue - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Demystifying industry–academia collaboration&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Demystifying industry–academia collaboration, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41573-019-00001-2&quot;&gt;doi:10.1038/d41573-019-00001-2&lt;/a&gt;&lt;/p&gt;Demystifying industry–academia collaboration&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/IwAjwgK3v4Y&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/d41573-019-00001-2</originId><crawled>1547641000647</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Knight, J. D. R.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168a167de5e:e42461:c2ce2e2e</id><content><direction>ltr</direction><content>Retrieving information about genes and gene products is a constant and time-consuming aspect of systems biology research. While there are many high quality and well-designed resources to fulfill this need, they require the user to navigate to different and often complex websites, execute a search, select the desired result and then view its information. This can be a repetitive, burdensome and disruptive process, for example when exploring the results of large scale genomics or proteomics screens or reading an online article. To address this issue we have developed a Chrome browser extension that allows users to retrieve customizable gene product information - especially as it relates to proteins and their expression and functions - directly on a website without having to navigate to another page.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/532523v2?rss=1</href></item></alternate><published>1548835200000</published><unread>True</unread><fingerprint>d16f39e3</fingerprint><link>http://biorxiv.org/cgi/content/short/532523v2?rss=1</link><engagement>0</engagement><title>Gene Info: A tool for facile retrieval of gene product information on any website [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Retrieving information about genes and gene products is a constant and time-consuming aspect of systems biology research. While there are many high quality and well-designed resources to fulfill this need, they require the user to navigate to different and often complex websites, execute a search, select the desired result and then view its information. This can be a repetitive, burdensome and disruptive process, for example when exploring the results of large scale genomics or proteomics screens or reading an online article. To address this issue we have developed a Chrome browser extension that allows users to retrieve customizable gene product information - especially as it relates to proteins and their expression and functions - directly on a website without having to navigate to another page.</description><originId>http://biorxiv.org/cgi/content/short/532523v2?rss=1</originId><crawled>1548896165470</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Xiaoxiao Liu, Bilan Wang, Yanyan Li, Yuzhu Hu, Xiaoling Li, Ting Yu, Yan Ju, Tao Sun, Xiang Gao, Yuquan Wei</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>1TYkl+7D2jbCAjv6kqe9qy39+K76tsp7YKV/mQVt7ps=_16894d2115b:229adb6:56b782f7</id><published>1548651600000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00688/20190128/images/medium/oc-2018-00688f_0013.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00688&lt;/div&gt;</content></summary><fingerprint>ccef03c3</fingerprint><link>http://dx.doi.org/10.1021/acscentsci.8b00688</link><engagement>0</engagement><crawled>1548685021531</crawled><title>[ASAP] Powerful Anticolon Tumor Effect of Targeted Gene Immunotherapy Using Folate-Modified Nanoparticle Delivery of CCL19 To Activate the Immune System</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acscii</streamId><title>ACS Central Science: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00688/20190128/images/medium/oc-2018-00688f_0013.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00688&lt;/div&gt;</description><originId>http://dx.doi.org/10.1021/acscentsci.8b00688</originId><alternate><item><type>text/html</type><href>http://dx.doi.org/10.1021/acscentsci.8b00688</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Alderton, G.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:15708a5:8675cc2c</id><published>1547145461000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>2be84234</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6423/137-u?rss=1</link><engagement>0</engagement><crawled>1547147463250</crawled><title>Combining organoids to assemble brain regions</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6423/137-u?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/137-u?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6423/137.21.full</canonicalUrl></item><item><author><name>Kelly, P. N.</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>AAAS</text></item></mentions><label>American Association for the Advancement of Science</label><id>nlp/f/entity/en/w/American Association for the Advancement of Science</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Science</text></item></mentions><label>Science</label><id>nlp/f/entity/en/w/Science</id></item></entities><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:15708b0:8675cc2c</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/137-j?rss=1</href></item></alternate><published>1547145461000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>53d02a69</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6423/137-j?rss=1</link><engagement>0</engagement><title>Metabolism as a driver of immune response</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6423/137-j?rss=1</originId><crawled>1547147463250</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6423/137.10.full</canonicalUrl><keywords><item>Evolution, Immunology, Physiology</item></keywords></item><item><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>WEBSITEnature_com</text></item></mentions><label>WEBSITEnature_com</label><id>nlp/f/entity/en/-/websitenature_com</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>CSS</text></item></mentions><label>Cascading Style Sheets</label><id>nlp/f/entity/en/w/Cascading Style Sheets</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Explorer</text></item></mentions><label>Explorer</label><id>nlp/f/entity/en/-/explorer</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>JavaScript</text></item></mentions><label>JavaScript</label><id>nlp/f/entity/en/w/JavaScript</id></item></entities><id>0qZSsMpEyvTD/JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I=_1681466db74:68a3833:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Research Highlights&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Research Highlights, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/nbt.4325&quot;&gt;doi:10.1038/nbt.4325&lt;/a&gt;&lt;/p&gt;Research Highlights</content></content><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://www.nature.com/articles/nbt.4325</href></item></alternate><published>1546502400000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>825cc015</fingerprint><link>https://www.nature.com/articles/nbt.4325</link><engagement>0</engagement><title>Research Highlights</title><origin><htmlUrl>http://feeds.nature.com/nbt/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nbt/current_issue/rss/</streamId><title>Nature Biotechnology</title></origin><description>&lt;p&gt;&lt;b&gt;Research Highlights&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Research Highlights, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/nbt.4325&quot;&gt;doi:10.1038/nbt.4325&lt;/a&gt;&lt;/p&gt;Research Highlights</description><originId>https://www.nature.com/articles/nbt.4325</originId><crawled>1546530511732</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/0qZSsMpEyvTD_JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I_oicon-166b30c5bda</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Altin Raxhimi</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Albanian</text></item><item><text>Albania</text></item></mentions><label>Albania</label><id>nlp/f/entity/en/w/Albania</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>PhDs</text></item></mentions><label>Doctor of Philosophy</label><id>nlp/f/entity/en/w/Doctor of Philosophy</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Getty</text></item></mentions><label>Getty Images</label><id>nlp/f/entity/en/w/Getty Images</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>AFP</text></item></mentions><label>AFP</label><id>nlp/f/entity/en/-/afp</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Gent Shkullaku</text></item></mentions><label>Gent Shkullaku</label><id>nlp/f/entity/en/-/gent shkullaku</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16857545347:3ca1cb4:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Mass student protests bring down Albania’s science minister &lt;/b&gt;&lt;/p&gt;&lt;p&gt;Mass student protests bring down Albania’s science minister , Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00144-7&quot;&gt;doi:10.1038/d41586-019-00144-7&lt;/a&gt;&lt;/p&gt;The government has bowed to pressure to fix the country’s research and higher education — but stopped short of repealing a controversial law.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00144-7</href></item></alternate><published>1547625600000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00144-7/d41586-019-00144-7_16389900.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>e8966b07</fingerprint><commonTopics><item><probability>1.0</probability><label>higher ed</label><id>nlp/f/topic/1063</id></item><item><probability>0.991</probability><label>science policy</label><id>nlp/f/topic/2019</id></item><item><probability>0.84</probability><label>education</label><id>nlp/f/topic/741</id></item><item><probability>0.81</probability><label>academic</label><id>nlp/f/topic/17</id></item><item><probability>0.751</probability><label>international law</label><id>nlp/f/topic/1186</id></item><item><probability>0.726</probability><label>university</label><id>nlp/f/topic/2378</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00144-7</link><engagement>11</engagement><title>Mass student protests bring down Albania’s science minister</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Mass student protests bring down Albania’s science minister &lt;/b&gt;&lt;/p&gt;&lt;p&gt;Mass student protests bring down Albania’s science minister , Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00144-7&quot;&gt;doi:10.1038/d41586-019-00144-7&lt;/a&gt;&lt;/p&gt;The government has bowed to pressure to fix the country’s research and higher education — but stopped short of repealing a controversial law.</description><originId>https://www.nature.com/articles/d41586-019-00144-7</originId><crawled>1547653370695</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Wolfe, M. S.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168a5541f68:15080c1:3a104d3b</id><published>1548959829000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>944a4506</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6426/453?rss=1</link><engagement>0</engagement><crawled>1548961980264</crawled><title>Membrane protein takes the brakes off</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6426/453?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6426/453?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6426/453.full</canonicalUrl></item><item><author><name>Shen, W.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168303ca93b:7dbcba:3a104d3b</id><content><direction>ltr</direction><content>TaxonKit is a command-line toolkit for rapid manipulation of NCBI taxonomy data. It provides executable binary files for major operating systems including Windows, Linux, and Mac OS X, and can be directly used without any dependencies nor local database buiding. TaxonKit demonstrates competitive performance in execution time compared to similar tools. The efficiency, scalability, and usability of TaxonKit enable researchers to rapidly investigate taxonomy data.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/513523v1?rss=1</href></item></alternate><published>1546934400000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>22c11c3</fingerprint><link>http://biorxiv.org/cgi/content/short/513523v1?rss=1</link><engagement>1</engagement><title>TaxonKit: a cross-platform and efficient NCBI taxonomy toolkit [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>TaxonKit is a command-line toolkit for rapid manipulation of NCBI taxonomy data. It provides executable binary files for major operating systems including Windows, Linux, and Mac OS X, and can be directly used without any dependencies nor local database buiding. TaxonKit demonstrates competitive performance in execution time compared to similar tools. The efficiency, scalability, and usability of TaxonKit enable researchers to rapidly investigate taxonomy data.</description><originId>http://biorxiv.org/cgi/content/short/513523v1?rss=1</originId><crawled>1546997508411</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/08/513523</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Ehud  Nakar</name></author><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16857ddbaa0:3dd05f6:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Heart of a stellar explosion revealed&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Heart of a stellar explosion revealed, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00043-x&quot;&gt;doi:10.1038/d41586-019-00043-x&lt;/a&gt;&lt;/p&gt;During the deaths of some massive stars, a narrow beam called a jet is launched through the stellar envelope, leaving an imprint that is difficult to detect. Such an imprint has now been seen in unprecedented detail.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00043-x</href></item></alternate><published>1547625600000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00043-x/d41586-019-00043-x_16392436.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>50bd6950</fingerprint><link>https://www.nature.com/articles/d41586-019-00043-x</link><engagement>27</engagement><title>Heart of a stellar explosion revealed</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Heart of a stellar explosion revealed&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Heart of a stellar explosion revealed, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00043-x&quot;&gt;doi:10.1038/d41586-019-00043-x&lt;/a&gt;&lt;/p&gt;During the deaths of some massive stars, a narrow beam called a jet is launched through the stellar envelope, leaving an imprint that is difficult to detect. Such an imprint has now been seen in unprecedented detail.</description><originId>https://www.nature.com/articles/d41586-019-00043-x</originId><crawled>1547662375584</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Tully, H. M.</name></author><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1680ffe2afb:62a4636:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;Motor patterns measured by wrist actigraphy differentiate epileptic seizures from nonepileptic spells.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/473/eaaw0530?rss=1</href></item></alternate><published>1546455083000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>672303d0</fingerprint><link>http://stm.sciencemag.org/cgi/content/short/11/473/eaaw0530?rss=1</link><engagement>0</engagement><title>[Editors&apos; Choice] Its all in the wrist</title><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><description>&lt;p&gt;Motor patterns measured by wrist actigraphy differentiate epileptic seizures from nonepileptic spells.&lt;/p&gt;</description><originId>http://stm.sciencemag.org/cgi/content/short/11/473/eaaw0530?rss=1</originId><crawled>1546456541947</crawled><canonicalUrl>http://stm.sciencemag.org/content/11/473/eaaw0530.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Derek Lowe</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>2k24/TFePIh3MUUJr/vqRk++EkKG/RZ2TtOvsKiJXX4=_1684cdcd1e0:2df5461:8675cc2c</id><unread>True</unread><visual><height>162</height><processor>feedly-nikon-v3.1</processor><url>http://blogs.sciencemag.org/pipeline/wp-content/uploads/sites/2/2019/01/Fluorotox.jpeg</url><contentType>image/jpeg</contentType><width>392</width></visual><fingerprint>5cd3d5c1</fingerprint><origin><htmlUrl>http://blogs.sciencemag.org/pipeline</htmlUrl><streamId>feed/http://blogs.sciencemag.org/pipeline/feed</streamId><title>Sciencemag</title></origin><originId>http://blogs.sciencemag.org/pipeline/?p=14103</originId><alternate><item><type>text/html</type><href>http://blogs.sciencemag.org/pipeline/archives/2019/01/14/a-toxicological-flag</href></item></alternate><canonicalUrl>http://blogs.sciencemag.org/pipeline/archives/2019/01/14/a-toxicological-flag</canonicalUrl><engagement>4</engagement><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>ADP ribose glycohydrolase</text></item></mentions><label>ADP ribose glycohydrolase</label><id>nlp/f/entity/en/-/adp ribose glycohydrolase</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>IRAK - 4</text></item></mentions><label>IRAK - 4</label><id>nlp/f/entity/en/-/irak - 4</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Monofluoroalkyls</text></item></mentions><label>Monofluoroalkyls</label><id>nlp/f/entity/en/-/monofluoroalkyls</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>fluorobenzyls</text></item></mentions><label>fluorobenzyls</label><id>nlp/f/entity/en/-/fluorobenzyls</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>cyclopropyl</text></item></mentions><label>cyclopropyl</label><id>nlp/f/entity/en/-/cyclopropyl</id></item></entities><updateCount>7</updateCount><published>1547477400000</published><link>http://blogs.sciencemag.org/pipeline/?p=14103</link><commonTopics><item><probability>0.992</probability><label>med chem</label><id>nlp/f/topic/1428</id></item></commonTopics><recrawled>1548773927780</recrawled><content><direction>ltr</direction><content>&lt;p&gt; &lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;&lt;img sizes=&quot;(max-width: 300px) 100vw, 300px&quot; src=&quot;http://blogs.sciencemag.org/pipeline/wp-content/uploads/sites/2/2019/01/Fluorotox-300x124.jpeg&quot; alt=&quot;&quot; width=&quot;300&quot; srcset=&quot;http://blogs.sciencemag.org/pipeline/wp-content/uploads/sites/2/2019/01/Fluorotox-300x124.jpeg 300w, http://blogs.sciencemag.org/pipeline/wp-content/uploads/sites/2/2019/01/Fluorotox.jpeg 392w&quot; class=&quot;wp-image-14107&quot; height=&quot;124&quot;&gt;&lt;/p&gt;
&lt;p&gt;Here’s a caution from &lt;a href=&quot;https://www.sciencedirect.com/science/article/pii/S0960894X18310278&quot;&gt;a new paper&lt;/a&gt; out of Manchester. The group &lt;a href=&quot;https://doi.org/10.1021/acs.jmedchem.8b01407&quot;&gt;had been synthesizing&lt;/a&gt; inhibitors of PARG (poly-ADP ribose glycohydrolase), an enzyme involved in DNA repair. The general chemotype is shown at right, but there are a number of variations. That fluorine is a new addition, though. The corresponding cyclopropylmethyl series came from their earlier paper, but they found that the series wasn’t particularly stable to metabolic oxidation. The major metabolites proved to be the primary sulfonamides in each case, suggesting that oxidation of the cyclopropylmethyl itself (which would be most likely at the methyl carbon) was the problem. Indeed, fluorination as shown increased the microsomal stability substantially (difluorination decreased the affinity for the PARG target itself, and deuteration, interestingly, had no real effect).&lt;/p&gt;
&lt;p&gt;So far, so good. But trouble hit when the compounds were dosed in mice – there were obvious signs of toxicity, and deaths at the higher doses. This had never been seen with the earlier compounds, and dosing a fluoromethyl analog that had significantly reduced PARG potency showed the same effects. The trouble was noted at around the five-hour point, and only after oral dosing. Necropsy showed obvious signs of liver damage, which fits with that observation as well.&lt;/p&gt;
&lt;p&gt;That all adds up to off-target tox brought on by metabolic activation of the fluoromethylcyclopropyl group. What the active species might be is not clear yet, nor is the specific liver target. But these observations alone are enough to flag that modification as a serious potential problem, which is the whole reason this new paper was published. Monofluoroalkyls can be a little odd – terminal monofluoroalkanes get cleaved down to fluoroacetic acid, for example, which is toxicological &lt;a href=&quot;http://blogs.sciencemag.org/pipeline/archives/2013/09/06/making_the_bacteria_make_your_fluorinated_compounds&quot;&gt;bad news&lt;/a&gt;. And fluorobenzyls (monofluoromethyl aryls) are reactive as electrophiles, despite the fluorocarbon reputation for stability. But this appears to be something different from either of those cases.&lt;/p&gt;
&lt;p&gt;It’s true that this may vary according to the rest of the molecule, but just seeing it show up this strongly in one series is cause for concern. And since cyclopropyl groups and fluorinated methyls are both pretty common motifs in medicinal chemistry, it’s important to realize that the combination could be bad news. A quick Reaxys search of the fluoromethylcyclopropylsulfonamide side chain gave 183 hits, but those are all from two patents filed by the Manchester group themselves.  But if you search for the corresponding amide, you also &lt;a href=&quot;http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PG01&amp;s1=20180230157&amp;OS=20180230157&amp;RS=20180230157&quot;&gt;pick up&lt;/a&gt; a couple of compounds from Gilead as IRAK-4 inhibitors. The amine is a perfectly reasonable-looking building block, and it would be a good thing if it did not spread through the med-chem literature without people knowing that there may be a red flag attached to it.&lt;/p&gt;</content></content><title>A Toxicological Flag</title><summary><direction>ltr</direction><content>    Here’s a caution from a new paper out of Manchester. The group had been synthesizing inhibitors of PARG (poly-ADP ribose glycohydrolase), an enzyme involved in DNA repair. The general chemotype is shown at right, but there are a number of variations. That fluorine is a new addition, though. The corresponding cyclopropylmethyl series came</content></summary><description>    Here’s a caution from a new paper out of Manchester. The group had been synthesizing inhibitors of PARG (poly-ADP ribose glycohydrolase), an enzyme involved in DNA repair. The general chemotype is shown at right, but there are a number of variations. That fluorine is a new addition, though. The corresponding cyclopropylmethyl series came</description><crawled>1547477766624</crawled><keywords><item>Animal Testing</item><item>Drug Assays</item><item>Pharmacokinetics</item><item>Toxicology</item><item>Uncategorized</item></keywords></item><item><author><name>T.V. Padma</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Indian</text></item><item><text>India</text></item></mentions><label>India</label><id>nlp/f/entity/en/w/India</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>congress</text></item></mentions><label>congress</label><id>nlp/f/entity/en/-/congress</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Reuters</text></item></mentions><label>Reuters</label><id>nlp/f/entity/en/w/Reuters</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Indian Science Congress Association</text></item><item><text>Indian Science Congress</text></item></mentions><label>Indian Science Congress Association</label><id>nlp/f/entity/en/w/Indian Science Congress Association</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Mahabharata</text></item></mentions><label>Mahabharata</label><id>nlp/f/entity/en/w/Mahabharata</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168312f1fde:933e1a:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Indian scientists protest against unscientific claims made at conference&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Indian scientists protest against unscientific claims made at conference, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00073-5&quot;&gt;doi:10.1038/d41586-019-00073-5&lt;/a&gt;&lt;/p&gt;For the second time in four years, the Indian Science Congress has been used as a platform for outlandish beliefs.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00073-5</href></item></alternate><published>1547020800000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00073-5/d41586-019-00073-5_16384554.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>bea1619d</fingerprint><commonTopics><item><probability>0.897</probability><label>science policy</label><id>nlp/f/topic/2019</id></item><item><probability>0.896</probability><label>india</label><id>nlp/f/topic/1149</id></item><item><probability>0.878</probability><label>skepticism</label><id>nlp/f/topic/2081</id></item><item><probability>0.784</probability><label>science</label><id>nlp/f/topic/2017</id></item><item><probability>0.756</probability><label>culture</label><id>nlp/f/topic/597</id></item><item><probability>0.729</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00073-5</link><engagement>15</engagement><title>Indian scientists protest against unscientific claims made at conference</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Indian scientists protest against unscientific claims made at conference&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Indian scientists protest against unscientific claims made at conference, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00073-5&quot;&gt;doi:10.1038/d41586-019-00073-5&lt;/a&gt;&lt;/p&gt;For the second time in four years, the Indian Science Congress has been used as a platform for outlandish beliefs.</description><originId>https://www.nature.com/articles/d41586-019-00073-5</originId><crawled>1547013398494</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Alexandra M. Miller</name></author><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1687be0093d:2e2c1c9:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0882-3&quot;&gt;doi:10.1038/s41586-019-0882-3&lt;/a&gt;&lt;/p&gt;Identification and sequencing of circulating tumour DNA in the cerebrospinal fluid of patients with glioma.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0882-3</href></item></alternate><published>1548230400000</published><unread>True</unread><visual><height>423</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-019-0882-3/MediaObjects/41586_2019_882_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>faee0a64</fingerprint><link>https://www.nature.com/articles/s41586-019-0882-3</link><engagement>20</engagement><title>Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0882-3&quot;&gt;doi:10.1038/s41586-019-0882-3&lt;/a&gt;&lt;/p&gt;Identification and sequencing of circulating tumour DNA in the cerebrospinal fluid of patients with glioma.</description><originId>https://www.nature.com/articles/s41586-019-0882-3</originId><crawled>1548266506557</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Bai, Y.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1683540a720:f0c99b:c2ce2e2e</id><content><direction>ltr</direction><content>The paired repeated measures (PRM) design has been commonly used in comparison studies to demonstrate that two measures agree sufficiently up to a pre-specified threshold. Due to the nature of dependence in repeated measures, existing methods for analyzing these comparison studies are often ad hoc and less than satisfactory. We propose a new test together with sample size and power calculation for PRM designs, which exhibit very good finite sample performance. We demonstrate favorable performance of the proposed methods through numerical studies. We provide very efficient R programs for our methods in a publicly available R package. Our proposed methods and developed R package provide practical tools which bridge an existing gap in the field.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/516658v1?rss=1</href></item></alternate><published>1547020800000</published><unread>True</unread><fingerprint>2d6a63f2</fingerprint><link>http://biorxiv.org/cgi/content/short/516658v1?rss=1</link><engagement>0</engagement><title>Statistical test with sample size and power calculation for paired repeated measures designs of method comparison studies [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>The paired repeated measures (PRM) design has been commonly used in comparison studies to demonstrate that two measures agree sufficiently up to a pre-specified threshold. Due to the nature of dependence in repeated measures, existing methods for analyzing these comparison studies are often ad hoc and less than satisfactory. We propose a new test together with sample size and power calculation for PRM designs, which exhibit very good finite sample performance. We demonstrate favorable performance of the proposed methods through numerical studies. We provide very efficient R programs for our methods in a publicly available R package. Our proposed methods and developed R package provide practical tools which bridge an existing gap in the field.</description><originId>http://biorxiv.org/cgi/content/short/516658v1?rss=1</originId><crawled>1547081656096</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/09/516658</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Dylan J. Lawrence</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1687f5d8127:341e60c:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Spectral photoacoustic imaging to estimate &lt;i&gt;in vivo&lt;/i&gt; placental oxygenation during preeclampsia&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Spectral photoacoustic imaging to estimate &amp;lt;i&gt;in vivo&amp;lt;/i&gt; placental oxygenation during preeclampsia, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37310-2&quot;&gt;doi:10.1038/s41598-018-37310-2&lt;/a&gt;&lt;/p&gt;Spectral photoacoustic imaging to estimate &lt;i&gt;in vivo&lt;/i&gt; placental oxygenation during preeclampsia&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/aTPgmn-ZotU&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/aTPgmn-ZotU/s41598-018-37310-2</href></item></alternate><published>1548316800000</published><unread>True</unread><visual><height>427</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37310-2/MediaObjects/41598_2018_37310_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>773ef457</fingerprint><link>https://www.nature.com/articles/s41598-018-37310-2</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37310-2</href></item></canonical><title>Spectral photoacoustic imaging to estimate in vivo placental oxygenation during preeclampsia</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Spectral photoacoustic imaging to estimate &lt;i&gt;in vivo&lt;/i&gt; placental oxygenation during preeclampsia&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Spectral photoacoustic imaging to estimate &amp;lt;i&gt;in vivo&amp;lt;/i&gt; placental oxygenation during preeclampsia, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37310-2&quot;&gt;doi:10.1038/s41598-018-37310-2&lt;/a&gt;&lt;/p&gt;Spectral photoacoustic imaging to estimate &lt;i&gt;in vivo&lt;/i&gt; placental oxygenation during preeclampsia&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/aTPgmn-ZotU&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-37310-2</originId><crawled>1548325060903</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Yeston, J.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:15708ab:8675cc2c</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/137-o?rss=1</href></item></alternate><published>1547145461000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>8a88a51a</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6423/137-o?rss=1</link><engagement>0</engagement><title>Toward nanotubes with periodic gaps</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6423/137-o?rss=1</originId><crawled>1547147463250</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6423/137.15.full</canonicalUrl><keywords><item>Chemistry</item></keywords></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1683dd9367d:1c458ad:8675cc2c</id><published>1547164800000</published><unread>True</unread><summary><direction>ltr</direction><content>A substrate-directed enantioselective anti-carboboration reaction of alkenes has been developed, wherein a carbon based nucleophile and a boron moiety are installed across the C=C bond through a 5- or 6-membered palladacycle intermediate. The reaction is promoted by a palladium(II) catalyst and a mondentate oxzazoline ligand. A range of enantioenriched secondary alkylboronate products were obtained with moderate to high enantioselectivity that could be further upgraded by recrystallization. This work represents a new method to synthesize versatile and valuable alkylboronate building blocks. Building on an earlier mechanistic proposal by Peng, He, and Chen, a revised model is proposed to account for the stereoconvergent nature of this transformation.</content></summary><fingerprint>9d6c4c0e</fingerprint><link>https://chemrxiv.org/articles/Directed_Palladium_II_-Catalyzed_Enantioselective_anti-Carboboration_of_Alkenyl_Carbonyl_Compounds/7577597</link><engagement>5</engagement><crawled>1547225871997</crawled><title>Directed, Palladium(II)-Catalyzed Enantioselective anti-Carboboration of Alkenyl Carbonyl Compounds</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>A substrate-directed enantioselective anti-carboboration reaction of alkenes has been developed, wherein a carbon based nucleophile and a boron moiety are installed across the C=C bond through a 5- or 6-membered palladacycle intermediate. The reaction is promoted by a palladium(II) catalyst and a mondentate oxzazoline ligand. A range of enantioenriched secondary alkylboronate products were obtained with moderate to high enantioselectivity that could be further upgraded by recrystallization. This work represents a new method to synthesize versatile and valuable alkylboronate building blocks. Building on an earlier mechanistic proposal by Peng, He, and Chen, a revised model is proposed to account for the stereoconvergent nature of this transformation.</description><originId>https://chemrxiv.org/articles/Directed_Palladium_II_-Catalyzed_Enantioselective_anti-Carboboration_of_Alkenyl_Carbonyl_Compounds/7577597</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Directed_Palladium_II_-Catalyzed_Enantioselective_anti-Carboboration_of_Alkenyl_Carbonyl_Compounds/7577597</href></item></alternate><visual><height>354</height><processor>feedly-nikon-v3.1</processor><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14074670/thumb.png</url><contentType>image/png</contentType><width>250</width></visual></item><item><author><name>Bergeson, S.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3c5:ad2b6584</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/33?rss=1</href></item></alternate><published>1546540591000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>aca3bf52</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6422/33?rss=1</link><engagement>0</engagement><title>Really cool neutral plasmas</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6422/33?rss=1</originId><crawled>1546542450273</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6422/33.full</canonicalUrl><keywords><item>Physics</item></keywords></item><item><author><name>Lavine, K.</name></author><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_168340336d8:d6f313:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;Exome sequencing reveals the genetic complexity of chronic kidney disease.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/474/eaaw0532?rss=1</href></item></alternate><published>1547059839000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>e24de218</fingerprint><link>http://stm.sciencemag.org/cgi/content/short/11/474/eaaw0532?rss=1</link><engagement>0</engagement><title>[Editors&apos; Choice] Defining chronic kidney disease at the genetic level</title><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><description>&lt;p&gt;Exome sequencing reveals the genetic complexity of chronic kidney disease.&lt;/p&gt;</description><originId>http://stm.sciencemag.org/cgi/content/short/11/474/eaaw0532?rss=1</originId><crawled>1547060852440</crawled><canonicalUrl>http://stm.sciencemag.org/content/11/474/eaaw0532.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Yan, H.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168052a2962:56b401a:ad2b6584</id><content><direction>ltr</direction><content>The characterization and classification of white blood cells (WBC) is critical for the diagnosis of anemia, leukemia and many other hematologic diseases. We developed WBC-Profiler, an unsupervised feature learning system for quantitative analysis of leukocytes. We demonstrate that WBC-Profiler enables automatic extraction of complex signatures from microscopic images without human-intervention and thereafter effective construction of leukocytes profiles, which decouples large scale complex leukocytes characterization from limitations in both human-based feature engineering/optimization and the end-to-end solutions provided by modern deep neural networks, and therefore has the potential to provide new opportunities towards meaningful studies/applications with scientific and/or clinical impact</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/508564v1?rss=1</href></item></alternate><published>1546243200000</published><unread>False</unread><fingerprint>aa389311</fingerprint><link>http://biorxiv.org/cgi/content/short/508564v1?rss=1</link><engagement>0</engagement><title>WBC-Profiler: an Unsupervised Feature Learning System for Leukocytes Characterization and Classification [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>The characterization and classification of white blood cells (WBC) is critical for the diagnosis of anemia, leukemia and many other hematologic diseases. We developed WBC-Profiler, an unsupervised feature learning system for quantitative analysis of leukocytes. We demonstrate that WBC-Profiler enables automatic extraction of complex signatures from microscopic images without human-intervention and thereafter effective construction of leukocytes profiles, which decouples large scale complex leukocytes characterization from limitations in both human-based feature engineering/optimization and the end-to-end solutions provided by modern deep neural networks, and therefore has the potential to provide new opportunities towards meaningful studies/applications with scientific and/or clinical impact</description><originId>http://biorxiv.org/cgi/content/short/508564v1?rss=1</originId><crawled>1546274875746</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2018/12/31/508564</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Mick Watson</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Nat</text></item><item><text>W. R. Nat</text></item></mentions><label>W. R. Nat</label><id>nlp/f/entity/en/-/w. r. nat</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Koren</text></item></mentions><label>Koren</label><id>nlp/f/entity/en/-/koren</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Jain</text></item></mentions><label>Jainism</label><id>nlp/f/entity/en/w/Jainism</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Genet</text></item><item><text>S. L. Trends Genet</text></item></mentions><label>S. L. Trends Genet</label><id>nlp/f/entity/en/-/s. l. trends genet</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Genome Res</text></item></mentions><label>Genome Research</label><id>nlp/f/entity/en/w/Genome Research</id></item></entities><id>0qZSsMpEyvTD/JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I=_168768c6f4b:2627b90:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Errors in long-read assemblies can critically affect protein prediction&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Errors in long-read assemblies can critically affect protein prediction, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41587-018-0004-z&quot;&gt;doi:10.1038/s41587-018-0004-z&lt;/a&gt;&lt;/p&gt;Errors in long-read assemblies can critically affect protein prediction</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41587-018-0004-z</href></item></alternate><published>1548144000000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>1a19a156</fingerprint><commonTopics><item><probability>0.976</probability><label>bioinformatics</label><id>nlp/f/topic/262</id></item><item><probability>0.952</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.936</probability><label>classics</label><id>nlp/f/topic/477</id></item><item><probability>0.909</probability><label>mp3</label><id>nlp/f/topic/1508</id></item><item><probability>0.905</probability><label>emergency medicine</label><id>nlp/f/topic/764</id></item><item><probability>0.721</probability><label>anthropology</label><id>nlp/f/topic/109</id></item><item><probability>0.718</probability><label>ecology</label><id>nlp/f/topic/725</id></item></commonTopics><link>https://www.nature.com/articles/s41587-018-0004-z</link><engagement>5</engagement><title>Errors in long-read assemblies can critically affect protein prediction</title><origin><htmlUrl>http://feeds.nature.com/nbt/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nbt/current_issue/rss/</streamId><title>Nature Biotechnology</title></origin><description>&lt;p&gt;&lt;b&gt;Errors in long-read assemblies can critically affect protein prediction&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Errors in long-read assemblies can critically affect protein prediction, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41587-018-0004-z&quot;&gt;doi:10.1038/s41587-018-0004-z&lt;/a&gt;&lt;/p&gt;Errors in long-read assemblies can critically affect protein prediction</description><originId>https://www.nature.com/articles/s41587-018-0004-z</originId><crawled>1548177141579</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/0qZSsMpEyvTD_JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I_oicon-166b30c5bda</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Bauer, A.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1687e402e4f:3285582:ad2b6584</id><content><direction>ltr</direction><content>Aerial imagery is regularly used by farmers and growers to monitor crops during the growing season. To extract meaningful phenotypic information from large-scale aerial images collected regularly from the field, high-throughput analytic solutions are required, which not only produce high-quality measures of key crop traits, but also support agricultural practitioners to make reliable management decisions of their crops. Here, we report AirSurf-Lettuce, an automated and open-source aerial image analysis platform that combines modern computer vision, up-to-date machine learning, and modular software engineering to measure yield-related phenotypes of millions of lettuces across the field. Utilising ultra-large normalized difference vegetation index (NDVI) images acquired by fixed-wing light aircrafts together with a deep-learning classifier trained with over 100,000 labelled lettuce signals, the platform is capable of scoring and categorising iceberg lettuces with high accuracy (&gt;98%). Furthermore, novel analysis functions have been developed to map lettuce size distribution in the field, based on which global positioning system (GPS) tagged harvest regions can be derived to enable growers and farmers&apos; precise harvest strategies and marketability estimates before the harvest.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/527184v1?rss=1</href></item></alternate><published>1548230400000</published><unread>True</unread><fingerprint>84d6cbef</fingerprint><link>http://biorxiv.org/cgi/content/short/527184v1?rss=1</link><engagement>1</engagement><title>AirSurf-Lettuce: an aerial image analysis platform for ultra-scale field phenotyping and precision agriculture using computer vision and deep learning [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Aerial imagery is regularly used by farmers and growers to monitor crops during the growing season. To extract meaningful phenotypic information from large-scale aerial images collected regularly from the field, high-throughput analytic solutions are required, which not only produce high-quality measures of key crop traits, but also support agricultural practitioners to make reliable management decisions of their crops. Here, we report AirSurf-Lettuce, an automated and open-source aerial image analysis platform that combines modern computer vision, up-to-date machine learning, and modular software engineering to measure yield-related phenotypes of millions of lettuces across the field. Utilising ultra-large normalized difference vegetation index (NDVI) images acquired by fixed-wing light aircrafts together with a deep-learning classifier trained with over 100,000 labelled lettuce signals, the platform is capable of scoring and categorising iceberg lettuces with high accuracy (&gt;98%). Furthermore, novel analysis functions have been developed to map lettuce size distribution in the field, based on which global positioning system (GPS) tagged harvest regions can be derived to enable growers and farmers&apos; precise harvest strategies and marketability estimates before the harvest.</description><originId>http://biorxiv.org/cgi/content/short/527184v1?rss=1</originId><crawled>1548306361935</crawled><canonicalUrl>https://www.biorxiv.org/content/10.1101/527184v1</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Knight, J. D. R.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1689b479304:55dab6:c2ce2e2e</id><content><direction>ltr</direction><content>Viewing information about gene products is a constant part of the molecular biologist&apos;s life. While there are many high quality and well-designed resources to fulfill this need, they require the user to navigate to these resources, execute a search, select the desired result and then view its information. This can be a repetitive, time-consuming and even disruptive process, for example when exploring the results of large scale genomics or proteomics screens or reading an online article. To address this issue we have developed a Chrome extension that allows users to retrieve customizable gene product information - especially as it relates to proteins and their expression and functions - directly on a website without having to navigate to another page.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/532523v1?rss=1</href></item></alternate><published>1548748800000</published><unread>True</unread><fingerprint>ad76b2a5</fingerprint><link>http://biorxiv.org/cgi/content/short/532523v1?rss=1</link><engagement>0</engagement><title>Gene Info: Easy retrieval of gene product information on any website [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Viewing information about gene products is a constant part of the molecular biologist&apos;s life. While there are many high quality and well-designed resources to fulfill this need, they require the user to navigate to these resources, execute a search, select the desired result and then view its information. This can be a repetitive, time-consuming and even disruptive process, for example when exploring the results of large scale genomics or proteomics screens or reading an online article. To address this issue we have developed a Chrome extension that allows users to retrieve customizable gene product information - especially as it relates to proteins and their expression and functions - directly on a website without having to navigate to another page.</description><originId>http://biorxiv.org/cgi/content/short/532523v1?rss=1</originId><crawled>1548793385732</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Matelsky, J. K.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1683b99d52b:1866a53:3a104d3b</id><content><direction>ltr</direction><content>As the scope of scientific questions increase and datasets grow larger, the visualization of relevant information correspondingly becomes more difficult and complex. Sharing visualizations amongst collaborators and with the public can be especially onerous, as it is challenging to reconcile software dependencies, data formats, and specific user needs in an easily accessible package. We present substrate, a data-visualization framework designed to simplify communication and code reuse across diverse research teams. Our platform provides a simple, powerful, browser-based interface for scientists to rapidly build effective three-dimensional scenes and visualizations. We aim to reduce the gap of existing systems, which commonly prescribe a limited set of high-level components, that are rarely optimized for arbitrarily large data visualization or for custom data types. To further engage the broader scientific community and enable seamless integration with existing scientific workflows, we also present pytri, a Python library that bridges the use of substrate with the ubiquitous scientific computing platform, Jupyter. Our intention is to reduce the activation energy required to transition between exploratory data analysis, data visualization, and publication-quality interactive scenes.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/217349v2?rss=1</href></item></alternate><published>1547107200000</published><unread>True</unread><fingerprint>73306843</fingerprint><link>http://biorxiv.org/cgi/content/short/217349v2?rss=1</link><engagement>0</engagement><title>A substrate for modular, extensible data-visualization [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>As the scope of scientific questions increase and datasets grow larger, the visualization of relevant information correspondingly becomes more difficult and complex. Sharing visualizations amongst collaborators and with the public can be especially onerous, as it is challenging to reconcile software dependencies, data formats, and specific user needs in an easily accessible package. We present substrate, a data-visualization framework designed to simplify communication and code reuse across diverse research teams. Our platform provides a simple, powerful, browser-based interface for scientists to rapidly build effective three-dimensional scenes and visualizations. We aim to reduce the gap of existing systems, which commonly prescribe a limited set of high-level components, that are rarely optimized for arbitrarily large data visualization or for custom data types. To further engage the broader scientific community and enable seamless integration with existing scientific workflows, we also present pytri, a Python library that bridges the use of substrate with the ubiquitous scientific computing platform, Jupyter. Our intention is to reduce the activation energy required to transition between exploratory data analysis, data visualization, and publication-quality interactive scenes.</description><originId>http://biorxiv.org/cgi/content/short/217349v2?rss=1</originId><crawled>1547188163883</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/10/217349</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Steve Stegen</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>HIF - 1α</text></item></mentions><label>HIF - 1α</label><id>nlp/f/entity/en/-/hif - 1α</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>αKG</text></item><item><text>αKG / Fum</text></item><item><text>Fum</text></item></mentions><label>αKG / Fum</label><id>nlp/f/entity/en/-/αkg / fum</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>o</text></item></mentions><label>o</label><id>nlp/f/entity/en/-/o</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Glu</text></item></mentions><label>Glu</label><id>nlp/f/entity/en/-/glu</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Suc</text></item></mentions><label>Suc</label><id>nlp/f/entity/en/-/suc</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16857ddbaa0:3dd05ec:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;HIF-1α metabolically controls collagen synthesis and modification in chondrocytes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;HIF-1α metabolically controls collagen synthesis and modification in chondrocytes, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0874-3&quot;&gt;doi:10.1038/s41586-019-0874-3&lt;/a&gt;&lt;/p&gt;Increased glutamine metabolism caused by unregulated HIF-1α signalling in mouse chondrocytes results in increased post-translational modification of collagen and skeletal dysplasia, demonstrating that strict regulation of HIF-1α signalling in chondrocytes is essential for normal bone growth.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0874-3</href></item></alternate><published>1547625600000</published><unread>True</unread><fingerprint>e20961c6</fingerprint><commonTopics><item><probability>0.957</probability><label>classics</label><id>nlp/f/topic/477</id></item><item><probability>0.892</probability><label>data science</label><id>nlp/f/topic/618</id></item><item><probability>0.883</probability><label>algorithms</label><id>nlp/f/topic/76</id></item><item><probability>0.852</probability><label>ctf</label><id>nlp/f/topic/592</id></item><item><probability>0.706</probability><label>nlp</label><id>nlp/f/topic/1585</id></item></commonTopics><link>https://www.nature.com/articles/s41586-019-0874-3</link><engagement>24</engagement><title>HIF-1α metabolically controls collagen synthesis and modification in chondrocytes</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;HIF-1α metabolically controls collagen synthesis and modification in chondrocytes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;HIF-1α metabolically controls collagen synthesis and modification in chondrocytes, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0874-3&quot;&gt;doi:10.1038/s41586-019-0874-3&lt;/a&gt;&lt;/p&gt;Increased glutamine metabolism caused by unregulated HIF-1α signalling in mouse chondrocytes results in increased post-translational modification of collagen and skeletal dysplasia, demonstrating that strict regulation of HIF-1α signalling in chondrocytes is essential for normal bone growth.</description><originId>https://www.nature.com/articles/s41586-019-0874-3</originId><crawled>1547662375584</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Mary C. Wildermuth</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Han</text></item></mentions><label>Han Chinese</label><id>nlp/f/entity/en/w/Han Chinese</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Han et al</text></item></mentions><label>Han et al</label><id>nlp/f/entity/en/-/han et al</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Zm KWL1 amino</text></item><item><text>Zm KWL1</text></item></mentions><label>Zm KWL1 amino</label><id>nlp/f/entity/en/-/zm kwl1 amino</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Cmu1</text></item><item><text>maydis Cmu1</text></item></mentions><label>maydis Cmu1</label><id>nlp/f/entity/en/-/maydis cmu1</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Kiwellins</text></item><item><text>kiwellins</text></item></mentions><label>kiwellins</label><id>nlp/f/entity/en/-/kiwellins</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16857ddbaa0:3dd05e5:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Plants fight fungi using kiwellin proteins&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Plants fight fungi using kiwellin proteins, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00092-2&quot;&gt;doi:10.1038/d41586-019-00092-2&lt;/a&gt;&lt;/p&gt;Fungal infection can affect crop yield. A plant protein found to counter fungal-induced interference with host metabolism illuminates antifungal defences and mechanisms that inhibit metabolic enzymes.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00092-2</href></item></alternate><published>1547625600000</published><unread>True</unread><visual><height>450</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00092-2/d41586-019-00092-2_16395374.jpg</url><contentType>image/jpeg</contentType><width>800</width></visual><fingerprint>1d7c552d</fingerprint><commonTopics><item><probability>0.999</probability><label>plants</label><id>nlp/f/topic/1770</id></item><item><probability>0.995</probability><label>biochemistry</label><id>nlp/f/topic/257</id></item><item><probability>0.922</probability><label>microbiology</label><id>nlp/f/topic/1455</id></item><item><probability>0.91</probability><label>proteomics</label><id>nlp/f/topic/1840</id></item><item><probability>0.89</probability><label>agriculture</label><id>nlp/f/topic/54</id></item><item><probability>0.84</probability><label>ecology</label><id>nlp/f/topic/725</id></item><item><probability>0.835</probability><label>cell</label><id>nlp/f/topic/403</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00092-2</link><engagement>2</engagement><title>Plants fight fungi using kiwellin proteins</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Plants fight fungi using kiwellin proteins&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Plants fight fungi using kiwellin proteins, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00092-2&quot;&gt;doi:10.1038/d41586-019-00092-2&lt;/a&gt;&lt;/p&gt;Fungal infection can affect crop yield. A plant protein found to counter fungal-induced interference with host metabolism illuminates antifungal defences and mechanisms that inhibit metabolic enzymes.</description><originId>https://www.nature.com/articles/d41586-019-00092-2</originId><crawled>1547662375584</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>David Hodgson</name></author><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_168813a2573:9d61a:875042c9</id><content><direction>ltr</direction><content>&lt;p&gt;by David Hodgson, Andrew D. Rowan, Francesco Falciani, Carole J. Proctor&lt;/p&gt;
Osteoarthritis (OA) is a degenerative condition caused by dysregulation of multiple molecular signalling pathways. Such dysregulation results in damage to cartilage, a smooth and protective tissue that enables low friction articulation of synovial joints. Matrix metalloproteinases (MMPs), especially MMP-13, are key enzymes in the cleavage of type II collagen which is a vital component for cartilage integrity. Transforming growth factor beta (TGFβ) can protect against pro-inflammatory cytokine-mediated MMP expression. With age there is a change in the ratio of two TGFβ type I receptors (Alk1/Alk5), a shift that results in TGFβ losing its protective role in cartilage homeostasis. Instead, TGFβ promotes cartilage degradation which correlates with the spontaneous development of OA in murine models. However, the mechanism by which TGFβ protects against pro-inflammatory responses and how this changes with age has not been extensively studied. As TGFβ signalling is complex, we used systems biology to combine experimental and computational outputs to examine how the system changes with age. Experiments showed that the repressive effect of TGFβ on chondrocytes treated with a pro-inflammatory stimulus required Alk5. Computational modelling revealed two independent mechanisms were needed to explain the crosstalk between TGFβ and pro-inflammatory signalling pathways. A novel meta-analysis of microarray data from OA patient tissue was used to create a Cytoscape network representative of human OA and revealed the importance of inflammation. Combining the modelled genes with the microarray network provided a global overview into the crosstalk between the different signalling pathways involved in OA development.
Our results provide further insights into the mechanisms that cause TGFβ signalling to change from a protective to a detrimental pathway in cartilage with ageing. Moreover, such a systems biology approach may enable restoration of the protective role of TGFβ as a potential therapy to prevent age-related loss of cartilage and the development of OA.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/djeTM0j7Dos&quot; height=&quot;1&quot;&gt;</content></content><updateCount>1</updateCount><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/djeTM0j7Dos/article</href></item></alternate><published>1548367200000</published><unread>True</unread><fingerprint>d0b35f88</fingerprint><link>10.1371/journal.pcbi.1006685</link><recrawled>1548365235969</recrawled><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006685</href></item></canonical><updated>1548367200000</updated><engagement>0</engagement><title>Systems biology reveals how altered TGFβ signalling with age reduces protection against pro-inflammatory stimuli</title><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><description>&lt;p&gt;by David Hodgson, Andrew D. Rowan, Francesco Falciani, Carole J. Proctor&lt;/p&gt;
Osteoarthritis (OA) is a degenerative condition caused by dysregulation of multiple molecular signalling pathways. Such dysregulation results in damage to cartilage, a smooth and protective tissue that enables low friction articulation of synovial joints. Matrix metalloproteinases (MMPs), especially MMP-13, are key enzymes in the cleavage of type II collagen which is a vital component for cartilage integrity. Transforming growth factor beta (TGFβ) can protect against pro-inflammatory cytokine-mediated MMP expression. With age there is a change in the ratio of two TGFβ type I receptors (Alk1/Alk5), a shift that results in TGFβ losing its protective role in cartilage homeostasis. Instead, TGFβ promotes cartilage degradation which correlates with the spontaneous development of OA in murine models. However, the mechanism by which TGFβ protects against pro-inflammatory responses and how this changes with age has not been extensively studied. As TGFβ signalling is complex, we used systems biology to combine experimental and computational outputs to examine how the system changes with age. Experiments showed that the repressive effect of TGFβ on chondrocytes treated with a pro-inflammatory stimulus required Alk5. Computational modelling revealed two independent mechanisms were needed to explain the crosstalk between TGFβ and pro-inflammatory signalling pathways. A novel meta-analysis of microarray data from OA patient tissue was used to create a Cytoscape network representative of human OA and revealed the importance of inflammation. Combining the modelled genes with the microarray network provided a global overview into the crosstalk between the different signalling pathways involved in OA development.
Our results provide further insights into the mechanisms that cause TGFβ signalling to change from a protective to a detrimental pathway in cartilage with ageing. Moreover, such a systems biology approach may enable restoration of the protective role of TGFβ as a potential therapy to prevent age-related loss of cartilage and the development of OA.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/djeTM0j7Dos&quot; height=&quot;1&quot;&gt;</description><originId>10.1371/journal.pcbi.1006685</originId><crawled>1548356298099</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Ashton, L. A., Griffiths, H. M., Parr, C. L., Evans, T. A., Didham, R. K., Hasan, F., Teh, Y. A., Tin, H. S., Vairappan, C. S., Eggleton, P.</name></author><content><direction>ltr</direction><content>&lt;p&gt;Termites perform key ecological functions in tropical ecosystems, are strongly affected by variation in rainfall, and respond negatively to habitat disturbance. However, it is not known how the projected increase in frequency and severity of droughts in tropical rainforests will alter termite communities and the maintenance of ecosystem processes. Using a large-scale termite suppression experiment, we found that termite activity and abundance increased during drought in a Bornean forest. This increase resulted in accelerated litter decomposition, elevated soil moisture, greater soil nutrient heterogeneity, and higher seedling survival rates during the extreme El Niño drought of 2015–2016. Our work shows how an invertebrate group enhances ecosystem resistance to drought, providing evidence that the dual stressors of climate change and anthropogenic shifts in biotic communities will have various negative consequences for the maintenance of rainforest ecosystems.&lt;/p&gt;</content></content><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:1570893:8675cc2c</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/174?rss=1</href></item></alternate><published>1547145461000</published><unread>True</unread><fingerprint>34750252</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6423/174?rss=1</link><engagement>692</engagement><title>Termites mitigate the effects of drought in tropical rainforest</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><description>&lt;p&gt;Termites perform key ecological functions in tropical ecosystems, are strongly affected by variation in rainfall, and respond negatively to habitat disturbance. However, it is not known how the projected increase in frequency and severity of droughts in tropical rainforests will alter termite communities and the maintenance of ecosystem processes. Using a large-scale termite suppression experiment, we found that termite activity and abundance increased during drought in a Bornean forest. This increase resulted in accelerated litter decomposition, elevated soil moisture, greater soil nutrient heterogeneity, and higher seedling survival rates during the extreme El Niño drought of 2015–2016. Our work shows how an invertebrate group enhances ecosystem resistance to drought, providing evidence that the dual stressors of climate change and anthropogenic shifts in biotic communities will have various negative consequences for the maintenance of rainforest ecosystems.&lt;/p&gt;</description><originId>http://science.sciencemag.org/cgi/content/short/363/6423/174?rss=1</originId><crawled>1547147463250</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6423/174.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><keywords><item>Ecology</item></keywords></item><item><author><name>Jessica Eise</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Getty</text></item></mentions><label>Getty Images</label><id>nlp/f/entity/en/w/Getty Images</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Feed the World</text></item></mentions><label>Feed the World</label><id>nlp/f/entity/en/-/feed the world</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>united 17</text></item></mentions><label>united 17</label><id>nlp/f/entity/en/-/united 17</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Ken Foster</text></item></mentions><label>Ken Foster</label><id>nlp/f/entity/en/-/ken foster</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>blogposts</text></item></mentions><label>blogposts</label><id>nlp/f/entity/en/-/blogposts</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168953b6dfa:4fc7fa0:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Herding experts and polishing text: 10 tips for creating an edited volume&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Herding experts and polishing text: 10 tips for creating an edited volume, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07814-y&quot;&gt;doi:10.1038/d41586-018-07814-y&lt;/a&gt;&lt;/p&gt;What you should know before starting an anthology.</content></content><engagementRate>0.22</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07814-y</href></item></alternate><published>1548662400000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07814-y/d41586-018-07814-y_16423714.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>8f4d609</fingerprint><commonTopics><item><probability>0.974</probability><label>academic</label><id>nlp/f/topic/17</id></item><item><probability>0.971</probability><label>editing</label><id>nlp/f/topic/737</id></item><item><probability>0.931</probability><label>phd</label><id>nlp/f/topic/1737</id></item><item><probability>0.833</probability><label>light novels</label><id>nlp/f/topic/1340</id></item><item><probability>0.826</probability><label>research</label><id>nlp/f/topic/1931</id></item></commonTopics><link>https://www.nature.com/articles/d41586-018-07814-y</link><engagement>2</engagement><title>Herding experts and polishing text: 10 tips for creating an edited volume</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Herding experts and polishing text: 10 tips for creating an edited volume&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Herding experts and polishing text: 10 tips for creating an edited volume, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07814-y&quot;&gt;doi:10.1038/d41586-018-07814-y&lt;/a&gt;&lt;/p&gt;What you should know before starting an anthology.</description><originId>https://www.nature.com/articles/d41586-018-07814-y</originId><crawled>1548691926522</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Bo Wu</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1689927a947:1ffc11:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Indirect tail states formation by thermal-induced polar fluctuations in halide perovskites&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Indirect tail states formation by thermal-induced polar fluctuations in halide perovskites, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08326-7&quot;&gt;doi:10.1038/s41467-019-08326-7&lt;/a&gt;&lt;/p&gt;The weak effects induced by lattice disorder on the optoelectronic properties of halide perovskites still remain elusive. Here Wu et al. confirm the indirect transition tail states in perovskite crystals which explain their low photoluminescence quantum yield, dual emission peaks and difficulties in realizing lasing.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/9eAu-Ec12EU&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/9eAu-Ec12EU/s41467-019-08326-7</href></item></alternate><published>1548748800000</published><unread>True</unread><visual><height>525</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-019-08326-7/MediaObjects/41467_2019_8326_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>d4e28b2d</fingerprint><link>https://www.nature.com/articles/s41467-019-08326-7</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-019-08326-7</href></item></canonical><title>Indirect tail states formation by thermal-induced polar fluctuations in halide perovskites</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Indirect tail states formation by thermal-induced polar fluctuations in halide perovskites&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Indirect tail states formation by thermal-induced polar fluctuations in halide perovskites, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08326-7&quot;&gt;doi:10.1038/s41467-019-08326-7&lt;/a&gt;&lt;/p&gt;The weak effects induced by lattice disorder on the optoelectronic properties of halide perovskites still remain elusive. Here Wu et al. confirm the indirect transition tail states in perovskite crystals which explain their low photoluminescence quantum yield, dual emission peaks and difficulties in realizing lasing.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/9eAu-Ec12EU&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-019-08326-7</originId><crawled>1548757739847</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Hendrik A. Messal</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Kras</text></item></mentions><label>KRAS</label><id>nlp/f/entity/en/w/KRAS</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Biol</text></item></mentions><label>Biol</label><id>nlp/f/entity/en/-/biol</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>SOX2</text></item></mentions><label>SOX2</label><id>nlp/f/entity/en/w/SOX2</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>K.</text></item></mentions><label>K.</label><id>nlp/f/entity/en/-/k.</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>4282</text></item></mentions><label>4282</label><id>nlp/f/entity/en/-/4282</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ff99aeb:c7ac4b:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Tissue curvature and apicobasal mechanical tension imbalance instruct cancer morphogenesis&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Tissue curvature and apicobasal mechanical tension imbalance instruct cancer morphogenesis, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0891-2&quot;&gt;doi:10.1038/s41586-019-0891-2&lt;/a&gt;&lt;/p&gt;Three-dimensional imaging of mouse pancreatic ducts before and after oncogenic transformation reveals that epithelial tumorigenesis is determined by the relationship between tissue curvature and apical–basal mechanical tension.</content></content><engagementRate>0.38</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0891-2</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><height>522</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-019-0891-2/MediaObjects/41586_2019_891_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>5a204c4b</fingerprint><commonTopics><item><probability>1.0</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>1.0</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.999</probability><label>stem cells</label><id>nlp/f/topic/2185</id></item><item><probability>0.993</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.992</probability><label>cancer</label><id>nlp/f/topic/377</id></item><item><probability>0.91</probability><label>hematology</label><id>nlp/f/topic/1058</id></item><item><probability>0.891</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item><item><probability>0.87</probability><label>biology</label><id>nlp/f/topic/263</id></item><item><probability>0.762</probability><label>biochemistry</label><id>nlp/f/topic/257</id></item></commonTopics><link>https://www.nature.com/articles/s41586-019-0891-2</link><engagement>3</engagement><title>Tissue curvature and apicobasal mechanical tension imbalance instruct cancer morphogenesis</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Tissue curvature and apicobasal mechanical tension imbalance instruct cancer morphogenesis&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Tissue curvature and apicobasal mechanical tension imbalance instruct cancer morphogenesis, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0891-2&quot;&gt;doi:10.1038/s41586-019-0891-2&lt;/a&gt;&lt;/p&gt;Three-dimensional imaging of mouse pancreatic ducts before and after oncogenic transformation reveals that epithelial tumorigenesis is determined by the relationship between tissue curvature and apical–basal mechanical tension.</description><originId>https://www.nature.com/articles/s41586-019-0891-2</originId><crawled>1548872162027</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_168145e0b4a:6871449:ad2b6584</id><published>1546473600000</published><unread>True</unread><summary><direction>ltr</direction><content>We
present the aerosol-assisted sol-gel preparation of hierarchically porous TiO2–SiO2
catalysts having a sphere-like shell morphology and a high Ti dispersion. In
order to control the porosity at the micro-, meso- and macro- levels, we use
the evaporation-induced self assembly (EISA) of a surfactant, possibly combined
with polymer beads as hard templates. These catalysts are tested for the
epoxidation of cyclohexene with cumene hydroperoxide as oxidant, and their
performance is compared to the reference TS-1 zeolite. The high catalytic
performance observed with the catalysts prepared by aerosol stems from their
high specific surface area, but also from the short diffusion path length generated
by the meso-/macro-pore architecture which provide entryways for bulky
reactants and products.</content></summary><fingerprint>ad5f40cc</fingerprint><link>https://chemrxiv.org/articles/Aerosol_route_to_TiO2_SiO2_catalysts_with_tailored_pore_architecture_and_high_epoxidation_activity/7542056</link><engagement>0</engagement><crawled>1546529934154</crawled><title>Aerosol route to TiO2–SiO2 catalysts with tailored pore architecture and high epoxidation activity</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>We
present the aerosol-assisted sol-gel preparation of hierarchically porous TiO2–SiO2
catalysts having a sphere-like shell morphology and a high Ti dispersion. In
order to control the porosity at the micro-, meso- and macro- levels, we use
the evaporation-induced self assembly (EISA) of a surfactant, possibly combined
with polymer beads as hard templates. These catalysts are tested for the
epoxidation of cyclohexene with cumene hydroperoxide as oxidant, and their
performance is compared to the reference TS-1 zeolite. The high catalytic
performance observed with the catalysts prepared by aerosol stems from their
high specific surface area, but also from the short diffusion path length generated
by the meso-/macro-pore architecture which provide entryways for bulky
reactants and products.</description><originId>https://chemrxiv.org/articles/Aerosol_route_to_TiO2_SiO2_catalysts_with_tailored_pore_architecture_and_high_epoxidation_activity/7542056</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Aerosol_route_to_TiO2_SiO2_catalysts_with_tailored_pore_architecture_and_high_epoxidation_activity/7542056</href></item></alternate></item><item><author><name>E. Yvonne  Jones</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>IL - 2</text></item></mentions><label>IL - 2</label><id>nlp/f/entity/en/-/il - 2</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>CD25</text></item></mentions><label>IL2RA</label><id>nlp/f/entity/en/w/IL2RA</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Silva</text></item><item><text>Silva et al</text></item></mentions><label>Silva et al</label><id>nlp/f/entity/en/-/silva et al</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>IL - 2Rβγ c</text></item><item><text>IL - 2Rβγ</text></item></mentions><label>IL - 2Rβγ c</label><id>nlp/f/entity/en/-/il - 2rβγ c</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Messenger</text></item></mentions><label>Messenger</label><id>nlp/f/entity/en/-/messenger</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16833ca2c4e:d2b070:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Designer protein delivers signal of choice&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Designer protein delivers signal of choice, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07883-z&quot;&gt;doi:10.1038/d41586-018-07883-z&lt;/a&gt;&lt;/p&gt;A computational strategy has delivered a redesigned, more stable version of a cytokine protein that mimics the natural protein’s interactions with receptors, opening the way for designer cytokine-based therapeutics.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07883-z</href></item></alternate><published>1547020800000</published><unread>True</unread><visual><height>449</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07883-z/d41586-018-07883-z_16381082.jpg</url><contentType>image/jpeg</contentType><width>800</width></visual><fingerprint>9a42eeb6</fingerprint><commonTopics><item><probability>0.931</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.93</probability><label>pharmacology</label><id>nlp/f/topic/1735</id></item><item><probability>0.818</probability><label>biochemistry</label><id>nlp/f/topic/257</id></item><item><probability>0.807</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>0.72</probability><label>proteomics</label><id>nlp/f/topic/1840</id></item><item><probability>0.718</probability><label>biology</label><id>nlp/f/topic/263</id></item></commonTopics><link>https://www.nature.com/articles/d41586-018-07883-z</link><engagement>7</engagement><title>Designer protein delivers signal of choice</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Designer protein delivers signal of choice&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Designer protein delivers signal of choice, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07883-z&quot;&gt;doi:10.1038/d41586-018-07883-z&lt;/a&gt;&lt;/p&gt;A computational strategy has delivered a redesigned, more stable version of a cytokine protein that mimics the natural protein’s interactions with receptors, opening the way for designer cytokine-based therapeutics.</description><originId>https://www.nature.com/articles/d41586-018-07883-z</originId><crawled>1547057114190</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Belmonte Reche, E.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1689b67dfb9:5b6aae:3a104d3b</id><content><direction>ltr</direction><content>We present G4-iM Grinder as a system for potential quadruplex and higher-order quadruplex identification and characterization. Several grading tools of biological relevance and formation probability are included in this modulable and robust engine. G4-iM Grinder improves other quadruplex search engines in capabilities and processing time. We used G4-iM Grinder to analyse the complete human genome whilst focusing on frequency and PQS score. We studied the most recurrent potential quadruplex sequences (PQS) and the longest highest scoring potential higher order quadruplex sequences (PHOQS). As proof of the analytical capabilities of G4-iM Grinder, we also analysed a new PHOQS and predicted the most probable subunits to form it. Taking the human average PQS density as reference, we examined the genomes of organisms that cause leishmaniosis, diphtheria, brucellosis, meningitis, pneumonia, toxoplasmosis, tuberculosis, leprosy, AIDS, dengue fever and hepatitis C, and found they are rich in PQS. G4-iM Grinder identified within many of these several already known-to-form sequences. Together, this suggests that G-quadruplexes may potentially be important therapeutic targets against many of these organisms that currently kill millions worldwide.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/532382v1?rss=1</href></item></alternate><published>1548748800000</published><unread>True</unread><fingerprint>2c9ed28</fingerprint><link>http://biorxiv.org/cgi/content/short/532382v1?rss=1</link><engagement>0</engagement><title>G4-iM Grinder: DNA and RNA G-Quadruplex, i-Motif and higher order structure search and analyser tool [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>We present G4-iM Grinder as a system for potential quadruplex and higher-order quadruplex identification and characterization. Several grading tools of biological relevance and formation probability are included in this modulable and robust engine. G4-iM Grinder improves other quadruplex search engines in capabilities and processing time. We used G4-iM Grinder to analyse the complete human genome whilst focusing on frequency and PQS score. We studied the most recurrent potential quadruplex sequences (PQS) and the longest highest scoring potential higher order quadruplex sequences (PHOQS). As proof of the analytical capabilities of G4-iM Grinder, we also analysed a new PHOQS and predicted the most probable subunits to form it. Taking the human average PQS density as reference, we examined the genomes of organisms that cause leishmaniosis, diphtheria, brucellosis, meningitis, pneumonia, toxoplasmosis, tuberculosis, leprosy, AIDS, dengue fever and hepatitis C, and found they are rich in PQS. G4-iM Grinder identified within many of these several already known-to-form sequences. Together, this suggests that G-quadruplexes may potentially be important therapeutic targets against many of these organisms that currently kill millions worldwide.</description><originId>http://biorxiv.org/cgi/content/short/532382v1?rss=1</originId><crawled>1548795502521</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Julie Gould</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>UK</text></item></mentions><label>United Kingdom</label><id>nlp/f/entity/en/w/United Kingdom</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>James Wilsdon</text></item><item><text>Wilsdon</text></item></mentions><label>James Wilsdon</label><id>nlp/f/entity/en/-/james wilsdon</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Mark Walport</text></item></mentions><label>Mark Walport</label><id>nlp/f/entity/en/w/Mark Walport</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>﻿Julie Gould</text></item></mentions><label>﻿Julie Gould</label><id>nlp/f/entity/en/-/﻿julie gould</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>ERC</text></item></mentions><label>ERC</label><id>nlp/f/entity/en/-/erc</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16885d1abf2:3da0943:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Working Scientist podcast: How to navigate the UK&apos;s new research funding landscape&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Working Scientist podcast: How to navigate the UK&apos;s new research funding landscape, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00300-z&quot;&gt;doi:10.1038/d41586-019-00300-z&lt;/a&gt;&lt;/p&gt;An expert guide for early career researchers to UK Research and Innovation, the UK&apos;s new central funding agency.</content></content><engagementRate>0.09</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00300-z</href></item></alternate><published>1548403200000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00300-z/d41586-019-00300-z_16419898.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>6f9830ae</fingerprint><commonTopics><item><probability>0.99</probability><label>science policy</label><id>nlp/f/topic/2019</id></item><item><probability>0.951</probability><label>strategy</label><id>nlp/f/topic/2192</id></item><item><probability>0.92</probability><label>phd</label><id>nlp/f/topic/1737</id></item><item><probability>0.869</probability><label>conservation</label><id>nlp/f/topic/532</id></item><item><probability>0.864</probability><label>management</label><id>nlp/f/topic/1398</id></item><item><probability>0.843</probability><label>university</label><id>nlp/f/topic/2378</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00300-z</link><engagement>1</engagement><title>Working Scientist podcast: How to navigate the UK&apos;s new research funding landscape</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Working Scientist podcast: How to navigate the UK&apos;s new research funding landscape&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Working Scientist podcast: How to navigate the UK&apos;s new research funding landscape, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00300-z&quot;&gt;doi:10.1038/d41586-019-00300-z&lt;/a&gt;&lt;/p&gt;An expert guide for early career researchers to UK Research and Innovation, the UK&apos;s new central funding agency.</description><originId>https://www.nature.com/articles/d41586-019-00300-z</originId><crawled>1548433337330</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Toepfer, C. N., Wakimoto, H., Garfinkel, A. C., McDonough, B., Liao, D., Jiang, J., Tai, A. C., Gorham, J. M., Lunde, I. G., Lun, M., Lynch, T. L., McNamara, J. W., Sadayappan, S., Redwood, C. S., Watkins, H. C., Seidman, J. G., Seidman, C. E.</name></author><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1687c1a95dc:2f64340:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;The mechanisms by which truncating mutations in &lt;i&gt;MYBPC3&lt;/i&gt; (encoding cardiac myosin-binding protein C; cMyBPC) or myosin missense mutations cause hypercontractility and poor relaxation in hypertrophic cardiomyopathy (HCM) are incompletely understood. Using genetic and biochemical approaches, we explored how depletion of cMyBPC altered sarcomere function. We demonstrated that stepwise loss of cMyBPC resulted in reciprocal augmentation of myosin contractility. Direct attenuation of myosin function, via a damaging missense variant (F764L) that causes dilated cardiomyopathy (DCM), normalized the increased contractility from cMyBPC depletion. Depletion of cMyBPC also altered dynamic myosin conformations during relaxation, enhancing the myosin state that enables ATP hydrolysis and thin filament interactions while reducing the super relaxed conformation associated with energy conservation. MYK-461, a pharmacologic inhibitor of myosin ATPase, rescued relaxation deficits and restored normal contractility in mouse and human cardiomyocytes with &lt;i&gt;MYBPC3&lt;/i&gt; mutations. These data define dosage-dependent effects of cMyBPC on myosin that occur across the cardiac cycle as the pathophysiologic mechanisms by which &lt;i&gt;MYBPC3&lt;/i&gt; truncations cause HCM. Therapeutic strategies to attenuate cMyBPC activity may rescue depressed cardiac contractility in patients with DCM, whereas inhibiting myosin by MYK-461 should benefit the substantial proportion of patients with HCM with &lt;i&gt;MYBPC3&lt;/i&gt; mutations.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/476/eaat1199?rss=1</href></item></alternate><published>1548269442000</published><unread>True</unread><fingerprint>8ebd7de8</fingerprint><link>http://stm.sciencemag.org/cgi/content/short/11/476/eaat1199?rss=1</link><engagement>0</engagement><title>[Research Articles] Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin</title><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><description>&lt;p&gt;The mechanisms by which truncating mutations in &lt;i&gt;MYBPC3&lt;/i&gt; (encoding cardiac myosin-binding protein C; cMyBPC) or myosin missense mutations cause hypercontractility and poor relaxation in hypertrophic cardiomyopathy (HCM) are incompletely understood. Using genetic and biochemical approaches, we explored how depletion of cMyBPC altered sarcomere function. We demonstrated that stepwise loss of cMyBPC resulted in reciprocal augmentation of myosin contractility. Direct attenuation of myosin function, via a damaging missense variant (F764L) that causes dilated cardiomyopathy (DCM), normalized the increased contractility from cMyBPC depletion. Depletion of cMyBPC also altered dynamic myosin conformations during relaxation, enhancing the myosin state that enables ATP hydrolysis and thin filament interactions while reducing the super relaxed conformation associated with energy conservation. MYK-461, a pharmacologic inhibitor of myosin ATPase, rescued relaxation deficits and restored normal contractility in mouse and human cardiomyocytes with &lt;i&gt;MYBPC3&lt;/i&gt; mutations. These data define dosage-dependent effects of cMyBPC on myosin that occur across the cardiac cycle as the pathophysiologic mechanisms by which &lt;i&gt;MYBPC3&lt;/i&gt; truncations cause HCM. Therapeutic strategies to attenuate cMyBPC activity may rescue depressed cardiac contractility in patients with DCM, whereas inhibiting myosin by MYK-461 should benefit the substantial proportion of patients with HCM with &lt;i&gt;MYBPC3&lt;/i&gt; mutations.&lt;/p&gt;</description><originId>http://stm.sciencemag.org/cgi/content/short/11/476/eaat1199?rss=1</originId><crawled>1548270343644</crawled><canonicalUrl>http://stm.sciencemag.org/content/11/476/eaat1199.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Nathan Schine</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>M.</text></item></mentions><label>M.</label><id>nlp/f/entity/en/-/m.</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Chiu</text></item></mentions><label>Chiu</label><id>nlp/f/entity/en/-/chiu</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Mod</text></item></mentions><label>Mod</label><id>nlp/f/entity/en/-/mod</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Thouless</text></item></mentions><label>Robert H. Thouless</label><id>nlp/f/entity/en/w/Robert H. Thouless</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>C. - K.</text></item></mentions><label>C. - K.</label><id>nlp/f/entity/en/-/c. - k.</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16833ca2c4e:d2b07e:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Electromagnetic and gravitational responses of photonic Landau levels&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Electromagnetic and gravitational responses of photonic Landau levels, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0817-4&quot;&gt;doi:10.1038/s41586-018-0817-4&lt;/a&gt;&lt;/p&gt;Probing the local response of an integer quantum Hall system enables three different measures of its topology to be explored.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0817-4</href></item></alternate><published>1547020800000</published><unread>True</unread><visual><height>311</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0817-4/MediaObjects/41586_2018_817_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>52673e4b</fingerprint><commonTopics><item><probability>0.99</probability><label>aps</label><id>nlp/f/topic/127</id></item><item><probability>0.941</probability><label>classics</label><id>nlp/f/topic/477</id></item><item><probability>0.785</probability><label>mp3</label><id>nlp/f/topic/1508</id></item><item><probability>0.736</probability><label>quantum</label><id>nlp/f/topic/1873</id></item></commonTopics><link>https://www.nature.com/articles/s41586-018-0817-4</link><engagement>44</engagement><title>Electromagnetic and gravitational responses of photonic Landau levels</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Electromagnetic and gravitational responses of photonic Landau levels&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Electromagnetic and gravitational responses of photonic Landau levels, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0817-4&quot;&gt;doi:10.1038/s41586-018-0817-4&lt;/a&gt;&lt;/p&gt;Probing the local response of an integer quantum Hall system enables three different measures of its topology to be explored.</description><originId>https://www.nature.com/articles/s41586-018-0817-4</originId><crawled>1547057114190</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Emma Marris</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Galapagos</text></item><item><text>Galápagos</text></item></mentions><label>Galápagos Islands</label><id>nlp/f/entity/en/w/Galápagos Islands</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Island Conservation</text></item></mentions><label>Island Conservation</label><id>nlp/f/entity/en/w/Island Conservation</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Karl Campbell</text></item><item><text>Campbell</text></item></mentions><label>Karl Campbell</label><id>nlp/f/entity/en/-/karl campbell</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Mosquera</text></item></mentions><label>Mosquera</label><id>nlp/f/entity/en/-/mosquera</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Craig Morley</text></item><item><text>Morley</text></item></mentions><label>Craig Morley</label><id>nlp/f/entity/en/-/craig morley</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16880aaa5ea:3516f3f:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Drones unleashed against invasive rats in the Galapagos&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Drones unleashed against invasive rats in the Galapagos, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00176-z&quot;&gt;doi:10.1038/d41586-019-00176-z&lt;/a&gt;&lt;/p&gt;Tiny copters deliver poisoned bait to islands where rodents threaten native birds and plants.</content></content><updateCount>1</updateCount><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00176-z</href></item></alternate><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00176-z/d41586-019-00176-z_16415716.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>e72e7fc0</fingerprint><commonTopics><item><probability>1.0</probability><label>drones</label><id>nlp/f/topic/694</id></item><item><probability>0.996</probability><label>conservation</label><id>nlp/f/topic/532</id></item><item><probability>0.962</probability><label>wildlife</label><id>nlp/f/topic/2486</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00176-z</link><recrawled>1548764816445</recrawled><engagement>26</engagement><title>Drones unleashed against invasive rats in the Galapagos</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Drones unleashed against invasive rats in the Galapagos&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Drones unleashed against invasive rats in the Galapagos, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00176-z&quot;&gt;doi:10.1038/d41586-019-00176-z&lt;/a&gt;&lt;/p&gt;Tiny copters deliver poisoned bait to islands where rodents threaten native birds and plants.</description><originId>https://www.nature.com/articles/d41586-019-00176-z</originId><crawled>1548346893802</crawled><published>1548316800000</published><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Mohammed AlQuraishi</name></author><id>6wY2EtDmLbeMr9WopopAzS1SKiHs2ogsOuunEriW7zs=_1682c9886f9:22aaa7:8675cc2c</id><content><direction>ltr</direction><content>&lt;img alt=&quot;Journal of Computational Chemistry Parallelized Natural Extension Reference Frame: Parallelized Conversion from Internal to Cartesian Coordinates&quot; src=&quot;https://onlinelibrary.wiley.com/cms/attachment/957e1e1c-a854-4b9c-81d2-b17974899b16/jcc25772-toc-0001-m.png&quot;&gt;
&lt;p&gt;Molecular models of polymers such as proteins utilize multiple representations of atomic coordinates, including internal (bond lengths and angles) and Cartesian (explicit positions) representations. Interconversion between these representations is a fundamental procedure in many computational tasks, including emerging machine learning‐based workflows, but is not currently parallelized along the polymer length, limiting utilization of modern CPUs and GPUs. The study describes an algorithm for parallelizing individual polymer interconversion, yielding an order‐of‐magnitude speed up in real‐world applications.
&lt;/p&gt;
&lt;br&gt;
&lt;p&gt;The conversion of polymer parameterization from internal coordinates (bond lengths, angles, and torsions) to Cartesian coordinates is a fundamental task in molecular modeling, often performed using the natural extension reference frame (NeRF) algorithm. NeRF can be parallelized to process multiple polymers simultaneously, but is not parallelizable along the length of a single polymer. A mathematically equivalent algorithm, pNeRF, has been derived that is parallelizable along a polymer&apos;s length. Empirical analysis demonstrates an order‐of‐magnitude speed up using modern GPUs and CPUs. In machine learning‐based workflows, in which partial derivatives are backpropagated through NeRF equations and neural network primitives, switching to pNeRF can reduce the fractional computational cost of coordinate conversion from over two‐thirds to around 10%. An optimized TensorFlow‐based implementation of pNeRF is available on GitHub at &lt;a href=&quot;https://github.com/aqlaboratory/pnerf&quot; title=&quot;Link to external resource&quot; target=&quot;_blank&quot;&gt;https://github.com/aqlaboratory/pnerf&lt;/a&gt; © 2018 Wiley Periodicals, Inc.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25772?af=R</href></item></alternate><published>1546862204000</published><unread>True</unread><summary><direction>ltr</direction><content>Molecular models of polymers such as proteins utilize multiple representations of atomic coordinates, including internal (bond lengths and angles) and Cartesian (explicit positions) representations. Interconversion between these representations is a fundamental procedure in many computational tasks, including emerging machine learning‐based workflows, but is not currently parallelized along the polymer length, limiting utilization of modern CPUs and GPUs. The study describes an algorithm for parallelizing individual polymer interconversion, yielding an order‐of‐magnitude speed up in real‐world applications.
The conversion of polymer parameterization from internal coordinates (bond lengths, angles, and torsions) to Cartesian coordinates is a fundamental task in molecular modeling, often performed using the natural extension reference frame (NeRF) algorithm. NeRF can be parallelized to process multiple polymers simultaneously, but is not parallelizable along the length of a single polymer. A mathematically equivalent algorithm, pNeRF, has been derived that is parallelizable along a polymer&apos;s length. Empirical analysis demonstrates an order‐of‐magnitude speed up using modern GPUs and CPUs. In machine learning‐based workflows, in which partial derivatives are backpropagated through NeRF equations and neural network primitives, switching to pNeRF can reduce the fractional computational cost of coordinate conversion from over two‐thirds to around 10%. An optimized TensorFlow‐based implementation of pNeRF is available on GitHub at https://github.com/aqlaboratory/pnerf © 2018 Wiley Periodicals, Inc.</content></summary><fingerprint>ec4af93b</fingerprint><link>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25772?af=R</link><title>Parallelized Natural Extension Reference Frame: Parallelized Conversion from Internal to Cartesian Coordinates</title><origin><htmlUrl>https://onlinelibrary.wiley.com/journal/1096987x?af=R</htmlUrl><streamId>feed/https://onlinelibrary.wiley.com/action/showFeed?jc=1096987x&amp;type=etoc&amp;feed=rss</streamId><title>Wiley: Journal of Computational Chemistry: Table of Contents</title></origin><description>Molecular models of polymers such as proteins utilize multiple representations of atomic coordinates, including internal (bond lengths and angles) and Cartesian (explicit positions) representations. Interconversion between these representations is a fundamental procedure in many computational tasks, including emerging machine learning‐based workflows, but is not currently parallelized along the polymer length, limiting utilization of modern CPUs and GPUs. The study describes an algorithm for parallelizing individual polymer interconversion, yielding an order‐of‐magnitude speed up in real‐world applications.
The conversion of polymer parameterization from internal coordinates (bond lengths, angles, and torsions) to Cartesian coordinates is a fundamental task in molecular modeling, often performed using the natural extension reference frame (NeRF) algorithm. NeRF can be parallelized to process multiple polymers simultaneously, but is not parallelizable along the length of a single polymer. A mathematically equivalent algorithm, pNeRF, has been derived that is parallelizable along a polymer&apos;s length. Empirical analysis demonstrates an order‐of‐magnitude speed up using modern GPUs and CPUs. In machine learning‐based workflows, in which partial derivatives are backpropagated through NeRF equations and neural network primitives, switching to pNeRF can reduce the fractional computational cost of coordinate conversion from over two‐thirds to around 10%. An optimized TensorFlow‐based implementation of pNeRF is available on GitHub at https://github.com/aqlaboratory/pnerf © 2018 Wiley Periodicals, Inc.</description><originId>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25772?af=R</originId><crawled>1546936420089</crawled><visual><height>394</height><processor>feedly-nikon-v3.1</processor><url>https://onlinelibrary.wiley.com/cms/attachment/957e1e1c-a854-4b9c-81d2-b17974899b16/jcc25772-toc-0001-m.png</url><contentType>image/png; charset=UTF-8</contentType><width>394</width></visual><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Reczek, P. R.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a88:c2ce2e2e</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/354-a?rss=1</href></item></alternate><published>1548355045000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>5e7040a4</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6425/354-a?rss=1</link><engagement>0</engagement><title>We are the (communication) champions</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6425/354-a?rss=1</originId><crawled>1548357093757</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6425/354.1.full</canonicalUrl><keywords><item>Scientific Community</item></keywords></item><item><author><name>Marion Brickwedde</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1685620d6e4:3ad9596:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Somatosensory alpha oscillations gate perceptual learning efficiency&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Somatosensory alpha oscillations gate perceptual learning efficiency, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08012-0&quot;&gt;doi:10.1038/s41467-018-08012-0&lt;/a&gt;&lt;/p&gt;Alpha power is known to play an important role in cognition and perception, but we do not understand the link between alpha power and perceptual learning efficacy. Here, the authors use neurofeedback training to show that increased alpha power enhances learning while reduced alpha impedes learning.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/VgpHDzNYFog&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/VgpHDzNYFog/s41467-018-08012-0</href></item></alternate><published>1547625600000</published><unread>True</unread><visual><height>321</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08012-0/MediaObjects/41467_2018_8012_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>3608051a</fingerprint><link>https://www.nature.com/articles/s41467-018-08012-0</link><engagement>2</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08012-0</href></item></canonical><title>Somatosensory alpha oscillations gate perceptual learning efficiency</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Somatosensory alpha oscillations gate perceptual learning efficiency&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Somatosensory alpha oscillations gate perceptual learning efficiency, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08012-0&quot;&gt;doi:10.1038/s41467-018-08012-0&lt;/a&gt;&lt;/p&gt;Alpha power is known to play an important role in cognition and perception, but we do not understand the link between alpha power and perceptual learning efficacy. Here, the authors use neurofeedback training to show that increased alpha power enhances learning while reduced alpha impedes learning.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/VgpHDzNYFog&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-08012-0</originId><crawled>1547633219300</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Dong, X.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168a5135438:1473248:ad2b6584</id><content><direction>ltr</direction><content>Background: Identification of de novo mutations from cell populations requires single-cell whole-genome sequencing (SCWGS). Although many experimental protocols of SCWGS have been developed, few computational tools are available for downstream analysis of different types of somatic mutations, including copy number variation (CNV). Results: We developed SCCNV, a software tool for detecting CNVs from whole genome-amplified single cells. SCCNV is a read-depth based approach with adjustment for the whole-genome amplification bias. Conclusions: We demonstrate its performance by analyzing data collected from most of the single-cell amplification methods, including DOP-PCR, MDA, MALBAC and LIANTI. SCCNV is freely available at https://github.com/biosinodx/SCCNV.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/535807v1?rss=1</href></item></alternate><published>1548921600000</published><unread>True</unread><fingerprint>7c1ca024</fingerprint><link>http://biorxiv.org/cgi/content/short/535807v1?rss=1</link><engagement>0</engagement><title>SCCNV: a software tool for identifying copy number variation from single-cell whole-genome sequencing [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Background: Identification of de novo mutations from cell populations requires single-cell whole-genome sequencing (SCWGS). Although many experimental protocols of SCWGS have been developed, few computational tools are available for downstream analysis of different types of somatic mutations, including copy number variation (CNV). Results: We developed SCCNV, a software tool for detecting CNVs from whole genome-amplified single cells. SCCNV is a read-depth based approach with adjustment for the whole-genome amplification bias. Conclusions: We demonstrate its performance by analyzing data collected from most of the single-cell amplification methods, including DOP-PCR, MDA, MALBAC and LIANTI. SCCNV is freely available at https://github.com/biosinodx/SCCNV.</description><originId>http://biorxiv.org/cgi/content/short/535807v1?rss=1</originId><crawled>1548957733944</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Florent Réal, 
Valérie Vallet, 
Michel Masella</name></author><id>6wY2EtDmLbeMr9WopopAzS1SKiHs2ogsOuunEriW7zs=_168a438bf8e:12956ba:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;img alt=&quot;Journal of Computational Chemistry Improving the description of solvent pairwise interactions using local solute/solvent three‐body functions. The case of halides and carboxylates in aqueous environment&quot; src=&quot;https://onlinelibrary.wiley.com/cms/attachment/c99104cc-0077-4c61-987e-8d310b8c5ebb/jcc25779-toc-0001-m.png&quot;&gt;
&lt;p&gt;A general strategy is proposed to remediate force‐field artifacts in describing solvent pairwise interactions in the vicinity of a solute, that is based on introducing a three‐body potential energy term that alters the solvent pairwise interactions in a space domain centered at the solute. We apply it to improve the description of the water interactions provided by the polarizable water model TCPE/2013 in the vicinity of halides, from F&lt;sup&gt;−&lt;/sup&gt; to At&lt;sup&gt;−&lt;/sup&gt;, and of the carboxylate anion CH3COO&lt;sup&gt;−&lt;/sup&gt;.
&lt;/p&gt;
&lt;br&gt;
&lt;p&gt;We propose a general strategy to remediate force‐field artifacts in describing pairwise interactions among similar molecules &lt;i&gt;M&lt;/i&gt; in the vicinity of another chemical species, &lt;i&gt;C&lt;/i&gt;, like water molecules interacting at short distance from a monoatomic ion. This strategy is based on introducing a three‐body potential energy term that alters the pairwise interactions among &lt;i&gt;M&lt;/i&gt;‐type molecules when they lie at short range from the species &lt;i&gt;C&lt;/i&gt;. In other words the species &lt;i&gt;C&lt;/i&gt; is the center of a space domain where the pairwise interactions among the molecules &lt;i&gt;M&lt;/i&gt; is altered. Here, we apply it to improve the description of the water interactions provided by the polarizable water model TCPE/2013 in the vicinity of halides, from &lt;span&gt;F&lt;sup&gt;−&lt;/sup&gt;
&lt;/span&gt; to &lt;span&gt;At&lt;sup&gt;−&lt;/sup&gt;
&lt;/span&gt;, and of the prototypical carboxylate anion &lt;span&gt;CH&lt;sub&gt;3&lt;/sub&gt;COO&lt;sup&gt;−&lt;/sup&gt;
&lt;/span&gt;. We show the accuracy and the transferability of such an approach to investigate not only the hydration process of single anions but also of a salt solution in aqueous phase. This strategy can be used to remediate the drawbacks of any kind of force fields. © 2019 Wiley Periodicals, Inc.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25779?af=R</href></item></alternate><published>1548942894000</published><unread>True</unread><summary><direction>ltr</direction><content>A general strategy is proposed to remediate force‐field artifacts in describing solvent pairwise interactions in the vicinity of a solute, that is based on introducing a three‐body potential energy term that alters the solvent pairwise interactions in a space domain centered at the solute. We apply it to improve the description of the water interactions provided by the polarizable water model TCPE/2013 in the vicinity of halides, from F− to At−, and of the carboxylate anion CH3COO−.
We propose a general strategy to remediate force‐field artifacts in describing pairwise interactions among similar molecules M in the vicinity of another chemical species, C, like water molecules interacting at short distance from a monoatomic ion. This strategy is based on introducing a three‐body potential energy term that alters the pairwise interactions among M‐type molecules when they lie at short range from the species C. In other words the species C is the center of a space domain where the pairwise interactions among the molecules M is altered. Here, we apply it to improve the description of the water interactions provided by the polarizable water model TCPE/2013 in the vicinity of halides, from F− to At−, and of the prototypical carboxylate anion CH3COO−. We show the accuracy and the transferability of such an approach to investigate not only the hydration process of single anions but also of a salt solution in aqueous phase. This strategy can be used to remediate the drawbacks of any kind of force fields. © 2019 Wiley Periodicals, Inc.</content></summary><fingerprint>d2ee8ba9</fingerprint><link>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25779?af=R</link><title>Improving the description of solvent pairwise interactions using local solute/solvent three‐body functions. The case of halides and carboxylates in aqueous environment</title><origin><htmlUrl>https://onlinelibrary.wiley.com/journal/1096987x?af=R</htmlUrl><streamId>feed/https://onlinelibrary.wiley.com/action/showFeed?jc=1096987x&amp;type=etoc&amp;feed=rss</streamId><title>Wiley: Journal of Computational Chemistry: Table of Contents</title></origin><description>A general strategy is proposed to remediate force‐field artifacts in describing solvent pairwise interactions in the vicinity of a solute, that is based on introducing a three‐body potential energy term that alters the solvent pairwise interactions in a space domain centered at the solute. We apply it to improve the description of the water interactions provided by the polarizable water model TCPE/2013 in the vicinity of halides, from F− to At−, and of the carboxylate anion CH3COO−.
We propose a general strategy to remediate force‐field artifacts in describing pairwise interactions among similar molecules M in the vicinity of another chemical species, C, like water molecules interacting at short distance from a monoatomic ion. This strategy is based on introducing a three‐body potential energy term that alters the pairwise interactions among M‐type molecules when they lie at short range from the species C. In other words the species C is the center of a space domain where the pairwise interactions among the molecules M is altered. Here, we apply it to improve the description of the water interactions provided by the polarizable water model TCPE/2013 in the vicinity of halides, from F− to At−, and of the prototypical carboxylate anion CH3COO−. We show the accuracy and the transferability of such an approach to investigate not only the hydration process of single anions but also of a salt solution in aqueous phase. This strategy can be used to remediate the drawbacks of any kind of force fields. © 2019 Wiley Periodicals, Inc.</description><originId>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25779?af=R</originId><crawled>1548943409038</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Jérôme Galon</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>O</text></item></mentions><label>O</label><id>nlp/f/entity/en/-/o</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>PD - 1</text></item></mentions><label>PD - 1</label><id>nlp/f/entity/en/-/pd - 1</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>J. Clin</text></item><item><text>Clin</text></item></mentions><label>J. Clin</label><id>nlp/f/entity/en/-/j. clin</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Nat</text></item></mentions><label>Nat</label><id>nlp/f/entity/en/-/nat</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>J. Oncol</text></item><item><text>Oncol</text></item></mentions><label>J. Oncol</label><id>nlp/f/entity/en/-/j. oncol</id></item></entities><id>YLwIhSxZAzQIEnJq1FGGcXUQMCbQUlr9cyNMExMVeyY=_16819b4bee3:4c6cb5:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Approaches to treat immune hot, altered and cold tumours with combination immunotherapies&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Approaches to treat immune hot, altered and cold tumours with combination immunotherapies, Published online: 04 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41573-018-0007-y&quot;&gt;doi:10.1038/s41573-018-0007-y&lt;/a&gt;&lt;/p&gt;Immunoscore classifies cancers according to their immune infiltration. In this Review, Galon and Bruni provide a panel of therapeutic strategies to use, combine and develop to treat hot, altered and cold tumours.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/SjvdXY5aVks&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nrd/rss/current/~3/SjvdXY5aVks/s41573-018-0007-y</href></item></alternate><published>1546588800000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41573-018-0007-y/MediaObjects/41573_2018_7_Fig1_HTML.png</url><contentType>image/png</contentType><width>560</width></visual><fingerprint>aea3987f</fingerprint><commonTopics><item><probability>0.988</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.949</probability><label>cancer</label><id>nlp/f/topic/377</id></item><item><probability>0.932</probability><label>classics</label><id>nlp/f/topic/477</id></item><item><probability>0.927</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.882</probability><label>hematology</label><id>nlp/f/topic/1058</id></item><item><probability>0.844</probability><label>emergency medicine</label><id>nlp/f/topic/764</id></item><item><probability>0.818</probability><label>rationality</label><id>nlp/f/topic/1895</id></item><item><probability>0.783</probability><label>mp3</label><id>nlp/f/topic/1508</id></item><item><probability>0.719</probability><label>ecology</label><id>nlp/f/topic/725</id></item><item><probability>0.718</probability><label>fat</label><id>nlp/f/topic/842</id></item></commonTopics><link>https://www.nature.com/articles/s41573-018-0007-y</link><engagement>3</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41573-018-0007-y</href></item></canonical><title>Approaches to treat immune hot, altered and cold tumours with combination immunotherapies</title><origin><htmlUrl>http://feeds.nature.com/nrd/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nrd/rss/current</streamId><title>Nature Reviews Drug Discovery - Issue - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Approaches to treat immune hot, altered and cold tumours with combination immunotherapies&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Approaches to treat immune hot, altered and cold tumours with combination immunotherapies, Published online: 04 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41573-018-0007-y&quot;&gt;doi:10.1038/s41573-018-0007-y&lt;/a&gt;&lt;/p&gt;Immunoscore classifies cancers according to their immune infiltration. In this Review, Galon and Bruni provide a panel of therapeutic strategies to use, combine and develop to treat hot, altered and cold tumours.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/SjvdXY5aVks&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41573-018-0007-y</originId><crawled>1546619502307</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Stern, P.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168a5541f68:150809c:3a104d3b</id><published>1548959829000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>6ddf552c</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6426/495-d?rss=1</link><engagement>0</engagement><crawled>1548961980264</crawled><title>Cognitive aging and memory</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6426/495-d?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6426/495-d?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6426/495.4.full</canonicalUrl></item><item><author><name>David J. Haw</name></author><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_16876e5d729:325dae2:b77f238b</id><content><direction>ltr</direction><content>&lt;p&gt;by David J. Haw, Derek A. T. Cummings, Justin Lessler, Henrik Salje, Jonathan M. Read, Steven Riley&lt;/p&gt;
Infectious disease transmission in animals is an inherently spatial process in which a host’s home location and their social mixing patterns are important, with the mixing of infectious individuals often different to that of susceptible individuals. Although incidence data for humans have traditionally been aggregated into low-resolution data sets, modern representative surveillance systems such as electronic hospital records generate high volume case data with precise home locations. Here, we use a gridded spatial transmission model of arbitrary resolution to investigate the theoretical relationship between population density, differential population movement and local variability in incidence. We show analytically that a uniform local attack rate is only possible for individual pixels in the grid if susceptible and infectious individuals move in the same way. Using a population in Guangdong, China, for which a robust quantitative description of movement is available (a movement kernel), and a natural history consistent with pandemic influenza; we show that local cumulative incidence is positively correlated with population density when susceptible individuals are more connected in space than infectious individuals. Conversely, under the less intuitively likely scenario, when infectious individuals are more connected, local cumulative incidence is negatively correlated with population density. The strength and direction of correlation changes sign for other kernel parameter values. We show that simulation models in which it is assumed implicitly that only infectious individuals move are assuming a slightly unusual specific correlation between population density and attack rate. However, we also show that this potential structural bias can be corrected by using the appropriate non-isotropic kernel that maps infectious-only code onto the isotropic dual-mobility kernel. These results describe a precise relationship between the spatio-social mixing of infectious and susceptible individuals and local variability in attack rates. More generally, these results suggest a genuine risk that mechanistic models of high-resolution attack rate data may reach spurious conclusions if the precise implications of spatial force-of-infection assumptions are not first fully characterized, prior to models being fit to data.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/bSUhdjfqBC8&quot; height=&quot;1&quot;&gt;</content></content><updateCount>1</updateCount><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/bSUhdjfqBC8/article</href></item></alternate><published>1548194400000</published><unread>True</unread><fingerprint>24f86c8e</fingerprint><link>10.1371/journal.pcbi.1006600</link><recrawled>1548192423393</recrawled><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006600</href></item></canonical><updated>1548194400000</updated><engagement>0</engagement><title>Differential mobility and local variation in infection attack rate</title><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><description>&lt;p&gt;by David J. Haw, Derek A. T. Cummings, Justin Lessler, Henrik Salje, Jonathan M. Read, Steven Riley&lt;/p&gt;
Infectious disease transmission in animals is an inherently spatial process in which a host’s home location and their social mixing patterns are important, with the mixing of infectious individuals often different to that of susceptible individuals. Although incidence data for humans have traditionally been aggregated into low-resolution data sets, modern representative surveillance systems such as electronic hospital records generate high volume case data with precise home locations. Here, we use a gridded spatial transmission model of arbitrary resolution to investigate the theoretical relationship between population density, differential population movement and local variability in incidence. We show analytically that a uniform local attack rate is only possible for individual pixels in the grid if susceptible and infectious individuals move in the same way. Using a population in Guangdong, China, for which a robust quantitative description of movement is available (a movement kernel), and a natural history consistent with pandemic influenza; we show that local cumulative incidence is positively correlated with population density when susceptible individuals are more connected in space than infectious individuals. Conversely, under the less intuitively likely scenario, when infectious individuals are more connected, local cumulative incidence is negatively correlated with population density. The strength and direction of correlation changes sign for other kernel parameter values. We show that simulation models in which it is assumed implicitly that only infectious individuals move are assuming a slightly unusual specific correlation between population density and attack rate. However, we also show that this potential structural bias can be corrected by using the appropriate non-isotropic kernel that maps infectious-only code onto the isotropic dual-mobility kernel. These results describe a precise relationship between the spatio-social mixing of infectious and susceptible individuals and local variability in attack rates. More generally, these results suggest a genuine risk that mechanistic models of high-resolution attack rate data may reach spurious conclusions if the precise implications of spatial force-of-infection assumptions are not first fully characterized, prior to models being fit to data.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/bSUhdjfqBC8&quot; height=&quot;1&quot;&gt;</description><originId>10.1371/journal.pcbi.1006600</originId><crawled>1548183000873</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Hannah Stower</name></author><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>WEBSITEnature_com</text></item></mentions><label>WEBSITEnature_com</label><id>nlp/f/entity/en/-/websitenature_com</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>CSS</text></item></mentions><label>Cascading Style Sheets</label><id>nlp/f/entity/en/w/Cascading Style Sheets</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Explorer</text></item></mentions><label>Explorer</label><id>nlp/f/entity/en/-/explorer</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>JavaScript</text></item></mentions><label>JavaScript</label><id>nlp/f/entity/en/w/JavaScript</id></item></entities><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_1682910372d:1629684:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Combination therapy&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Combination therapy, Published online: 07 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0328-8&quot;&gt;doi:10.1038/s41591-018-0328-8&lt;/a&gt;&lt;/p&gt;Combination therapy&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/nbWjVnCBPho&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/nbWjVnCBPho/s41591-018-0328-8</href></item></alternate><published>1546848000000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>66cb6c5b</fingerprint><commonTopics><item><probability>0.933</probability><label>web design</label><id>nlp/f/topic/2461</id></item><item><probability>0.933</probability><label>css</label><id>nlp/f/topic/590</id></item></commonTopics><link>https://www.nature.com/articles/s41591-018-0328-8</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41591-018-0328-8</href></item></canonical><title>Combination therapy</title><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Combination therapy&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Combination therapy, Published online: 07 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0328-8&quot;&gt;doi:10.1038/s41591-018-0328-8&lt;/a&gt;&lt;/p&gt;Combination therapy&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/nbWjVnCBPho&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41591-018-0328-8</originId><crawled>1546877155117</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Matsuda, T., Kawakami, R., Namba, R., Nakajima, T., Gong, J. P.</name></author><content><direction>ltr</direction><content>&lt;p&gt;Living tissues, such as muscle, autonomously grow and remodel themselves to adapt to their surrounding mechanical environment through metabolic processes. By contrast, typical synthetic materials cannot grow and reconstruct their structures once formed. We propose a strategy for developing &amp;quot;self-growing&amp;quot; polymeric materials that respond to repetitive mechanical stress through an effective mechanochemical transduction. Robust double-network hydrogels provided with a sustained monomer supply undergo self-growth, and the materials are substantially strengthened under repetitive loading through a structural destruction-reconstruction process. This strategy also endows the hydrogels with tailored functions at desired positions by mechanical stamping. This work may pave the way for the development of self-growing gel materials for applications such as soft robots and intelligent devices.&lt;/p&gt;</content></content><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168a5541f68:1508097:3a104d3b</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6426/504?rss=1</href></item></alternate><published>1548959829000</published><unread>True</unread><fingerprint>cd66370</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6426/504?rss=1</link><engagement>0</engagement><title>Mechanoresponsive self-growing hydrogels inspired by muscle training</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><description>&lt;p&gt;Living tissues, such as muscle, autonomously grow and remodel themselves to adapt to their surrounding mechanical environment through metabolic processes. By contrast, typical synthetic materials cannot grow and reconstruct their structures once formed. We propose a strategy for developing &amp;quot;self-growing&amp;quot; polymeric materials that respond to repetitive mechanical stress through an effective mechanochemical transduction. Robust double-network hydrogels provided with a sustained monomer supply undergo self-growth, and the materials are substantially strengthened under repetitive loading through a structural destruction-reconstruction process. This strategy also endows the hydrogels with tailored functions at desired positions by mechanical stamping. This work may pave the way for the development of self-growing gel materials for applications such as soft robots and intelligent devices.&lt;/p&gt;</description><originId>http://science.sciencemag.org/cgi/content/short/363/6426/504?rss=1</originId><crawled>1548961980264</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6426/504.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><keywords><item>Materials Science</item></keywords></item><item><author><name>Lovett, R. A.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168a5541f68:15080cd:3a104d3b</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6426/437?rss=1</href></item></alternate><published>1548959829000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>a23173c</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6426/437?rss=1</link><engagement>0</engagement><title>Ancient Earth rock found on the moon</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6426/437?rss=1</originId><crawled>1548961980264</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6426/437.full</canonicalUrl><keywords><item>Astronomy, Planetary Science</item></keywords></item><item><author><name>Yang, L., Li, Y., Bhattacharya, A., Zhang, Y.</name></author><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1687c1a95dc:2f6433f:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;Resistance to current human epidermal growth factor receptor 2 (HER2) inhibitors, such as trastuzumab (Ttzm), is a major unresolved clinical problem in HER2-positive breast cancer (HER2-BC). Because HER2 remains overexpressed in drug-resistant HER2-BC cells, we investigated whether PEPD&lt;sup&gt;G278D&lt;/sup&gt; can overcome the resistance. PEPD&lt;sup&gt;G278D&lt;/sup&gt; is a recombinant enzymatically inactive mutant of human peptidase D, which strongly inhibits HER2 in cancer cells by binding to its extracellular domain. Here, we show that PEPD&lt;sup&gt;G278D&lt;/sup&gt; is highly active in preclinical models of HER2-BC resistant to Ttzm and other HER2 inhibitors and also enhances the therapeutic efficacy of paclitaxel. The therapeutic activity is underscored by its ability to bind to HER2 and free it from protection by mucin 4, disrupt its interplay with other receptor tyrosine kinases, and subsequently direct HER2 for degradation. PEPD&lt;sup&gt;G278D&lt;/sup&gt; also down-regulates epidermal growth factor receptor, which contributes to drug resistance in HER2-BC. In contrast, Ttzm, whose therapeutic activity also depends on its binding to the extracellular domain of HER2, cannot perform any of these functions of PEPD&lt;sup&gt;G278D&lt;/sup&gt;. PEPD&lt;sup&gt;G278D&lt;/sup&gt; inhibits HER2-BC cells and tumors that carry clinically relevant molecular changes that confer resistance to Ttzm. Our results show that HER2 remains a critical target in drug-resistant HER2-BC and that PEPD&lt;sup&gt;G278D&lt;/sup&gt; is a promising agent for overcoming drug resistance in this disease.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/476/eaav1620?rss=1</href></item></alternate><published>1548269442000</published><unread>True</unread><fingerprint>12e417a6</fingerprint><link>http://stm.sciencemag.org/cgi/content/short/11/476/eaav1620?rss=1</link><engagement>34</engagement><title>[Research Articles] A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer</title><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><description>&lt;p&gt;Resistance to current human epidermal growth factor receptor 2 (HER2) inhibitors, such as trastuzumab (Ttzm), is a major unresolved clinical problem in HER2-positive breast cancer (HER2-BC). Because HER2 remains overexpressed in drug-resistant HER2-BC cells, we investigated whether PEPD&lt;sup&gt;G278D&lt;/sup&gt; can overcome the resistance. PEPD&lt;sup&gt;G278D&lt;/sup&gt; is a recombinant enzymatically inactive mutant of human peptidase D, which strongly inhibits HER2 in cancer cells by binding to its extracellular domain. Here, we show that PEPD&lt;sup&gt;G278D&lt;/sup&gt; is highly active in preclinical models of HER2-BC resistant to Ttzm and other HER2 inhibitors and also enhances the therapeutic efficacy of paclitaxel. The therapeutic activity is underscored by its ability to bind to HER2 and free it from protection by mucin 4, disrupt its interplay with other receptor tyrosine kinases, and subsequently direct HER2 for degradation. PEPD&lt;sup&gt;G278D&lt;/sup&gt; also down-regulates epidermal growth factor receptor, which contributes to drug resistance in HER2-BC. In contrast, Ttzm, whose therapeutic activity also depends on its binding to the extracellular domain of HER2, cannot perform any of these functions of PEPD&lt;sup&gt;G278D&lt;/sup&gt;. PEPD&lt;sup&gt;G278D&lt;/sup&gt; inhibits HER2-BC cells and tumors that carry clinically relevant molecular changes that confer resistance to Ttzm. Our results show that HER2 remains a critical target in drug-resistant HER2-BC and that PEPD&lt;sup&gt;G278D&lt;/sup&gt; is a promising agent for overcoming drug resistance in this disease.&lt;/p&gt;</description><originId>http://stm.sciencemag.org/cgi/content/short/11/476/eaav1620?rss=1</originId><crawled>1548270343644</crawled><canonicalUrl>http://stm.sciencemag.org/content/11/476/eaav1620.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Jennifer Rampling</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Aristotle</text></item></mentions><label>Aristotle</label><id>nlp/f/entity/en/w/Aristotle</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>sixteenth century</text></item></mentions><label>sixteenth century</label><id>nlp/f/entity/en/-/sixteenth century</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Son</text></item></mentions><label>Son</label><id>nlp/f/entity/en/-/son</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Alamy</text></item></mentions><label>Alamy</label><id>nlp/f/entity/en/w/Alamy</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Democritus</text></item></mentions><label>Democritus</label><id>nlp/f/entity/en/w/Democritus</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168993d8792:220316:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;More than 2,000 years of elements: a prehistory of the periodic table&lt;/b&gt;&lt;/p&gt;&lt;p&gt;More than 2,000 years of elements: a prehistory of the periodic table, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00289-5&quot;&gt;doi:10.1038/d41586-019-00289-5&lt;/a&gt;&lt;/p&gt;Jennifer Rampling traces how ideas of material essence and indivisibility evolved in the centuries before modern atomic theory.</content></content><engagementRate>0.67</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00289-5</href></item></alternate><published>1548748800000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00289-5/d41586-019-00289-5_16420138.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>40d6f624</fingerprint><commonTopics><item><probability>0.849</probability><label>history</label><id>nlp/f/topic/1068</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00289-5</link><engagement>6</engagement><title>More than 2,000 years of elements: a prehistory of the periodic table</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;More than 2,000 years of elements: a prehistory of the periodic table&lt;/b&gt;&lt;/p&gt;&lt;p&gt;More than 2,000 years of elements: a prehistory of the periodic table, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00289-5&quot;&gt;doi:10.1038/d41586-019-00289-5&lt;/a&gt;&lt;/p&gt;Jennifer Rampling traces how ideas of material essence and indivisibility evolved in the centuries before modern atomic theory.</description><originId>https://www.nature.com/articles/d41586-019-00289-5</originId><crawled>1548759173010</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_16857b48157:3d4da02:c2ce2e2e</id><published>1547596800000</published><unread>True</unread><summary><direction>ltr</direction><content>AKT1 is emerging as a useful target for treating cancer. Herein, we discovered a new set of ligands that inhibit the AKT1, as shown by in vitro binding and cell line studies, using a newly designed virtual screening protocol that combines structure-based pharmacophore and docking screens. Taking together with the biological data, the combination of structure based pharamcophore and docking methods demonstrated reasonable success rate in identifying new inhibitors (60-70%) proving the success of aforementioned approach. A detail analysis of the ligand-protein interactions was performed explaining observed activities.</content></summary><fingerprint>691927b</fingerprint><link>https://chemrxiv.org/articles/Discovery_of_New_AKT1_Inhibitors_by_Combination_of_In_silico_Structure_Based_Virtual_Screening_Approaches_and_Biological_Evaluations/7591202</link><engagement>0</engagement><crawled>1547659673943</crawled><title>Discovery of New AKT1 Inhibitors by Combination of In silico Structure Based Virtual Screening Approaches and Biological Evaluations</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>AKT1 is emerging as a useful target for treating cancer. Herein, we discovered a new set of ligands that inhibit the AKT1, as shown by in vitro binding and cell line studies, using a newly designed virtual screening protocol that combines structure-based pharmacophore and docking screens. Taking together with the biological data, the combination of structure based pharamcophore and docking methods demonstrated reasonable success rate in identifying new inhibitors (60-70%) proving the success of aforementioned approach. A detail analysis of the ligand-protein interactions was performed explaining observed activities.</description><originId>https://chemrxiv.org/articles/Discovery_of_New_AKT1_Inhibitors_by_Combination_of_In_silico_Structure_Based_Virtual_Screening_Approaches_and_Biological_Evaluations/7591202</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Discovery_of_New_AKT1_Inhibitors_by_Combination_of_In_silico_Structure_Based_Virtual_Screening_Approaches_and_Biological_Evaluations/7591202</href></item></alternate></item><item><author><name>Hamid Bolouri</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Publisher Correction</text></item></mentions><label>Publisher Correction</label><id>nlp/f/entity/en/-/publisher correction</id></item></entities><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_168a4b9a9a0:137c5c0:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Publisher Correction: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Publisher Correction: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions, Published online: 31 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-019-0369-7&quot;&gt;doi:10.1038/s41591-019-0369-7&lt;/a&gt;&lt;/p&gt;Publisher Correction: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/fh4jgvWnhXA&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/fh4jgvWnhXA/s41591-019-0369-7</href></item></alternate><published>1548921600000</published><unread>True</unread><fingerprint>6a0d7f66</fingerprint><commonTopics><item><probability>0.918</probability><label>hematology</label><id>nlp/f/topic/1058</id></item></commonTopics><link>https://www.nature.com/articles/s41591-019-0369-7</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41591-019-0369-7</href></item></canonical><title>Publisher Correction: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions</title><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Publisher Correction: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Publisher Correction: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions, Published online: 31 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-019-0369-7&quot;&gt;doi:10.1038/s41591-019-0369-7&lt;/a&gt;&lt;/p&gt;Publisher Correction: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/fh4jgvWnhXA&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41591-019-0369-7</originId><crawled>1548951857568</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Kelly Krause</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Frankel</text></item><item><text>Felice Frankel</text></item></mentions><label>Felice Frankel</label><id>nlp/f/entity/en/w/Felice Frankel</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Picturing Science and Engineering</text></item><item><text>Picturing Science</text></item></mentions><label>Picturing Science and Engineering</label><id>nlp/f/entity/en/-/picturing science and engineering</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Twitter</text></item></mentions><label>Twitter</label><id>nlp/f/entity/en/w/Twitter</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Felice C. Frankel MIT Press</text></item></mentions><label>Felice C. Frankel MIT Press</label><id>nlp/f/entity/en/-/felice c. frankel mit press</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>velvet</text></item></mentions><label>velvet</label><id>nlp/f/entity/en/-/velvet</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168a34f7224:117ae4f:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;How to land a journal cover&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How to land a journal cover, Published online: 31 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00349-w&quot;&gt;doi:10.1038/d41586-019-00349-w&lt;/a&gt;&lt;/p&gt;Kelly Krause extols a handbook on the art and science of the research photo shoot from Felice Frankel.</content></content><engagementRate>1.25</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00349-w</href></item></alternate><published>1548921600000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00349-w/d41586-019-00349-w_16427176.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>cd31a888</fingerprint><commonTopics><item><probability>0.958</probability><label>religion</label><id>nlp/f/topic/1928</id></item><item><probability>0.937</probability><label>photography</label><id>nlp/f/topic/1748</id></item><item><probability>0.908</probability><label>lightroom</label><id>nlp/f/topic/1342</id></item><item><probability>0.876</probability><label>children</label><id>nlp/f/topic/444</id></item><item><probability>0.868</probability><label>science</label><id>nlp/f/topic/2017</id></item><item><probability>0.864</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item><item><probability>0.839</probability><label>music</label><id>nlp/f/topic/1521</id></item><item><probability>0.816</probability><label>nano</label><id>nlp/f/topic/1532</id></item><item><probability>0.8</probability><label>pediatrics</label><id>nlp/f/topic/1714</id></item><item><probability>0.742</probability><label>skepticism</label><id>nlp/f/topic/2081</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00349-w</link><engagement>5</engagement><title>How to land a journal cover</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;How to land a journal cover&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How to land a journal cover, Published online: 31 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00349-w&quot;&gt;doi:10.1038/d41586-019-00349-w&lt;/a&gt;&lt;/p&gt;Kelly Krause extols a handbook on the art and science of the research photo shoot from Felice Frankel.</description><originId>https://www.nature.com/articles/d41586-019-00349-w</originId><crawled>1548928119332</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Ferrarelli, L. K.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168a5541f68:15080a1:3a104d3b</id><published>1548959829000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>d590999c</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6426/494-p?rss=1</link><engagement>0</engagement><crawled>1548961980264</crawled><title>SP3 is key to Smac mimetic efficacy</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6426/494-p?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6426/494-p?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6426/494.16.full</canonicalUrl></item><item><author><name>Ludivine C. Litzler</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_168133ec2e2:66e24e1:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;PRMT5 is essential for B cell development and germinal center dynamics&lt;/b&gt;&lt;/p&gt;&lt;p&gt;PRMT5 is essential for B cell development and germinal center dynamics, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07884-6&quot;&gt;doi:10.1038/s41467-018-07884-6&lt;/a&gt;&lt;/p&gt;Protective antibody responses depend critically on proper B cell development and differentiation at multiple stages. Here the authors show that a protein arginine methyltransferase, Prmt5 uses multiples pathways to prevent death of immature B cells, yet modulates, in p53-independent manners, the survival and differentiation of mature B cells.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/xJTK5jameck&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/xJTK5jameck/s41467-018-07884-6</href></item></alternate><published>1546502400000</published><unread>True</unread><visual><height>461</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-07884-6/MediaObjects/41467_2018_7884_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>74a42412</fingerprint><link>https://www.nature.com/articles/s41467-018-07884-6</link><engagement>31</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-07884-6</href></item></canonical><title>PRMT5 is essential for B cell development and germinal center dynamics</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;PRMT5 is essential for B cell development and germinal center dynamics&lt;/b&gt;&lt;/p&gt;&lt;p&gt;PRMT5 is essential for B cell development and germinal center dynamics, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07884-6&quot;&gt;doi:10.1038/s41467-018-07884-6&lt;/a&gt;&lt;/p&gt;Protective antibody responses depend critically on proper B cell development and differentiation at multiple stages. Here the authors show that a protein arginine methyltransferase, Prmt5 uses multiples pathways to prevent death of immature B cells, yet modulates, in p53-independent manners, the survival and differentiation of mature B cells.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/xJTK5jameck&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-07884-6</originId><crawled>1546511106786</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Taylor, J. M.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1687dcb412d:31d4741:3a104d3b</id><content><direction>ltr</direction><content>Three-dimensional fluorescence time-lapse imaging of structural, cellular and subcellular processes in the beating heart is an increasingly achievable goal using the latest imaging and computational techniques. However, previous approaches have had significant limitations. Temporarily arresting the heart using drugs disrupts the heart&apos;s physiological state, and the use of ultra-high frame-rates for fluorescence image acquisition causes phototoxic cell damage. Real-time triggered imaging, synchronized to a specific phase in the cardiac-cycle, can computationally &amp;quot;freeze&amp;quot; the heart to acquire the minimal number of fluorescence images required for 3D time-lapse imaging. However, until now no solution has been able to maintain phase-lock to the same point in the cardiac cycle for more than about one hour. Our new hybrid optical gating system maintains phase-lock for up to 24 h, acquiring synchronized 3D+time video stacks of the unperturbed heart in vivo. This approach has enabled us to observe detailed developmental, structural, cellular and subcellular processes, including live cell division and cell fate tracking, in the embryonic zebrafish heart using transgenic fish lines expressing cell-specific fluorophores. We show that our approach not only provides high spatial and temporal resolution 3D-imaging, but also avoids phototoxic injury, where alternative approaches induce measurable harm. This provides superb cellular and subcellular imaging of the heart while it is beating in its normal physiological state, and opens up new and exciting opportunities for further study in the heart and other moving cellular and subcellular structures in vivo.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/526830v1?rss=1</href></item></alternate><published>1548230400000</published><unread>True</unread><fingerprint>f917413f</fingerprint><link>http://biorxiv.org/cgi/content/short/526830v1?rss=1</link><engagement>0</engagement><title>Hybrid optical gating for long-term 3D time-lapse imaging of the beating embryonic zebrafish heart [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Three-dimensional fluorescence time-lapse imaging of structural, cellular and subcellular processes in the beating heart is an increasingly achievable goal using the latest imaging and computational techniques. However, previous approaches have had significant limitations. Temporarily arresting the heart using drugs disrupts the heart&apos;s physiological state, and the use of ultra-high frame-rates for fluorescence image acquisition causes phototoxic cell damage. Real-time triggered imaging, synchronized to a specific phase in the cardiac-cycle, can computationally &amp;quot;freeze&amp;quot; the heart to acquire the minimal number of fluorescence images required for 3D time-lapse imaging. However, until now no solution has been able to maintain phase-lock to the same point in the cardiac cycle for more than about one hour. Our new hybrid optical gating system maintains phase-lock for up to 24 h, acquiring synchronized 3D+time video stacks of the unperturbed heart in vivo. This approach has enabled us to observe detailed developmental, structural, cellular and subcellular processes, including live cell division and cell fate tracking, in the embryonic zebrafish heart using transgenic fish lines expressing cell-specific fluorophores. We show that our approach not only provides high spatial and temporal resolution 3D-imaging, but also avoids phototoxic injury, where alternative approaches induce measurable harm. This provides superb cellular and subcellular imaging of the heart while it is beating in its normal physiological state, and opens up new and exciting opportunities for further study in the heart and other moving cellular and subcellular structures in vivo.</description><originId>http://biorxiv.org/cgi/content/short/526830v1?rss=1</originId><crawled>1548298699053</crawled><canonicalUrl>https://www.biorxiv.org/content/10.1101/526830v1</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Marchet, C.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168295c4696:16a7e4d:ad2b6584</id><content><direction>ltr</direction><content>Motivation: In the last few years, third generation sequencing error rates have been capped above 5%, including many insertions and deletions. Thereby, an increasing number of long reads correction methods have been proposed to reduce the noise in these sequences. Whether hybrid or self-correction methods, there exist multiple approaches to correct long reads data. As the quality of the error correction has huge impacts on downstream processes, developing methods allowing to evaluate error correction tools with precise and reliable statistics is therefore a crucial need. Since error correction is often a resource bottleneck in long reads pipelines. A key feature of assessment methods is therefore to be efficient, in order to allow the fast comparison of different tools. Results: We propose ELECTOR, a reliable and efficient tool to evaluate long reads correction, that enables the evaluation of hybrid and self-correction methods. Our tool provides a complete and relevant set of metrics to assess the read quality improvement after correction and scales to large datasets. ELECTOR is directly compatible with a wide range of state-of-the-art error correction tools, using whether simulated or real long reads. We show that ELECTOR displays a wider range of metrics than the state-of-the-art tool, LRCstats, and additionally importantly decreases the runtime needed for assessment on most datasets.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/512889v1?rss=1</href></item></alternate><published>1546848000000</published><unread>True</unread><fingerprint>43974156</fingerprint><link>http://biorxiv.org/cgi/content/short/512889v1?rss=1</link><engagement>0</engagement><title>ELECTOR: Evaluator for long reads correction methods [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Motivation: In the last few years, third generation sequencing error rates have been capped above 5%, including many insertions and deletions. Thereby, an increasing number of long reads correction methods have been proposed to reduce the noise in these sequences. Whether hybrid or self-correction methods, there exist multiple approaches to correct long reads data. As the quality of the error correction has huge impacts on downstream processes, developing methods allowing to evaluate error correction tools with precise and reliable statistics is therefore a crucial need. Since error correction is often a resource bottleneck in long reads pipelines. A key feature of assessment methods is therefore to be efficient, in order to allow the fast comparison of different tools. Results: We propose ELECTOR, a reliable and efficient tool to evaluate long reads correction, that enables the evaluation of hybrid and self-correction methods. Our tool provides a complete and relevant set of metrics to assess the read quality improvement after correction and scales to large datasets. ELECTOR is directly compatible with a wide range of state-of-the-art error correction tools, using whether simulated or real long reads. We show that ELECTOR displays a wider range of metrics than the state-of-the-art tool, LRCstats, and additionally importantly decreases the runtime needed for assessment on most datasets.</description><originId>http://biorxiv.org/cgi/content/short/512889v1?rss=1</originId><crawled>1546882139798</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/07/512889</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Mustafa, M. I.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1684d17a89e:2d264d9:c2ce2e2e</id><content><direction>ltr</direction><content>Background: Hereditary pancreatitis (HP) is an autosomal dominant disorder with incomplete penetrance characterized by recurring episodes of severe abdominal pain often presenting in childhood. The comprehensive in silico analysis of coding SNPs, and their functional impacts on protein level, still remains unknown. In this study, we aimed to identify the pathogenic SNPs in PRSS1 gene by computational analysis approach. Materials and Methods: We carried out in silico analysis of structural effect of each SNP using different bioinformatics tools to predict Single-nucleotide polymorphisms influence on protein structure and function. Result: Two novel mutations out of 339 nsSNPs that are found be deleterious effect on the PRSS1 structure and function. Conclusion: This is the first in silico analysis in PRSS1 gene, which will be a valuable resource for future targeted mechanistic and population-based studies.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/519926v1?rss=1</href></item></alternate><published>1547452800000</published><unread>True</unread><fingerprint>849d7ee4</fingerprint><link>http://biorxiv.org/cgi/content/short/519926v1?rss=1</link><engagement>0</engagement><title>Novel mutations within PRSS1 Gene that could potentially cause hereditary pancreatitis: Using Comprehensive in silico Approach [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Background: Hereditary pancreatitis (HP) is an autosomal dominant disorder with incomplete penetrance characterized by recurring episodes of severe abdominal pain often presenting in childhood. The comprehensive in silico analysis of coding SNPs, and their functional impacts on protein level, still remains unknown. In this study, we aimed to identify the pathogenic SNPs in PRSS1 gene by computational analysis approach. Materials and Methods: We carried out in silico analysis of structural effect of each SNP using different bioinformatics tools to predict Single-nucleotide polymorphisms influence on protein structure and function. Result: Two novel mutations out of 339 nsSNPs that are found be deleterious effect on the PRSS1 structure and function. Conclusion: This is the first in silico analysis in PRSS1 gene, which will be a valuable resource for future targeted mechanistic and population-based studies.</description><originId>http://biorxiv.org/cgi/content/short/519926v1?rss=1</originId><crawled>1547481622686</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/14/519926</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Katrin Möller</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_168a37fcf91:11e1ecb:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;MITF has a central role in regulating starvation-induced autophagy in melanoma&lt;/b&gt;&lt;/p&gt;&lt;p&gt;MITF has a central role in regulating starvation-induced autophagy in melanoma, Published online: 31 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37522-6&quot;&gt;doi:10.1038/s41598-018-37522-6&lt;/a&gt;&lt;/p&gt;MITF has a central role in regulating starvation-induced autophagy in melanoma&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/0t_7A4QYUCw&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/0t_7A4QYUCw/s41598-018-37522-6</href></item></alternate><published>1548921600000</published><unread>True</unread><visual><height>338</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37522-6/MediaObjects/41598_2018_37522_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>e2915fe4</fingerprint><link>https://www.nature.com/articles/s41598-018-37522-6</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37522-6</href></item></canonical><title>MITF has a central role in regulating starvation-induced autophagy in melanoma</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;MITF has a central role in regulating starvation-induced autophagy in melanoma&lt;/b&gt;&lt;/p&gt;&lt;p&gt;MITF has a central role in regulating starvation-induced autophagy in melanoma, Published online: 31 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37522-6&quot;&gt;doi:10.1038/s41598-018-37522-6&lt;/a&gt;&lt;/p&gt;MITF has a central role in regulating starvation-induced autophagy in melanoma&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/0t_7A4QYUCw&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-37522-6</originId><crawled>1548931288977</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>NA</name></author><id>6wY2EtDmLbeMr9WopopAzS1SKiHs2ogsOuunEriW7zs=_1688955e43c:4237aef:3a104d3b</id><content><direction>ltr</direction><content>Journal of Computational Chemistry, Volume 40, Issue 8, Page 911-915, March 30, 2019.</content></content><alternate><item><type>text/html</type><href>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25470?af=R</href></item></alternate><published>1548415794000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>935e8dd4</fingerprint><link>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25470?af=R</link><title>Issue Information</title><origin><htmlUrl>https://onlinelibrary.wiley.com/journal/1096987x?af=R</htmlUrl><streamId>feed/https://onlinelibrary.wiley.com/action/showFeed?jc=1096987x&amp;type=etoc&amp;feed=rss</streamId><title>Wiley: Journal of Computational Chemistry: Table of Contents</title></origin><description>Journal of Computational Chemistry, Volume 40, Issue 8, Page 911-915, March 30, 2019.</description><originId>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25470?af=R</originId><crawled>1548492334140</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Alexander Kirpich, Mukundan Ragavan, James A. Bankson, Lauren M. McIntyre, Matthew E. Merritt</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>bE0mPve90xtDW7Mgx9+xm/gIKXt54qktoOvefuUy0ZI=_168537adabb:628aba:56b782f7</id><published>1547528400000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00745/20190115/images/medium/ci-2018-00745k_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00745&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=5K41F2DAvx0:sZXaCWO0l3M:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/5K41F2DAvx0&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>4f9ea1aa</fingerprint><link>http://dx.doi.org/10.1021/acs.jcim.8b00745</link><crawled>1547588786875</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jcim.8b00745</href></item></canonical><engagement>0</engagement><title>[ASAP] Kinetic Analysis of Hepatic Metabolism Using Hyperpolarized Dihydroxyacetone</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jcisd8</streamId><title>Journal of Chemical Information and Modeling: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00745/20190115/images/medium/ci-2018-00745k_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00745&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=5K41F2DAvx0:sZXaCWO0l3M:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/5K41F2DAvx0&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jcim.8b00745</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jcisd8/~3/5K41F2DAvx0/acs.jcim.8b00745</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Bermudez-Barrientos, J. R.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1680f155e7d:615cb34:3a104d3b</id><content><direction>ltr</direction><content>Many organisms exchange small RNAs during their interactions, and these RNAs can target or bolster defense strategies in host-pathogen systems. Current sRNA-Seq technology can determine the small RNAs present in any symbiotic system, but there are very few bioinformatic tools available to interpret the results. We show that one of the biggest challenges comes from sequences that map equally well to the genomes of both interacting organisms. This arises due to the small size of the sRNA compared to large genomes, and because many of the produced sRNAs come from genomic regions that encode highly conserved miRNAs, rRNAs or tRNAs. Here we present strategies to disentangle sRNA-Seq data from samples of communicating organisms, developed using diverse plant and animal species that are known to exchange RNA with their parasites. We show that sequence assembly, both de novo and genome-guided, can be used for sRNA-Seq data, greatly reducing the ambiguity of mapping reads. Even confidently mapped sequences can be misleading, so we further demonstrate the use of differential expression strategies to determine the true parasitic sRNAs within host cells. Finally, we validate our methods on new experiments designed to probe the nature of the extracellular vesicle sRNAs from the parasitic nematode H. bakeri that get into mouse epithelial cells.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/508937v1?rss=1</href></item></alternate><published>1546416000000</published><unread>True</unread><fingerprint>3721475</fingerprint><link>http://biorxiv.org/cgi/content/short/508937v1?rss=1</link><engagement>0</engagement><title>Disentangling sRNA-Seq data to study RNA communication between species [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Many organisms exchange small RNAs during their interactions, and these RNAs can target or bolster defense strategies in host-pathogen systems. Current sRNA-Seq technology can determine the small RNAs present in any symbiotic system, but there are very few bioinformatic tools available to interpret the results. We show that one of the biggest challenges comes from sequences that map equally well to the genomes of both interacting organisms. This arises due to the small size of the sRNA compared to large genomes, and because many of the produced sRNAs come from genomic regions that encode highly conserved miRNAs, rRNAs or tRNAs. Here we present strategies to disentangle sRNA-Seq data from samples of communicating organisms, developed using diverse plant and animal species that are known to exchange RNA with their parasites. We show that sequence assembly, both de novo and genome-guided, can be used for sRNA-Seq data, greatly reducing the ambiguity of mapping reads. Even confidently mapped sequences can be misleading, so we further demonstrate the use of differential expression strategies to determine the true parasitic sRNAs within host cells. Finally, we validate our methods on new experiments designed to probe the nature of the extracellular vesicle sRNAs from the parasitic nematode H. bakeri that get into mouse epithelial cells.</description><originId>http://biorxiv.org/cgi/content/short/508937v1?rss=1</originId><crawled>1546441285245</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/02/508937</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Shun He</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>intraepithelial</text></item></mentions><label>intraepithelial</label><id>nlp/f/entity/en/-/intraepithelial</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Nat</text></item></mentions><label>Nat</label><id>nlp/f/entity/en/-/nat</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>β7</text></item></mentions><label>β7</label><id>nlp/f/entity/en/-/β7</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Immunol</text></item><item><text>J. Immunol</text></item></mentions><label>J. Immunol</label><id>nlp/f/entity/en/-/j. immunol</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>B.</text></item></mentions><label>B.</label><id>nlp/f/entity/en/-/b.</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ff99aeb:c7ac5d:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0849-9&quot;&gt;doi:10.1038/s41586-018-0849-9&lt;/a&gt;&lt;/p&gt;Integrin β7-dependent Glp1rhigh natural gut intraepithelial T lymphocytes that reside in the small intestine modulate dietary metabolism in mice by restricting the bioavailability of GLP-1.</content></content><engagementRate>4.25</engagementRate><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0849-9</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><height>442</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0849-9/MediaObjects/41586_2018_849_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>589c5dd0</fingerprint><commonTopics><item><probability>1.0</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>0.996</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.94</probability><label>pharmacology</label><id>nlp/f/topic/1735</id></item><item><probability>0.939</probability><label>stem cells</label><id>nlp/f/topic/2185</id></item><item><probability>0.891</probability><label>neurology</label><id>nlp/f/topic/1563</id></item><item><probability>0.853</probability><label>diabetes</label><id>nlp/f/topic/653</id></item><item><probability>0.838</probability><label>hematology</label><id>nlp/f/topic/1058</id></item><item><probability>0.822</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item><item><probability>0.819</probability><label>microbiology</label><id>nlp/f/topic/1455</id></item><item><probability>0.782</probability><label>cardiology</label><id>nlp/f/topic/387</id></item></commonTopics><link>https://www.nature.com/articles/s41586-018-0849-9</link><engagement>34</engagement><title>Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0849-9&quot;&gt;doi:10.1038/s41586-018-0849-9&lt;/a&gt;&lt;/p&gt;Integrin β7-dependent Glp1rhigh natural gut intraepithelial T lymphocytes that reside in the small intestine modulate dietary metabolism in mice by restricting the bioavailability of GLP-1.</description><originId>https://www.nature.com/articles/s41586-018-0849-9</originId><crawled>1548872162027</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>J. Fujioka</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1686ff3b71e:1d335e9:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Strong-correlation induced high-mobility electrons in Dirac semimetal of perovskite oxide&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Strong-correlation induced high-mobility electrons in Dirac semimetal of perovskite oxide, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08149-y&quot;&gt;doi:10.1038/s41467-018-08149-y&lt;/a&gt;&lt;/p&gt;Electron correlation normally makes electrons less mobile, but it is still not clear when correlation becomes very strong in Dirac semimetals. Here, Fujioka et al. report a very high electron mobility exceeding 60,000 cm2V−1s−1 in correlated Dirac semimetal of perovskite CaIrO3, due to the enhanced electron correlation nearby the Mott transition.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/8CV-KMajaEU&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/8CV-KMajaEU/s41467-018-08149-y</href></item></alternate><published>1548057600000</published><unread>True</unread><visual><height>601</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08149-y/MediaObjects/41467_2018_8149_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>fe1d845</fingerprint><link>https://www.nature.com/articles/s41467-018-08149-y</link><engagement>1</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08149-y</href></item></canonical><title>Strong-correlation induced high-mobility electrons in Dirac semimetal of perovskite oxide</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Strong-correlation induced high-mobility electrons in Dirac semimetal of perovskite oxide&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Strong-correlation induced high-mobility electrons in Dirac semimetal of perovskite oxide, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08149-y&quot;&gt;doi:10.1038/s41467-018-08149-y&lt;/a&gt;&lt;/p&gt;Electron correlation normally makes electrons less mobile, but it is still not clear when correlation becomes very strong in Dirac semimetals. Here, Fujioka et al. report a very high electron mobility exceeding 60,000 cm2V−1s−1 in correlated Dirac semimetal of perovskite CaIrO3, due to the enhanced electron correlation nearby the Mott transition.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/8CV-KMajaEU&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-08149-y</originId><crawled>1548066469662</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Lieselotte Cnops</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Ebola</text></item></mentions><label>Ebola virus disease</label><id>nlp/f/entity/en/w/Ebola virus disease</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>DRC</text></item><item><text>Democratic Republic of the Congo</text></item></mentions><label>Democratic Republic of the Congo</label><id>nlp/f/entity/en/w/Democratic Republic of the Congo</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>FDA</text></item><item><text>FDA*</text></item><item><text>US Food and Drug Administration</text></item></mentions><label>Food and Drug Administration</label><id>nlp/f/entity/en/w/Food and Drug Administration</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>CDC</text></item></mentions><label>CDC</label><id>nlp/f/entity/en/-/cdc</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Cepheid</text></item></mentions><label>Cepheid variable</label><id>nlp/f/entity/en/w/Cepheid variable</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1687506b083:23a99d7:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Where are the Ebola diagnostics from last time?&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Where are the Ebola diagnostics from last time?, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00212-y&quot;&gt;doi:10.1038/d41586-019-00212-y&lt;/a&gt;&lt;/p&gt;Analysis reveals commercial tests for Ebola are too hard to come by in the current outbreak — sustain investment, urge Lieselotte Cnops, Kevin K. Ariën and colleagues.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00212-y</href></item></alternate><published>1548144000000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00212-y/d41586-019-00212-y_16402552.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>20bc6492</fingerprint><commonTopics><item><probability>0.986</probability><label>global health</label><id>nlp/f/topic/977</id></item><item><probability>0.976</probability><label>public health</label><id>nlp/f/topic/1850</id></item><item><probability>0.938</probability><label>poverty</label><id>nlp/f/topic/1805</id></item><item><probability>0.791</probability><label>fda</label><id>nlp/f/topic/846</id></item><item><probability>0.759</probability><label>africa</label><id>nlp/f/topic/47</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00212-y</link><engagement>2</engagement><title>Where are the Ebola diagnostics from last time?</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Where are the Ebola diagnostics from last time?&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Where are the Ebola diagnostics from last time?, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00212-y&quot;&gt;doi:10.1038/d41586-019-00212-y&lt;/a&gt;&lt;/p&gt;Analysis reveals commercial tests for Ebola are too hard to come by in the current outbreak — sustain investment, urge Lieselotte Cnops, Kevin K. Ariën and colleagues.</description><originId>https://www.nature.com/articles/d41586-019-00212-y</originId><crawled>1548151599235</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_16895e58199:5102379:ad2b6584</id><published>1548633600000</published><unread>True</unread><summary><direction>ltr</direction><content>We present a flexible and efficient framework for multiscale modeling in computational chemistry (MiMiC). It is based on a multiple-program multiple-data (MPMD) model with loosely coupled programs. Fast data exchange between programs is achieved through the use of MPI intercommunicators. This allows exploiting the existing parallelization strategies used by the coupled programs while maintaining a high degree of flexibility. MiMiC has been used in a new electrostatic embedding quantum mechanics/molecular mechanics (QM/MM) implementation coupling the highly efficient CPMD and GROMACS programs but it can also be extended to use other programs. The framework can also be utilized to extend the partitioning of the system into several domains that can be treated using different models, such as models based on wavefunction or density functional theory as well as coarse-graining and continuum models. The new QM/MM implementation treats long-range electrostatic QM-MM interactions through the multipoles of the QM subsystem which substantially reduces the computational cost without loss of accuracy compared to an exact treatment. This enables QM/MM molecular dynamics (MD) simulations of very large systems.</content></summary><fingerprint>400c32a2</fingerprint><link>https://chemrxiv.org/articles/MiMiC_A_Novel_Framework_for_Multiscale_Modeling_in_Computational_Chemistry/7635986</link><engagement>0</engagement><crawled>1548703072665</crawled><title>MiMiC: A Novel Framework for Multiscale Modeling in Computational Chemistry</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>We present a flexible and efficient framework for multiscale modeling in computational chemistry (MiMiC). It is based on a multiple-program multiple-data (MPMD) model with loosely coupled programs. Fast data exchange between programs is achieved through the use of MPI intercommunicators. This allows exploiting the existing parallelization strategies used by the coupled programs while maintaining a high degree of flexibility. MiMiC has been used in a new electrostatic embedding quantum mechanics/molecular mechanics (QM/MM) implementation coupling the highly efficient CPMD and GROMACS programs but it can also be extended to use other programs. The framework can also be utilized to extend the partitioning of the system into several domains that can be treated using different models, such as models based on wavefunction or density functional theory as well as coarse-graining and continuum models. The new QM/MM implementation treats long-range electrostatic QM-MM interactions through the multipoles of the QM subsystem which substantially reduces the computational cost without loss of accuracy compared to an exact treatment. This enables QM/MM molecular dynamics (MD) simulations of very large systems.</description><originId>https://chemrxiv.org/articles/MiMiC_A_Novel_Framework_for_Multiscale_Modeling_in_Computational_Chemistry/7635986</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/MiMiC_A_Novel_Framework_for_Multiscale_Modeling_in_Computational_Chemistry/7635986</href></item></alternate></item><item><author><name>Simon Hauri</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1684be81d08:2c839b3:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Rapid determination of quaternary protein structures in complex biological samples&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Rapid determination of quaternary protein structures in complex biological samples, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07986-1&quot;&gt;doi:10.1038/s41467-018-07986-1&lt;/a&gt;&lt;/p&gt;Protein structure determination in complex biological samples is still challenging. Here, the authors develop a computational modeling-guided cross-linking mass spectrometry method, obtaining a high-resolution model of a 1.8 MDa protein assembly from cross-links detected in a mixture of human plasma and bacteria.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/7oRNyyU2pAc&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/7oRNyyU2pAc/s41467-018-07986-1</href></item></alternate><published>1547452800000</published><unread>True</unread><visual><height>643</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-07986-1/MediaObjects/41467_2018_7986_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>b8aca85d</fingerprint><link>https://www.nature.com/articles/s41467-018-07986-1</link><engagement>24</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-07986-1</href></item></canonical><title>Rapid determination of quaternary protein structures in complex biological samples</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Rapid determination of quaternary protein structures in complex biological samples&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Rapid determination of quaternary protein structures in complex biological samples, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07986-1&quot;&gt;doi:10.1038/s41467-018-07986-1&lt;/a&gt;&lt;/p&gt;Protein structure determination in complex biological samples is still challenging. Here, the authors develop a computational modeling-guided cross-linking mass spectrometry method, obtaining a high-resolution model of a 1.8 MDa protein assembly from cross-links detected in a mixture of human plasma and bacteria.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/7oRNyyU2pAc&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-07986-1</originId><crawled>1547461729544</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Joseph P.  Menetski</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>FNIH Biomarkers Consortium</text></item><item><text>Biomarkers Consortium</text></item></mentions><label>FNIH Biomarkers Consortium</label><id>nlp/f/entity/en/-/fnih biomarkers consortium</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>FDA</text></item></mentions><label>Food and Drug Administration</label><id>nlp/f/entity/en/w/Food and Drug Administration</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>FNIH</text></item><item><text>Foundation for the National Institutes of Health</text></item></mentions><label>Foundation for the National Institutes of Health</label><id>nlp/f/entity/en/w/Foundation for the National Institutes of Health</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>National Institutes of Health</text></item><item><text>NIH</text></item></mentions><label>National Institutes of Health</label><id>nlp/f/entity/en/w/National Institutes of Health</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>COAs</text></item></mentions><label>COAs</label><id>nlp/f/entity/en/-/coas</id></item></entities><id>YLwIhSxZAzQIEnJq1FGGcXUQMCbQUlr9cyNMExMVeyY=_168a4a15399:13cc5a7:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;The FNIH Biomarkers Consortium embraces the BEST&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The FNIH Biomarkers Consortium embraces the BEST, Published online: 31 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41573-019-00015-w&quot;&gt;doi:10.1038/d41573-019-00015-w&lt;/a&gt;&lt;/p&gt;The Biomarkers Consortium aims to facilitate drug development with biomarkers across a range of diseases. Here, we briefly highlight its accomplishments so far and its recent expansion in scope to include related tools along the lines of the Biomarkers, EndpointS and other Tools (BEST) resource, such as patient-reported outcomes and clinical outcome assessments.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/gJjnrxWPqdM&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nrd/rss/current/~3/gJjnrxWPqdM/d41573-019-00015-w</href></item></alternate><published>1548921600000</published><unread>True</unread><fingerprint>325fa74e</fingerprint><commonTopics><item><probability>0.975</probability><label>gear</label><id>nlp/f/topic/951</id></item><item><probability>0.882</probability><label>fda</label><id>nlp/f/topic/846</id></item><item><probability>0.88</probability><label>outdoors</label><id>nlp/f/topic/1665</id></item><item><probability>0.874</probability><label>drugs</label><id>nlp/f/topic/698</id></item><item><probability>0.771</probability><label>statistics journals</label><id>nlp/f/topic/2178</id></item><item><probability>0.767</probability><label>pharmacology</label><id>nlp/f/topic/1735</id></item><item><probability>0.764</probability><label>pharma</label><id>nlp/f/topic/1734</id></item><item><probability>0.759</probability><label>pharmacy</label><id>nlp/f/topic/1736</id></item></commonTopics><link>https://www.nature.com/articles/d41573-019-00015-w</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/d41573-019-00015-w</href></item></canonical><title>The FNIH Biomarkers Consortium embraces the BEST</title><origin><htmlUrl>http://feeds.nature.com/nrd/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nrd/rss/current</streamId><title>Nature Reviews Drug Discovery - Issue - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;The FNIH Biomarkers Consortium embraces the BEST&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The FNIH Biomarkers Consortium embraces the BEST, Published online: 31 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41573-019-00015-w&quot;&gt;doi:10.1038/d41573-019-00015-w&lt;/a&gt;&lt;/p&gt;The Biomarkers Consortium aims to facilitate drug development with biomarkers across a range of diseases. Here, we briefly highlight its accomplishments so far and its recent expansion in scope to include related tools along the lines of the Biomarkers, EndpointS and other Tools (BEST) resource, such as patient-reported outcomes and clinical outcome assessments.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/gJjnrxWPqdM&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/d41573-019-00015-w</originId><crawled>1548950262681</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Motoi Kimata</name></author><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16857ddbaa0:3dd05f2:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Magnetic and magnetic inverse spin Hall effects in a non-collinear antiferromagnet&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Magnetic and magnetic inverse spin Hall effects in a non-collinear antiferromagnet, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0853-0&quot;&gt;doi:10.1038/s41586-018-0853-0&lt;/a&gt;&lt;/p&gt;A magnetic contribution to the spin Hall effect is observed in the non-collinear antiferromagnet Mn3Sn, which is attributed to momentum-dependent spin splitting produced by non-collinear magnetic order.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0853-0</href></item></alternate><published>1547625600000</published><unread>True</unread><visual><height>312</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0853-0/MediaObjects/41586_2018_853_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>938d86f0</fingerprint><link>https://www.nature.com/articles/s41586-018-0853-0</link><engagement>97</engagement><title>Magnetic and magnetic inverse spin Hall effects in a non-collinear antiferromagnet</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Magnetic and magnetic inverse spin Hall effects in a non-collinear antiferromagnet&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Magnetic and magnetic inverse spin Hall effects in a non-collinear antiferromagnet, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0853-0&quot;&gt;doi:10.1038/s41586-018-0853-0&lt;/a&gt;&lt;/p&gt;A magnetic contribution to the spin Hall effect is observed in the non-collinear antiferromagnet Mn3Sn, which is attributed to momentum-dependent spin splitting produced by non-collinear magnetic order.</description><originId>https://www.nature.com/articles/s41586-018-0853-0</originId><crawled>1547662375584</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Das, A.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1686d1728f6:19546c4:c2ce2e2e</id><content><direction>ltr</direction><content>With unprecedented progress of cancer research, the world is now prepared with versatile arsenal of drugs to combat cancer. However, response of an individual to any drug or combination treatment stands as a major challenge and hence there exists the sheer need for personalized medication. Identification of drug response biomarkers from a wholistic tumor microenvironment analysis would guide researchers to develop custom-tailored treatment regimen. In this study, a fast and robust method has been developed to identify drug response biomarkers from entire transcriptomics data analysis in a data-driven manner. The biomarkers which were identified by the method, were able to stratify patients between responders vs non-responders population. Furthermore, bayesian network (BN) analysis, done on the data, brought forth a mechanistic insight into the role of identified biomarkers in regulating drug efficacy. The importance of this work lies with the protocol that is time saving and requires less computation power, yet analyzes a whole system data and helps the researchers to take a step forward towards the development of personalized care in effective cancer treatment.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/525337v1?rss=1</href></item></alternate><published>1547971200000</published><unread>True</unread><fingerprint>a9a3563a</fingerprint><link>http://biorxiv.org/cgi/content/short/525337v1?rss=1</link><engagement>0</engagement><title>Fast and robust method for drug response biomarker identification and sample stratification. [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>With unprecedented progress of cancer research, the world is now prepared with versatile arsenal of drugs to combat cancer. However, response of an individual to any drug or combination treatment stands as a major challenge and hence there exists the sheer need for personalized medication. Identification of drug response biomarkers from a wholistic tumor microenvironment analysis would guide researchers to develop custom-tailored treatment regimen. In this study, a fast and robust method has been developed to identify drug response biomarkers from entire transcriptomics data analysis in a data-driven manner. The biomarkers which were identified by the method, were able to stratify patients between responders vs non-responders population. Furthermore, bayesian network (BN) analysis, done on the data, brought forth a mechanistic insight into the role of identified biomarkers in regulating drug efficacy. The importance of this work lies with the protocol that is time saving and requires less computation power, yet analyzes a whole system data and helps the researchers to take a step forward towards the development of personalized care in effective cancer treatment.</description><originId>http://biorxiv.org/cgi/content/short/525337v1?rss=1</originId><crawled>1548018460918</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/20/525337</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Teruyoshi Kobayashi</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_168510df8ce:3410aef:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;The structured backbone of temporal social ties&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The structured backbone of temporal social ties, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08160-3&quot;&gt;doi:10.1038/s41467-018-08160-3&lt;/a&gt;&lt;/p&gt;Complex networks can be useful to describe social interactions but for large datasets one needs to identify significant links to extract information. While most existing methods work for static networks, here the authors propose a method to extract the backbone of significant links in temporal networks.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/DaoOb69fOZg&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/DaoOb69fOZg/s41467-018-08160-3</href></item></alternate><published>1547539200000</published><unread>True</unread><visual><height>413</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08160-3/MediaObjects/41467_2018_8160_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>558d55a3</fingerprint><link>https://www.nature.com/articles/s41467-018-08160-3</link><engagement>3</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08160-3</href></item></canonical><title>The structured backbone of temporal social ties</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;The structured backbone of temporal social ties&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The structured backbone of temporal social ties, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08160-3&quot;&gt;doi:10.1038/s41467-018-08160-3&lt;/a&gt;&lt;/p&gt;Complex networks can be useful to describe social interactions but for large datasets one needs to identify significant links to extract information. While most existing methods work for static networks, here the authors propose a method to extract the backbone of significant links in temporal networks.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/DaoOb69fOZg&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-08160-3</originId><crawled>1547548096718</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Laura J. S. Lopes, 
Tony Lelièvre</name></author><id>6wY2EtDmLbeMr9WopopAzS1SKiHs2ogsOuunEriW7zs=_1689dd99162:8fcf14:3a104d3b</id><content><direction>ltr</direction><content>&lt;img alt=&quot;Journal of Computational Chemistry Analysis of the adaptive multilevel splitting method on the isomerization of alanine dipeptide&quot; src=&quot;https://onlinelibrary.wiley.com/cms/attachment/d352a250-5b8c-4d72-a1c2-b1c59d0a289b/jcc25778-toc-0001-m.png&quot;&gt;
&lt;p&gt;Rare events in molecular dynamics, which include processes like ligand‐protein unbinding, have been an important field of research. The low probability of occurrence entails the need to use adapted methods to simulate these processes. In this article, we apply the adaptive multilevel splitting method to the isomerization of alanine dipeptide. Some properties of the algorithm are numerically illustrated, and the method is then used to obtain the transition time between the two stable structures.
&lt;/p&gt;
&lt;br&gt;
&lt;p&gt;We apply the adaptive multilevel splitting (AMS) method to the &lt;span&gt;
&lt;i&gt;C&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;eq&lt;/i&gt;
&lt;/sub&gt; → &lt;i&gt;C&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;ax&lt;/i&gt;
&lt;/sub&gt;
&lt;/span&gt; transition of alanine dipeptide in vacuum. Some properties of the algorithm are numerically illustrated, such as the unbiasedness of the probability estimator and the robustness of the method with respect to the reaction coordinate. We also calculate the transition time obtained via the probability estimator, using an appropriate ensemble of initial conditions. Finally, we show how the AMS method can be used to compute an approximation of the committor function. © 2019 Wiley Periodicals, Inc.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25778?af=R</href></item></alternate><unread>True</unread><origin><htmlUrl>https://onlinelibrary.wiley.com/journal/1096987x?af=R</htmlUrl><streamId>feed/https://onlinelibrary.wiley.com/action/showFeed?jc=1096987x&amp;type=etoc&amp;feed=rss</streamId><title>Wiley: Journal of Computational Chemistry: Table of Contents</title></origin><fingerprint>21dc846d</fingerprint><link>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25778?af=R</link><summary><direction>ltr</direction><content>Rare events in molecular dynamics, which include processes like ligand‐protein unbinding, have been an important field of research. The low probability of occurrence entails the need to use adapted methods to simulate these processes. In this article, we apply the adaptive multilevel splitting method to the isomerization of alanine dipeptide. Some properties of the algorithm are numerically illustrated, and the method is then used to obtain the transition time between the two stable structures.
We apply the adaptive multilevel splitting (AMS) method to the C
eq → C
ax transition of alanine dipeptide in vacuum. Some properties of the algorithm are numerically illustrated, such as the unbiasedness of the probability estimator and the robustness of the method with respect to the reaction coordinate. We also calculate the transition time obtained via the probability estimator, using an appropriate ensemble of initial conditions. Finally, we show how the AMS method can be used to compute an approximation of the committor function. © 2019 Wiley Periodicals, Inc.</content></summary><title>Analysis of the adaptive multilevel splitting method on the isomerization of alanine dipeptide</title><published>1548777760000</published><description>Rare events in molecular dynamics, which include processes like ligand‐protein unbinding, have been an important field of research. The low probability of occurrence entails the need to use adapted methods to simulate these processes. In this article, we apply the adaptive multilevel splitting method to the isomerization of alanine dipeptide. Some properties of the algorithm are numerically illustrated, and the method is then used to obtain the transition time between the two stable structures.
We apply the adaptive multilevel splitting (AMS) method to the C
eq → C
ax transition of alanine dipeptide in vacuum. Some properties of the algorithm are numerically illustrated, such as the unbiasedness of the probability estimator and the robustness of the method with respect to the reaction coordinate. We also calculate the transition time obtained via the probability estimator, using an appropriate ensemble of initial conditions. Finally, we show how the AMS method can be used to compute an approximation of the committor function. © 2019 Wiley Periodicals, Inc.</description><originId>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25778?af=R</originId><crawled>1548836508002</crawled><visual><height>394</height><processor>feedly-nikon-v3.1</processor><url>https://onlinelibrary.wiley.com/cms/attachment/d352a250-5b8c-4d72-a1c2-b1c59d0a289b/jcc25778-toc-0001-m.png</url><contentType>image/png; charset=UTF-8</contentType><width>394</width></visual><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>David Adam</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Nick Sireau</text></item><item><text>Nick</text></item></mentions><label>Nick Sireau</label><id>nlp/f/entity/en/-/nick sireau</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Alkaptonuria</text></item><item><text>alkaptonuria</text></item><item><text>AKU</text></item></mentions><label>Alkaptonuria</label><id>nlp/f/entity/en/w/Alkaptonuria</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>son Julien</text></item><item><text>Julien</text></item></mentions><label>son Julien</label><id>nlp/f/entity/en/-/son julien</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Sonya</text></item></mentions><label>Sonya Mitchell</label><id>nlp/f/entity/en/w/Sonya Mitchell</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Ranga</text></item></mentions><label>Ranga</label><id>nlp/f/entity/en/-/ranga</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16832148f03:a78421:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;A father’s fight to help his sons — and fix clinical trials&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A father’s fight to help his sons — and fix clinical trials, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00035-x&quot;&gt;doi:10.1038/d41586-019-00035-x&lt;/a&gt;&lt;/p&gt;Nick Sireau’s quest to give his sons weedkiller could help thousands struggling with rare genetic conditions.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00035-x</href></item></alternate><published>1547020800000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00035-x/d41586-019-00035-x_16380782.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>f0cda6c3</fingerprint><commonTopics><item><probability>0.941</probability><label>regulatory</label><id>nlp/f/topic/1924</id></item><item><probability>0.883</probability><label>security intel</label><id>nlp/f/topic/2038</id></item><item><probability>0.823</probability><label>medicine</label><id>nlp/f/topic/1433</id></item><item><probability>0.797</probability><label>digital health</label><id>nlp/f/topic/657</id></item><item><probability>0.793</probability><label>drugs</label><id>nlp/f/topic/698</id></item><item><probability>0.787</probability><label>ted</label><id>nlp/f/topic/2261</id></item><item><probability>0.766</probability><label>ehealth</label><id>nlp/f/topic/745</id></item><item><probability>0.745</probability><label>fda</label><id>nlp/f/topic/846</id></item><item><probability>0.722</probability><label>pharmacology</label><id>nlp/f/topic/1735</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00035-x</link><engagement>12</engagement><title>A father’s fight to help his sons — and fix clinical trials</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;A father’s fight to help his sons — and fix clinical trials&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A father’s fight to help his sons — and fix clinical trials, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00035-x&quot;&gt;doi:10.1038/d41586-019-00035-x&lt;/a&gt;&lt;/p&gt;Nick Sireau’s quest to give his sons weedkiller could help thousands struggling with rare genetic conditions.</description><originId>https://www.nature.com/articles/d41586-019-00035-x</originId><crawled>1547028434691</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Yara Seif</name></author><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_16833ecf761:cf806a:b77f238b</id><content><direction>ltr</direction><content>&lt;p&gt;by Yara Seif, Jonathan M. Monk, Nathan Mih, Hannah Tsunemoto, Saugat Poudel, Cristal Zuniga, Jared Broddrick, Karsten Zengler, Bernhard O. Palsson&lt;/p&gt;
&lt;i&gt;S&lt;/i&gt;. &lt;i&gt;aureus&lt;/i&gt; is classified as a serious threat pathogen and is a priority that guides the discovery and development of new antibiotics. Despite growing knowledge of &lt;i&gt;S&lt;/i&gt;. &lt;i&gt;aureus&lt;/i&gt; metabolic capabilities, our understanding of its systems-level responses to different media types remains incomplete. Here, we develop a manually reconstructed genome-scale model (GEM-PRO) of metabolism with 3D protein structures for &lt;i&gt;S&lt;/i&gt;. &lt;i&gt;aureus&lt;/i&gt; USA300 str. JE2 containing 854 genes, 1,440 reactions, 1,327 metabolites and 673 3-dimensional protein structures. Computations were in 85% agreement with gene essentiality data from random barcode transposon site sequencing (RB-TnSeq) and 68% agreement with experimental physiological data. Comparisons of computational predictions with experimental observations highlight: 1) cases of non-essential biomass precursors; 2) metabolic genes subject to transcriptional regulation involved in Staphyloxanthin biosynthesis; 3) the essentiality of purine and amino acid biosynthesis in synthetic physiological media; and 4) a switch to aerobic fermentation upon exposure to extracellular glucose elucidated as a result of integrating time-course of quantitative exo-metabolomics data. An up-to-date GEM-PRO thus serves as a knowledge-based platform to elucidate &lt;i&gt;S&lt;/i&gt;. &lt;i&gt;aureus’&lt;/i&gt; metabolic response to its environment.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/2DiKjhA9eEg&quot; height=&quot;1&quot;&gt;</content></content><updateCount>1</updateCount><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/2DiKjhA9eEg/article</href></item></alternate><published>1547071200000</published><unread>True</unread><visual><height>170</height><processor>feedly-nikon-v3.1</processor><url>https://journals.plos.org/ploscompbiol/article/figure/image?size=inline&amp;id=10.1371/journal.pcbi.1006644.g001</url><contentType>image/png</contentType><width>320</width></visual><fingerprint>79d0cd62</fingerprint><link>10.1371/journal.pcbi.1006644</link><recrawled>1547069228337</recrawled><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006644</href></item></canonical><updated>1547071200000</updated><engagement>124</engagement><title>A computational knowledge-base elucidates the response of &amp;lt;i&gt;Staphylococcus aureus&amp;lt;/i&gt; to different media types</title><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><description>&lt;p&gt;by Yara Seif, Jonathan M. Monk, Nathan Mih, Hannah Tsunemoto, Saugat Poudel, Cristal Zuniga, Jared Broddrick, Karsten Zengler, Bernhard O. Palsson&lt;/p&gt;
&lt;i&gt;S&lt;/i&gt;. &lt;i&gt;aureus&lt;/i&gt; is classified as a serious threat pathogen and is a priority that guides the discovery and development of new antibiotics. Despite growing knowledge of &lt;i&gt;S&lt;/i&gt;. &lt;i&gt;aureus&lt;/i&gt; metabolic capabilities, our understanding of its systems-level responses to different media types remains incomplete. Here, we develop a manually reconstructed genome-scale model (GEM-PRO) of metabolism with 3D protein structures for &lt;i&gt;S&lt;/i&gt;. &lt;i&gt;aureus&lt;/i&gt; USA300 str. JE2 containing 854 genes, 1,440 reactions, 1,327 metabolites and 673 3-dimensional protein structures. Computations were in 85% agreement with gene essentiality data from random barcode transposon site sequencing (RB-TnSeq) and 68% agreement with experimental physiological data. Comparisons of computational predictions with experimental observations highlight: 1) cases of non-essential biomass precursors; 2) metabolic genes subject to transcriptional regulation involved in Staphyloxanthin biosynthesis; 3) the essentiality of purine and amino acid biosynthesis in synthetic physiological media; and 4) a switch to aerobic fermentation upon exposure to extracellular glucose elucidated as a result of integrating time-course of quantitative exo-metabolomics data. An up-to-date GEM-PRO thus serves as a knowledge-based platform to elucidate &lt;i&gt;S&lt;/i&gt;. &lt;i&gt;aureus’&lt;/i&gt; metabolic response to its environment.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/2DiKjhA9eEg&quot; height=&quot;1&quot;&gt;</description><originId>10.1371/journal.pcbi.1006644</originId><crawled>1547059394401</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Laura DeFrancesco</name></author><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>CSS</text></item></mentions><label>Cascading Style Sheets</label><id>nlp/f/entity/en/w/Cascading Style Sheets</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Explorer</text></item></mentions><label>Explorer</label><id>nlp/f/entity/en/-/explorer</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>JavaScript</text></item></mentions><label>JavaScript</label><id>nlp/f/entity/en/w/JavaScript</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>WEBSITEnature_com</text></item></mentions><label>WEBSITEnature_com</label><id>nlp/f/entity/en/-/websitenature_com</id></item></entities><id>0qZSsMpEyvTD/JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I=_1681466db74:68a3835:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Not &apos;fake&apos; meat but &apos;clean&apos;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Not &apos;fake&apos; meat but &apos;clean&apos;, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/nbt0119-9b&quot;&gt;doi:10.1038/nbt0119-9b&lt;/a&gt;&lt;/p&gt;Not &apos;fake&apos; meat but &apos;clean&apos;</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/nbt0119-9b</href></item></alternate><published>1546502400000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>f1be1322</fingerprint><link>https://www.nature.com/articles/nbt0119-9b</link><engagement>0</engagement><title>Not &apos;fake&apos; meat but &apos;clean&apos;</title><origin><htmlUrl>http://feeds.nature.com/nbt/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nbt/current_issue/rss/</streamId><title>Nature Biotechnology</title></origin><description>&lt;p&gt;&lt;b&gt;Not &apos;fake&apos; meat but &apos;clean&apos;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Not &apos;fake&apos; meat but &apos;clean&apos;, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/nbt0119-9b&quot;&gt;doi:10.1038/nbt0119-9b&lt;/a&gt;&lt;/p&gt;Not &apos;fake&apos; meat but &apos;clean&apos;</description><originId>https://www.nature.com/articles/nbt0119-9b</originId><crawled>1546530511732</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/0qZSsMpEyvTD_JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I_oicon-166b30c5bda</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Mao, S.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:15708af:8675cc2c</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/137-k?rss=1</href></item></alternate><published>1547145461000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>2c628497</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6423/137-k?rss=1</link><engagement>0</engagement><title>A cap-specific m6A writer</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6423/137-k?rss=1</originId><crawled>1547147463250</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6423/137.11.full</canonicalUrl><keywords><item>Biochemistry, Molecular Biology</item></keywords></item><item><author><name>Catarina Silva-Costa</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_16832228f3e:a8de3e:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015), Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36799-x&quot;&gt;doi:10.1038/s41598-018-36799-x&lt;/a&gt;&lt;/p&gt;Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Dz0PLDKaUjc&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/Dz0PLDKaUjc/s41598-018-36799-x</href></item></alternate><published>1547020800000</published><unread>True</unread><visual><height>429</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36799-x/MediaObjects/41598_2018_36799_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>1d1cf447</fingerprint><link>https://www.nature.com/articles/s41598-018-36799-x</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36799-x</href></item></canonical><title>Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015), Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36799-x&quot;&gt;doi:10.1038/s41598-018-36799-x&lt;/a&gt;&lt;/p&gt;Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Dz0PLDKaUjc&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-36799-x</originId><crawled>1547029352254</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Hurtley, S. M.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce08d:ad2b6584</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/241-k?rss=1</href></item></alternate><published>1547750305000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>9d044908</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6424/241-k?rss=1</link><engagement>0</engagement><title>Combining expansion and the lattice light sheet</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6424/241-k?rss=1</originId><crawled>1547752389672</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6424/241.11.full</canonicalUrl><keywords><item>Neuroscience, Physics</item></keywords></item><item><author><name>Kim, T. H., Yoo, J.-Y., Choi, K.-C., Shin, J.-H., Leach, R. E., Fazleabas, A. T., Young, S. L., Lessey, B. A., Yoon, H.-G., Jeong, J.-W.</name></author><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_168340336d8:d6f30d:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;Endometriosis is a disease in which tissue that normally grows inside the uterus grows outside the uterus and causes chronic pelvic pain and infertility. However, the exact mechanisms of the pathogenesis of endometriosis-associated infertility are unknown. Epigenetic dysregulation has recently been implicated in infertility. Here, we report a reduction of histone deacetylase 3 (HDAC3) protein amounts in eutopic endometrium of infertile women with endometriosis compared to a control group. To investigate the effect of HDAC3 loss in the uterus, we generated mice with conditional ablation of &lt;i&gt;Hdac3&lt;/i&gt; in progesterone receptor (PGR)–positive cells (&lt;i&gt;Pgr&lt;sup&gt;cre/+&lt;/sup&gt;Hdac3&lt;sup&gt;f/f&lt;/sup&gt;&lt;/i&gt;; &lt;i&gt;Hdac3&lt;sup&gt;d/d&lt;/sup&gt;&lt;/i&gt;). Loss of &lt;i&gt;Hdac3&lt;/i&gt; in the uterus of mice results in infertility due to implantation failure and decidualization defect. Expression microarray and ChIP-seq analyses identified &lt;i&gt;COL1A1&lt;/i&gt; and &lt;i&gt;COL1A2&lt;/i&gt; as direct targets of HDAC3 in both mice and humans. Reduction of &lt;i&gt;HDAC3&lt;/i&gt; abrogated decidualization in a primary culture of human endometrial stromal cells (hESCs) similar to that observed in infertile patients with endometriosis. Whereas attenuation of &lt;i&gt;HDAC3&lt;/i&gt; resulted in p300 recruitment to &lt;i&gt;Col1a1&lt;/i&gt; and &lt;i&gt;Col1a2&lt;/i&gt; genes in the uterus of mice as well as hESCs, inhibition of p300 permitted hESCs to undergo decidualization. Collectively, we found attenuation of HDAC3 and overexpression of collagen type I in the eutopic endometrium of infertile patients with endometriosis. HDAC3 loss caused a defect of decidualization through the aberrant transcriptional activation of &lt;i&gt;Col1a1&lt;/i&gt; and &lt;i&gt;Col1a2&lt;/i&gt; genes in mice and &lt;i&gt;COL1A1&lt;/i&gt; and &lt;i&gt;COL1A2&lt;/i&gt; genes in humans. Our results suggest that HDAC3 is critical for endometrial receptivity and decidualization.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/474/eaaf7533?rss=1</href></item></alternate><published>1547059839000</published><unread>True</unread><fingerprint>cf890e9e</fingerprint><link>http://stm.sciencemag.org/cgi/content/short/11/474/eaaf7533?rss=1</link><engagement>8</engagement><title>[Research Articles] Loss of HDAC3 results in nonreceptive endometrium and female infertility</title><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><description>&lt;p&gt;Endometriosis is a disease in which tissue that normally grows inside the uterus grows outside the uterus and causes chronic pelvic pain and infertility. However, the exact mechanisms of the pathogenesis of endometriosis-associated infertility are unknown. Epigenetic dysregulation has recently been implicated in infertility. Here, we report a reduction of histone deacetylase 3 (HDAC3) protein amounts in eutopic endometrium of infertile women with endometriosis compared to a control group. To investigate the effect of HDAC3 loss in the uterus, we generated mice with conditional ablation of &lt;i&gt;Hdac3&lt;/i&gt; in progesterone receptor (PGR)–positive cells (&lt;i&gt;Pgr&lt;sup&gt;cre/+&lt;/sup&gt;Hdac3&lt;sup&gt;f/f&lt;/sup&gt;&lt;/i&gt;; &lt;i&gt;Hdac3&lt;sup&gt;d/d&lt;/sup&gt;&lt;/i&gt;). Loss of &lt;i&gt;Hdac3&lt;/i&gt; in the uterus of mice results in infertility due to implantation failure and decidualization defect. Expression microarray and ChIP-seq analyses identified &lt;i&gt;COL1A1&lt;/i&gt; and &lt;i&gt;COL1A2&lt;/i&gt; as direct targets of HDAC3 in both mice and humans. Reduction of &lt;i&gt;HDAC3&lt;/i&gt; abrogated decidualization in a primary culture of human endometrial stromal cells (hESCs) similar to that observed in infertile patients with endometriosis. Whereas attenuation of &lt;i&gt;HDAC3&lt;/i&gt; resulted in p300 recruitment to &lt;i&gt;Col1a1&lt;/i&gt; and &lt;i&gt;Col1a2&lt;/i&gt; genes in the uterus of mice as well as hESCs, inhibition of p300 permitted hESCs to undergo decidualization. Collectively, we found attenuation of HDAC3 and overexpression of collagen type I in the eutopic endometrium of infertile patients with endometriosis. HDAC3 loss caused a defect of decidualization through the aberrant transcriptional activation of &lt;i&gt;Col1a1&lt;/i&gt; and &lt;i&gt;Col1a2&lt;/i&gt; genes in mice and &lt;i&gt;COL1A1&lt;/i&gt; and &lt;i&gt;COL1A2&lt;/i&gt; genes in humans. Our results suggest that HDAC3 is critical for endometrial receptivity and decidualization.&lt;/p&gt;</description><originId>http://stm.sciencemag.org/cgi/content/short/11/474/eaaf7533?rss=1</originId><crawled>1547060852440</crawled><canonicalUrl>http://stm.sciencemag.org/content/11/474/eaaf7533.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Berg, J.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3d4:ad2b6584</id><published>1546540591000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>93f49e66</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6422/7?rss=1</link><engagement>254</engagement><crawled>1546542450273</crawled><title>Examining author gender data</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6422/7?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/7?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6422/7.full</canonicalUrl></item><item><author><name>Naoki Miyazawa</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_168a37fcf91:11e1ec7:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Electronic origin of antimicrobial activity owing to surface effect&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Electronic origin of antimicrobial activity owing to surface effect, Published online: 31 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37645-w&quot;&gt;doi:10.1038/s41598-018-37645-w&lt;/a&gt;&lt;/p&gt;Electronic origin of antimicrobial activity owing to surface effect&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Q1WuuDQeXy4&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/Q1WuuDQeXy4/s41598-018-37645-w</href></item></alternate><published>1548921600000</published><unread>True</unread><visual><height>463</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37645-w/MediaObjects/41598_2018_37645_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>e9ba91ea</fingerprint><link>https://www.nature.com/articles/s41598-018-37645-w</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37645-w</href></item></canonical><title>Electronic origin of antimicrobial activity owing to surface effect</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Electronic origin of antimicrobial activity owing to surface effect&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Electronic origin of antimicrobial activity owing to surface effect, Published online: 31 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37645-w&quot;&gt;doi:10.1038/s41598-018-37645-w&lt;/a&gt;&lt;/p&gt;Electronic origin of antimicrobial activity owing to surface effect&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Q1WuuDQeXy4&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-37645-w</originId><crawled>1548931288977</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Alzheimer</text></item></mentions><label>Alzheimer&apos;s disease</label><id>nlp/f/entity/en/w/Alzheimer&apos;s disease</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Anna Balazs</text></item></mentions><label>Anna Balazs</label><id>nlp/f/entity/en/-/anna balazs</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>University of Pittsburgh</text></item></mentions><label>University of Pittsburgh</label><id>nlp/f/entity/en/w/University of Pittsburgh</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Pennsylvania</text></item></mentions><label>Pennsylvania</label><id>nlp/f/entity/en/w/Pennsylvania</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1685225fd69:34cdece:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Stroke drug shows promise for Alzheimer’s disease&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Stroke drug shows promise for Alzheimer’s disease, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00147-4&quot;&gt;doi:10.1038/d41586-019-00147-4&lt;/a&gt;&lt;/p&gt;Genetically engineered protein prevents brain damage that leads to memory loss.</content></content><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00147-4</href></item></alternate><published>1547539200000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00147-4/d41586-019-00147-4_16395276.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>2fa1ffc3</fingerprint><commonTopics><item><probability>0.965</probability><label>biochemistry</label><id>nlp/f/topic/257</id></item><item><probability>0.964</probability><label>robotics</label><id>nlp/f/topic/1955</id></item><item><probability>0.941</probability><label>neurology</label><id>nlp/f/topic/1563</id></item><item><probability>0.862</probability><label>swimming</label><id>nlp/f/topic/2220</id></item><item><probability>0.738</probability><label>pharma</label><id>nlp/f/topic/1734</id></item><item><probability>0.701</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00147-4</link><engagement>11</engagement><title>Stroke drug shows promise for Alzheimer’s disease</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Stroke drug shows promise for Alzheimer’s disease&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Stroke drug shows promise for Alzheimer’s disease, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00147-4&quot;&gt;doi:10.1038/d41586-019-00147-4&lt;/a&gt;&lt;/p&gt;Genetically engineered protein prevents brain damage that leads to memory loss.</description><originId>https://www.nature.com/articles/d41586-019-00147-4</originId><crawled>1547566447977</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Derek Lowe</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>2k24/TFePIh3MUUJr/vqRk++EkKG/RZ2TtOvsKiJXX4=_1685202b4a7:3497f57:c2ce2e2e</id><unread>True</unread><visual><url>none</url></visual><fingerprint>4775b536</fingerprint><origin><htmlUrl>http://blogs.sciencemag.org/pipeline</htmlUrl><streamId>feed/http://blogs.sciencemag.org/pipeline/feed</streamId><title>Sciencemag</title></origin><originId>http://blogs.sciencemag.org/pipeline/?p=14112</originId><alternate><item><type>text/html</type><href>http://blogs.sciencemag.org/pipeline/archives/2019/01/15/niviens-shot</href></item></alternate><canonicalUrl>http://blogs.sciencemag.org/pipeline/archives/2019/01/15/niviens-shot</canonicalUrl><engagement>6</engagement><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Nivien Therapeutics</text></item><item><text>Nivien</text></item></mentions><label>Nivien Therapeutics</label><id>nlp/f/entity/en/-/nivien therapeutics</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Nathaniel Brooks Horwitz</text></item><item><text>Horwitz</text></item></mentions><label>Nathaniel Brooks Horwitz</label><id>nlp/f/entity/en/-/nathaniel brooks horwitz</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Harvard</text></item></mentions><label>Harvard University</label><id>nlp/f/entity/en/w/Harvard University</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>YAP</text></item></mentions><label>YAP</label><id>nlp/f/entity/en/-/yap</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>LaMattina</text></item><item><text>John LaMattina</text></item></mentions><label>John LaMattina</label><id>nlp/f/entity/en/-/john lamattina</id></item></entities><updateCount>6</updateCount><published>1547563713000</published><link>http://blogs.sciencemag.org/pipeline/?p=14112</link><commonTopics><item><probability>0.823</probability><label>pr</label><id>nlp/f/topic/1810</id></item><item><probability>0.807</probability><label>drugs</label><id>nlp/f/topic/698</id></item><item><probability>0.721</probability><label>pharma</label><id>nlp/f/topic/1734</id></item><item><probability>0.71</probability><label>cancer</label><id>nlp/f/topic/377</id></item></commonTopics><recrawled>1548773927780</recrawled><content><direction>ltr</direction><content>&lt;p&gt;Have you ever heard of Nivien Therapeutics? Unless you follow the oncology world pretty closely, probably not. But they are – well, were – a startup out of Harvard that was working on a promising approach to overcoming chemotherapy resistance in pancreatic cancer. Now that’s what we call an “unmet medical need”, considering the steepness and swiftness of the death rates from resistant pancreatic tumors, and Nivien’s approach was a new one. They were targeting the &lt;a href=&quot;https://en.wikipedia.org/wiki/Hippo_signaling_pathway&quot;&gt;Hippo pathway&lt;/a&gt;, which is normally a regulator of organ size during development. It was first discovered in &lt;em&gt;Drosophila&lt;/em&gt;, and as is often the case the fruit flies led to an &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124840/&quot;&gt;even more complicated&lt;/a&gt; situation in humans and other mammals on further research. The YAP/TAZ/TEAD transcription factors are involved in both the Hippo pathway and in many tumor types, though, which suggested that there could be an application in oncology. More specifically, &lt;a href=&quot;https://www.pnas.org/content/114/18/E3729&quot;&gt;it appeared that&lt;/a&gt; the YAP pathway itself might be one of the regulators of a general drug resistance pathway in tumor cells and that this had therapeutic potential.&lt;/p&gt;
&lt;p&gt;Well, did it? &lt;a href=&quot;https://medium.com/@nbhorwitz/no-go-2f996ef3d17a&quot;&gt;Here’s an essay&lt;/a&gt; on Medium from founder Nathaniel Brooks Horwitz, and &lt;a href=&quot;https://www.forbes.com/sites/johnlamattina/2019/01/15/the-demise-of-a-once-promising-pancreatic-cancer-drug-is-all-too-common/#785799656758&quot;&gt;here’s an epitaph&lt;/a&gt; from John LaMattina at &lt;em&gt;Forbes&lt;/em&gt;. Those, and my switch to the past tense in the above paragraph, will give you the short answer: it turns out that inhibition of this pathway is (A) possible but (B) not enough to be useful for cancer patients. I would not like to try to count the number of times I have experienced something similar over my career. Those have been within the structure of larger companies with more things going, so they didn’t wind up costing everyone their job as can happen with a startup, but it is a very common story on any scale. John LaMattina makes the same point, and he is also most definitely in a position to know from personal experience as well. Most ideas for new drugs, and new modes of action for drugs, don’t work out. Nivien didn’t even get to human trials themselves, with their famous 90% failure rate, but anyone who’s done this work will tell you that preclinical failure rates are no joke, either.&lt;/p&gt;
&lt;p&gt;And both Horwitz and LaMattina are right that hardly anyone outside the industry seems to know this. That’s been one of the purposes of this blog from the beginning, to get across what it’s really like to do drug research (and to get across just how difficult and tricky it can be). &lt;em&gt;The two opposite errors in talking about this work are to despair of anything and to hype everything&lt;/em&gt;, and you have to walk between those. The despair part is illustrated by my often-used example of not turning into the guy in the conference room who sits in the back and says “Yeah, that’s not gonna work” to every idea. You’re right 95% of the time, but to what end? And as for the hype part, here’s Horwitz:&lt;/p&gt;
&lt;blockquote&gt;
&lt;p&gt;&lt;em&gt;It’s easy to accidentally generate the impression of an imminent win. Often, new biotechnologies &lt;a rel=&quot;noopener&quot; href=&quot;https://medium.com/@nbhorwitz/11-10-biomedical-wins-in-2017-235f6f71ca6c&quot; target=&quot;_blank&quot;&gt;really are revolutionary&lt;/a&gt;. Many companies, however, generate this impression intentionally, even when undeserved.&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;&lt;em&gt;Raising money, recruiting people and building a movement around your mission almost demands irrational optimism, especially in failure-riddled drug development.&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;&lt;em&gt;There is an allure and a danger to believing in something like this, giving it your all, and seeking to convince others to do the same while knowing the chances of success are lean. No one wants to commit to a marginal endeavor.&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;&lt;em&gt;But employees want transparency. Investors want a fair bet. And patients, who know more than anyone, want honesty. They are not one-liners for your PR machines or slides for your pitch decks. Now, reading the latest and greatest biotech PR, I’m furious when I see overstated results and oversold potential.&lt;/em&gt;&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;That’s exactly the territory. Realism would demand that you make clear that you are very likely to fail, but that will not bring you any resources to even get that far. But the kinds of stories that some investors (and some journalists, and some patients) might want to hear the most are not the true ones, and that’s not good, either. Unfortunately, the field is absolutely drenched with that oversold potential, and there’s probably no way to keep that from happening, humans being what they are.&lt;/p&gt;
&lt;p&gt;Horwitz’s essay is an honest look at just what it’s like to work out on the cutting edge of the business – new company, new mode of action, new chemical matter, new employees, new funding – and the story he tells is how most of those stories go. Just not quite all. And it’s that “not quite all” that keeps this whole business rolling. . .&lt;/p&gt;</content></content><title>Nivien’s Shot</title><summary><direction>ltr</direction><content>Have you ever heard of Nivien Therapeutics? Unless you follow the oncology world pretty closely, probably not. But they are – well, were – a startup out of Harvard that was working on a promising approach to overcoming chemotherapy resistance in pancreatic cancer. Now that’s what we call an “unmet medical need”, considering the steepness</content></summary><description>Have you ever heard of Nivien Therapeutics? Unless you follow the oncology world pretty closely, probably not. But they are – well, were – a startup out of Harvard that was working on a promising approach to overcoming chemotherapy resistance in pancreatic cancer. Now that’s what we call an “unmet medical need”, considering the steepness</description><crawled>1547564135591</crawled><keywords><item>Business and Markets</item><item>Cancer</item><item>Drug Development</item></keywords></item><item><author><name>Diba Emal</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1684be0b9cb:2b4c869:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37482-x&quot;&gt;doi:10.1038/s41598-018-37482-x&lt;/a&gt;&lt;/p&gt;Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/yLhA3-x1tbk&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/yLhA3-x1tbk/s41598-018-37482-x</href></item></alternate><published>1547452800000</published><unread>True</unread><visual><height>172</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37482-x/MediaObjects/41598_2018_37482_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>b91c1539</fingerprint><link>https://www.nature.com/articles/s41598-018-37482-x</link><engagement>4</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37482-x</href></item></canonical><title>Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37482-x&quot;&gt;doi:10.1038/s41598-018-37482-x&lt;/a&gt;&lt;/p&gt;Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/yLhA3-x1tbk&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-37482-x</originId><crawled>1547461245387</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Hee Jeung Oh, Mariam S. Aboian, Michael Y. J. Yi, Jacqueline A. Maslyn, Whitney S. Loo, Xi Jiang, Dilworth Y. Parkinson, Mark W. Wilson, Terilyn Moore, Colin R. Yee, Gregory R. Robbins, Florian M. Barth, Joseph M. DeSimone, Steven W. Hetts, Nitash P. Balsara</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>1TYkl+7D2jbCAjv6kqe9qy39+K76tsp7YKV/mQVt7ps=_16832ccd847:b12954:56b782f7</id><published>1547010000000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00700/20181221/images/medium/oc-2018-00700e_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00700&lt;/div&gt;</content></summary><fingerprint>ed376f9b</fingerprint><link>http://dx.doi.org/10.1021/acscentsci.8b00700</link><engagement>0</engagement><crawled>1547040512071</crawled><title>[ASAP] 3D Printed Absorber for Capturing Chemotherapy Drugs before They Spread through the Body</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acscii</streamId><title>ACS Central Science: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00700/20181221/images/medium/oc-2018-00700e_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00700&lt;/div&gt;</description><originId>http://dx.doi.org/10.1021/acscentsci.8b00700</originId><alternate><item><type>text/html</type><href>http://dx.doi.org/10.1021/acscentsci.8b00700</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Jung Jun Kim</name></author><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_168848de9d4:3bb247b:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36602-x&quot;&gt;doi:10.1038/s41598-018-36602-x&lt;/a&gt;&lt;/p&gt;Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/6hMdBqJnOR8&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/6hMdBqJnOR8/s41598-018-36602-x</href></item></alternate><published>1548403200000</published><unread>True</unread><fingerprint>3fab443c</fingerprint><link>https://www.nature.com/articles/s41598-018-36602-x</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36602-x</href></item></canonical><title>Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma</title><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36602-x&quot;&gt;doi:10.1038/s41598-018-36602-x&lt;/a&gt;&lt;/p&gt;Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/6hMdBqJnOR8&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41598-018-36602-x</originId><crawled>1548412119508</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Kim, D., Englund, D. R.</name></author><content><direction>ltr</direction><content>&lt;p&gt;Optical scattering is generally considered to be a nuisance of microscopy that limits imaging depth and spatial resolution. Wavefront shaping techniques enable optical imaging at unprecedented depth, but attaining superresolution within complex media remains a challenge. We used a quantum reference beacon (QRB), consisting of solid-state quantum emitters with spin-dependent fluorescence, to provide subwavelength guidestar feedback for wavefront shaping to achieve a superresolution optical focus. We implemented the QRB-guided imaging with nitrogen-vacancy centers in diamond nanocrystals, which enable optical focusing with a subdiffraction resolution below 186 nanometers (less than half the wavelength). QRB-assisted wavefront-shaping should find use in a range of applications, including deep-tissue quantum enhanced sensing and individual optical excitation of magnetically coupled spin ensembles for applications in quantum information processing.&lt;/p&gt;</content></content><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168a5541f68:1508092:3a104d3b</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6426/528?rss=1</href></item></alternate><published>1548959829000</published><unread>True</unread><fingerprint>6e7ed877</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6426/528?rss=1</link><engagement>0</engagement><title>Quantum reference beacon-guided superresolution optical focusing in complex media</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><description>&lt;p&gt;Optical scattering is generally considered to be a nuisance of microscopy that limits imaging depth and spatial resolution. Wavefront shaping techniques enable optical imaging at unprecedented depth, but attaining superresolution within complex media remains a challenge. We used a quantum reference beacon (QRB), consisting of solid-state quantum emitters with spin-dependent fluorescence, to provide subwavelength guidestar feedback for wavefront shaping to achieve a superresolution optical focus. We implemented the QRB-guided imaging with nitrogen-vacancy centers in diamond nanocrystals, which enable optical focusing with a subdiffraction resolution below 186 nanometers (less than half the wavelength). QRB-assisted wavefront-shaping should find use in a range of applications, including deep-tissue quantum enhanced sensing and individual optical excitation of magnetically coupled spin ensembles for applications in quantum information processing.&lt;/p&gt;</description><originId>http://science.sciencemag.org/cgi/content/short/363/6426/528?rss=1</originId><crawled>1548961980264</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6426/528.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><keywords><item>Physics, Applied, Physics</item></keywords></item><item><author><name>Chiara Riganti, Marialessandra Contino, Stefano Guglielmo, Maria G. Perrone, Iris C. Salaroglio, Vladan Milosevic, Roberta Giampietro, Francesco Leonetti, Barbara Rolando, Loretta Lazzarato, Nicola A. Colabufo, Roberta Fruttero</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_16833ab6f18:d9ef3:875042c9</id><published>1547010000000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01655/20190109/images/medium/jm-2018-016555_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01655&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=-pBEp68p29M:7SO45h4Tiq0:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/-pBEp68p29M&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>18521d2b</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01655</link><crawled>1547055099672</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01655</href></item></canonical><engagement>0</engagement><title>[ASAP] Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01655/20190109/images/medium/jm-2018-016555_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01655&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=-pBEp68p29M:7SO45h4Tiq0:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/-pBEp68p29M&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01655</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/-pBEp68p29M/acs.jmedchem.8b01655</href></item></alternate><visual><url>none</url></visual></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_168961c9a9e:50250f7:c2ce2e2e</id><published>1548633600000</published><unread>True</unread><summary><direction>ltr</direction><content>This article presents a chemical description of a simple topological insulators model in order to translate concepts such as &amp;quot;symmetry protected&amp;quot;, &amp;quot;surface states&amp;quot; to the chemistry vocabulary</content></summary><fingerprint>90676f2c</fingerprint><link>https://chemrxiv.org/articles/A_Chemical_Theory_of_Topological_Insulators/7637009</link><engagement>0</engagement><crawled>1548706683550</crawled><title>A Chemical Theory of Topological Insulators</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>This article presents a chemical description of a simple topological insulators model in order to translate concepts such as &amp;quot;symmetry protected&amp;quot;, &amp;quot;surface states&amp;quot; to the chemistry vocabulary</description><originId>https://chemrxiv.org/articles/A_Chemical_Theory_of_Topological_Insulators/7637009</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/A_Chemical_Theory_of_Topological_Insulators/7637009</href></item></alternate><visual><height>324</height><processor>feedly-nikon-v3.1</processor><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14188247/thumb.png</url><contentType>image/png</contentType><width>250</width></visual></item><item><author><name>Rui Wang</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1687c2d8177:2f7efe2:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Ultrafast hole transfer mediated by polaron pairs in all-polymer photovoltaic blends&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Ultrafast hole transfer mediated by polaron pairs in all-polymer photovoltaic blends, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08361-4&quot;&gt;doi:10.1038/s41467-019-08361-4&lt;/a&gt;&lt;/p&gt;All-polymer solar cells have shown high efficiencies but the ultrafast charge transfer processes are less known. Here Wang et al. show that polaron pairs play vital role facilitating the hole transfer, which is quite different from the exciton dominated pathway in polymer-fullerene blends.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/sHqBWmudcII&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/sHqBWmudcII/s41467-019-08361-4</href></item></alternate><published>1548230400000</published><unread>True</unread><visual><height>447</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-019-08361-4/MediaObjects/41467_2019_8361_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>a45d5402</fingerprint><link>https://www.nature.com/articles/s41467-019-08361-4</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-019-08361-4</href></item></canonical><title>Ultrafast hole transfer mediated by polaron pairs in all-polymer photovoltaic blends</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Ultrafast hole transfer mediated by polaron pairs in all-polymer photovoltaic blends&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Ultrafast hole transfer mediated by polaron pairs in all-polymer photovoltaic blends, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08361-4&quot;&gt;doi:10.1038/s41467-019-08361-4&lt;/a&gt;&lt;/p&gt;All-polymer solar cells have shown high efficiencies but the ultrafast charge transfer processes are less known. Here Wang et al. show that polaron pairs play vital role facilitating the hole transfer, which is quite different from the exciton dominated pathway in polymer-fullerene blends.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/sHqBWmudcII&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-019-08361-4</originId><crawled>1548271583607</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Philipp Nicolas Depta, Uwe Jandt, Maksym Dosta, An-Ping Zeng, Stefan Heinrich</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>bE0mPve90xtDW7Mgx9+xm/gIKXt54qktoOvefuUy0ZI=_1681ac7efcf:518b9:ce262a36</id><published>1546578000000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00613/20190104/images/medium/ci-2018-00613n_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00613&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=StIvXcIZreM:T_CXj7wFjMU:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/StIvXcIZreM&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>12b8b417</fingerprint><link>http://dx.doi.org/10.1021/acs.jcim.8b00613</link><crawled>1546637537231</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jcim.8b00613</href></item></canonical><engagement>0</engagement><title>[ASAP] Toward Multiscale Modeling of Proteins and Bioagglomerates: An Orientation-Sensitive Diffusion Model for the Integration of Molecular Dynamics and the Discrete Element Method</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jcisd8</streamId><title>Journal of Chemical Information and Modeling: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00613/20190104/images/medium/ci-2018-00613n_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00613&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=StIvXcIZreM:T_CXj7wFjMU:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/StIvXcIZreM&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jcim.8b00613</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jcisd8/~3/StIvXcIZreM/acs.jcim.8b00613</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Chun Wang</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Li</text></item></mentions><label>Li</label><id>nlp/f/entity/en/-/li</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Biol</text></item></mentions><label>Biol</label><id>nlp/f/entity/en/-/biol</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>C.</text></item></mentions><label>C.</label><id>nlp/f/entity/en/-/c.</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Ma</text></item></mentions><label>Ma</label><id>nlp/f/entity/en/-/ma</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>bp</text></item></mentions><label>BP</label><id>nlp/f/entity/en/w/BP</id></item></entities><id>0qZSsMpEyvTD/JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I=_168186db3a2:2d4561:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Clonal seeds from hybrid rice by simultaneous genome engineering of meiosis and fertilization genes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Clonal seeds from hybrid rice by simultaneous genome engineering of meiosis and fertilization genes, Published online: 04 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41587-018-0003-0&quot;&gt;doi:10.1038/s41587-018-0003-0&lt;/a&gt;&lt;/p&gt;Hybrids can be self-pollinated to produce true-breeding progeny through seeds by simultaneous genome editing of four endogenous genes in a rice F1 hybrid variety.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41587-018-0003-0</href></item></alternate><published>1546588800000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41587-018-0003-0/MediaObjects/41587_2018_3_Fig1_HTML.png</url><contentType>image/png</contentType><width>427</width></visual><fingerprint>e15ce6cb</fingerprint><commonTopics><item><probability>0.987</probability><label>bioinformatics</label><id>nlp/f/topic/262</id></item><item><probability>0.965</probability><label>genetics</label><id>nlp/f/topic/955</id></item><item><probability>0.946</probability><label>classics</label><id>nlp/f/topic/477</id></item><item><probability>0.927</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.891</probability><label>ecology</label><id>nlp/f/topic/725</id></item><item><probability>0.866</probability><label>emergency medicine</label><id>nlp/f/topic/764</id></item><item><probability>0.837</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.825</probability><label>rationality</label><id>nlp/f/topic/1895</id></item><item><probability>0.754</probability><label>mp3</label><id>nlp/f/topic/1508</id></item></commonTopics><link>https://www.nature.com/articles/s41587-018-0003-0</link><engagement>3</engagement><title>Clonal seeds from hybrid rice by simultaneous genome engineering of meiosis and fertilization genes</title><origin><htmlUrl>http://feeds.nature.com/nbt/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nbt/current_issue/rss/</streamId><title>Nature Biotechnology</title></origin><description>&lt;p&gt;&lt;b&gt;Clonal seeds from hybrid rice by simultaneous genome engineering of meiosis and fertilization genes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Clonal seeds from hybrid rice by simultaneous genome engineering of meiosis and fertilization genes, Published online: 04 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41587-018-0003-0&quot;&gt;doi:10.1038/s41587-018-0003-0&lt;/a&gt;&lt;/p&gt;Hybrids can be self-pollinated to produce true-breeding progeny through seeds by simultaneous genome editing of four endogenous genes in a rice F1 hybrid variety.</description><originId>https://www.nature.com/articles/s41587-018-0003-0</originId><crawled>1546598069154</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/0qZSsMpEyvTD_JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I_oicon-166b30c5bda</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Carson W. Reed, Samantha E. Yohn, Jordan P. Washecheck, Hanna F. Roenfanz, Marc C. Quitalig, Vincent B. Luscombe, Matthew T. Jenkins, Alice L. Rodriguez, Darren W. Engers, Anna L. Blobaum, P. Jeffrey Conn, Colleen M. Niswender, Craig W. Lindsley</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_1685bf551f2:dfaec:1451c985</id><published>1547701200000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01810/20190116/images/medium/jm-2018-01810z_0012.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01810&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=VQpxeqk5iho:wObwwkJBD6c:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/VQpxeqk5iho&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>f1632424</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01810</link><crawled>1547731030514</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01810</href></item></canonical><engagement>0</engagement><title>[ASAP] Discovery of an Orally Bioavailable and Central Nervous System (CNS) Penetrant mGlu7 Negative Allosteric Modulator (NAM) in Vivo Tool Compound: N-(2-(1H-1,2,4-triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide (VU6012962)</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01810/20190116/images/medium/jm-2018-01810z_0012.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01810&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=VQpxeqk5iho:wObwwkJBD6c:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/VQpxeqk5iho&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01810</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/VQpxeqk5iho/acs.jmedchem.8b01810</href></item></alternate><visual><url>none</url></visual></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_168a4c1d525:140ba45:3a104d3b</id><published>1548892800000</published><unread>True</unread><summary><direction>ltr</direction><content>Seven
million of the currently 94 million entries in the PubChem database break at
least one of the four Lipinski constraints for oral bioavailability, 183,185 of
which are also found in the ChEMBL database. These non-Lipinski PubChem (NLP)
and ChEMBL (NLC) subsets are interesting because they contain new modalities
that can display biological properties not accessible to small molecule drugs.
Unfortunately, the current search tools in PubChem and ChEMBL are designed for
small molecules and are not well suited to explore these subsets, which
therefore remain poorly appreciated. Herein we report MXFP (macromolecule
extended atom-pair fingerprint), a 217-D fingerprint
tailored to analyze large molecules in terms of molecular shape and
pharmacophores. We implement MXFP in two web-based applications, the first one
to visualize NLP and NLC interactively using Faerun (http://faerun.gdb.tools/),
the second one to perform MXFP nearest neighbor searches in NLP (http://similaritysearch.gdb.tools/).
We show that these tools provide a meaningful insight into the diversity of
large molecules in NLP and NLC. The interactive tools presented here are
publicly available at http://gdb.unibe.ch and can be used freely to explore and
better understand the diversity of non-Lipinski molecules in PubChem and
ChEMBL.</content></summary><fingerprint>74135811</fingerprint><link>https://chemrxiv.org/articles/PubChem_and_ChEMBL_Beyond_Lipinski/7650071</link><engagement>0</engagement><crawled>1548952392997</crawled><title>PubChem and ChEMBL Beyond Lipinski</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>Seven
million of the currently 94 million entries in the PubChem database break at
least one of the four Lipinski constraints for oral bioavailability, 183,185 of
which are also found in the ChEMBL database. These non-Lipinski PubChem (NLP)
and ChEMBL (NLC) subsets are interesting because they contain new modalities
that can display biological properties not accessible to small molecule drugs.
Unfortunately, the current search tools in PubChem and ChEMBL are designed for
small molecules and are not well suited to explore these subsets, which
therefore remain poorly appreciated. Herein we report MXFP (macromolecule
extended atom-pair fingerprint), a 217-D fingerprint
tailored to analyze large molecules in terms of molecular shape and
pharmacophores. We implement MXFP in two web-based applications, the first one
to visualize NLP and NLC interactively using Faerun (http://faerun.gdb.tools/),
the second one to perform MXFP nearest neighbor searches in NLP (http://similaritysearch.gdb.tools/).
We show that these tools provide a meaningful insight into the diversity of
large molecules in NLP and NLC. The interactive tools presented here are
publicly available at http://gdb.unibe.ch and can be used freely to explore and
better understand the diversity of non-Lipinski molecules in PubChem and
ChEMBL.</description><originId>https://chemrxiv.org/articles/PubChem_and_ChEMBL_Beyond_Lipinski/7650071</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/PubChem_and_ChEMBL_Beyond_Lipinski/7650071</href></item></alternate></item><item><author><name>Yeston, J.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a72:c2ce2e2e</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/360-o?rss=1</href></item></alternate><published>1548355045000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>955edf24</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6425/360-o?rss=1</link><engagement>0</engagement><title>Olefin shuffle for just a nickel</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6425/360-o?rss=1</originId><crawled>1548357093757</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6425/360.15.full</canonicalUrl><keywords><item>Chemistry</item></keywords></item><item><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>﻿Rare</text></item></mentions><label>﻿Rare</label><id>nlp/f/entity/en/-/﻿rare</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Anna Balazs</text></item></mentions><label>Anna Balazs</label><id>nlp/f/entity/en/-/anna balazs</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>University of Pittsburgh</text></item></mentions><label>University of Pittsburgh</label><id>nlp/f/entity/en/w/University of Pittsburgh</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Pennsylvania</text></item></mentions><label>Pennsylvania</label><id>nlp/f/entity/en/w/Pennsylvania</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1686200d0a6:caad25:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;﻿Rare whales and seals thrive thanks to controversial US law&lt;/b&gt;&lt;/p&gt;&lt;p&gt;﻿Rare whales and seals thrive thanks to controversial US law, Published online: 18 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00192-z&quot;&gt;doi:10.1038/d41586-019-00192-z&lt;/a&gt;&lt;/p&gt;Animals protected by the Endangered Species Act for more than two decades are the most likely to recover.</content></content><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00192-z</href></item></alternate><published>1547798400000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00192-z/d41586-019-00192-z_16398754.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>456fba4</fingerprint><commonTopics><item><probability>0.964</probability><label>robotics</label><id>nlp/f/topic/1955</id></item><item><probability>0.862</probability><label>swimming</label><id>nlp/f/topic/2220</id></item><item><probability>0.843</probability><label>biochemistry</label><id>nlp/f/topic/257</id></item><item><probability>0.827</probability><label>ai</label><id>nlp/f/topic/56</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00192-z</link><engagement>20</engagement><title>﻿Rare whales and seals thrive thanks to controversial US law</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;﻿Rare whales and seals thrive thanks to controversial US law&lt;/b&gt;&lt;/p&gt;&lt;p&gt;﻿Rare whales and seals thrive thanks to controversial US law, Published online: 18 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00192-z&quot;&gt;doi:10.1038/d41586-019-00192-z&lt;/a&gt;&lt;/p&gt;Animals protected by the Endangered Species Act for more than two decades are the most likely to recover.</description><originId>https://www.nature.com/articles/d41586-019-00192-z</originId><crawled>1547832447142</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Yong Chen, Xue Yuan, Wanhua Zhang, Minghai Tang, Li Zheng, Fang Wang, Wei Yan, Shengyong Yang, Yuquan Wei, Jun He, Lijuan Chen</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_16881c0fe42:ce842a:56b782f7</id><published>1548306000000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01825/20190124/images/medium/jm-2018-01825x_0004.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01825&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=Jx2chX4jE7M:2sIfprR8KKc:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/Jx2chX4jE7M&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>ee205d2a</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01825</link><crawled>1548365135426</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01825</href></item></canonical><engagement>0</engagement><title>[ASAP] Discovery of Novel Dual Histone Deacetylase and Mammalian Target of Rapamycin Target Inhibitors as a Promising Strategy for Cancer Therapy</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01825/20190124/images/medium/jm-2018-01825x_0004.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01825&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=Jx2chX4jE7M:2sIfprR8KKc:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/Jx2chX4jE7M&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01825</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/Jx2chX4jE7M/acs.jmedchem.8b01825</href></item></alternate><visual><url>none</url></visual></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1680fbb85b0:615f865:c2ce2e2e</id><published>1546387200000</published><unread>True</unread><summary><direction>ltr</direction><content>The interaction of atomic and molecular hydrogen with the
actinide dioxide (AnO2, An = U, Np, Pu) (111) surfaces has been
investigated by DFT+U, where noncollinear 3k antiferromagnetic (AFM) behaviour
and spin-orbit interactions (SOI) are considered. The adsorption of atomic
hydrogen forms a hydroxide group, and is coupled to the reduction of an
actinide ion. The energy of atomic hydrogen
adsorption on the UO2 (0.82 eV), NpO2 (-0.10 eV), and PuO2
(-1.25 eV) surfaces has been calculated. The dissociation of molecular hydrogen
is not observed, and shown to be due to kinetic rather than thermodynamic
factors. As a barrier in the formation of a second hydroxyl group, an unusual charge
distribution has been shown. This is possibly a limitation of a (1·1) unit cell
method. The recombination of hydrogen ions on the AnO2 (111)
surfaces is favoured over hydroxide formation.</content></summary><fingerprint>1454269b</fingerprint><link>https://chemrxiv.org/articles/The_Interaction_of_Hydrogen_with_Actinide_Dioxide_111_Surfaces/7533359</link><engagement>3</engagement><crawled>1546452174256</crawled><title>The Interaction of Hydrogen with Actinide Dioxide (111) Surfaces</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>The interaction of atomic and molecular hydrogen with the
actinide dioxide (AnO2, An = U, Np, Pu) (111) surfaces has been
investigated by DFT+U, where noncollinear 3k antiferromagnetic (AFM) behaviour
and spin-orbit interactions (SOI) are considered. The adsorption of atomic
hydrogen forms a hydroxide group, and is coupled to the reduction of an
actinide ion. The energy of atomic hydrogen
adsorption on the UO2 (0.82 eV), NpO2 (-0.10 eV), and PuO2
(-1.25 eV) surfaces has been calculated. The dissociation of molecular hydrogen
is not observed, and shown to be due to kinetic rather than thermodynamic
factors. As a barrier in the formation of a second hydroxyl group, an unusual charge
distribution has been shown. This is possibly a limitation of a (1·1) unit cell
method. The recombination of hydrogen ions on the AnO2 (111)
surfaces is favoured over hydroxide formation.</description><originId>https://chemrxiv.org/articles/The_Interaction_of_Hydrogen_with_Actinide_Dioxide_111_Surfaces/7533359</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/The_Interaction_of_Hydrogen_with_Actinide_Dioxide_111_Surfaces/7533359</href></item></alternate></item><item><author><name>Szuromi, P.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a73:c2ce2e2e</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/360-n?rss=1</href></item></alternate><published>1548355045000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>e2b2ab84</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6425/360-n?rss=1</link><engagement>0</engagement><title>Flexibility in gas absorption</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6425/360-n?rss=1</originId><crawled>1548357093757</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6425/360.14.full</canonicalUrl><keywords><item>Chemistry, Materials Science</item></keywords></item><item><author><name>Stern, P.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3b2:ad2b6584</id><published>1546540591000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>484d8322</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6422/39-p?rss=1</link><engagement>0</engagement><crawled>1546542450273</crawled><title>Another primary visual cortex</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6422/39-p?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/39-p?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6422/39.16.full</canonicalUrl></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1684dca5d84:2e4a28b:c2ce2e2e</id><published>1547424000000</published><unread>True</unread><summary><direction>ltr</direction><content>We report herein the synthesis and characterization of bPNA+, a new variant of bifacial peptide nucleic acid (bPNA) that binds oligo T/U nucleic acids to form triplex hybrids with good affinity but half the molecular footprint of bPNA. This is accomplished via display of two melamine (M) bases melamine per lysine sidechain on bPNA+ rather than one as previously reported. Lysine derivatives bearing two bases were prepared by double reductive alkylation with melamine acetaldehyde, resulting in a tertiary amine branch point. Importantly, this amino sidechain fosters oligo T/U binding through both base-triple formation and electrostatic interactions, while maintaining selectivity and peptide solubility. The bPNA+ binding site roughly the size of a 6 base-pair stem; this relatively compact perturbation can be genetically encoded at virtually any position within an RNA transcript, and may replace existing stem elements. Subsequent triplex hybridization with fluorophore-labeled bPNA+ triplex hybrids thus accomplishes site-specific labeling of internal RNA locations without the need for chemical modification. We demonstrate herein the use of this strategy for reporting on intermolecular RNA-RNA kissing loop interactions, RNA-protein binding as well as intramolecular RNA tetraloop-tetraloop receptor binding. We anticipate that bPNA+ will have utility as structural probes for dynamic tertiary interactions in long noncoding RNAs.</content></summary><fingerprint>4cbeee8a</fingerprint><link>https://chemrxiv.org/articles/Branched_Sidechain_bPNA_Reports_on_RNA-Loop_Tertiary_Interactions_via_Triplex_Hybridization_Stem_Replacement_at_Internal_Domains/7583624</link><engagement>0</engagement><crawled>1547493334404</crawled><title>Branched Sidechain bPNA + Reports on RNA-Loop Tertiary Interactions via Triplex Hybridization Stem Replacement at Internal Domains</title><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><description>We report herein the synthesis and characterization of bPNA+, a new variant of bifacial peptide nucleic acid (bPNA) that binds oligo T/U nucleic acids to form triplex hybrids with good affinity but half the molecular footprint of bPNA. This is accomplished via display of two melamine (M) bases melamine per lysine sidechain on bPNA+ rather than one as previously reported. Lysine derivatives bearing two bases were prepared by double reductive alkylation with melamine acetaldehyde, resulting in a tertiary amine branch point. Importantly, this amino sidechain fosters oligo T/U binding through both base-triple formation and electrostatic interactions, while maintaining selectivity and peptide solubility. The bPNA+ binding site roughly the size of a 6 base-pair stem; this relatively compact perturbation can be genetically encoded at virtually any position within an RNA transcript, and may replace existing stem elements. Subsequent triplex hybridization with fluorophore-labeled bPNA+ triplex hybrids thus accomplishes site-specific labeling of internal RNA locations without the need for chemical modification. We demonstrate herein the use of this strategy for reporting on intermolecular RNA-RNA kissing loop interactions, RNA-protein binding as well as intramolecular RNA tetraloop-tetraloop receptor binding. We anticipate that bPNA+ will have utility as structural probes for dynamic tertiary interactions in long noncoding RNAs.</description><originId>https://chemrxiv.org/articles/Branched_Sidechain_bPNA_Reports_on_RNA-Loop_Tertiary_Interactions_via_Triplex_Hybridization_Stem_Replacement_at_Internal_Domains/7583624</originId><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Branched_Sidechain_bPNA_Reports_on_RNA-Loop_Tertiary_Interactions_via_Triplex_Hybridization_Stem_Replacement_at_Internal_Domains/7583624</href></item></alternate><visual><height>324</height><processor>feedly-nikon-v3.1</processor><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14083016/thumb.png</url><contentType>image/png</contentType><width>250</width></visual></item><item><author><name>Andreae, L. C.</name></author><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1687c1a95dc:2f6433c:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;Gene network analysis in stem cell–derived cortical neurons from individuals with autism reveals accelerated neuronal maturation.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/476/eaaw5314?rss=1</href></item></alternate><published>1548269442000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>9c8969d8</fingerprint><link>http://stm.sciencemag.org/cgi/content/short/11/476/eaaw5314?rss=1</link><engagement>0</engagement><title>[Editors&apos; Choice] Brain development in autism: Timing is everything</title><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><description>&lt;p&gt;Gene network analysis in stem cell–derived cortical neurons from individuals with autism reveals accelerated neuronal maturation.&lt;/p&gt;</description><originId>http://stm.sciencemag.org/cgi/content/short/11/476/eaaw5314?rss=1</originId><crawled>1548270343644</crawled><canonicalUrl>http://stm.sciencemag.org/content/11/476/eaaw5314.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Liston, C.</name></author><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_168a028b953:cc891e:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;Hyperpolarization-activated cyclic nucleotide–gated channel dysfunction drives stress susceptibility and depression-like behavior.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/477/eaaw5318?rss=1</href></item></alternate><published>1548874208000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>69e317a2</fingerprint><link>http://stm.sciencemag.org/cgi/content/short/11/477/eaaw5318?rss=1</link><engagement>0</engagement><title>[Editors&apos; Choice] Targeting pacemaker channels in depression</title><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><description>&lt;p&gt;Hyperpolarization-activated cyclic nucleotide–gated channel dysfunction drives stress susceptibility and depression-like behavior.&lt;/p&gt;</description><originId>http://stm.sciencemag.org/cgi/content/short/11/477/eaaw5318?rss=1</originId><crawled>1548875250003</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>NA</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168a5541f68:15080ce:3a104d3b</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6426/434?rss=1</href></item></alternate><published>1548959829000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>668d50cf</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6426/434?rss=1</link><engagement>0</engagement><title>News at a glance</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6426/434?rss=1</originId><crawled>1548961980264</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6426/434.full</canonicalUrl><keywords><item>Scientific Community</item></keywords></item><item><author><name>Koeberl, C.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce0a4:ad2b6584</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/224?rss=1</href></item></alternate><published>1547750305000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>98b93911</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6424/224?rss=1</link><engagement>0</engagement><title>When Earth got pummeled</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6424/224?rss=1</originId><crawled>1547752389672</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6424/224.full</canonicalUrl><keywords><item>Planetary Science</item></keywords></item><item><author><name>Wonsuk Choi</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1682d035c6a:2a73e1:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Publisher Correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosis&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Publisher Correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosis, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08085-x&quot;&gt;doi:10.1038/s41467-018-08085-x&lt;/a&gt;&lt;/p&gt;Publisher Correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosis&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/DfEbqeWyOaM&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/DfEbqeWyOaM/s41467-018-08085-x</href></item></alternate><published>1546934400000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>b1d3d4db</fingerprint><link>https://www.nature.com/articles/s41467-018-08085-x</link><engagement>1</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08085-x</href></item></canonical><title>Publisher Correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosis</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Publisher Correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosis&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Publisher Correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosis, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08085-x&quot;&gt;doi:10.1038/s41467-018-08085-x&lt;/a&gt;&lt;/p&gt;Publisher Correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosis&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/DfEbqeWyOaM&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-018-08085-x</originId><crawled>1546943421546</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Hande Boyaci</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>Nat</text></item></mentions><label>Nat</label><id>nlp/f/entity/en/-/nat</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>J.</text></item><item><text>J</text></item></mentions><label>Jan Lievens</label><id>nlp/f/entity/en/w/Jan Lievens</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>A.</text></item></mentions><label>A.</label><id>nlp/f/entity/en/-/a.</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>J. Mol</text></item><item><text>Mol</text></item></mentions><label>J. Mol</label><id>nlp/f/entity/en/-/j. mol</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>G.</text></item></mentions><label>G.</label><id>nlp/f/entity/en/-/g.</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16833ca2c4e:d2b07f:8675cc2c</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Structures of an RNA polymerase promoter melting intermediate elucidate DNA unwinding&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Structures of an RNA polymerase promoter melting intermediate elucidate DNA unwinding, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0840-5&quot;&gt;doi:10.1038/s41586-018-0840-5&lt;/a&gt;&lt;/p&gt;Cryo-electron microscopy structures of bacterial RNAP–promoter DNA complexes, including structures of partially melted intermediates, suggest a universally conserved common mechanism for promoter DNA opening prior to gene expression.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0840-5</href></item></alternate><published>1547020800000</published><unread>True</unread><visual><height>635</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0840-5/MediaObjects/41586_2018_840_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>70226ed8</fingerprint><commonTopics><item><probability>0.972</probability><label>classics</label><id>nlp/f/topic/477</id></item><item><probability>0.855</probability><label>emergency medicine</label><id>nlp/f/topic/764</id></item><item><probability>0.841</probability><label>nlp</label><id>nlp/f/topic/1585</id></item><item><probability>0.791</probability><label>mp3</label><id>nlp/f/topic/1508</id></item><item><probability>0.773</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>0.753</probability><label>graphics</label><id>nlp/f/topic/1000</id></item><item><probability>0.749</probability><label>bioinformatics</label><id>nlp/f/topic/262</id></item><item><probability>0.721</probability><label>genetics</label><id>nlp/f/topic/955</id></item><item><probability>0.719</probability><label>rationality</label><id>nlp/f/topic/1895</id></item></commonTopics><link>https://www.nature.com/articles/s41586-018-0840-5</link><engagement>2</engagement><title>Structures of an RNA polymerase promoter melting intermediate elucidate DNA unwinding</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Structures of an RNA polymerase promoter melting intermediate elucidate DNA unwinding&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Structures of an RNA polymerase promoter melting intermediate elucidate DNA unwinding, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0840-5&quot;&gt;doi:10.1038/s41586-018-0840-5&lt;/a&gt;&lt;/p&gt;Cryo-electron microscopy structures of bacterial RNAP–promoter DNA complexes, including structures of partially melted intermediates, suggest a universally conserved common mechanism for promoter DNA opening prior to gene expression.</description><originId>https://www.nature.com/articles/s41586-018-0840-5</originId><crawled>1547057114190</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Itay Katzir</name></author><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_168a01c7caf:45eee:875042c9</id><content><direction>ltr</direction><content>&lt;p&gt;by Itay Katzir, Murat Cokol, Bree B. Aldridge, Uri Alon&lt;/p&gt;
Drug combinations are a promising approach to achieve high efficacy at low doses and to overcome resistance. Drug combinations are especially useful when drugs cannot achieve effectiveness at tolerable doses, as occurs in cancer and tuberculosis (TB). However, discovery of effective drug combinations faces the challenge of combinatorial explosion, in which the number of possible combinations increases exponentially with the number of drugs and doses. A recent advance, called the dose model, uses a mathematical formula to overcome combinatorial explosion by reducing the problem to a feasible quadratic one: using data on drug pairs at a few doses, the dose model accurately predicts the effect of combinations of three and four drugs at all doses. The dose model has not yet been tested on higher-order combinations beyond four drugs. To address this, we measured the effect of combinations of up to ten antibiotics on &lt;i&gt;E&lt;/i&gt;. &lt;i&gt;coli&lt;/i&gt; growth, and of up to five tuberculosis (TB) drugs on the growth of &lt;i&gt;M&lt;/i&gt;. &lt;i&gt;tuberculosis&lt;/i&gt;. We find that the dose model accurately predicts the effect of these higher-order combinations, including cases of strong synergy and antagonism. This study supports the view that the interactions between drug pairs carries key information that largely determines higher-order interactions. Therefore, systematic study of pairwise drug interactions is a compelling strategy to prioritize drug regimens in high-dimensional spaces.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/HjJA1n5znGo&quot; height=&quot;1&quot;&gt;</content></content><updateCount>1</updateCount><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/HjJA1n5znGo/article</href></item></alternate><published>1548885600000</published><unread>True</unread><fingerprint>65ba1e70</fingerprint><link>10.1371/journal.pcbi.1006774</link><recrawled>1548883625992</recrawled><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006774</href></item></canonical><updated>1548885600000</updated><engagement>0</engagement><title>Prediction of ultra-high-order antibiotic combinations based on pairwise interactions</title><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><description>&lt;p&gt;by Itay Katzir, Murat Cokol, Bree B. Aldridge, Uri Alon&lt;/p&gt;
Drug combinations are a promising approach to achieve high efficacy at low doses and to overcome resistance. Drug combinations are especially useful when drugs cannot achieve effectiveness at tolerable doses, as occurs in cancer and tuberculosis (TB). However, discovery of effective drug combinations faces the challenge of combinatorial explosion, in which the number of possible combinations increases exponentially with the number of drugs and doses. A recent advance, called the dose model, uses a mathematical formula to overcome combinatorial explosion by reducing the problem to a feasible quadratic one: using data on drug pairs at a few doses, the dose model accurately predicts the effect of combinations of three and four drugs at all doses. The dose model has not yet been tested on higher-order combinations beyond four drugs. To address this, we measured the effect of combinations of up to ten antibiotics on &lt;i&gt;E&lt;/i&gt;. &lt;i&gt;coli&lt;/i&gt; growth, and of up to five tuberculosis (TB) drugs on the growth of &lt;i&gt;M&lt;/i&gt;. &lt;i&gt;tuberculosis&lt;/i&gt;. We find that the dose model accurately predicts the effect of these higher-order combinations, including cases of strong synergy and antagonism. This study supports the view that the interactions between drug pairs carries key information that largely determines higher-order interactions. Therefore, systematic study of pairwise drug interactions is a compelling strategy to prioritize drug regimens in high-dimensional spaces.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/HjJA1n5znGo&quot; height=&quot;1&quot;&gt;</description><originId>10.1371/journal.pcbi.1006774</originId><crawled>1548874448047</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Liyang Shi, Zhenpeng Zhong, Xitao Li, Yiqing Zhou, Zhengying Pan</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_1682a2b21a3:16ebe64:56b782f7</id><published>1546837200000</published><unread>True</unread><summary><direction>ltr</direction><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01823/20190107/images/medium/jm-2018-01823p_0018.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01823&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=DX3W9aXs0UA:4naGnF6Edhw:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/DX3W9aXs0UA&quot; height=&quot;1&quot;&gt;</content></summary><fingerprint>20fd3d11</fingerprint><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01823</link><crawled>1546895696291</crawled><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01823</href></item></canonical><engagement>0</engagement><title>[ASAP] Discovery of an Orally Available Janus Kinase 3 Selective Covalent Inhibitor</title><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01823/20190107/images/medium/jm-2018-01823p_0018.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01823&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=DX3W9aXs0UA:4naGnF6Edhw:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/DX3W9aXs0UA&quot; height=&quot;1&quot;&gt;</description><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01823</originId><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/DX3W9aXs0UA/acs.jmedchem.8b01823</href></item></alternate><visual><url>none</url></visual></item><item><author><name>Fahrenkamp-Uppenbrink, J.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3a8:ad2b6584</id><published>1546540591000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>84a85a68</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6422/40-e?rss=1</link><engagement>20</engagement><crawled>1546542450273</crawled><title>Scallops seasoned with nanoplastics</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6422/40-e?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/40-e?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6422/40.5.full</canonicalUrl></item><item><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>MU69</text></item></mentions><label>(486958) 2014 MU69</label><id>nlp/f/entity/en/w/(486958) 2014 MU69</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>NASA</text></item></mentions><label>NASA</label><id>nlp/f/entity/en/w/NASA</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>New Horizons</text></item></mentions><label>New Horizons</label><id>nlp/f/entity/en/w/New Horizons</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>MU 69</text></item></mentions><label>MU 69</label><id>nlp/f/entity/en/-/mu 69</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>Southwest Research Institute</text></item></mentions><label>Southwest Research Institute</label><id>nlp/f/entity/en/w/Southwest Research Institute</id></item></entities><author><name>NA</name></author><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16810843f8c:6285c7e:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Cosmic collision created ‘snowman’ MU&lt;sub&gt;69&lt;/sub&gt; — the farthest world ever explored&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Cosmic collision created ‘snowman’ MU&amp;lt;sub&gt;69&amp;lt;/sub&gt; — the farthest world ever explored, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00006-2&quot;&gt;doi:10.1038/d41586-019-00006-2&lt;/a&gt;&lt;/p&gt;Close-up images from NASA’s New Horizons probe show that space rock has two distinct lobes.</content></content><updateCount>1</updateCount><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00006-2</href></item></alternate><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00006-2/d41586-019-00006-2_16369702.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>d1065a47</fingerprint><link>https://www.nature.com/articles/d41586-019-00006-2</link><recrawled>1546466617980</recrawled><engagement>11</engagement><title>Cosmic collision created ‘snowman’ MU69 — the farthest world ever explored</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Cosmic collision created ‘snowman’ MU&lt;sub&gt;69&lt;/sub&gt; — the farthest world ever explored&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Cosmic collision created ‘snowman’ MU&amp;lt;sub&gt;69&amp;lt;/sub&gt; — the farthest world ever explored, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00006-2&quot;&gt;doi:10.1038/d41586-019-00006-2&lt;/a&gt;&lt;/p&gt;Close-up images from NASA’s New Horizons probe show that space rock has two distinct lobes.</description><originId>https://www.nature.com/articles/d41586-019-00006-2</originId><crawled>1546465329036</crawled><published>1546416000000</published><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Kajimoto, T., Caliman, A. D., Tobias, I. S., Okada, T., Pilo, C. A., Van, A.-A. N., Andrew McCammon, J., Nakamura, S.-i., Newton, A. C.</name></author><id>RuJRIXzN26JgDGk9YhlIBfh4YrPi0r+1c4exm9G1IBw=_1680ada2f60:5c7ce38:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;Atypical protein kinase C (aPKC) isozymes are unique in the PKC superfamily in that they are not regulated by the lipid second messenger diacylglycerol, which has led to speculation about whether a different second messenger acutely controls their function. Here, using a genetically encoded reporter that we designed, aPKC-specific C kinase activity reporter (aCKAR), we found that the lipid mediator sphingosine 1-phosphate (S1P) promoted the cellular activity of aPKC. Intracellular S1P directly bound to the purified kinase domain of aPKC and relieved autoinhibitory constraints, thereby activating the kinase. In silico studies identified potential binding sites on the kinase domain, one of which was validated biochemically. In HeLa cells, S1P-dependent activation of aPKC suppressed apoptosis. Together, our findings identify a previously undescribed molecular mechanism of aPKC regulation, a molecular target for S1P in cell survival regulation, and a tool to further explore the biochemical and biological functions of aPKC.&lt;/p&gt;</content></content><alternate><item><type>text/html</type><href>http://stke.sciencemag.org/cgi/content/short/12/562/eaat6662?rss=1</href></item></alternate><published>1546368670000</published><unread>True</unread><fingerprint>3bd38672</fingerprint><link>http://stke.sciencemag.org/cgi/content/short/12/562/eaat6662?rss=1</link><engagement>0</engagement><title>Activation of atypical protein kinase C by sphingosine 1-phosphate revealed by an aPKC-specific activity reporter</title><origin><htmlUrl>http://stke.sciencemag.org</htmlUrl><streamId>feed/http://stke.sciencemag.org/rss/current.xml</streamId><title>Science Signaling current issue</title></origin><description>&lt;p&gt;Atypical protein kinase C (aPKC) isozymes are unique in the PKC superfamily in that they are not regulated by the lipid second messenger diacylglycerol, which has led to speculation about whether a different second messenger acutely controls their function. Here, using a genetically encoded reporter that we designed, aPKC-specific C kinase activity reporter (aCKAR), we found that the lipid mediator sphingosine 1-phosphate (S1P) promoted the cellular activity of aPKC. Intracellular S1P directly bound to the purified kinase domain of aPKC and relieved autoinhibitory constraints, thereby activating the kinase. In silico studies identified potential binding sites on the kinase domain, one of which was validated biochemically. In HeLa cells, S1P-dependent activation of aPKC suppressed apoptosis. Together, our findings identify a previously undescribed molecular mechanism of aPKC regulation, a molecular target for S1P in cell survival regulation, and a tool to further explore the biochemical and biological functions of aPKC.&lt;/p&gt;</description><originId>http://stke.sciencemag.org/cgi/content/short/12/562/eaat6662?rss=1</originId><crawled>1546370297696</crawled><canonicalUrl>http://stke.sciencemag.org/content/12/562/eaat6662.full</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Cairns, J.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1687949fd16:2a3edb9:c2ce2e2e</id><content><direction>ltr</direction><content>Capture Hi-C is a powerful approach for detecting chromosomal interactions involving, at least on one end, DNA regions of interest, such as gene promoters. We present Chicdiff, an R package for robust detection of differential interactions in Capture Hi-C data. Chicdiff enhances a state-of-the-art differential testing approach for count data with bespoke normalisation and multiple testing procedures that account for specific statistical properties of Capture Hi-C. We validate Chicdiff on published Promoter Capture Hi-C data in human monocytes and CD4+ T cells, identifying multitudes of cell type-specific interactions, and confirming the overall positive association between promoter interactions and gene expression.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/526269v2?rss=1</href></item></alternate><published>1548144000000</published><unread>True</unread><fingerprint>73d13c87</fingerprint><link>http://biorxiv.org/cgi/content/short/526269v2?rss=1</link><engagement>0</engagement><title>Chicdiff: a computational pipeline for detecting differential chromosomal interactions in Capture Hi-C data [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>Capture Hi-C is a powerful approach for detecting chromosomal interactions involving, at least on one end, DNA regions of interest, such as gene promoters. We present Chicdiff, an R package for robust detection of differential interactions in Capture Hi-C data. Chicdiff enhances a state-of-the-art differential testing approach for count data with bespoke normalisation and multiple testing procedures that account for specific statistical properties of Capture Hi-C. We validate Chicdiff on published Promoter Capture Hi-C data in human monocytes and CD4+ T cells, identifying multitudes of cell type-specific interactions, and confirming the overall positive association between promoter interactions and gene expression.</description><originId>http://biorxiv.org/cgi/content/short/526269v2?rss=1</originId><crawled>1548223118614</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/22/526269.1</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Valentina Sukonina</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>FOXK1</text></item></mentions><label>FOXK1</label><id>nlp/f/entity/en/-/foxk1</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>FOXK2</text></item></mentions><label>FOXK2</label><id>nlp/f/entity/en/-/foxk2</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>M.</text></item></mentions><label>M.</label><id>nlp/f/entity/en/-/m.</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Campbell</text></item></mentions><label>Campbell</label><id>nlp/f/entity/en/-/campbell</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>J. Physiol</text></item><item><text>Physiol</text></item></mentions><label>J. Physiol</label><id>nlp/f/entity/en/-/j. physiol</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ff99aeb:c7ac5a:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;FOXK1 and FOXK2 regulate aerobic glycolysis&lt;/b&gt;&lt;/p&gt;&lt;p&gt;FOXK1 and FOXK2 regulate aerobic glycolysis, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0900-5&quot;&gt;doi:10.1038/s41586-019-0900-5&lt;/a&gt;&lt;/p&gt;The Forkhead transcription factors FOXK1 and FOXK2, which are induced by starvation, reprogram cellular metabolism to induce aerobic glycolysis.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0900-5</href></item></alternate><published>1548835200000</published><unread>True</unread><visual><height>555</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-019-0900-5/MediaObjects/41586_2019_900_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>c5eff70f</fingerprint><commonTopics><item><probability>1.0</probability><label>brain</label><id>nlp/f/topic/314</id></item><item><probability>1.0</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>0.993</probability><label>bioinformatics</label><id>nlp/f/topic/262</id></item><item><probability>0.987</probability><label>immunology</label><id>nlp/f/topic/1145</id></item><item><probability>0.96</probability><label>stem cells</label><id>nlp/f/topic/2185</id></item><item><probability>0.869</probability><label>neuroscience</label><id>nlp/f/topic/1565</id></item><item><probability>0.82</probability><label>neurology</label><id>nlp/f/topic/1563</id></item><item><probability>0.798</probability><label>genetics</label><id>nlp/f/topic/955</id></item><item><probability>0.766</probability><label>biology</label><id>nlp/f/topic/263</id></item></commonTopics><link>https://www.nature.com/articles/s41586-019-0900-5</link><engagement>0</engagement><title>FOXK1 and FOXK2 regulate aerobic glycolysis</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;FOXK1 and FOXK2 regulate aerobic glycolysis&lt;/b&gt;&lt;/p&gt;&lt;p&gt;FOXK1 and FOXK2 regulate aerobic glycolysis, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0900-5&quot;&gt;doi:10.1038/s41586-019-0900-5&lt;/a&gt;&lt;/p&gt;The Forkhead transcription factors FOXK1 and FOXK2, which are induced by starvation, reprogram cellular metabolism to induce aerobic glycolysis.</description><originId>https://www.nature.com/articles/s41586-019-0900-5</originId><crawled>1548872162027</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Charlotte Harrison</name></author><entities><item><salienceLevel>about</salienceLevel><mentions><item><text>UC</text></item></mentions><label>UC</label><id>nlp/f/entity/en/-/uc</id></item><item><salienceLevel>about</salienceLevel><mentions><item><text>CRISPR</text></item></mentions><label>CRISPR</label><id>nlp/f/entity/en/w/CRISPR</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>CSS</text></item></mentions><label>Cascading Style Sheets</label><id>nlp/f/entity/en/w/Cascading Style Sheets</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>WEBSITEnature_com</text></item></mentions><label>WEBSITEnature_com</label><id>nlp/f/entity/en/-/websitenature_com</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Explorer</text></item></mentions><label>Explorer</label><id>nlp/f/entity/en/-/explorer</id></item></entities><id>0qZSsMpEyvTD/JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I=_1681466db74:68a3830:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;UC&apos;s latest CRISPR patent&lt;/b&gt;&lt;/p&gt;&lt;p&gt;UC&apos;s latest CRISPR patent, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/nbt0119-6&quot;&gt;doi:10.1038/nbt0119-6&lt;/a&gt;&lt;/p&gt;UC&apos;s latest CRISPR patent</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/nbt0119-6</href></item></alternate><published>1546502400000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>e2fc7c99</fingerprint><link>https://www.nature.com/articles/nbt0119-6</link><engagement>0</engagement><title>UC&apos;s latest CRISPR patent</title><origin><htmlUrl>http://feeds.nature.com/nbt/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nbt/current_issue/rss/</streamId><title>Nature Biotechnology</title></origin><description>&lt;p&gt;&lt;b&gt;UC&apos;s latest CRISPR patent&lt;/b&gt;&lt;/p&gt;&lt;p&gt;UC&apos;s latest CRISPR patent, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/nbt0119-6&quot;&gt;doi:10.1038/nbt0119-6&lt;/a&gt;&lt;/p&gt;UC&apos;s latest CRISPR patent</description><originId>https://www.nature.com/articles/nbt0119-6</originId><crawled>1546530511732</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/0qZSsMpEyvTD_JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I_oicon-166b30c5bda</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>Anna Balazs</text></item></mentions><label>Anna Balazs</label><id>nlp/f/entity/en/-/anna balazs</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>University of Pittsburgh</text></item></mentions><label>University of Pittsburgh</label><id>nlp/f/entity/en/w/University of Pittsburgh</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Pennsylvania</text></item></mentions><label>Pennsylvania</label><id>nlp/f/entity/en/w/Pennsylvania</id></item></entities><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1685f0f4846:84b845:c2ce2e2e</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;How a fever helps the immune system to battle infection&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How a fever helps the immune system to battle infection, Published online: 18 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00175-0&quot;&gt;doi:10.1038/d41586-019-00175-0&lt;/a&gt;&lt;/p&gt;One type of immune cell jumps into the fray after b﻿ody temperature rises, according to experiments in mice.</content></content><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00175-0</href></item></alternate><published>1547798400000</published><unread>True</unread><visual><height>576</height><processor>feedly-nikon-v3.1</processor><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00175-0/d41586-019-00175-0_16398152.jpg</url><contentType>image/jpeg</contentType><width>1024</width></visual><fingerprint>c8abd22c</fingerprint><commonTopics><item><probability>0.964</probability><label>robotics</label><id>nlp/f/topic/1955</id></item><item><probability>0.903</probability><label>cell</label><id>nlp/f/topic/403</id></item><item><probability>0.862</probability><label>swimming</label><id>nlp/f/topic/2220</id></item><item><probability>0.843</probability><label>biochemistry</label><id>nlp/f/topic/257</id></item></commonTopics><link>https://www.nature.com/articles/d41586-019-00175-0</link><engagement>21</engagement><title>How a fever helps the immune system to battle infection</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;How a fever helps the immune system to battle infection&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How a fever helps the immune system to battle infection, Published online: 18 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00175-0&quot;&gt;doi:10.1038/d41586-019-00175-0&lt;/a&gt;&lt;/p&gt;One type of immune cell jumps into the fray after b﻿ody temperature rises, according to experiments in mice.</description><originId>https://www.nature.com/articles/d41586-019-00175-0</originId><crawled>1547783063622</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Pakawat Chongsathidkiet</name></author><entities><item><salienceLevel>mention</salienceLevel><mentions><item><text>CSS</text></item></mentions><label>Cascading Style Sheets</label><id>nlp/f/entity/en/w/Cascading Style Sheets</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>Explorer</text></item></mentions><label>Explorer</label><id>nlp/f/entity/en/-/explorer</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>WEBSITEnature_com</text></item></mentions><label>WEBSITEnature_com</label><id>nlp/f/entity/en/-/websitenature_com</id></item><item><salienceLevel>mention</salienceLevel><mentions><item><text>JavaScript</text></item></mentions><label>JavaScript</label><id>nlp/f/entity/en/w/JavaScript</id></item></entities><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_1687660db0c:269a3bc:ad2b6584</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-019-0355-0&quot;&gt;doi:10.1038/s41591-019-0355-0&lt;/a&gt;&lt;/p&gt;Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/a3-AtrSlgyE&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/a3-AtrSlgyE/s41591-019-0355-0</href></item></alternate><published>1548144000000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>7e861e13</fingerprint><link>https://www.nature.com/articles/s41591-019-0355-0</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41591-019-0355-0</href></item></canonical><title>Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors</title><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-019-0355-0&quot;&gt;doi:10.1038/s41591-019-0355-0&lt;/a&gt;&lt;/p&gt;Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/a3-AtrSlgyE&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41591-019-0355-0</originId><crawled>1548174285580</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Jun-Ha Hwang</name></author><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1687f678758:3406954:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;TAZ couples Hippo/Wnt signalling and insulin sensitivity through &lt;i&gt;Irs1&lt;/i&gt; expression&lt;/b&gt;&lt;/p&gt;&lt;p&gt;TAZ couples Hippo/Wnt signalling and insulin sensitivity through &amp;lt;i&gt;Irs1&amp;lt;/i&gt; expression, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08287-x&quot;&gt;doi:10.1038/s41467-019-08287-x&lt;/a&gt;&lt;/p&gt;Insulin resistance is associated with development of type 2 diabetes. Here the authors show that TAZ interacts with c-Jun and Tead4, inducing expression of the insulin receptor substrate 1 (IRS1) leading to increased glucose uptake in muscle, and that its activity is counteracted by statin administration.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/g-Ydx11pf_0&quot; height=&quot;1&quot;&gt;</content></content><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/g-Ydx11pf_0/s41467-019-08287-x</href></item></alternate><published>1548316800000</published><unread>True</unread><visual><height>430</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-019-08287-x/MediaObjects/41467_2019_8287_Fig1_HTML.png</url><contentType>image/png</contentType><width>685</width></visual><fingerprint>9639532b</fingerprint><link>https://www.nature.com/articles/s41467-019-08287-x</link><engagement>0</engagement><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-019-08287-x</href></item></canonical><title>TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression</title><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><description>&lt;p&gt;&lt;b&gt;TAZ couples Hippo/Wnt signalling and insulin sensitivity through &lt;i&gt;Irs1&lt;/i&gt; expression&lt;/b&gt;&lt;/p&gt;&lt;p&gt;TAZ couples Hippo/Wnt signalling and insulin sensitivity through &amp;lt;i&gt;Irs1&amp;lt;/i&gt; expression, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08287-x&quot;&gt;doi:10.1038/s41467-019-08287-x&lt;/a&gt;&lt;/p&gt;Insulin resistance is associated with development of type 2 diabetes. Here the authors show that TAZ interacts with c-Jun and Tead4, inducing expression of the insulin receptor substrate 1 (IRS1) leading to increased glucose uptake in muscle, and that its activity is counteracted by statin administration.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/g-Ydx11pf_0&quot; height=&quot;1&quot;&gt;</description><originId>https://www.nature.com/articles/s41467-019-08287-x</originId><crawled>1548325717848</crawled><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Rai, T. S.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168a5541f68:150809b:3a104d3b</id><published>1548959829000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>3b3cb2e6</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6426/495-e?rss=1</link><engagement>0</engagement><crawled>1548961980264</crawled><title>Self-control and authentic goals</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6426/495-e?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6426/495-e?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6426/495.5.full</canonicalUrl></item><item><author><name>McLaughlin, K.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168a5541f68:15080c5:3a104d3b</id><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6426/446?rss=1</href></item></alternate><published>1548959829000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>9eba4b25</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6426/446?rss=1</link><engagement>0</engagement><title>Saving the steppes</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6426/446?rss=1</originId><crawled>1548961980264</crawled><canonicalUrl>http://science.sciencemag.org/content/363/6426/446.full</canonicalUrl><keywords><item>Asia/Pacific News, Ecology</item></keywords></item><item><author><name>Julie Parenteau</name></author><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16857ddbaa0:3dd05f1:3a104d3b</id><content><direction>ltr</direction><content>&lt;p&gt;&lt;b&gt;Introns are mediators of cell response to starvation&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Introns are mediators of cell response to starvation, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0859-7&quot;&gt;doi:10.1038/s41586-018-0859-7&lt;/a&gt;&lt;/p&gt;Transcriptomic and genetic analyses of a deletion set of all known introns in genes of the budding yeast Saccharomyces cerevisiae indicate that introns promote resistance to starvation.</content></content><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0859-7</href></item></alternate><published>1547625600000</published><unread>True</unread><visual><height>685</height><processor>feedly-nikon-v3.1</processor><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0859-7/MediaObjects/41586_2018_859_Fig1_HTML.png</url><contentType>image/png</contentType><width>530</width></visual><fingerprint>ebbf9ed1</fingerprint><link>https://www.nature.com/articles/s41586-018-0859-7</link><engagement>20</engagement><title>Introns are mediators of cell response to starvation</title><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><description>&lt;p&gt;&lt;b&gt;Introns are mediators of cell response to starvation&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Introns are mediators of cell response to starvation, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0859-7&quot;&gt;doi:10.1038/s41586-018-0859-7&lt;/a&gt;&lt;/p&gt;Transcriptomic and genetic analyses of a deletion set of all known introns in genes of the budding yeast Saccharomyces cerevisiae indicate that introns promote resistance to starvation.</description><originId>https://www.nature.com/articles/s41586-018-0859-7</originId><crawled>1547662375584</crawled><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Peluso, A.</name></author><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16849626246:298d05b:8675cc2c</id><content><direction>ltr</direction><content>A key issue in the omics literature is the search for statistically significant relationships between molecular markers and phenotype. The aim is to detect disease-related discriminatory features while controlling for false positive associations at adequate power. Metabolome-wide association studies have revealed significant relationships of metabolic phenotypes with disease risk by analysing hundreds to tens of thousands of molecular variables leading to multivariate data which are highly noisy and collinear. In this context, conventional Bonferroni or Sidak multiple testing corrections are rather useful as these are valid for independent tests, while permutation procedures allow for the estimation of significance levels from the null distribution without assuming independence among features. Nevertheless, under the permutation approach the distribution of p-values may present systematic deviations from the theoretical null distribution which leads to overly conservative adjusted threshold estimates i.e. smaller than a Bonferroni or Sidak correction. We make use of parametric approximation methods based on a multivariate Normal distribution to derive stable estimates of the metabolome-wide significance level. A univariate approach is applied based on a permutation procedure which effectively controls the overall type I error rate at the level. We illustrate the approach for different model parametrizations and distributional features of the outcome measure, using both simulated and real data. We also investigate different levels of correlation within the features and between the features and the outcome. MWSL is an open-source R software package for the empirical estimation of the metabolome-wide significance level available at https://github.com/AlinaPeluso/MWSL.</content></content><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/478370v2?rss=1</href></item></alternate><published>1547366400000</published><unread>True</unread><fingerprint>15fa76ab</fingerprint><link>http://biorxiv.org/cgi/content/short/478370v2?rss=1</link><engagement>0</engagement><title>Estimation of permutation-based metabolome-wide significance thresholds [NEW RESULTS]</title><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><description>A key issue in the omics literature is the search for statistically significant relationships between molecular markers and phenotype. The aim is to detect disease-related discriminatory features while controlling for false positive associations at adequate power. Metabolome-wide association studies have revealed significant relationships of metabolic phenotypes with disease risk by analysing hundreds to tens of thousands of molecular variables leading to multivariate data which are highly noisy and collinear. In this context, conventional Bonferroni or Sidak multiple testing corrections are rather useful as these are valid for independent tests, while permutation procedures allow for the estimation of significance levels from the null distribution without assuming independence among features. Nevertheless, under the permutation approach the distribution of p-values may present systematic deviations from the theoretical null distribution which leads to overly conservative adjusted threshold estimates i.e. smaller than a Bonferroni or Sidak correction. We make use of parametric approximation methods based on a multivariate Normal distribution to derive stable estimates of the metabolome-wide significance level. A univariate approach is applied based on a permutation procedure which effectively controls the overall type I error rate at the level. We illustrate the approach for different model parametrizations and distributional features of the outcome measure, using both simulated and real data. We also investigate different levels of correlation within the features and between the features and the outcome. MWSL is an open-source R software package for the empirical estimation of the metabolome-wide significance level available at https://github.com/AlinaPeluso/MWSL.</description><originId>http://biorxiv.org/cgi/content/short/478370v2?rss=1</originId><crawled>1547419411014</crawled><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/13/478370</canonicalUrl><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories></item><item><author><name>Vahedifard, F., Ermagun, A., Mortezaei, K., AghaKouchak, A.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:15708bc:8675cc2c</id><published>1547145461000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>c36c9e1c</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6423/134-a?rss=1</link><engagement>0</engagement><crawled>1547147463250</crawled><title>Integrated data could augment resilience</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6423/134-a?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/134-a?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6423/134.1.full</canonicalUrl></item><item><author><name>Yeston, J.</name></author><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce07d:ad2b6584</id><published>1547750305000</published><unread>True</unread><visual><url>none</url></visual><fingerprint>baca38b2</fingerprint><link>http://science.sciencemag.org/cgi/content/short/363/6424/242-f?rss=1</link><engagement>0</engagement><crawled>1547752389672</crawled><title>Targeting CH2 sites</title><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><originId>http://science.sciencemag.org/cgi/content/short/363/6424/242-f?rss=1</originId><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/242-f?rss=1</href></item></alternate><canonicalUrl>http://science.sciencemag.org/content/363/6424/242.6.full</canonicalUrl></item></channel></rss>